Documentos de Académico
Documentos de Profesional
Documentos de Cultura
TABLAS DISMOD
GRUPO I II - III
Encargado por:
Ministerio de Salud de Chile. Subsecretara de Salud Pblica
Ejecutado por:
Departamento de Salud Pblica, Escuela de Medicina, P. Universidad Catlica de
Chile
Abril 2008
ii
INDICE
GRUPO I
A.
B.
C.
D.
E.
Infecciosas y Parasitarias
Tuberculosis
Sifilis Primaria
Sifilis Secundaria
Sifilis Terciaria
Clamidias
Gonorrea
VIH /SIDA
SIDA
Diarreas
Fiebre Tifoidea
Parotiditis
Rubeola
Coqueluche
Meningitis No Meningococica
Enfermedad Meningococica
Hepatitis A
Hepatitis B - Aguda
Hepatitis B Cirrosis
Hepatitis C -Aguda
Hepatitis Crnica Sintomtica
Hepatitis C - Cirrosis
Chagas
Ascaridasis
Hidatidosis
Teniasis Cistercosis
Triquinosis
Angina Estreptoccica
Escarlatina
Sepsis por EBHA
Enfermedad Invasora por EBHA
Varicela Zoster
GRIA - 01
GRIA 03
GRIA 05
GRIA 07
GRIA - 09
GRIA - 11
GRIA 13
GRIA - 15
GRIA - 17
GRIA 19
GRIA - 21
GRIA - 23
GRIA - 25
GRIA - 29
GRIA - 27
GRIA - 31
GRIA 33
GRIA - 35
GRIA 37
GRIA - 39
GRIA 41
GRIA - 43
GRIA - 45
GRIA - 47
GRIA - 49
GRIA - 51
GRIA - 53
GRIA 55
GRIA - 57
GRIA 59
GRIA - 61
Infecciosas Respiratorias
IRA Bajas
IRA Altas
Otitis Media
GRIB - 01
GRIB - 03
GRIB 05
Condiciones Maternas
Aborto
Trastornos Hipertensivos del Embarazo
GRIC 01
GRIC - 02
Condiciones Perinatales
Bajo peso de nacimiento
Traumatismo del Parto
Hipoxia intrauterina asfixia al nacer
Sepsis Neonatal
GRID - 01
GRID - 04
GRID - 07
GRID - 10
Deficiencias Nutricionales
Desnutricin
Anemia
GRIE - 01
GRIE - 03
iii
GRUPO II
A.
Neoplasias Malignas
Cncer de Esfago
Leucemia
Cncer de Boca y Orofaringe
Cncer Gstrico
Cncer de Colon
Cncer de Recto
Cncer Heptico
Cncer de Pncreas
Cncer Traquea, Bronquio y Pulmn
Melanoma
Otros Canceres de piel
Cncer de mama
Cncer Cervicouterino
Cncer del Cuerpo Uterino
Cncer de Ovario
Cncer de Prstata
Cncer de Vejiga
Linfomas
Mieloma Mltiple
Cncer de Vescula y Va Biliar
Cncer de Testculo
Cncer de Encfalo
Tumores seos
Tumores de partes blandas
B.
GRIIA - 01
GRIIA - 03
GRIIA - 05
GRIIA - 07
GRIIA - 09
GRIIA - 11
GRIIA - 13
GRIIA - 15
GRIIA - 17
GRIIA - 19
GRIIA - 21
GRIIA - 23
GRIIA - 25
GRIIA - 27
GRIIA - 29
GRIIA - 31
GRIIA - 33
GRIIA - 35
GRIIA - 37
GRIIA - 39
GRIIA - 41
GRIIA - 43
GRIIA - 45
GRIIA - 47
Otras Neoplasias
Tumores y Quistes del S.N.C
GRIIB - 01
C.
Diabetes Mellitus
Diabetes Mellitus I
Diabetes Tipo II
Pie Diabtico
Amputacin
Neuropata
Retinopata
GRIIC - 01
GRIIC 03
GRIIC 05
GRIIC 07
GRIIC 09
GRIIC - 11
D.
Trastornos Endocrinos
Hipotiroidismo Congnito
Hipotiroidismo
Obesidad
Obesidad Morbida
Hemofilia
Fibrosis Quistica
Enfermedad de Gaucher
Fenilcetonuria
GRIID - 01
GRIID - 03
GRIID 05
GRIID - 07
GRIID - 09
GRIID - 10
GRIID - 12
GRIID - 16
iv
E.
Condiciones Neuropsiquiatricas
Trastornos Depresivos Unipolares
Trastorno Bipolar
Esquizofrenia
Trastornos Ansiosos
Trastorno por estrs postraumatico
Trastornos por Consumo de Drogas
Trastornos por Consumo de alcohol
Epilepsia
Demencias
Parkinson
Migraa
Parlisis Cerebral
Sndrome Dficit Atencional e Hiperactividad
Esclerosis Mltiple
GRIIE - 01
GRIIE - 03
GRIIE - 05
GRIIE - 07
GRIIE - 09
GRIIE - 11
GRIIE - 13
GRIIE - 15
GRIIE - 17
GRIIE - 19
GRIIE - 21
GRIIE - 23
GRIIE - 25
GRIIE - 27
F.
GRIIF - 01
GRIIF - 03
GRIIF - 05
GRIIF - 09
GRIIF - 11
GRIIF - 13
Enfermedades Cardiovasculares
Enfermedad Reumtica
Enfermedad Hipertensiva
Hipertensin Arterial
Angina estable
Enfermedad Isqumica de Corazn
Hemorragia Intraencefalica
Enfermedad Cerebrovascular Isqumica
Hemorragia Subaracnidea
Transtornos Valvulares
Trastornos de la Conduccin
Aneurismas de la aorta
Venas varicosas miembros inferiores
Enfermedades Cardacas Inflamatorias
GRIIG - 01
GRIIG 03
GRIIG -05
GRIIG - 07
GRIIG 09
GRIIG - 11
GRIIG - 13
GRIIG - 15
GRIIG 17
GRIIG - 19
GRIIG - 21
GRIIG - 23
GRIIG - 25
H.
Enfermedades Respiratorias
Asma
EPOC
Silicosis
GRIIH - 01
GRIIH - 03
GRIIH - 05
I.
Enfermedades Digestivas
Ulcera pptica
Cirrosis Heptica
Apendicitis Aguda
Hernias de la Cavidad Abdominal
Colelitiasis
Colecistitis
GRII I - 01
GRII I - 03
GRII I - 05
GRII I - 07
GRII I 09
GRII I - 11
G.
J.
Enfermedades genitourinarias
Nefritis/Nefrosis
Hipertrofia de Prstata
Litiasis Renal U
Infreccion Tracto Urinario
Insuficiencia Renal Terminal
Insuficiencia Renal no Terminal
Infertilidad
GRIIJ - 01
GRIIJ - 03
GRIIJ - 04
GRIIJ 06
GRIIJ 08
GRIIJ - 10
GRIIJ - 12
K.
Enfermedades de la Piel
Psoriasis
GRIIK - 01
GRIIL - 01
GRIIL - 02
GRIIL - 03
GRIIL - 04
GRIIL - 06
GRIIL - 08
GRIIL - 09
Anomalias Congenitas
Labio Leporino y Fisura Palatina
Sindrome de Down
Trisomia 18
Hernia diafragmtica
Deformidades Congnitas de la Cadera
Pie Bot
Hidrocefalia Congnita
Mielomeningocele Alto
Mielomeningocele Bajo
Menigocele
Cardiopata Congnita Operable con secuelas
Cardiopata Congnita Operable curado
GRIIM - 01
GRIIM - 03
GRIIM - 05
GRIIM - 07
GRIIM - 09
GRIIM 11
GRIIM 13
GRIIM 15
GRIIM 17
GRIIM - 19
GRIIM 21
GRIM - 23
Condiciones Orales
Caries Dental
Edentulismo
Enfermedades Periodontales
GRIIN - 01
GRIIN - 03
GRIIN - 05
L.
M.
N.
GRUPO III
A.
Lesiones Intencionales
Lesiones autoinfligidas
Violencia intrafamiliar
Agresiones
GRIIIB - 01
GRIIIB - 05
GRIIIB - 09
B.
Lesiones No Intencionales
Accidentes del Trnsito
Envenenamientos
Cadas
Ahogamientos
Por Fuego
GRIIIA - 01
GRIIIA - 05
GRIIIA - 07
GRIIIA - 14
GRIIIA - 18
TABLAS DISMOD
GRUPO I
vi
GRIA 1
TBC
Males, Disease: TBC (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,002
0,002
0,051
0,248
0,4533
0,6267
0,68
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
800
0
0,0024
800
0,0008
0,0024
800
0
0,0169
800
0,0132
0,2214
800
0,0654
0,4228
800
0,0225
0,6132
800
0,8896
0,7795
NA
Prevalence
(rates * 1000)
0,0008
0,0024
0,0136
0,2458
0,4465
0,7072
0,3364
Remission
(rates * 1000)
800
800
800
800
800
800
800
Case fatality
(rates * 1000)
214,9634
157,081
45,8204
50,8242
113,7252
51,8405
1577,0149
Age of onset
(years)
0,5
5,3989
17,7952
34,2055
53,0608
67,7126
93,9452
0,0381
0,2212
0,2305
800
122,5367
1,0717
0,0282
28,6935
52,7547
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,002
0,002
0,051
0,248
0,4533
0,6267
0,68
Remission
(rates * 1000)
800
800
800
800
800
800
800
Mortality
(numbers)
0
1
0
41
82
14
166
Incidence
(numbers)
0
3
25
688
530
370
145
Prevalence
(numbers)
0
3
20
764
560
427
63
Remission
(numbers)
0
2
16
611
448
341
50
Case fatality
(numbers)
0
0
1
39
64
22
99
Duration
(years)
0,982
1,0609
1,17
1,1716
1,0862
1,1243
0,3966
Mortality
(numbers)
0
0
1
39
64
22
99
RR mortality
(number)
26,7114
492,7103
68,7069
29,8332
20,3496
5,5838
36,3273
Age of onset
(years)
0,5
5,3989
17,7952
34,2055
53,0608
67,7126
93,9452
NA
NA
304
1762
1836
1469
225
1,0717
225
28,6935
52,7547
GRIA 2
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,002
0,002
0,051
0,164
0,2
0,28
0,3
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
800
0
0,002
800
0
0,0033
800
0,0021
0,0418
800
0,0036
0,1481
800
0,0291
0,1998
800
0,0965
0,2764
800
0,3439
0,3408
NA
0,0277
Prevalence
(rates * 1000)
0,0007
0,0031
0,0418
0,1732
0,216
0,2265
0,1372
Remission
(rates * 1000)
800
800
800
800
800
800
800
Case fatality
(rates * 1000)
0
1,9695
32,4668
21,0598
123,694
420,3777
1719,6978
Age of onset
(years)
0,5
6,8781
16,1753
33,7616
52,7486
67,7257
96,7744
0,1332
0,1333
800
173,0469
1,0216
0,023
49,325
51,8114
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,002
0,002
0,051
0,164
0,2
0,28
0,3
Remission
(rates * 1000)
800
800
800
800
800
800
800
Mortality
(numbers)
0
0
3
11
38
69
104
Incidence
(numbers)
0
4
60
457
261
198
103
Prevalence
(numbers)
0
4
60
534
282
162
41
Remission
(numbers)
0
3
48
428
225
130
33
Case fatality
(numbers)
0
0
2
11
35
68
71
Duration
(years)
1,2427
1,2411
1,1998
1,2152
1,0584
0,7987
0,3854
Mortality
(numbers)
0
0
2
11
35
68
71
RR mortality
(number)
0
72,1063
110,9934
31,4653
36,5927
39,9849
65,6393
Age of onset
(years)
0,5
6,8781
16,1753
33,7616
52,7486
67,7257
96,7744
NA
NA
225
1083
1083
867
187
1,0216
187
49,325
51,8114
GRIA 3
SIFILIS PRIMARIA
Males, Disease: Sfilis primaria (Rates * 100,000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
70,0863
293,5518
178,6334
66,3076
42,872
NA
Prevalence
(rates *
100000)
0
0
3,0272
13,1171
8,3534
3,2578
2,018
Remission
(rates *
100000)
0
0
2200000
2200000
2200000
2200000
2200000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
161,6849
7,2884
2200000
0,0454
35,714
Remission
Incidence
(rates * Mortality (rates * (rates *
100000)
100000)
100000)
2200000
0
0
2200000
0
0
2200000
0
70,0863
2200000
0
293,5518
2200000
0
178,6334
2200000
0
66,3076
2200000
0
42,872
NA
NA
Age of onset
(years)
0
0
14,9475
32,3837
51,6579
66,4413
83,9535
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
0,0007
0,0029
0,0018
0,0007
0,0004
Remission
(rates *
100000)
22
22
22
22
22
22
22
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
1040
9119
2240
400
80
Prevalence
(numbers)
0
0
45
408
105
20
4
Remission
(numbers)
0
0
988
8965
2304
432
83
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0,0455
0,0455
0,0454
0,0454
0,0452
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
1
Age of onset
(years)
0
0
14,9475
32,3837
51,6579
66,4413
83,9535
NA
NA
NA
12879
581
12773
0,0454
35,714
GRIA 4
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(rates *
100000)
0
0
6,3826
10,174
4,3133
1,6364
0,085
Remission
(rates *
100000)
0
0
2200000
2200000
2200000
2200000
2200000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
128,9486
5,8296
2200000
0,0455
31,852
Incidence
(numbers)
0
0
2120
6959
1160
240
0
Prevalence
(numbers)
0
0
92
314
56
12
0
Remission
(numbers)
0
0
2015
6907
1238
258
6
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0,0455
0,0455
0,0454
0,0454
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
1
0
0
Age of onset
(years)
0
0
14,9513
32,4838
51,7435
66,7137
0
10479
474
10423
0,0455
31,852
Remission
Incidence
(rates * Mortality (rates * (rates *
100000)
100000)
100000)
2200000
0
0
2200000
0
0
2200000
0
147,7618
2200000
0
225,5298
2200000
0
88,9061
2200000
0
33,5538
2200000
0
0
Incidence
(rates *
100000)
0
0
147,7618
225,5298
88,9061
33,5538
0
NA
NA
NA
Age of onset
(years)
0
0
14,9513
32,4838
51,7435
66,7137
0
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Remission
(rates *
100000)
2200000
Incidence
(rates *
100000)
0
0
147,7618
225,5298
88,9061
33,5538
0
2200000
2200000
2200000
2200000
2200000
2200000
Mortality
(numbers)
0
0
0
0
0
0
0
NA
NA
NA
GRIA 5
SIFILIS SECUNDARIA
Males, Disease: Sifilis secundaria (Rates * 100,000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
75+
All ages
Incidence
(rates *
100000)
0
0
13,316
55,775
55,775
33,94
12,598
8,146
NA
Remission
Incidence
(rates * Mortality (rates * (rates *
100000)
100000)
100000)
1500000
0
0
1500000
0
0
1500000
0
13,316
1500000
0
55,775
1500000
0
55,775
1500000
0
33,94
1500000
0
12,598
1500000
0
8,146
NA
NA
NA
Prevalence
(rates *
100000)
0
0
0,844
3,563
3,718
2,328
0,908
0,562
Remission
(rates *
100000)
0
0
1500000
1500000
1500000
1500000
1500000
1500000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
0
Age of onset
(years)
0
0
14,947
24,856
37,465
51,658
66,441
83,954
NA
30,72
2,031
1500000
0,067
35,71
Mortality
(numbers)
0
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
198
698
1034
426
76
15
Prevalence
(numbers)
0
0
13
45
69
29
5
1
Remission
(numbers)
0
0
188
669
1034
438
82
16
Case fatality
(numbers)
0
0
0
0
0
0
0
0
Duration
(years)
0
0
0,067
0,067
0,067
0,067
0,067
0,066
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
1
Age of onset
(years)
0
0
14,947
24,856
37,465
51,658
66,441
83,954
NA
2447
162
2427
0,067
35,71
GRIA 6
Age
0
1-9
10-19
20-44
45-59
60-74
75+
75+
All ages
Incidence
(rates *
100000)
0
0
28,075
42,851
42,851
16,892
6,375
0
NA
Remission
Incidence
(rates * Mortality (rates * (rates *
100000)
100000)
100000)
1500000
0
0
1500000
0
0
1500000
0
28,075
1500000
0
42,851
1500000
0
42,851
1500000
0
16,892
1500000
0
6,375
1500000
0
0
NA
NA
NA
Prevalence
(rates *
100000)
0
0
1,779
2,803
2,857
1,202
0,456
0,024
Remission
(rates *
100000)
0
0
1500000
1500000
1500000
1500000
1500000
1500000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
0
Age of onset
(years)
0
0
14,951
24,874
37,496
51,743
66,714
0
NA
24,5
1,625
1500000
0,067
31,85
Mortality
(numbers)
0
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
403
525
797
220
46
0
Prevalence
(numbers)
0
0
26
34
53
16
3
0
Remission
(numbers)
0
0
383
515
797
235
49
1
Case fatality
(numbers)
0
0
0
0
0
0
0
0
Duration
(years)
0
0
0,067
0,067
0,067
0,067
0,067
0
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
1
0
0
1
0
Age of onset
(years)
0
0
14,951
24,874
37,496
51,743
66,714
0
NA
1991
132
1981
0,067
31,85
GRIA 7
SIFILIS TERCIARIA
Males, Disease: Sifilis terciaria (Rates * 100,000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
6,13
25,66
15,61
5,8
3,75
Remission
(rates *
100000)
20000
20000
20000
20000
20000
20000
20000
Case fatality
(rates *
100000)
0
0
0
13315,58
0
13315,58
0
Incidence
(rates *
100000)
0
0
6,13
25,66
15,61
5,8
3,75
Prevalence
(rates *
100000)
0
0
17,24
70,55
77,62
32,88
18,36
Remission
(rates *
100000)
0
0
20000
20000
20000
20000
20000
Case fatality
(rates *
100000)
0
0
0
13315,58
0
13315,58
0
NA
NA
NA
14,13
45,86
20000
8710,89
3,46
78,32
35,71
Age of onset
(years)
0
0
14,95
32,38
51,66
66,44
83,95
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
0,006
0,026
0,016
0,006
0,004
Remission
(rates *
100000)
20
20
20
20
20
20
20
Case fatality
(rates *
100000)
0
0
0
13,316
0
13,316
0
Incidence
(numbers)
0
0
91
797
196
35
7
Prevalence
(numbers)
0
0
256
2192
973
198
34
Remission
(numbers)
0
0
51
438
195
40
7
Case fatality
(numbers)
0
0
0
292
0
26
0
Duration
(years)
0
0
4,136
3,198
4,326
2,904
3,039
Mortality
(numbers)
0
0
0
292
0
26
0
RR mortality
(number)
1
1
0
84,55
0
9,111
1
Age of onset
(years)
0
0
14,947
32,383
51,658
66,442
83,953
NA
NA
NA
1125
3653
731
318
3,46
318
78,319
35,713
GRIA 8
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
12,91
19,71
7,77
2,93
0
Remission
(rates *
100000)
30000
30000
30000
30000
30000
30000
30000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(rates *
100000)
0
0
12,91
19,71
7,77
2,93
0
Prevalence
(rates *
100000)
0
0
29,19
62,24
36,32
14,15
2,8
Remission
(rates *
100000)
0
0
30000
30000
30000
30000
30000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
NA
NA
NA
11,27
35,97
30000
3,31
31,85
Age of onset
(years)
0
0
14,95
32,48
51,74
66,71
0
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
12,91
19,71
7,77
2,93
0
Remission
(rates *
100000)
30
30
30
30
30
30
30
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
185
608
101
21
0
Prevalence
(numbers)
0
0
419
1921
474
101
8
Remission
(numbers)
0
0
126
576
142
30
3
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
3,33
3,32
3,28
3,13
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
0
0
1
1
Age of onset
(years)
0
0
14,95
32,48
51,74
66,71
0
NA
NA
NA
915
2923
877
3,32
31,85
GRIA 9
CLAMIDIAS
Males, Disease: clamidiaincagudo (Rates * 100,000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
170
200
10
10
10
Remission
(rates *
100000)
0
0
3000000
3000000
3000000
3000000
3000000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(rates *
100000)
0
0
169,9908
199,9867
9,9999
10
10
Prevalence
(rates *
100000)
0
0
5,3846
6,6441
0,6175
0,3333
0,3333
Remission
(rates *
100000)
0
0
3000000
3000000
3000000
3000000
3000000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
NA
NA
NA
112,2253
3,7245
3000000
0,0333
28,0756
Age of onset
(years)
0
0
14,9475
32,3837
51,6579
66,4413
82,0209
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
170
200
10
10
10
Remission
(rates *
100000)
0
0
3000000
3000000
3000000
3000000
3000000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
2522
6213
125
60
19
Prevalence
(numbers)
0
0
80
206
8
2
1
Remission
(numbers)
0
0
2397
6193
232
60
19
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0,0333
0,0333
0,0333
0,0333
0,0332
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
0
0
0
0
Age of onset
(years)
0
0
14,9475
32,3837
51,6579
66,4413
82,0209
NA
NA
NA
8940
297
8901
0,0333
28,0756
GRIA 10
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
660
190
40
40
40
Remission
(rates *
100000)
0
0
3000000
3000000
3000000
3000000
3000000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(rates *
100000)
0
0
659,862
189,9873
39,9994
39,9995
39,9995
Prevalence
(rates *
100000)
0
0
20,9033
6,6711
1,5525
1,3333
1,3333
Remission
(rates *
100000)
0
0
3000000
3000000
3000000
3000000
3000000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
NA
NA
NA
200,0595
6,6395
3000000
0,0333
23,9316
Age of onset
(years)
0
0
14,9513
32,4839
51,7435
66,7137
83,7035
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
660
190
40
40
40
Remission
(rates *
100000)
0
0
3000000
3000000
3000000
3000000
3000000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
9467
5863
522
286
121
Prevalence
(numbers)
0
0
300
206
20
10
4
Remission
(numbers)
0
0
8997
6176
608
286
121
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0,0333
0,0333
0,0333
0,0333
0,0333
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0
0
14,9513
32,4839
51,7435
66,7137
83,7035
NA
NA
NA
16259
540
16188
0,0333
23,9316
GRIA 11
GONORREA
Males, Disease: Gonorrea (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates * Incidence
Prevalence
Remission
Case fatality Duration Mortality (rates * RR mortality
(rates * 1000) (rates * 1000)
1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (years)
1000)
(number)
0
50000
0
0
0
0
0
0
0
0
0
50000
0
0
0
0
0
0
0
0
0,15
50000
0
0,15
0,0028
50000
0
0,02
0
0
0,39
50000
0
0,39
0,0077
50000
0
0,02
0
0
0,12
50000
0
0,12
0,0026
50000
0
0,02
0
0
0,08
50000
0
0,08
0,0016
50000
0
0,02
0
0
0,02
50000
0
0,02
0,0004
50000
0
0,02
0
0
NA
NA
Age of onset
(years)
0
0
15
32,5
52,5
67,5
93,5984
0,2055
0,0041
50000
0,02
33,1772
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
223
1212
150
48
4
Prevalence
(numbers)
0
0
4
24
3
1
0
Remission
(numbers)
0
0
211
1197
162
49
4
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0,02
0,02
0,02
0,02
0,02
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0
0
15
32,5
52,5
67,5
93,5984
1637
32
1623
0,02
33,1772
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
50000
0
50000
0,15
50000
0,39
50000
0,12
50000
0,08
50000
0,02
50000
NA
NA
GRIA 12
NA
NA
NA
NA
Age of onset
(years)
0
5,5
15
32,5
52,5
0
0
0,0608
0,0012
50000
0,02
29,8719
Incidence
(numbers)
0
12
86
370
26
0
0
Prevalence
(numbers)
0
0
2
7
1
0
0
Remission
(numbers)
0
11
82
367
30
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0,02
0,02
0,02
0,02
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
1
1
0
Age of onset
(years)
0
5,5
15
32,5
52,5
0
0
494
10
491
0,02
29,8719
VIH/SIDA
CASOS VIH
DisMod II input and output, database OA
Males, Disease: VIH (Rates * 100,000), sex: Males
Remission
Mortality
Incidence (rates (rates *
(rates *
Age
* 100000)
100000)
100000)
0
0,797
0
0
1-9
0,0832
0
0
10-19
1,6848
0
0
20-44
14,5
7400
0
45-59
5,5
5666,6667
0
60-74
1,5
5000
0
75+
0
5000
0
All ages
NA
NA
NA
NA
GRIA 13
Prevalence
Incidence (rates (rates *
* 100000)
100000)
0,797
0,3985
0,0832
1,1809
1,6846
9,8807
14,4837
112,2317
5,4925
136,4023
1,4985
100,2539
0
62,2434
6,9657
Incidence
(numbers)
1
1
25
450
69
9
0
555
76,3172
Prevalence
(numbers)
0
14
147
3487
1710
605
116
6080
Remission
Mortality
Case fatality
(rates *
(rates *
(rates * 100000) Duration (years) 100000)
100000)
0
0
33,7845
0
0
0
28,8798
0
0
0
19,6061
0
7880,4724
0
13,0069
0
5884,2488
0
13,4601
0
5000
0
9,6046
0
5000
0
0
0
6768,1083
Remission
(numbers)
0
0
0
275
101
30
6
411
Case fatality
(numbers)
0
0
0
0
0
0
0
0
13,3712
Mortality
Duration (years) (numbers)
33,7845
0
28,8798
0
19,6061
0
13,0069
0
13,4601
0
9,6046
0
0
0
13,3712
RR mortality
(number)
0
0
0
1
1
0
0
0
RR mortality
(number)
0
0
0
1
1
0
0
0
Age of onset
(years)
0,5
5,6143
14,9472
32,3788
51,6587
66,4425
0
34,4341
Age of onset
(years)
0,5
5,6143
14,9472
32,3788
51,6587
66,4425
0
34,4341
GRIA 14
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(rates *
1000)
0,0035
0,0107
0,0489
0,2567
0,2693
0,171
0,0968
Remission
(rates *
1000)
0
0
0
77,8058
59,0712
50
50
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
0,0142
0,1696
65,2883
14,4074
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
1
1
10
93
10
1
0
Prevalence
(numbers)
0
12
70
792
351
122
29
Remission
(numbers)
0
0
0
62
21
6
1
Case fatality
(numbers)
0
0
0
0
0
0
0
116
1378
90
NA
Mortality
Duration (years) (rates * 1000)
34,1634
0
29,2155
0
19,9211
0
13,4863
0
14,5882
0
10,9146
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,6157
14,9512
32,483
51,7437
66,714
0
32,4596
Duration (years)
34,1634
29,2155
19,9211
13,4863
14,5882
10,9146
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,6157
14,9512
32,483
51,7437
66,714
0
14,4074
32,4596
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
NA
GRIA 15
SIDA
DisMod II input and output, database OA
Males, Disease: sida (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
Incidence (rates Remission
Mortality
Incidence (rates (rates *
* 1000)
(rates * 1000) (rates * 1000) * 1000)
1000)
0
0
0
0
0
0
0
0
0
0
0,004
0
0,0014
0,004
0,0166
0,11
0
0,0776
0,1099
0,6697
0,071
0
0,0797
0,0709
1,0145
0,031
0
0,0348
0,031
0,7489
0,003
0
0,0025
0,003
0,0079
NA
NA
0,0458
0,0572
0,4809
Remission
(rates *
1000)
0
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
61,3466
101,2046
76,2093
113,4652
1110,504
94,4805
Mortality
RR mortality
Duration (years) (rates * 1000) (number)
0
0
0
0
0
13,2217
11,433
0,001
118,1698
10,1766
0,0678
66,4211
9,8537
0,0773
16,7885
4,2019
0,0838
11,201
0,9437
0,0081
20,3653
9,8735
Age of onset
(years)
0
0
14,9474
32,38
51,6582
66,4434
82,0209
0,0453
45,3932
37,3766
Mortality
Duration (years) (numbers)
0
0
0
0
11,433
2
10,1766
211
9,8537
97
4,2019
51
0,9437
2
RR mortality
(number)
0
13,2217
118,1698
66,4211
16,7885
11,201
20,3653
Age of onset
(years)
0
0
14,9474
32,38
51,6582
66,4434
82,0209
45,3932
37,3766
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
NA
364
Incidence
(numbers)
0
0
6
342
89
19
1
456
Prevalence
(numbers)
0
0
25
2081
1272
452
1
3831
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
2
211
97
51
2
362
9,8735
361
GRIA 16
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
Incidence (rates Remission
Mortality
Incidence (rates (rates *
* 1000)
(rates * 1000) (rates * 1000) * 1000)
1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,014
0
0,0091
0,014
0,0916
0,013
0
0,0099
0,013
0,1733
0,005
0
0,0028
0,005
0,21
0,001
0
0
0,001
0,226
NA
NA
0,0053
0,0079
0,0895
Remission
(rates *
1000)
0
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
86,1066
55,2857
17,0564
3,1925
54,4836
Mortality
RR mortality
Duration (years) (rates * 1000) (number)
0
0
0
0
0
0
0
0
104,3824
14,2841
0,0079
158,7688
18,9681
0,0096
23,406
16,4108
0,0036
3,1817
9,8362
0,0007
1,2258
15,6223
0,0049
105,166
Mortality
Duration (years) (numbers)
0
0
0
0
0
0
14,2841
24
18,9681
13
16,4108
3
9,8362
0
RR mortality
(number)
0
0
104,3824
158,7688
23,406
3,1817
1,2258
Age of onset
(years)
0
0
0
32,4833
51,7434
66,7136
83,7035
39,762
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
NA
43
Incidence
(numbers)
0
0
0
43
17
4
0
64
Prevalence
(numbers)
0
0
0
283
226
150
68
727
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
24
12
3
0
40
15,6223
40
105,166
Age of onset
(years)
0
0
0
32,4833
51,7434
66,7136
83,7035
39,762
GRIA 17
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
NA
0,0114
NA
NA
91
Prevalence
(rates * 1000)
0,3747
0,5334
0,3332
0,3332
0,3332
0,333
0,3316
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
Case fatality
(rates * 1000)
7,8657
6,6336
3,0808
1,9093
10,3168
101,4597
650,9375
Age of onset
(years)
0,5
4,7117
14,9475
32,3837
51,6579
66,4413
82,0209
43,9961
0,3641
120000
25,2033
0,0083
0,0092
7,8905
28,8071
Incidence
(numbers)
11288
73899
59336
124230
50142
24122
7462
Prevalence
(numbers)
47
643
494
1035
418
201
62
Remission
(numbers)
5641
77205
59334
124228
50138
24102
7425
Case fatality
(numbers)
0
4
2
2
4
20
40
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
Mortality
(numbers)
1
4
2
2
4
20
40
RR mortality
(number)
1,85
25,4756
11,7263
2,2439
3,3297
5,6259
7,9793
Age of onset
(years)
0,5
4,7117
14,9475
32,3837
51,6579
66,4413
82,0209
350478
2901
348074
73
0,0083
73
7,8905
28,8071
GRIA 18
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
NA
0,0016
Prevalence
(rates * 1000)
0,3747
0,5333
0,3332
0,3332
0,3332
0,3332
0,333
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
Case fatality
(rates * 1000)
0,28
0,3148
0,3267
0,309
1,1625
6,0443
73,8578
43,7741
0,3625
120000
3,4163
0,0083
0,0012
1,9397
30,6561
Incidence
(numbers)
10872
71257
57371
123402
52172
28601
12089
Prevalence
(numbers)
45
620
478
1028
435
238
101
Remission
(numbers)
5434
74450
57370
123401
52172
28600
12082
Case fatality
(numbers)
0
0
0
0
1
1
7
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
Mortality
(numbers)
0
0
0
0
1
1
7
RR mortality
(number)
1,0388
2,7172
2,5811
1,5548
1,3894
1,4759
2,0534
Age of onset
(years)
0,5
4,7131
14,9514
32,4838
51,7435
66,7137
83,7035
1,9397
30,6561
All ages
NA
NA
13
355764
2946
353509
10
0,0083
10
supuestos:
duracin 2 das
90% entre 1 y 2 das y 10% restante 6 das en promedio
incidencia A partir de egresos hospitalarios se estimo el nmero de caso incidentes: 0,5% de los casos de hospitalizan, segn bibliografa
29500
egresos
5.900.000 casos incidentes
37
El 10% consulta:
590.000
Lo que equivale a una tasa de 4%
En menores de 5 aos segn centros centinlea de diarrea es de 8,9%
mortalidad:
Se supone que en los nios es el doble que en los adultos
para los menores de 5 aos, a partir de los centro centinela de diarrea se estiman 1,7 episodios por hab. Al ao
para resto de las edad se mantiene la estructura etrea de los egresos hospitalarios
tasas DEIS
Age of onset
(years)
0,5
4,7131
14,9514
32,4838
51,7435
66,7137
83,7035
GRIA 19
FIEBRE TIFOIDEA
Males, Disease: Fiebre tifica 3 (Rates * 100,000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
4,58
5,9
4,13
2,68
2,98
1,29
NA
Case
Age of
RR
Mortality
Incidence Prevalence Remission fatality
Remission Mortality
onset
Duration
mortality
(rates *
(rates *
(rates *
(rates *
(rates *
(rates *
(rates *
(years)
(years)
(number)
100000)
100000)
100000)
100000)
100000)
100000)
100000)
1200000
0
0
0
0
0
0
0
0
0
1200000
0
4,58
0,3617
1200000
0
0,0833
0
0
5,6143
1200000
0
5,9
0,4862
1200000
0
0,0833
0
0
14,9475
1200000
0
4,13
0,3474
1200000
0
0,0833
0
0
32,3837
1200000
0
2,68
0,2288
1200000
0
0,0833
0
1
51,6579
1200000
250
2,98
0,2471
1200000
250
0,0832
0,0006
1,129
66,4413
1200000
750
1,29
0,1166
1200000
750
0,0825
0,0008
1,0899
83,9535
NA
NA
4,0809
0,3383
1200000
19,8837
0,0833
0,0001
1,1177
27,4085
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
0,0001
0
0
0
0
NA
RR
Case
Remission
Age of
Duration
Mortality
Mortality
Incidence Prevalence Remission fatality
mortality
(rates *
onset
(numbers) (number)
(numbers) (numbers) (numbers) (numbers) (numbers) (years)
100000)
(years)
12
0
0
0
0
0
0
0
0
0
12
0
55
4
52
0
0,0833
0
0
5,6143
12
0
88
7
87
0
0,0833
0
0
14,9475
12
0
128
11
130
0
0,0833
0
0
32,3837
12
0
34
3
34
0
0,0833
0
1
51,6579
12
0,0025
18
1
18
0
0,0832
0
1,129
66,4413
12
0,0075
2
0
3
0
0,0825
0
1,0899
83,9535
NA
NA
325
27
323
0,0833
1,1177
27,4085
GRIA 20
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Case
Age of
RR
Mortality
Incidence Prevalence Remission fatality
Incidence Remission Mortality
Duration
onset
mortality
(rates *
(rates *
(rates *
(rates *
(rates *
(rates *
(rates *
(rates *
(years)
(years)
(number)
100000)
100000)
100000)
100000)
100000)
100000)
100000)
100000)
1,99
1200000
0
1,99
0,0829
1200000
0
0,0833
0
0
0,5
4,54
1200000
0
4,54
0,3672
1200000
0
0,0833
0
0
5,6157
6,02
1200000
0
6,02
0,4955
1200000
0
0,0833
0
1
14,9514
3,62
1200000
0
3,62
0,306
1200000
0
0,0833
0
0
32,4838
3,04
1200000
0
3,04
0,2555
1200000
0
0,0833
0
0
51,7435
2,85
1200000
250
2,85
0,2382
1200000
250
0,0832
0,0006
1,2221
66,7137
1,59
1200000
750
1,59
0,1383
1200000
750
0,0827
0,001
1,1364
84,9406
All ages
NA
NA
NA
3,9147
0,3246
1200000
28,0288
0,0833
0,0001
1,1865
28,4433
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
0,0001
0
0
0
0
NA
RR
Case
Remission
Age of
Duration
Mortality
Mortality
Incidence Prevalence Remission fatality
mortality
(rates *
onset
(numbers) (number)
(numbers) (numbers) (numbers) (numbers) (numbers) (years)
100000)
(years)
12
0
2
0
1
0
0,0833
0
0
0,5
12
0
53
4
51
0
0,0833
0
0
5,6157
12
0
86
7
85
0
0,0833
0
1
14,9514
12
0
112
9
113
0
0,0833
0
0
32,4838
12
0
40
3
40
0
0,0833
0
0
51,7435
12
0,0025
20
2
20
0
0,0832
0
1,2221
66,7137
12
0,0075
5
0
5
0
0,0827
0
1,1364
84,9406
NA
NA
318
26
317
0,0833
1,1865
28,4433
GRIA 21
PAROTIDITIS
Males, Disease: Parotiditis (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence (rates *
1000)
0,55
0,76
0,145
0,05
0,014
0,014
0,014
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
40000
0
0,55
40000
0
0,76
40000
0
0,145
40000
0
0,05
40000
0
0,014
40000
0
0,014
40000
0
0,014
NA
NA
NA
Prevalence
(rates * 1000)
0,0069
0,0187
0,0044
0,0013
0,0004
0,0003
0,0003
Remission
(rates * 1000)
40000
40000
40000
40000
40000
40000
40000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,5
15
32,5
52,5
67,5
93,5984
0,1738
0,0044
40000
0,025
10,949
Incidence
(numbers)
69
917
215
155
18
8
3
Prevalence
(numbers)
1
23
7
4
0
0
0
Remission
(numbers)
35
903
261
161
19
8
3
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,025
0,025
0,025
0,025
0,025
0,025
0,025
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
0
0
0
Age of onset
(years)
0,5
5,5
15
32,5
52,5
67,5
93,5984
1385
35
1389
0,025
10,949
GRIA 22
NA
NA
NA
NA
Prevalence
(rates * 1000)
0,0069
0,0187
0,0044
0,0013
0,0004
0,0003
0,0003
Remission
(rates * 1000)
40000
40000
40000
40000
40000
40000
40000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,5
15
32,5
52,5
67,5
96,5129
0,1655
0,0042
40000
0,025
11,3489
Incidence
(numbers)
66
884
208
154
18
10
4
Prevalence
(numbers)
1
22
6
4
0
0
0
Remission
(numbers)
33
871
252
160
20
10
4
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,025
0,025
0,025
0,025
0,025
0,025
0,025
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
0
0
0
Age of onset
(years)
0,5
5,5
15
32,5
52,5
67,5
96,5129
1345
34
1350
0,025
11,3489
GRIA 23
RUBEOLA
Males, Disease: Rubeola (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence (rates *
1000)
0
0
0,001
0,0076
0,0051
0
0
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
24000
0
0
24000
0
0,0004
24000
0
0,001
24000
0
0,0062
24000
0
0,005
24000
0
0,0005
24000
0
0
NA
Prevalence
(rates * 1000)
0
0
0
0,0003
0,0002
0
0
Remission
(rates * 1000)
0
24000
24000
24000
24000
24000
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
7,4461
15,2277
33,9491
51,9471
61,75
86,7962
0,0035
0,0001
24000
0,0417
36,7829
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence (rates *
1000)
0
0
0,001
0,0076
0,0051
0
0
Remission
(rates * 1000)
24000
24000
24000
24000
24000
24000
24000
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
2
19
6
0
0
Prevalence
(numbers)
0
0
0
1
0
0
0
Remission
(numbers)
0
0
2
19
6
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0,0417
0,0417
0,0417
0,0417
0,0416
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
1
1
1
0
Age of onset
(years)
0,5
7,4461
15,2277
33,9491
51,9471
61,75
86,7962
NA
NA
28
28
0,0417
36,7829
GRIA 24
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence (rates *
1000)
0
0
0
0,0003
0,0002
0
0
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
24000
0
0
24000
0
0
24000
0
0,0001
24000
0
0,0003
24000
0
0,0002
24000
0
0
24000
0
0
NA
Prevalence
(rates * 1000)
0
0
0
0
0
0
0
Remission
(rates * 1000)
0
0
24000
24000
24000
24000
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,5
17,9819
32,4501
51,9446
61,75
0
0,0002
24000
0,0417
35,8073
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence (rates *
1000)
0
0
0
0,0003
0,0002
0
0
Remission
(rates * 1000)
24000
24000
24000
24000
24000
24000
24000
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
0
1
0
0
0
Prevalence
(numbers)
0
0
0
0
0
0
0
Remission
(numbers)
0
0
0
1
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0,0417
0,0417
0,0417
0,0417
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
1
1
0
0
Age of onset
(years)
0,5
5,5
17,9819
32,4501
51,9446
61,75
0
NA
NA
0,0417
35,8073
GRIA 25
COQUELUCHE
Males, Disease: Tos ferina (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
3,96
0,6
0,036
0,0137
0,0024
0,0024
0,0024
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
10000
0,0475
3,9592
10000
0
0,6
10000
0
0,036
10000
0
0,0137
10000
0
0,0024
10000
0
0,0024
10000
0
0,0024
NA
0,0007
NA
NA
Prevalence
(rates * 1000)
0,1957
0,078
0,0064
0,0014
0,0003
0,0002
0,0002
Remission
(rates * 1000)
10000
10000
10000
10000
10000
10000
10000
Case fatality
(rates * 1000)
111,8279
78,2297
4,1029
0
0
0
0
Age of onset
(years)
0,5
5,5001
15
32,5
52,5
67,5
93,5984
0,1659
0,0167
10000
76,2282
0,0992
0,0013
73,41
5,0895
Incidence
(numbers)
497
724
53
43
3
1
0
Prevalence
(numbers)
25
94
10
4
0
0
0
Remission
(numbers)
246
941
95
44
3
1
0
Case fatality
(numbers)
3
7
0
0
0
0
0
Duration
(years)
0,0988
0,0993
0,1
0,1
0,0999
0,0998
0,0995
Mortality
(numbers)
5
5
0
0
0
0
0
RR mortality
(number)
14,3755
127,8836
64,3386
1
0
0
0
Age of onset
(years)
0,5
5,5001
15
32,5
52,5
67,5
93,5984
1321
133
1331
10
0,0992
10
73,41
5,0895
GRIA 26
NA
NA
0,0006
NA
NA
Prevalence
(rates * 1000)
0,1959
0,0781
0,0064
0,0014
0,0003
0,0002
0,0002
Remission
(rates * 1000)
10000
10000
10000
10000
10000
10000
10000
Case fatality
(rates * 1000)
100,1566
70,0752
3,6749
0
0
0
0
Age of onset
(years)
0,5
5,5001
15
32,5
52,5
67,5
96,5129
0,157
0,0158
10000
68,1537
0,0993
0,0011
84,5272
5,1832
Incidence
(numbers)
478
698
52
42
3
2
1
Prevalence
(numbers)
24
91
9
4
0
0
0
Remission
(numbers)
237
908
92
44
4
2
1
Case fatality
(numbers)
2
6
0
0
0
0
0
Duration
(years)
0,0989
0,0994
0,1
0,1
0,1
0,0999
0,0997
Mortality
(numbers)
4
5
0
0
0
0
0
RR mortality
(number)
15,9799
147,6576
90,8324
0
0
0
0
Age of onset
(years)
0,5
5,5001
15
32,5
52,5
67,5
96,5129
1276
129
1287
0,0993
84,5272
5,1832
GRIA 27
MENINGITIS MENINGOCOCICA
Males. Disease: M Meningo (Rates*100) sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,012
0,0073
0,002
0,0006
0,0006
0,0006
0,0007
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
3100
18
0,012
3100
9,1111
0,0071
3100
3,5
0,0021
3100
5
0,0006
3100
5
0,0006
3100
5
0,0006
3100
5
0,0007
NA
NA
Prevalence
(rates * 1000)
0,0002
0,0002
0,0001
0
0
0
0
Remission
(rates * 1000)
3100
3100
3100
3100
3100
3100
3100
Case fatality
(rates * 1000)
18
12,7843
2,5879
5
5
5
5
Age of onset
(years)
0,5
4,2868
131,999
32,3837
51,6579
66,7171
82,0209
0,002
0,0001
3100
9,5036
0,0321
415,8093
13,0025
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,012
0,0073
0,002
0,0006
0,0006
0,0006
0,0007
Remission
(rates * 1000)
3100
3100
3100
3100
3100
3100
3100
Mortality
(numbers)
18
9,1111
3,5
5
5
5
5
Incidence
(numbers)
15
86
30
18
7
4
1
Prevalence
(numbers)
0
3
1
1
0
0
0
Remission
(numbers)
7
91
33
18
7
4
1
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0321
0,0321
0,0322
0,0322
0,0322
0,0322
0,0321
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
20,4526
578,2571
85,081
33,4122
11,1653
3,5143
1,6194
Age of onset
(years)
0,5
4,2868
13,1999
32,3837
51,6579
66,7171
82,0209
NA
NA
NA
162
162
0,0321
415,8093
13,0025
MENINGITIS MENINGOCOCICA
Females. Disease: M Meningo (Rates*100) sex: Females
Incidence
Remission
Mortality (rates
Incidence
Age
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000)
0
0,0117
3100
18
0,0117
1-9
0,0066
3100
9,1111
0,0065
10-19
0,0015
3100
3,5
0,0016
20-44
0,0005
3100
5
0,0005
45-59
0,0005
3100
5
0,0005
60-74
0,0005
3100
5
0,0005
75+
0,0005
3100
5
0,0005
All ages
NA
NA
NA
GRIA 28
Prevalence
(rates * 1000)
0,0002
0,0002
0,0001
0
0
0
0
Remission
(rates * 1000)
3100
3100
3100
3100
3100
3100
3100
Case fatality
(rates * 1000)
18
13,431
5
5
5
5
5
Age of onset
(years)
0,5
4,0551
13,2831
32,4838
51,7435
66,7492
83,7035
0,0017
0,0001
3100
10,1784
0,0321
421,7499
13,0812
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,01
0,01
0
0
0
0
0
Remission
(rates * 1000)
3100
3100
3100
3100
3100
3100
3100
Mortality
(numbers)
18
9,11
3,5
5
5
5
5
Incidence
(numbers)
14
75
22
15
6
4
2
Prevalence
(numbers)
0
3
1
0
0
0
0
Remission
(numbers)
7
81
24
15
6
4
2
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,03
0,03
0,03
0,03
0,03
0,03
0,03
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
25,92
571,89
135,71
93,48
20,08
5,43
1,9
Age of onset
(years)
0,5
4,06
13,28
32,48
51,74
66,75
83,7
NA
NA
NA
138
138
0,03
421,75
13,08
GRIA 29
MENINGITIS NO MENINGOCOCICAS
Males, Disease: Meningitis no meningococicas 2 (Rates * 1000), sex: Males
Age
0
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates * 1000)
0,5499
0,0547
0,0175
0,0138
0,0183
0,0348
0,0268
Remission
(rates * 1000)
26000
26000
26000
26000
26000
26000
26000
Case fatality
(rates * 1000)
90
90,9
192,3
162,8
260,9
476,2
171,4286
Incidence
(rates * 1000)
0,5499
0,0547
0,0175
0,0138
0,0183
0,0348
0,0268
Prevalence
(rates * 1000)
0,0105
0,0031
0,0007
0,0005
0,0007
0,0013
0,001
Remission
(rates * 1000)
26000
26000
26000
26000
26000
26000
26000
Case fatality
(rates * 1000)
90
90,9
192,3
162,8
260,9
476,2
342,3585
All ages
NA
NA
NA
0,0317
0,0012
26000
165,9782
0,0382
0,0002
158,1154
20,5602
Prevalence
(numbers)
1
4
1
2
1
1
0
Remission
(numbers)
34
97
29
43
22
20
5
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0383
0,0383
0,0382
0,0382
0,0381
0,0377
0,0378
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
10,7263
372,1612
572,4516
106,5594
54,0163
25,5637
10,879
Age of onset
(years)
0,5
5,6143
14,9475
32,3837
51,6579
66,4413
83,232
10
250
0,0382
158,1154
20,5602
NA
NA
NA
253
Age of onset
(years)
0,5
5,6143
14,9475
32,3837
51,6579
66,4413
83,232
GRIA 30
NA
NA
NA
0,0208
0,0008
NA
NA
NA
169
Remission
(numbers)
26000
26000
26000
26000
26000
26000
26000
Case fatality
(numbers)
130
137,9
83,3
214,3
241,4
400
231,417
Duration
(years)
0,0383
0,0383
0,0383
0,0381
0,0381
0,0379
0,038
Mortality
(numbers)
0,0014
0,0001
0
0,0001
0,0002
0,0005
0,0003
RR mortality
(number)
18,9957
786,5749
389,2225
397,3525
93,0035
36,5101
13,3614
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7435
66,7137
84,5105
26000
207,2624
0,0381
0,0002
205,4199
32,1082
Remission
(rates * 1000)
17
45
13
28
28
24
11
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
166
205,4199
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7435
66,7137
84,5105
32,1082
GRIA 31
HEPATITIS A
Males, Disease: Hepatitis A (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,1
1,04
0,74
0,18
0,008
0,06
0,1
Remission
(rates * 1000)
8000
8000
8000
8000
8000
8000
8000
Case fatality
(rates * 1000)
0,5
0,5
1
3
22
100
100
Incidence
(rates * 1000)
0,1
1,0399
0,7399
0,18
0,008
0,06
0,1
Prevalence
(rates * 1000)
0,0062
0,1234
0,0944
0,0239
0,0017
0,0072
0,0123
Remission
(rates * 1000)
8000
8000
8000
8000
8000
8000
8000
Case fatality
(rates * 1000)
0,5
0,5
1
3
22
100
100
NA
NA
NA
0,3752
0,0468
8000
3,0786
0,1249
0,0001
4,4574
15,6456
Incidence
(numbers)
13
1254
1098
559
10
36
19
Prevalence
(numbers)
1
149
140
74
2
4
2
Remission
(numbers)
6
1191
1120
594
17
35
18
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,1249
0,125
0,125
0,1249
0,1245
0,1232
0,1227
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1,0598
3,3266
4,284
2,6808
5,8355
6,1305
3,1741
Age of onset
(years)
0,5
5,4999
15
32,5
52,5
67,5
93,5984
2989
373
2982
0,1249
4,4574
15,6456
NA
NA
NA
Age of onset
(years)
0,5
5,4999
15
32,5
52,5
67,5
93,5984
NA
NA
NA
NA
NA
NA
GRIA 32
Incidence
(rates * 1000)
0,1
1,0099
0,61
0,14
0,06
0,07
0,04
Prevalence
(rates * 1000)
0,0062
0,1199
0,0787
0,0187
0,0078
0,0086
0,005
Remission
(rates * 1000)
8000
8000
8000
8000
8000
8000
8000
Case fatality
(rates * 1000)
0,5
0,5
1
3
22
100
100
Age of onset
(years)
0,5
5,4999
15
32,5
52,5
67,5
96,5129
0,3242
0,0404
8000
4,0983
0,1249
0,0002
8,187
16,2526
Incidence
(numbers)
12
1175
875
432
78
50
12
Prevalence
(numbers)
1
139
113
58
10
6
2
Remission
(numbers)
6
1116
904
461
82
49
12
Case fatality
(numbers)
0
0
0
0
0
1
0
Duration
(years)
0,1249
0,125
0,125
0,1249
0,1246
0,1233
0,123
Mortality
(numbers)
0
0
0
0
0
1
0
RR mortality
(number)
1,0748
4,1843
7,0682
5,2102
9,2787
10,0814
4,8617
Age of onset
(years)
0,5
5,4999
15
32,5
52,5
67,5
96,5129
2634
329
2629
0,1249
8,187
16,2526
GRIA 33
HEPATITIS B AGUDA
Males, Disease: Hepatitis B aguda nueva dic (Rates * 1000), sex: Males
Age
0
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates * 1000)
0
0,0077
0,0503
0,063
0,0516
0,0226
0,0054
Remission
(rates * 1000)
12000
12000
12000
12000
12000
12000
12000
Case fatality
(rates * 1000)
15
15
15
15
15
15
15
Incidence
(rates * 1000)
0
0,0079
0,0496
0,0633
0,0567
0,0197
0,0054
Prevalence
(rates * 1000)
0
0,0006
0,0038
0,0053
0,0049
0,0016
0,0006
Remission
(rates * 1000)
0
12000
12000
12000
12000
12000
12000
Case fatality
(rates * 1000)
0
15
15
15
15
15
15
All ages
NA
NA
NA
0,0457
0,0038
12000
15
0,0832
0,0001
14,8857
33,0389
Prevalence
(numbers)
0
1
6
16
6
1
0
Remission
(numbers)
0
9
68
198
73
11
1
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0,0832
0,0832
0,0832
0,0832
0,083
0,0826
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
73,4699
30,7073
10,888
4,4939
1,5846
1,1915
Age of onset
(years)
0
7,5437
16,7666
31,8901
49,7328
69,0081
82,0209
30
360
0,0832
14,8857
33,0389
NA
NA
NA
364
Age of onset
(years)
0
7,5437
16,7666
31,8901
49,7328
69,0081
82,0209
GRIA 34
NA
NA
NA
0,0108
NA
NA
NA
88
Remission
(rates * 1000)
0
12000
12000
12000
12000
12000
12000
Case fatality
(rates * 1000)
0
60
60
60
60
60
60
Age of onset
(years)
0
7,544
17,2493
30,8744
50,3401
69,1374
83,7035
0,0009
12000
60
0,0828
0,0001
94,2064
43,3927
Prevalence
(numbers)
0
0
1
4
1
1
1
Remission
(numbers)
0
0
10
42
12
11
10
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0,0829
0,0829
0,0829
0,0829
0,0828
0,0824
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
470,9569
222,1705
122,058
26,372
5,1065
2,0826
Age of onset
(years)
0
7,544
17,2493
30,8744
50,3401
69,1374
83,7035
86
0,0828
94,2064
43,3927
GRIA 35
HEPATITIS B CIRROSIS
Males, Disease: cirrosis VHB nueva dic (Rates * 1000), sex: Males
Age
0
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates * 1000)
0
0
0
0,0013
0,0063
0,0137
0,0312
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
20
20
20
20
20
20
20
Incidence
(rates * 1000)
0
0
0
0,0013
0,006
0,0129
0,0312
Prevalence
(rates * 1000)
0
0
0
0,0082
0,0576
0,1602
0,3505
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
20
20
20
20
All ages
NA
NA
NA
0,0031
0,0326
20
15,222
0,0007
3,3197
62,0218
Prevalence
(numbers)
0
0
0
25
72
97
65
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
1
1
2
1
Duration
(years)
0
0
0
26,1822
19,3454
11,8427
6,9824
Mortality
(numbers)
0
0
0
1
1
2
1
RR mortality
(number)
0
0
0
10,4436
4,5655
1,9224
1,2351
Age of onset
(years)
0
0
0
37,8137
52,5362
67,4752
82,0204
260
15,222
3,3197
62,0218
NA
NA
NA
25
Age of onset
(years)
0
0
0
37,8137
52,5362
67,4752
82,0204
NA
NA
NA
0,0004
NA
NA
NA
GRIA 36
Prevalence
(rates * 1000)
0
0
0
0,0004
0,0055
0,0176
0,0349
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
20
20
20
20
Age of onset
(years)
0
0
0
39,9761
52,6112
67,5851
83,7035
0,0039
20
16,1851
0,0001
3,9078
65,2748
Prevalence
(numbers)
0
0
0
1
7
13
11
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
27,6518
21,826
14,0707
8,35
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
19,8617
7,3841
2,5941
1,3439
Age of onset
(years)
0
0
0
39,9761
52,6112
67,5851
83,7035
32
16,1851
3,9078
65,2748
GRIA 37
HEPATITIS C AGUDA
DisMod II input and output, database Hepatiits B y C
Males, Disease: Hepatitis C aguda v2 diciembre (Rates * 1000), sex: Males
Incidence
Remission
Case fatality
Incidence
Prevalence
Remission
Case fatality
Duration Mortality (rates *
RR mortality Age of onset
Age
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (years)
1000)
(number)
(years)
0
0
8000
40
0
0
0
0
0
0
0
0
1a9
0,0001
8000
40
0,0001
0
8000
40
0,1244
0
170,1321
5,6143
10 a 19
0,0036
8000
40
0,0036
0,0004
8000
40
0,1244
0
118,2789
14,9475
20-44
0,0063
8000
40
0,0063
0,0008
8000
40
0,1244
0
26,897
32,3837
45-59
0,0416
8000
40
0,0416
0,005
8000
40
0,1243
0,0002
9,0863
51,6579
60-74
0,0189
8000
40
0,0189
0,0025
8000
40
0,124
0,0001
3,0826
66,4413
75+
0,0134
8000
40
0,0134
0,0017
8000
40
0,1229
0,0001
1,4975
82,0209
All ages
NA
NA
NA
0,0114
0,0014
NA
NA
NA
91
8000
Remission
(numbers)
40
Case fatality
(numbers)
0,1242
Duration
(years)
0,0001
18,5124
RR mortality
(number)
Mortality (numbers)
48,0515
Age of onset
(years)
0
0
1
2
6
1
0
0
0
5
19
50
12
3
0
0
0
0
0
0
0
0
0,1244
0,1244
0,1244
0,1243
0,124
0,1229
0
0
0
0
0
0
0
0
170,1321
118,2789
26,897
9,0863
3,0826
1,4975
0
5,6143
14,9475
32,3837
51,6579
66,4413
82,0209
11
89
0,1242
18,5124
48,0515
GRIA 38
NA
NA
NA
0,0108
0,0013
8000
30
0
0
4
19
44
16
4
0
0
0
2
5
2
1
0
0
4
19
42
16
4
0
0
0
0
0
0
0
All ages
88
11
86
NA
NA
NA
Prevalence
(numbers)
Remission
(numbers)
Case fatality
(numbers)
0,1244
26,2741
50,1712
Duration
RR mortality Age of onset
Mortality (numbers)
(years)
(number)
(years)
0,1244
0
5,1529
0,5
0,1245
0
178,087
5,6157
0,1245
0
140,0837
14,9514
0,1245
0
56,3714
32,4838
0,1245
0
12,3792
51,7435
0,1243
0
3,6728
66,7137
0,1234
0
1,5451
83,7035
0,1244
26,2741
50,1712
GRIA 39
0
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates * 1000)
0
0
0,0007
0,0013
0,0087
0,004
0,0028
Remission
(rates * 1000)
15000
15000
15000
15000
15000
15000
15000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Incidence
(rates * 1000)
0
0
0,0007
0,0013
0,0087
0,004
0,0028
Prevalence
(rates * 1000)
0
0
0
0,0001
0,0006
0,0003
0,0002
Remission
(rates * 1000)
0
0
15000
15000
15000
15000
15000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
All ages
NA
NA
NA
0,0024
0,0002
15000
0,0666
48,317
Prevalence
(numbers)
0
0
0
0
1
0
0
Remission
(numbers)
0
0
1
4
10
3
1
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0,0667
0,0667
0,0666
0,0666
0,0662
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
1
1
1
Age of onset
(years)
0
0
14,9475
32,3837
51,6579
66,4413
82,0209
19
0,0666
48,317
Age
NA
NA
NA
19
Age of onset
(years)
0
0
14,9475
32,3837
51,6579
66,4413
82,0209
GRIA 40
NA
NA
NA
0,0023
0,0001
NA
NA
NA
18
Remission
(rates * 1000)
0
0
15000
15000
15000
15000
15000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Age of onset
(years)
0
0
14,9514
32,4838
51,7435
66,7137
83,7035
15000
0,0666
50,3883
Remission
(numbers)
0
0
1
4
9
3
1
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0,0667
0,0667
0,0667
0,0666
0,0663
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
0
1
1
1
Age of onset
(years)
0
0
14,9514
32,4838
51,7435
66,7137
83,7035
18
0,0666
50,3883
GRIA 41
0
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates * 1000)
0
0
0
0,0033
0,0058
0,0384
0,0175
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
20
20
20
20
20
20
20
Incidence
(rates * 1000)
0
0
0
0,0033
0,0058
0,0384
0,0175
Prevalence
(rates * 1000)
0
0
0
0,0348
0,0923
0,3346
0,6093
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
20
20
20
20
All ages
NA
NA
NA
0,0055
0,0677
20
16,903
0,0014
4,4114
57,3304
Incidence
(numbers)
0
0
0
10
7
23
3
Prevalence
(numbers)
0
0
0
108
116
202
114
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
2
2
4
2
Duration
(years)
0
0
0
28,2932
19,7864
12,353
6,9825
Mortality
(numbers)
0
0
0
2
2
4
2
RR mortality
(number)
0
0
0
12,0549
4,8016
1,8733
1,2462
Age of onset
(years)
0
0
0
32,3835
51,6578
66,4401
82,0208
44
539
11
16,903
11
4,4114
57,3304
Age
NA
NA
NA
Age of onset
(years)
0
0
0
32,3835
51,6578
66,4401
82,0208
GRIA 42
NA
NA
NA
0,0054
NA
NA
NA
44
Prevalence
(rates * 1000)
0
0
0
0,0276
0,0805
0,2877
0,5238
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
20
20
20
20
Age of onset
(years)
0
0
0
32,4836
51,7433
66,7128
83,7033
0,0682
20
17,9141
0,0014
7,5471
60,6602
Prevalence
(numbers)
0
0
0
85
105
206
158
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
2
2
4
3
Duration
(years)
0
0
0
30,471
22,2587
14,5364
8,3507
Mortality
(numbers)
0
0
0
2
2
4
3
RR mortality
(number)
0
0
0
30,5719
8,0048
2,5309
1,3549
Age of onset
(years)
0
0
0
32,4836
51,7433
66,7128
83,7033
554
11
17,9141
11
7,5471
60,6602
GRIA 43
CHAGAS
Males, Disease: chagas (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,04
0
0,01
0,01
0,04
0,2663
0
0,0002
0,25
0
0,022
0,01
0,2494
2,2073
0
0,0006
0,35
0
0,025
0,01
0,348
5,6522
0
0,0011
NA
NA
0,0038
Duration
(years)
0
0
0
0
26,5532
15,0292
8,0307
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0
0
0
0
0
0
0
0
0
0
0
1
51,6564
0
1
66,4322
0
1
82,0148
NA
0,0333
0,3415
0,0007
15,4938
Mortality
(numbers)
0
0
0
0
13
13
5
RR Mortality
(rates * 1000)
0
0
0
0
0,01
0,01
0,01
Incidence
(numbers)
0
0
0
0
50
150
65
Prevalence
(numbers)
0
0
0
0
334
1332
1055
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
0
26,5532
15,0292
8,0307
Mortality
(numbers)
0
0
0
0
0
0
0
30
NA
266
2720
15,4938
67,6768
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0,04
0
0,25
0
0,35
0
NA
NA
67,6768
GRIA 44
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,04
0
0,005
0,01
0,04
0,2697
0
0,0001
0,25
0
0,012
0,01
0,2494
2,2752
0
0,0004
0,25
0
0,012
0,01
0,2487
5,329
0
0,0008
NA
NA
0,0023
Duration
(years)
0
0
0
0
31,0104
18,2763
9,8991
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0
0
0
0
0
0
0
0
0
0
0
1
51,742
0
1
66,7045
0
1
83,6988
NA
0,0376
0,4418
0,0006
18,3895
Mortality
(numbers)
0
0
0
0
7
9
4
RR Mortality
(rates * 1000)
0
0
0
0
0,01
0,01
0,01
Incidence
(numbers)
0
0
0
0
52
178
75
Prevalence
(numbers)
0
0
0
0
352
1627
1611
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
0
31,0104
18,2763
9,8991
Mortality
(numbers)
0
0
0
0
0
0
0
19
NA
306
3590
18,3895
68,7642
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0,04
0
0,25
0
0,25
0
NA
NA
68,7642
GRIA 45
ASCARIDIASIS
Males, Disease: Ascaris (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0,01
0,01
0,01
0,01
0,01
0
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
1000
0
0,01
1000
0
0,01
1000
0
0,01
1000
0
0,01
1000
0
0,01
1000
0
0,0099
1000
0
0,0014
NA
Prevalence
(rates * 1000)
0,0032
0,0096
0,01
0,01
0,01
0,01
0,0018
Remission
(rates * 1000)
1000
1000
1000
1000
1000
1000
1000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,5
15
32,5
52,5
67,4568
77,6457
0,0098
0,0096
1000
0,9961
30,5322
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0,01
0,01
0,01
0,01
0,01
0
Remission
(rates * 1000)
1000
1000
1000
1000
1000
1000
1000
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
1
12
15
31
13
6
0
Prevalence
(numbers)
0
12
15
31
13
6
0
Remission
(numbers)
0
12
15
31
13
6
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,9937
0,9991
0,9993
0,9981
0,9928
0,9797
0,9695
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
1
0
0
0
Age of onset
(years)
0,5
5,5
15
32,5
52,5
67,4568
77,6457
NA
NA
78
77
77
0,9961
30,5322
GRIA 46
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0,01
0,01
0,01
0,01
0,01
0
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
1000
0
0,01
1000
0
0,01
1000
0
0,01
1000
0
0,01
1000
0
0,01
1000
0
0,0099
1000
0
0,0014
NA
Prevalence
(rates * 1000)
0,0032
0,0096
0,01
0,01
0,01
0,01
0,0018
Remission
(rates * 1000)
1000
1000
1000
1000
1000
1000
1000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,5
15
32,5
52,5
67,4568
77,6457
0,0097
0,0095
1000
0,9977
31,5389
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0,01
0,01
0,01
0,01
0,01
0
Remission
(rates * 1000)
1000
1000
1000
1000
1000
1000
1000
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
1
12
14
31
13
7
0
Prevalence
(numbers)
0
11
14
31
13
7
1
Remission
(numbers)
0
11
14
31
13
7
1
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,995
0,9993
0,9997
0,9992
0,996
0,9884
0,9827
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
1
0
0
0
Age of onset
(years)
0,5
5,5
15
32,5
52,5
67,4568
77,6457
NA
NA
79
77
77
0,9977
31,5389
GRIA 47
HIDATIDOSIS
Males, Disease: Hidatidosis (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,0513
0,0513
0,0664
0,0814
0,0814
0,1185
0,137
NA
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
80
0
0,0513
0,0247
80
0,0061
0,2
80
0
0,0513
0,219
80
0,0061
0,3
80
0
0,0663
0,4263
80
64,5988
0,4
80
0,13
0,0814
0,106
80
830,8087
0,5
80
0,4
0,0814
0,0391
80
2000
0,6
80
0,66
0,1185
0,0558
80
2000
0,7
80
1,61
0,137
0,0659
80
1999,9998
0,3827
NA
Duration
(years)
9,7291
8,4815
4,1308
0,8486
0,4792
0,4761
0,4689
Mortality
(rates * 1000)
0
0
0,0275
0,0874
0,0783
0,1122
0,1317
RR mortality
(number)
1,0007
1,0375
132,5863
716,9979
389,5883
101,814
44,5419
0,2014
0,0777
0,1663
80
381,0403
2,1067
0,0631
489,9686
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,0513
0,0513
0,0664
0,0814
0,0814
0,1185
0,137
Prevalence
(numbers)
0
241
445
1243
627
362
131
Remission
(rates * 1000)
80
80
80
80
80
80
80
Mortality
(numbers)
0
0
0
404
502
398
300
Incidence
(numbers)
6
62
98
253
102
71
26
Prevalence
(numbers)
3
264
633
329
49
34
12
Remission
(numbers)
0
21
51
26
4
3
1
Case fatality
(numbers)
0
0
41
274
98
67
25
Duration
(years)
9,7291
8,4815
4,1308
0,8486
0,4792
0,4761
0,4689
Mortality
(numbers)
0
0
41
272
98
68
25
RR mortality
(number)
1,0007
1,0375
132,5863
716,9979
389,5883
101,814
44,5419
NA
3049
NA
1604
619
1324
106
505
2,1067
503
489,9686
GRIA 48
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,0513
0,0513
0,0664
0,0814
0,0814
0,1185
0,137
NA
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
300
0
0,0513
0,0222
300
0
300
0
0,0513
0,1269
300
0
300
0
0,0663
0,1842
300
34,0541
300
0,03
0,0814
0,178
300
166,0499
300
0,03
0,0814
0,1596
300
249,277
300
0,42
0,1185
0,0564
300
1828,5572
300
2,32
0,137
0,0596
300
1999,9999
NA
0,1395
Duration
(years)
3,2949
3,2832
2,7155
2,124
1,6981
0,4552
0,4292
Mortality
(rates * 1000)
0
0
0,0063
0,0296
0,0395
0,1031
0,1191
RR mortality
(number)
0
0
160,0497
232,3185
83,6259
167,1912
78,0346
Age of onset
(years)
0,5
5,4998
15,567
32,5001
52,5001
68,2822
96,5129
0,0793
0,1514
300
212,8888
1,9315
0,0322
160,9005
41,2207
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,0513
0,0513
0,0664
0,0814
0,0814
0,1185
0,137
Remission
(rates * 1000)
300
300
300
300
300
300
300
Mortality
(numbers)
0
0
0
93
39
300
701
Incidence
(numbers)
6
60
95
251
106
85
41
Prevalence
(numbers)
3
148
264
549
208
40
18
Remission
(numbers)
1
44
79
165
62
12
5
Case fatality
(numbers)
0
0
9
91
52
74
36
Duration
(years)
3,2949
3,2832
2,7155
2,124
1,6981
0,4552
0,4292
Mortality
(numbers)
0
0
9
91
52
74
36
RR mortality
(number)
0
0
160,0497
232,3185
83,6259
167,1912
78,0346
Age of onset
(years)
0,5
5,4998
15,567
32,5001
52,5001
68,2822
96,5129
NA
NA
1134
645
1230
369
262
1,9315
262
160,9005
41,2207
GRIA 49
TENIASIS Y CISTECERCOSIS
Males, Disease: Teniasis (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0,0028
0,0014
0
0,0061
0,4
0,01
0
0
0,0025
0,0144
0
0,0061
0,4
0,05
0
0
0,0086
0,0621
0
1,2744
0,8
0,1
0
0,0006
0,0092
0,1874
0
3,3073
0,8
0,4
0
0,0024
0,0844
0,84
0
60,3742
0,5
0,2
0
0
0,2227
0,4969
0
493,9387
0,7
0,2
0
0,0054
0,0072
0,4852
0
17,2934
NA
0,1326
NA
Duration
(years)
53,9235
49,7673
39,7504
22,3033
7,1518
3,7273
13,1658
Mortality
RR mortality
(rates * 1000)
(number)
0
1,0007
0
1,0385
0,0001
2,9323
0,0006
2,8598
0,0506
17,9794
0,2449
29,5764
0,0084
2,0518
Age of onset
(years)
0,5
5,4501
15,7559
35,8771
52,8148
66,6901
89,435
0,0007
0,0359
0,2681
100,7992
9,049
0,027
25,6957
55,6282
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0,4
0,4
0,8
0,8
0,5
0,7
Prevalence
(numbers)
0
12
74
311
502
121
37
Remission
(rates * 1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
2
3
0
1
Incidence
(numbers)
0
3
13
28
106
134
1
Prevalence
(numbers)
0
17
92
582
1053
300
91
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
2
64
148
2
Duration
(years)
53,9235
49,7673
39,7504
22,3033
7,1518
3,7273
13,1658
Mortality
(numbers)
0
0
0
2
63
148
2
RR mortality
(number)
1,0007
1,0385
2,9323
2,8598
17,9794
29,5764
2,0518
Age of onset
(years)
0,5
5,4501
15,7559
35,8771
52,8148
66,6901
89,435
NA
1056
NA
286
2136
215
9,049
215
25,6957
55,6282
GRIA 50
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0,0028
0,0014
0
0,0061
0,4
0,01
0
0
0,0025
0,0144
0
0,0061
0,4
0,05
0
0
0,0086
0,0621
0
0,0061
0,8
0,1
0
0
0,0089
0,1807
0
9,9959
0,8
0,3
0
0,0008
0,0517
0,5926
0
45,9107
0,4
0,2
0
0
0,1958
0,4919
0
421,1218
0,8
0,2
0
0,0066
0,0073
0,4558
0
21,2765
NA
0,1214
NA
Duration
(years)
53,58
49,2621
39,1075
22,0782
7,5837
4,9308
17,732
Mortality
RR mortality
(rates * 1000)
(number)
0
1,0009
0
1,0533
0
1,0278
0,0018
20,7069
0,0272
24,131
0,207
41,5656
0,0097
2,7938
Age of onset
(years)
0,5
5,4501
15,7396
35,6329
53,1729
66,8325
92,8301
0,0004
0,0311
0,2371
99,7484
9,849
0,0236
37,1478
56,879
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0,4
0,4
0,8
0,8
0,4
0,8
Prevalence
(numbers)
0
12
72
309
391
143
60
Remission
(rates * 1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
1
0
2
Incidence
(numbers)
0
3
12
27
68
140
2
Prevalence
(numbers)
0
17
89
558
773
352
138
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
6
35
148
3
Duration
(years)
53,58
49,2621
39,1075
22,0782
7,5837
4,9308
17,732
Mortality
(numbers)
0
0
0
6
35
148
3
RR mortality
(number)
1,0009
1,0533
1,0278
20,7069
24,131
41,5656
2,7938
Age of onset
(years)
0,5
5,4501
15,7396
35,6329
53,1729
66,8325
92,8301
NA
987
NA
253
1927
192
9,849
192
37,1478
56,879
GRIA 51
TRIQUINOSIS
Males, Disease: Triquinosis (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence (rates
* 1000)
0
0,004
0,004
0,004
0,004
0,004
0,004
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
24000
0
0,004
24000
0
0,004
24000
0
0,004
24000
0,0016
0,0073
24000
0
0,0044
24000
0,0017
0,0083
24000
0,008
0,009
NA
0,0009
Prevalence
(rates * 1000)
0,0001
0,0002
0,0002
0,0003
0,0002
0,0003
0,0003
Remission
(rates * 1000)
24000
24000
24000
24000
24000
24000
24000
Case fatality
(rates * 1000)
0
0
10,7439
3343,5233
361,6258
4247,4769
4882,7693
Age of onset
(years)
0,5
5,5
15,0261
32,8706
52,7373
67,7919
93,6403
0,0058
0,0002
24000
2224,157
0,0381
0,0005
1615,695
36,4145
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence (rates
* 1000)
0
0,004
0,004
0,004
0,004
0,004
0,004
Remission
(rates * 1000)
24000
24000
24000
24000
24000
24000
24000
Mortality
(numbers)
0
0
0
5
0
1
1
Incidence
(numbers)
1
5
6
23
5
5
2
Prevalence
(numbers)
0
0
0
1
0
0
0
Remission
(numbers)
0
5
6
20
5
4
1
Case fatality
(numbers)
0
0
0
3
0
1
0
Duration
(years)
0,0417
0,0417
0,0416
0,0366
0,041
0,0354
0,0346
Mortality
(numbers)
0
0
0
3
0
1
0
RR mortality
(number)
0
0
83,8231
2197,2256
114,6727
215,8489
106,1683
Age of onset
(years)
0,5
5,5
15,0261
32,8706
52,7373
67,7919
93,6403
NA
NA
46
42
0,0381
1615,695
36,4145
GRIA 52
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence (rates
* 1000)
0
0,004
0,004
0,004
0,004
0,004
0,004
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
24000
0
0,004
24000
0
0,004
24000
0
0,004
24000
0
0,004
24000
0
0,0042
24000
0,001
0,0066
24000
0
0,004
NA
0,0001
Prevalence
(rates * 1000)
0,0001
0,0002
0,0002
0,0002
0,0002
0,0003
0,0002
Remission
(rates * 1000)
24000
24000
24000
24000
24000
24000
24000
Case fatality
(rates * 1000)
0
0
0
0
198,4564
2396,8795
32,5412
Age of onset
(years)
0,5
5,5
15
32,5
52,7871
67,2723
96,3749
0,0043
0,0002
24000
338,5174
0,0411
0,0001
211,134
36,8778
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence (rates
* 1000)
0
0,004
0,004
0,004
0,004
0,004
0,004
Remission
(rates * 1000)
24000
24000
24000
24000
24000
24000
24000
Mortality
(numbers)
0
0
0
0
0
1
0
Incidence
(numbers)
0
5
6
12
5
5
1
Prevalence
(numbers)
0
0
0
1
0
0
0
Remission
(numbers)
0
5
6
12
5
4
1
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0417
0,0417
0,0417
0,0417
0,0413
0,0379
0,0416
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
1
120,3355
221,4453
24,3137
Age of onset
(years)
0,5
5,5
15
32,5
52,7871
67,2723
96,3749
NA
NA
35
34
0,0411
211,134
36,8778
ANGINA ESTREPTOCOCICA
HOMBRES
DisMod II input and output, database esteptococicas
Males, Disease: angina v2 (Rates * 1000), sex: Males
Incidence
Remission
Case fatality
Age
(rates * 1000) (rates * 1000) (rates * 1000)
0
20
90000
0,02
1-9
53,3333
90000
0,02
10-19
34,5
90000
0,02
20-44
9
90000
0,02
45-59
5
90000
0,02
60-74
5
90000
0,02
75+
5
90000
0,02
All ages
NA
NA
NA
NA
NA
NA
GRIA 53
Incidence
(rates * 1000)
20
54,4338
34,743
9,03
5
5
5
Prevalence
(rates * 1000)
0,1111
0,5678
0,4229
0,1025
0,0556
0,0556
0,0556
Remission
(rates * 1000)
90000
90000
90000
90000
90000
90000
90000
Case fatality
(rates * 1000)
0,02
0,02
0,02
0,02
0,02
0,02
0,02
Age of onset
(years)
0,5
6,8343
12,9954
29,0247
51,6579
66,4413
82,0209
19,8332
0,2207
90000
0,02
0,0111
1,0675
16,0752
Incidence
(numbers)
2509
65608
51519
28051
6269
3016
933
Prevalence
(numbers)
14
685
627
318
70
34
10
Remission
(numbers)
1254
61634
56474
28660
6269
3016
933
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0111
0,0111
0,0111
0,0111
0,0111
0,0111
0,0111
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1,0022
1,0919
1,0814
1,0147
1,0041
1,001
1,0002
Age of onset
(years)
0,5
6,8343
12,9954
29,0247
51,6579
66,4413
82,0209
157905
1758
158240
0,0111
1,0675
16,0752
NA
NA
NA
NA
NA
NA
GRIA 54
Prevalence
(rates * 1000)
0,1111
0,5679
0,4225
0,1018
0,0556
0,0556
0,0556
Remission
(rates * 1000)
90000
90000
90000
90000
90000
90000
90000
Case fatality
(rates * 1000)
0,01
0,01
0,01
0,01
0,01
0,01
0,01
Age of onset
(years)
0,5
6,8352
12,9984
29,1158
51,7435
66,7137
83,7035
19,0543
0,2121
90000
0,01
0,0111
1,0509
16,8108
Incidence
(numbers)
2417
63292
49773
27682
6523
3576
1512
Prevalence
(numbers)
13
661
606
314
72
40
17
Remission
(numbers)
1208
59459
54559
28285
6523
3576
1512
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0111
0,0111
0,0111
0,0111
0,0111
0,0111
0,0111
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1,0014
1,0711
1,0555
1,0215
1,0038
1,0009
1,0002
Age of onset
(years)
0,5
6,8352
12,9984
29,1158
51,7435
66,7137
83,7035
154774
1724
155122
0,0111
1,0509
16,8108
GRIA 55
ESCARLATINA
Males, Disease: escarlatina (Rates * 100,000), sex: Males
Age
0
1a 9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
43,84
72,54
9,1
0,16
0
0,83
0
Remission
(rates *
100000)
1600000
1600000
1600000
1600000
1600000
1600000
1600000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(rates *
100000)
43,839
72,537
9,1
0,16
0
0,83
0
Prevalence
(rates *
100000)
1,37
4,44
0,766
0,022
0
0,049
0,003
Remission
(rates *
100000)
1600000
1600000
1600000
1600000
1600000
1600000
1600000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Duration
(years)
0,062
0,062
0,062
0,062
0
0,062
0
Mortality
(rates *
100000)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
1
1
0
1
Age of onset
(years)
0,5
5,614
14,947
32,384
0
66,441
0
All ages
NA
NA
NA
13,494
0,849
1600000
0,062
6,932
Age
0
1a 9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
43,84
72,54
9,1
0,16
0
0,83
0
Remission
(rates *
100000)
1600000
1600000
1600000
1600000
1600000
1600000
1600000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(numbers)
55
875
135
5
0
5
0
Prevalence
(numbers)
2
54
11
1
0
0
0
Remission
(numbers)
28
857
182
11
0
5
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,062
0,062
0,062
0,062
0
0,062
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
1
1
0
1
Age of onset
(years)
0,5
5,614
14,947
32,384
0
66,441
0
All ages
NA
NA
NA
1075
68
1082
0,062
6,932
GRIA 56
Age
0
1a 9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
28,96
66,19
8,02
1,3
0,38
0
0
Remission
(rates *
100000)
1600000
1600000
1600000
1600000
1600000
1600000
1600000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(rates *
100000)
28,96
66,187
8,02
1,3
0,38
0
0
Prevalence
(rates *
100000)
0,905
4,015
0,682
0,09
0,026
0,001
0
Remission
(rates *
100000)
1600000
1600000
1600000
1600000
1600000
1600000
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Duration
(years)
0,062
0,062
0,062
0,062
0,062
0
0
Mortality
(rates *
100000)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
1
1
0
Age of onset
(years)
0,5
5,616
14,951
32,484
51,743
0
0
All ages
NA
NA
NA
11,875
0,747
1600000
0,062
7,897
Age
0
1a 9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
28,96
66,19
8,02
1,3
0,38
0
0
Remission
(rates *
100000)
1600000
1600000
1600000
1600000
1600000
1600000
1600000
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(numbers)
35
770
115
40
5
0
0
Prevalence
(numbers)
1
47
10
3
0
0
0
Remission
(numbers)
17
747
156
45
5
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,062
0,062
0,062
0,062
0,062
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
1
1
0
Age of onset
(years)
0,5
5,616
14,951
32,484
51,743
0
0
All ages
NA
NA
NA
965
61
971
0,062
7,897
GRIA 57
NA
NA
NA
0,0064
NA
NA
NA
51
Prevalence
(rates * 1000)
0,0011
0,0008
0,0003
0,0003
0,0001
0,0004
0,003
Remission
(rates * 1000)
15000
15000
15000
15000
15000
15000
15000
Case fatality
(rates * 1000)
0
154
0
0
0
250
222
Age of onset
(years)
0,5
5,6143
14,9475
32,3837
51,6579
66,4413
82,0209
0,0004
15000
100,9962
0,0661
265,1277
33,9409
Prevalence
(numbers)
0
1
0
1
0
0
1
Remission
(numbers)
2
14
6
12
3
4
8
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0666
0,066
0,0667
0,0667
0,0666
0,0655
0,0653
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
639,9249
1
0
1
13,8745
3,7379
Age of onset
(years)
0,5
5,6143
14,9475
32,3837
51,6579
66,4413
82,0209
50
0,0661
265,1277
33,9409
GRIA 58
NA
NA
NA
0,0044
NA
NA
NA
35
Remission
(rates * 1000)
15000
15000
15000
15000
15000
15000
15000
Case fatality
(rates * 1000)
0
0
0
0
333
0
0
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7435
66,7137
83,7035
0,0003
15000
23,7857
0,0665
127,8424
29,7187
Prevalence
(numbers)
0
1
0
0
0
0
0
Remission
(numbers)
5
14
2
3
2
3
6
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0666
0,0667
0,0667
0,0667
0,0652
0,0666
0,0663
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1
1
0
0
127,8424
1
0
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7435
66,7137
83,7035
35
0,0665
127,8424
29,7187
NA
NA
NA
0,0215
NA
NA
NA
171
GRIA 59
Prevalence
(rates * 1000)
0,0017
0,0021
0,0006
0,0012
0,0014
0,0025
0,003
Remission
(rates * 1000)
15000
15000
15000
15000
15000
15000
15000
Case fatality
(rates * 1000)
80
63,3502
50
91,1215
150
190,7015
220
Age of onset
(years)
0,5
5,6143
15,7778
32,5987
51,9112
66,5168
83,1243
0,0014
15000
110,4732
0,0661
0,0002
60,8562
35,2109
Prevalence
(numbers)
0
2
1
4
2
1
1
Remission
(numbers)
3
37
12
58
26
22
8
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0663
0,0664
0,0664
0,0663
0,066
0,0657
0,0653
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
9,6456
254,8509
129,2885
60,5717
30,799
9,8948
3,4981
Age of onset
(years)
0,5
5,6143
15,7778
32,5987
51,9112
66,5168
83,1243
11
167
0,0661
60,8562
35,2109
NA
NA
NA
0,0222
NA
NA
NA
181
GRIA 60
Prevalence
(rates * 1000)
0,0017
0,0021
0,0006
0,0012
0,0014
0,0025
0,003
Remission
(rates * 1000)
15000
15000
15000
15000
15000
15000
15000
Case fatality
(rates * 1000)
80
63,3425
50
91,6702
150
192,4123
220
Age of onset
(years)
0,5
5,6157
15,7815
32,6965
51,9966
66,7933
84,9249
0,0014
15000
116,9984
0,0661
0,0002
92,1216
38,6743
Prevalence
(numbers)
0
2
1
4
2
2
1
Remission
(numbers)
3
36
12
58
27
27
14
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0663
0,0664
0,0664
0,0663
0,066
0,0658
0,0653
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
12,0743
319,8281
218,0257
148,5921
56,9113
16,4769
4,5328
Age of onset
(years)
0,5
5,6157
15,7815
32,6965
51,9966
66,7933
84,9249
12
176
0,0661
92,1216
38,6743
GRIA 61
Varicela
NA
NA
Prevalence
(rates * 1000)
0,2204
0,4446
0,1121
0,0143
0,0023
0,0018
0,0018
Remission
(rates * 1000)
50000
50000
50000
50000
50000
50000
50000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,1056
14,0326
32,3838
51,6579
66,4413
82,0209
4,8648
0,0978
50000
0,02
8,1531
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
2766
26504
7237
2062
113
54
17
Prevalence
(numbers)
28
536
166
45
3
1
0
Remission
(numbers)
1383
26812
8321
2225
145
54
17
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,02
0,02
0,02
0,02
0,02
0,02
0,02
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
1
1
0
0
Age of onset
(years)
0,5
5,1056
14,0326
32,3838
51,6579
66,4413
82,0209
38753
779
38957
0,02
8,1531
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission (rates *
(rates * 1000)
1000)
22,0536
50000
22,1695
50000
4,8468
50000
0,6636
50000
0,09
50000
0,09
50000
0,09
50000
NA
NA
GRIA 62
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission (rates * Mortality (rates
Incidence
(rates * 1000)
1000)
* 1000)
(rates * 1000)
22,0536
50000
0
22,0487
22,1695
50000
0
21,9714
4,8468
50000
0
4,875
0,6636
50000
0
0,6636
0,09
50000
0
0,09
0,09
50000
0
0,09
0,09
50000
0
0,09
NA
NA
NA
NA
Prevalence
(rates * 1000)
0,2204
0,4445
0,1121
0,0143
0,0023
0,0018
0,0018
Remission
(rates * 1000)
50000
50000
50000
50000
50000
50000
50000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
4,611
0,0927
50000
0,02
8,2588
Incidence
(numbers)
2665
25559
6994
2048
117
64
27
Prevalence
(numbers)
27
517
161
44
3
1
1
Remission
(numbers)
1332
25856
8041
2207
150
64
27
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,02
0,02
0,02
0,02
0,02
0,02
0,02
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
1
1
0
0
Age of onset
(years)
0,5
5,1071
14,0359
32,4839
51,7435
66,7137
83,7035
37475
754
37677
0,02
8,2588
Supuestos
Incidencia de centros centinela de varicela
>1
1-4
5-9
Oct-14
15-19
20-44
45 y mas
tasa
1837,8
2315,4
1473,1
554,1
253,7
55,3
7,5
20% de subnotificacin
2205,36
2778,48
1767,72
664,92
304,44
66,36
9
Duracin 7 dias
Sin mortalidad
Discapcidad: 0,087 (igual a la rubeola)
Age of onset
(years)
0,5
5,1071
14,0359
32,4839
51,7435
66,7137
83,7035
GRIB 1
IRA BAJAS
DisMod II input and output, database OA
Males, Disease: ira baja (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
50
24000
0,3798
50,0436
1,0414
24000
2,3584
50
24000
0,0049
30,8334
1,3782
24000
8,8351
28,35
24000
0,002
6,4054
0,2726
24000
12,083
6,7
24000
0,0161
6,7722
0,2819
24000
49,6946
6,7
24000
0,059
6,7526
0,279
24000
240,6047
62,2333
24000
0,5106
46,3291
1,7696
24000
551,6807
90
24000
6,3461
90,2767
3,593
24000
1284,755
NA
NA
0,21
Duration
(years)
0,0416
0,0417
0,0416
0,0416
0,0412
0,0406
0,0394
Mortality
RR mortality
(rates * 1000)
(number)
0,0047
1,2549
0,011
59,4996
0,0032
52,4791
0,014
32,5567
0,067
48,6172
1,0748
50,5369
4,5873
14,9588
Age of onset
(years)
0,5
4,4445
15,175
32,3331
51,6328
69,3103
82,0092
15,9771
0,6479
24000
309,605
0,0411
0,2072
31,5733
37,6938
Mortality
(numbers)
48
6
3
50
74
308
1184
Incidence
(numbers)
6279
37190
9505
21040
8468
27948
16846
Prevalence
(numbers)
131
1662
405
876
350
1068
670
Remission
(numbers)
3136
39897
9708
21016
8395
25620
16091
Case fatality
(numbers)
0
15
5
44
84
589
861
Duration
(years)
0,0416
0,0417
0,0416
0,0416
0,0412
0,0406
0,0394
Mortality
(numbers)
1
13
5
44
84
648
856
RR mortality
(number)
1,2549
59,4996
52,4791
32,5567
48,6172
50,5369
14,9588
Age of onset
(years)
0,5
4,4445
15,175
32,3331
51,6328
69,3103
82,0092
1673
127275
5161
123864
1598
0,0411
1650
31,5733
37,6938
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
50
24000
50
24000
28,35
24000
6,7
24000
6,7
24000
62,2333
24000
90
24000
NA
NA
GRIB 2
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
35
24000
0,357
35,0214
0,7289
24000
5,8567
35
24000
0,0085
21,0524
0,9443
24000
34,4924
19,5
24000
0,0014
3,5666
0,1517
24000
35,1538
4
24000
0,0075
4,0515
0,1687
24000
39,4649
4
24000
0,0184
4,0349
0,1672
24000
160,2696
34,6667
24000
0,2642
27,0462
1,0397
24000
467,8866
50
24000
5,256
62,2246
2,398
24000
1523,9527
NA
NA
0,2313
Duration
(years)
0,0416
0,0416
0,0416
0,0416
0,0414
0,0408
0,0391
Mortality
RR mortality
(rates * 1000)
(number)
0,0082
1,8107
0,0291
382,0715
0,0049
302,3137
0,0067
68,5654
0,0268
67,6071
0,5326
73,3658
3,7137
22,1201
Age of onset
(years)
0,5
4,3698
15,3517
32,4215
51,7149
69,5028
84,1454
11,0448
0,4444
24000
430,3729
0,0409
0,197
44,7381
43,3667
Mortality
(numbers)
43
10
2
23
24
189
1589
Incidence
(numbers)
4232
24490
5117
12503
5265
19345
18812
Prevalence
(numbers)
88
1098
218
521
218
744
725
Remission
(numbers)
2114
26362
5225
12494
5236
17848
17399
Case fatality
(numbers)
1
38
8
21
35
348
1105
Duration
(years)
0,0416
0,0416
0,0416
0,0416
0,0414
0,0408
0,0391
Mortality
(numbers)
1
34
7
21
35
381
1123
RR mortality
(number)
1,8107
382,0715
302,3137
68,5654
67,6071
73,3658
22,1201
Age of onset
(years)
0,5
4,3698
15,3517
32,4215
51,7149
69,5028
84,1454
1880
89764
3612
86678
1554
0,0409
1601
44,7381
43,3667
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
35
24000
35
24000
19,5
24000
4
24000
4
24000
34,6667
24000
50
24000
NA
NA
GRIB 3
IRA ALTAS
DisMod II input and output, database OA
Males, Disease: ira alta (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
280
225,2222
173,5
112,72
99
155,8667
230,4
NA
Remission
Incidence
Mortality (rates
(rates * 1000)
* 1000)
(rates * 1000)
120000
0
217,7694
120000
0
196,4314
120000
0
159,7221
120000
0
109,7244
120000
0
99,1205
120000
0
134,1598
120000
0
197,6244
NA
Prevalence
(rates * 1000)
0,9057
1,6556
1,337
0,9226
0,8253
1,0948
1,6269
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
Mortality (rates
* 1000)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
1
1
1
1
1
Age of onset
(years)
0,5
5,4072
14,8768
31,4993
51,6574
67,3453
82,2068
136,1082
1,1247
120000
0,0083
28,2293
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
280
225,2222
173,5
112,72
99
155,8667
230,4
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
27299
236534
236692
340567
124191
80839
36817
Prevalence
(numbers)
114
1997
1984
2866
1035
660
304
Remission
(numbers)
13637
239632
238078
343940
124194
79252
36430
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
1
1
1
1
1
Age of onset
(years)
0,5
5,4072
14,8768
31,4993
51,6574
67,3453
82,2068
NA
NA
1082939
8960
1075162
0,0083
28,2293
GRIB 4
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
355,3
299,4111
222,85
139,8
125
198,3333
294
NA
Incidence
Mortality (rates
Remission
* 1000)
(rates * 1000)
(rates * 1000)
120000
0
274,7586
120000
0
252,7815
120000
0
197,0962
120000
0
130,5075
120000
0
117,9076
120000
0
167,1833
120000
0
244,4234
NA
Prevalence
(rates * 1000)
1,1435
2,1294
1,6623
1,0975
0,9825
1,3647
2,016
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
Mortality (rates
* 1000)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
1
1
1
1
1
Age of onset
(years)
0,5
5,4481
14,7677
31,6695
51,7456
67,6589
83,9002
167,3515
1,3848
120000
0,0083
30,3686
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
355,3
299,4111
222,85
139,8
125
198,3333
294
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
33204
294054
282782
402755
153840
119581
73894
Prevalence
(numbers)
138
2477
2385
3387
1282
976
609
Remission
(numbers)
16583
297244
286204
406448
153831
117136
73139
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
1
1
1
1
1
Age of onset
(years)
0,5
5,4481
14,7677
31,6695
51,7456
67,6589
83,9002
NA
NA
1360110
11255
1350584
0,0083
30,3686
GRIB 5
OTITIS MEDIA
Males, Disease: OMA (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
625,5
40000
0
171,541
2,1397
40000
0
225,5
40000
0
139,3314
3,5854
40000
0
60,75
40000
0
57,9041
1,5238
40000
0
26,478
40000
0
26,9281
0,6789
40000
0
25,65
40000
0
25,65
0,6413
40000
0
25,65
40000
0
26,6777
0,6632
40000
23,9933
25,65
40000
0,1
26,4056
0,6596
40000
150,0281
NA
NA
Duration
(years)
0,025
0,025
0,025
0,025
0,025
0,025
0,0249
Age of onset
(years)
0,5
5,0434
14,2008
32,0278
52,5
67,6974
93,2586
0,0023
51,7627
1,2918
40000
2,7274
0,025
0,0035
4,385
19,7025
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates)
0,6255
0,2255
0,0608
0,0265
0,0257
0,0257
0,0256
Remission
(rates)
40
40
40
40
40
40
40
Mortality
(numbers)
0
0
0
0
0
0
19
Incidence
(numbers)
21523
168056
85923
83660
32164
16093
4927
Prevalence
(numbers)
268
4325
2261
2109
804
400
123
Remission
(numbers)
10738
172985
90445
84366
32164
16004
4924
Case fatality
(numbers)
0
0
0
0
0
10
18
Duration
(years)
0,025
0,025
0,025
0,025
0,025
0,025
0,0249
Mortality
(numbers)
0
0
0
0
0
10
18
RR mortality
(number)
0
1
1
1
0
4,7504
4,1927
Age of onset
(years)
0,5
5,0434
14,2008
32,0278
52,5
67,6974
93,2586
NA
NA
19
412347
10291
411626
28
0,025
28
4,385
19,7025
GRIB 6
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
628
40000
0
175,6161
2,1904
40000
0
229,7778
40000
0
143,0979
3,6806
40000
0
63
40000
0
60,4336
1,5883
40000
0
28,8
40000
0
29,2727
0,7375
40000
0
28
40000
0
28
0,7
40000
0
28
40000
0
28
0,7
40000
0
28
40000
0
28
0,7
40000
0
NA
NA
Duration
(years)
0,025
0,025
0,025
0,025
0,025
0,025
0,025
Age of onset
(years)
0,5
5,0512
14,2205
32,0676
52,5
67,5
96,5129
52,8781
1,3198
40000
0,025
21,9162
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
21223
166462
86707
90337
36533
20028
8465
Prevalence
(numbers)
265
4282
2279
2276
913
501
212
Remission
(numbers)
10588
171264
91154
91034
36533
20028
8465
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,025
0,025
0,025
0,025
0,025
0,025
0,025
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1
1
1
1
0
0
0
Age of onset
(years)
0,5
5,0512
14,2205
32,0676
52,5
67,5
96,5129
429754
10727
429066
0,025
21,9162
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
628
40000
229,7778
40000
63
40000
28,8
40000
28
40000
28
40000
28
40000
NA
NA
GRIC - 1
ABORTO
Females, Disease: Aborto (Rates * ), sex: Females
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
25
30
10
0
0
Remission
(rates * 1000)
0
20000
20000
20000
20000
20000
20000
Case fatality
(rates * 1000)
0
0
0,0007
0,001
0
0
0
Incidence
(rates * 1000)
0
0
24,9703
29,9552
9,9947
0
0
Prevalence
(rates * 1000)
0
0
1,186
1,4928
0,533
0,0167
0
Remission
(rates * 1000)
0
0
20000
20000
20000
20000
0
Case fatality
(rates * 1000)
0
0
0,0007
0,001
0
0
0
Age of onset
(years)
0
0
14,9994
32,4999
52,5005
0
0
NA
NA
NA
17,3872
0,8632
20000
0,0008
0,05
1,002
29,9096
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
25
30
10
0
0
Remission
(rates * 1000)
0
20000
20000
20000
20000
20000
20000
Case fatality
(rates * 1000)
0
0
0,0007
0,001
0
0
0
Incidence
(numbers)
0
0
35826
92444
13041
0
0
Prevalence
(numbers)
0
0
1702
4607
695
12
0
Remission
(numbers)
0
0
34033
92136
13909
238
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0,05
0,05
0,05
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1,0042
1,0014
0
0
0
Age of onset
(years)
0
0
14,9994
32,4999
52,5005
0
0
NA
NA
NA
141310
7016
140316
0,05
1,002
29,9096
Peso discapacidad: no hay al aborto, asociado a infertilidad es de 0,180. Para Chile se modelan los episodios, se estima peso la mitad de la infertilidad. 0,09
Duracin: se estima promedio 10 das en Victoria. Para Chile estimacin al menos 15 das.
GRIC - 2
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
11
0
0
0
NA
Remission
Mortality (rates *
Incidence
(rates * 1000)
1000)
(rates * 1000)
0
0
0
0
0
0
4000
0
0,1787
4000
0,0324
7,9566
4000
0
0,2267
0
0
0
0
0
0
NA
0,0123
3,0892
Prevalence
(rates * 1000)
0
0
0,0347
1,9683
0,0806
0
0
Remission
(rates * 1000)
0
0
4000
4000
4000
0
0
Case fatality
(rates * 1000)
0
0
47,4002
19,7829
17,3606
0
0
Age of onset
(years)
0,5
5,5
18,1888
33,2181
46,4022
0
0
0,7665
4000
19,963
0,2487
0,0157
49,7573
33,2199
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
11
0
0
0
Remission
(rates * 1000)
0
0
4000
4000
4000
0
0
Mortality
(numbers)
0
0
0
100
0
0
0
Incidence
(numbers)
0
0
256
24555
296
0
0
Prevalence
(numbers)
0
0
50
6074
105
0
0
Remission
(numbers)
0
0
199
24297
420
0
0
Case fatality
(numbers)
0
0
2
120
2
0
0
Duration
(years)
0
0
0,2469
0,2487
0,2488
0
0
Mortality
(numbers)
0
0
3
123
2
0
0
RR mortality
(number)
0
0
116,4311
48,7536
13,6974
0
0
Age of onset
(years)
0,5
5,5
18,1888
33,2181
46,4022
0
0
NA
NA
100
25107
6229
24917
124
0,2487
127
49,7573
33,2199
GRID 1
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
11,7
0
0,8388
11,6322
5,7917
0
8,3818
0
0
0
0
11,2475
0
5,0123
0
0
0
0
11,0625
0
0,0798
0
0
0
0
11,0619
0
0
0
0
0
0
11,0619
0
0
0
0
0
0
11,0619
0
0
0
0
0
0
11,0619
0
0
NA
NA
0,0132
Duration
(years)
70,8014
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,1832
11,0071
0,8599
70,8014
0,0095
20,3915
0,5
Mortality
(numbers)
105
0
0
0
0
0
0
Incidence
(numbers)
1459
0
0
0
0
0
0
Prevalence
(numbers)
727
13566
16416
34367
13871
6673
2064
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
6
68
1
0
0
0
0
Duration
(years)
70,8014
0
0
0
0
0
0
Mortality
(numbers)
6
68
1
0
0
0
0
RR mortality
(number)
1,9058
22,3797
3,4286
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
105
1459
87684
75
70,8014
75
20,3915
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
11,7
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
GRID 2
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
11,7
0
0,5645
11,6324
5,7794
0
12,6672
0
0
0
0
11,0566
0
7,5979
0
0
0
0
10,7822
0
0,1205
0
0
0
0
10,7813
0
0
0
0
0
0
10,7813
0
0
0
0
0
0
10,7813
0
0
0
0
0
0
10,7813
0
0
NA
NA
0,0084
0,173
Duration
(years)
74,7289
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
10,7465
1,2415
74,7289
0,0133
35,8758
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
11,7
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
Mortality
(numbers)
68
0
0
0
0
0
0
Incidence
(numbers)
1406
0
0
0
0
0
0
Prevalence
(numbers)
698
12862
15470
33272
14067
7712
3259
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
9
98
2
0
0
0
0
Duration
(years)
74,7289
0
0
0
0
0
0
Mortality
(numbers)
9
98
2
0
0
0
0
RR mortality
(number)
2,7535
39,4675
5,4195
0
0
0
1
Age of onset
(years)
0,5
0
0
0
0
0
0
68
1406
87340
108
74,7289
108
35,8758
0,5
Supuestos 5,3% de los RN son de bajo peso. De los cuales se estima que 30% tendrn discapacidad. El resto no.
25% discapacidad en menores de 1500 y 5% en el resto.
Perfil de discapacidad:
Retardo mental: 9%
0,11
0,0099
Parlisis cerebral: 26,3%
0,17
0,04471
Epilepsia: 4,2 %
0,11
0,00462
Sordera: 3,6%
0,37
0,01332
Visin: 4,8%
0,17
0,00816
Otras secuelas: 52,1%
0,0521
Total sin PC
73,70%
0,13281 Discapacidad pesada
Promedio duracin: 34 aos
GB duracin 68,1%
Hombres
Mujeres
<1
125469
120848
0,053
0,053
RN bajo peso n
6649,857
6404,944
Discapacidad
1994,9571
1921,4832
Disc modelable 1470,283383 1416,133118
11,7183
Tasa disca mod
Duracin
60 aos
Remisin
0
Discapacidad
11,7183
GRID 3
GRID 4
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Case fatality
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
2
1000
0,02
0,0159
1,9987
0,6316
1000
0,02
0
0
0
0
0
1,2631
0
0,0121
0
0
0
0
0
1,263
0
0,0002
0
0
0
0
0
1,263
0
0
0
0
0
0
0
1,263
0
0
0
0
0
0
0
1,263
0
0
0
0
0
0
0
1,263
0
0
NA
NA
NA
Duration
(years)
50,4701
0
0
0
0
0
0
Mortality
RR mortality Age of onset
(rates * 1000)
(number) (years)
0
1,0024
0,5
0
1,0246
0
0
1,0101
0
0
0
0
0
0
0
0
0
0
0
0
0
0,0003
0,0315
1,2531
7,9385
0,002
50,4701
Mortality
(numbers)
2
0
0
0
0
0
0
Incidence
(numbers)
251
0
0
0
0
0
0
Prevalence
(numbers)
79
1523
1874
3924
1584
762
236
Remission
(numbers)
79
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
50,4701
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
251
9982
79
50,4701
1,0224
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000)
2
1000
0,02
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
NA
0,5
GRID 5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Case fatality
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
2
1000
0,05
0,0496
1,9987
0,6316
1000
0,0494
0
0
0
0
0
1,2629
0
0,03
0
0
0
0
0
1,2628
0
0,0005
0
0
0
0
0
1,2628
0
0
0
0
0
0
0
1,2628
0
0
0
0
0
0
0
1,2628
0
0
0
0
0
0
0
1,2628
0
0
NA
NA
NA
Duration
(years)
58,6793
0
0
0
0
0
0
Mortality
RR mortality Age of onset
(rates * 1000)
(number) (years)
0
1,0074
0,5
0
1,0786
0
0
1,0396
0
0
0
0
0
0
0
0
0
0
0
1
0
0,0007
0,0297
1,2534
7,4923
0,0048
58,6793
Mortality
(numbers)
6
0
0
0
0
0
0
Incidence
(numbers)
242
0
0
0
0
0
0
Prevalence
(numbers)
76
1469
1812
3897
1648
903
382
Remission
(numbers)
76
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
58,6793
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
242
10187
76
58,6793
1,0716
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000)
2
1000
0,05
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
NA
0,5
Trauma se estima
En Chile egresos por trauma son en tota para 2004l: 414
<1
125469
120848
246317
Tasa egresos
1,68
Del totoal de las asfixias (5 por 1000)
Se estima que 40% son por trauma
Por lo tanto la tasa de incidencia de trauma en Chile es de 3 por 1000 NV
Esto equivale al 40% de la tasa de 5 por 1000 NV segn estimaciones nacionales e internacionales para asfixia y trauma
Es concordante con egresos
Discapacidad:
Del total de RN: 0,1% asfixia severa, leve a moderada 0,4% a 0,3%.
Total 0,5% con asfixia
Asfixia leve
0% discapac
Moderada
25% discapac
Severa
100% discapa
Tipos de discapacidad
PC
16% (incluido en otro tem)
Sordera
42%
Convulsiones
42%
Peso discapacidad
Leve
0,29
0,145
Moderada
0,43
0,129
Severa
0,82
0,164
Peso discap
0,438
GRID 6
GRID 7
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
1,5
12
0,7122
1,4989
0,745
12
0,0061
0
12
0
0
1,4123
12
0,0038
0
12
0
0
1,2602
12
0,0001
0
12
0
0
1,0247
12
0
0
12
0
0
0,8042
12
0
0
12
0
0
0,6717
12
0
0
12
0
0
0,5266
12
0
NA
NA
0,0112
0,0236
Duration
(years)
49,8958
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
1,0498
12
0,0009
49,8958
1,0068
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
1,5
12
0
12
0
12
0
12
0
12
0
12
0
12
NA
NA
Mortality
(numbers)
89
0
0
0
0
0
0
Incidence
(numbers)
188
0
0
0
0
0
0
Prevalence
(numbers)
93
1703
1870
3184
1008
405
98
Remission
(numbers)
1
20
22
38
12
5
1
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
49,8958
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1,0007
1,0074
1,0031
1
0
1
0
Age of onset
(years)
0,5
0
0
0
0
0
0
89
188
8362
100
49,8958
1,0068
0,5
GRID 8
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
1,5
12
0,6559
1,4989
0,745
12
0,0061
0
12
0
0
1,4123
12
0,0038
0
12
0
0
1,2602
12
0,0001
0
12
0
0
1,0247
12
0
0
12
0
0
0,8042
12
0
0
12
0
0
0,6717
12
0
0
12
0
0
0,5266
12
0
NA
NA
0,0098
0,0223
Duration
(years)
54,2989
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
1,0326
12
0,0008
54,2989
1,0088
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
1,5
12
0
12
0
12
0
12
0
12
0
12
0
12
NA
NA
Mortality
(numbers)
79
0
0
0
0
0
0
Incidence
(numbers)
181
0
0
0
0
0
0
Prevalence
(numbers)
90
1643
1808
3162
1049
480
159
Remission
(numbers)
1
20
22
38
13
6
2
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
54,2989
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1,0009
1,0095
1,0049
1
0
1
0
Age of onset
(years)
0,5
0
0
0
0
0
0
79
181
8392
101
54,2989
1,0088
0,5
GRID 9
Nmero RN
Hombres
Mujeres
125469
120848
0,003
0,003
376,407
362,544
501,876
362,544
878,283
725,088
<1
Severo
Resto
Total
0,8
246317
0,428571429
1603,371
GRID 10
SEPSIS NEONATAL
DisMod II input and output, database Sepsis
Males, Disease: sepsis neonatal (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
1
800000
0,2151
1
0,0006
800000
0,0061
0
0
0
0
0,0012
0
0,0037
0
0
0
0
0,0012
0
0,0001
0
0
0
0
0,0012
0
0
0
0
0
0
0,0012
0
0
0
0
0
0
0,0012
0
0
0
0
0
0
0,0012
0
0
NA
NA
0,0034
Duration
(years)
0,1006
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0158
0,0012
6350,35
0,0006
0,1006
1,0065
0,5
Mortality
(numbers)
27
0
0
0
0
0
0
Incidence
(numbers)
125
0
0
0
0
0
0
Prevalence
(numbers)
0
2
2
4
2
1
0
Remission
(numbers)
63
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,1006
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1,0007
1,0076
1,0031
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
27
125
10
63
0,1006
1,0065
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
1
800000
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
GRID 11
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
Duration
(years)
Age of onset
(years)
1
0
0
0
0
0
0
900000
0
0
0
0
0
0
0,1985
0
0
0
0
0
0
1
0
0
0
0
0
0
0,0006
0,0011
0,0011
0,0011
0,0011
0,0011
0,0011
900000
0
0
0
0
0
0
0,0061
0,0037
0,0001
0
0
0
0
0,1039
0
0
0
0
0
0
0
0
0
0
0
0
0
1,0009
1,0098
1,0049
0
0
0
0
0,5
0
0
0
0
0
0
NA
NA
0,003
0,0149
0,0011
6741,5883
0,0006
0,1039
1,0084
0,5
Mortality
(numbers)
24
0
0
0
0
0
0
Incidence
(numbers)
121
0
0
0
0
0
0
Prevalence
(numbers)
0
1
2
3
1
1
0
Remission
(numbers)
60
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,1039
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1,0009
1,0098
1,0049
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
24
121
60
0,1039
1,0084
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
1
900000
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
DESNUTRICION
DisMod II input and output, database OA
Males, Disease: desnutricion (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(rates * 1000)
9
5,4514
10,0307
6,1074
2
5,9621
9
6,1946
0,0237
Prevalence
(rates * 1000)
7,8599
5,003
9,052
6,3947
2,2683
4,7366
9,7622
Remission
(rates * 1000)
500
500
500
491,3178
310,7183
16,2283
0,0061
Case fatality
(rates * 1000)
0,9932
0,6197
0,0898
0,3739
4,164
13,7387
48,0818
Duration
(years)
1,987
1,9975
1,9968
2,0744
4,5251
10,8491
6,4726
Age of onset
(years)
0,5
6,2942
15,4981
28,5287
51,0386
67,6667
76,6953
2,5934
6,0058
437,2116
3,1779
2,2988
0,0191
1,6664
21,8418
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(numbers)
1129
6575
14884
18974
2508
3597
1679
Remission
(rates * 1000)
800
800
700
500
300
0
0
Mortality
(numbers)
1
0
1
8
11
39
129
Incidence
(numbers)
202
2986
7678
8594
791
399
10
Prevalence
(numbers)
986
6034
13432
19867
2844
2857
1822
Remission
(numbers)
493
3017
6716
9761
884
46
0
Case fatality
(numbers)
1
4
1
7
12
39
88
Duration
(years)
1,987
1,9975
1,9968
2,0744
4,5251
10,8491
6,4726
Mortality
(numbers)
1
4
1
7
12
39
88
RR mortality
(number)
1,1073
3,4969
1,3028
1,3004
1,8309
1,8345
1,5329
Age of onset
(years)
0,5
6,2942
15,4981
28,5287
51,0386
67,6667
76,6953
49347
NA
189
20659
47843
20917
152
2,2988
152
1,6664
21,8418
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(rates * 1000)
9
5,4514
11,197
11,6525
2
14,9945
24
9,8489
0,0364
Prevalence
(rates * 1000)
7,8596
5,0058
9,4872
11,7903
10,0063
15,3582
26,3599
Remission
(rates * 1000)
500
500
500
453,7444
10,3109
0,0196
0,0061
Case fatality
(rates * 1000)
2,0334
1,225
0,0892
0,0858
0,8207
7,3561
20,3329
Duration
(years)
1,9853
1,9963
1,9987
4,3749
30,7246
14,3414
9,4874
Age of onset
(years)
0,5
6,2935
15,6622
30,0229
46,2292
68,8545
76,5487
3,4543
10,9238
302,2854
3,007
3,8663
0,0328
1,5985
24,5286
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(numbers)
1088
6341
16065
35960
2609
10725
7256
Remission
(rates * 1000)
800
800
700
500
0
0
0
Mortality
(numbers)
2
0
1
3
3
72
215
Incidence
(numbers)
195
2886
7995
16004
139
827
27
Prevalence
(numbers)
950
5823
13612
36386
13056
10985
7969
Remission
(numbers)
475
2912
6806
16510
135
0
0
Case fatality
(numbers)
2
7
1
3
11
81
162
Duration
(years)
1,9853
1,9963
1,9987
4,3749
30,7246
14,3414
9,4874
Mortality
(numbers)
2
7
1
3
11
81
162
RR mortality
(number)
1,2815
7,1142
1,5669
1,1507
1,5849
1,7478
1,2953
Age of onset
(years)
0,5
6,2935
15,6622
30,0229
46,2292
68,8545
76,5487
80045
NA
296
28074
88780
26837
267
3,8663
267
1,5985
24,5286
GRIE - 3
ANEMIA
DisMod II input and output, database OA
Males, Disease: anemia ferropriva (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(rates * 1000)
45
10
19
8
20
54
54
Remission
(rates * 1000)
1000
1000
1000
1000
1000
500
500
17,3845
NA
Remission
(rates * 1000)
763,294
671,6197
527,6633
523,2126
520,9451
502,1704
500
8,532
16,1847
539,4087
Case fatality
Mortality (rates
(rates * 1000) Duration (years)
* 1000)
0,0061
1,3259
0,0002
0,0061
1,6528
0,0001
0,0061
1,8904
0,0001
0,0061
1,9124
0,0001
0,0061
1,8952
0,0001
0,0915
1,8866
0,0045
0,5761
1,6468
0,0311
0,0702
1,8487
RR mortality
(number)
1,0007
1,0237
1,0177
1,004
1,0011
1,0067
1,0069
Age of onset
(years)
0,5
6,0521
14,7679
32,8212
52,7092
66,5477
82,0049
0,0011
1,007
41,985
Mortality
(numbers)
0
0
0
0
0
3
6
RR mortality
(number)
1,0007
1,0237
1,0177
1,004
1,0011
1,0067
1,0069
Age of onset
(years)
0,5
6,0521
14,7679
32,8212
52,7092
66,5477
82,0049
1,007
41,985
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(numbers)
5646
12062
28194
24854
25079
32575
10077
Remission
(rates * 1000)
1000
1000
1000
1000
1000
500
500
Mortality
(numbers)
0
0
0
0
0
0
6
Incidence
(numbers)
542
6779
12383
13829
13255
16142
5038
Prevalence
(numbers)
4329
12493
22831
27199
22443
29566
10069
Remission
(numbers)
3304
8390
12047
14231
11692
14847
5034
138487
NA
67967
128929
69546
Case fatality
(numbers) Duration (years)
0
1,3259
0
1,6528
0
1,8904
0
1,9124
0
1,8952
3
1,8866
6
1,6468
9
1,8487
GRIE - 4
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(rates * 1000)
45
10
46
48
44
82
82
Remission
(rates * 1000)
1000
1000
1000
1000
1000
500
500
45,7782
NA
Remission
(rates * 1000)
763,294
668,8468
539,8146
523,5506
521,5476
502,1151
499,9831
23,3578
43,4764
528,5426
Case fatality
Mortality (rates
(rates * 1000) Duration (years)
* 1000)
0,0061
1,327
0,0002
0,0061
1,6584
0,0001
0,0061
1,8597
0,0002
0,0061
1,9089
0,0003
0,0067
1,9097
0,0003
0,0184
1,9297
0,0014
0,2379
1,7119
0,0196
0,0244
1,8798
RR mortality
(number)
1,0009
1,0339
1,0265
1,0114
1,0024
1,0014
1,0034
Age of onset
(years)
0,5
6,3218
15,5026
32,4046
51,9945
66,8266
83,6639
0,0011
1,0051
40,2909
Mortality
(numbers)
0
0
0
1
0
1
6
RR mortality
(number)
1,0009
1,0339
1,0265
1,0114
1,0024
1,0014
1,0034
Age of onset
(years)
0,5
6,3218
15,5026
32,4046
51,9945
66,8266
83,6639
1,0051
40,2909
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(numbers)
5438
11633
65998
148131
57409
58652
24790
Remission
(rates * 1000)
1000
1000
1000
1000
1000
500
500
Mortality
(numbers)
0
0
0
0
0
1
8
Incidence
(numbers)
522
7189
32540
76797
31415
28998
12374
Prevalence
(numbers)
4169
12460
50775
147411
59211
54439
24881
Remission
(numbers)
3183
8334
27409
77177
30881
27334
12440
372051
NA
189835
353345
186758
Case fatality
(numbers) Duration (years)
0
1,327
0
1,6584
0
1,8597
1
1,9089
0
1,9097
1
1,9297
6
1,7119
9
1,8798
TABLAS DISMOD
GRUPO II
vii
GRIIA 1
ESOFAGO
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0
0,00000363
0,00009302
0,00059
0,00105453
Remission
(rates)
0,17
0,17
0,17
0,17
0,17
0,17
0,17
Mortality (rates)
0
0
0
0,000001
0,00003515
0,00033264
0,00110061
Incidence
(rates)
0
0
0,0000151
0,000016
0,00006175
0,00048361
0,00100223
Prevalence
(rates)
0
0
0,00002363
0,00010981
0,00005607
0,00058138
0,00157158
Remission
(rates)
0
0
0,17039717
0,16395862
0,17133413
0,17079966
0,16789496
Case fatality
RR mortality
Duration (years) Mortality (rates)
(rates)
(number)
0
0
0
0
0
0
0
0
0,00203501
5,73989353
0,00000005
3,62569786
0,01038103
5,44882144
0,00000114
17,3993862
0,67438679
1,17323102
0,0000386
132,5636152
0,53666784
1,40249546
0,00031407
30,84034362
0,50397661
1,24183403
0,00078966
6,45315912
Age of onset
(years)
0,5
7,43646492
17,92783469
25,1492645
55,7175274
68,06253485
82,14249112
NA
NA
0,00005689
0,00007887
0,00013689
0,16789991
0,35492413
34,13335984
65,88438978
Incidence
(rates)
0
0
0
0,00000578
0,00003971
0,00027226
0,00059063
Remission
(rates)
0,15
0,15
0,15
0,15
0,15
0,15
0,15
Mortality (rates)
0
0
0
0,00000101
0,00001453
0,00014832
0,00061795
Incidence
(rates)
0
0
0,0000012
0,00000517
0,00002914
0,00021746
0,00056719
Prevalence
(rates)
0
0
0,00000189
0,00002145
0,00005571
0,00025734
0,00096441
Remission
(rates)
0
0
0,14884926
0,1490555
0,14990217
0,15049845
0,14849998
Case fatality
Duration (years) Mortality (rates)
(rates)
0
0
0
0
0
0
0,02329392
5,3682054
0,00000004
0,04684066
4,5958013
0,00000101
0,28719804
1,94081114
0,00001604
0,52783366
1,54383327
0,00013698
0,46036592
1,39169388
0,00044304
RR mortality
(number)
0
0
88,5816763
77,06891959
83,16447652
58,66300491
7,64987326
Age of onset
(years)
0
0
17,94526387
33,13030419
54,53143941
68,97269102
83,98037798
NA
NA
0,00003876
0,00004709
0,00007595
0,1493222
0,41382035
34,20834225
73,15779269
5,7
3,9
7,9
4,7
1,80122528
0,00004881
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
1,65961492
0,0000315
4,9
3,2
Diferencia en onset years
0,8
0,7
7,3
GRIIA 2
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0
0,00000363
0,00009302
0,00059
0,00105453
Remission
(rates)
0,17
0,17
0,17
0,17
0,17
0,17
0,17
Mortality
(numbers)
0
0
0
3
44
201
205
Incidence
(numbers)
0
0
22
50
77
292
187
Prevalence
(numbers)
0
0
35
341
70
351
293
Remission
(numbers)
0
0
6
56
12
60
49
NA
NA
453
628
1090
183
Incidence
(rates)
0
0
0
0,00000578
0,00003971
0,00027226
0,00059063
Remission
(rates)
0,15
0,15
0,15
0,15
0,15
0,15
0,15
Mortality
(numbers)
0
0
0
3
19
106
187
Incidence
(numbers)
0
0
2
16
38
156
171
Prevalence
(numbers)
0
0
3
66
73
184
292
Remission
(numbers)
0
0
0
10
11
28
43
NA
NA
315
383
617
92
Case fatality
(numbers) Duration (years)
0
0
0
0
0
5,73989353
4
5,44882144
47
1,17323102
188
1,40249546
148
1,24183403
387
1,80122528
Mortality
(numbers)
0
0
0
4
48
189
147
RR mortality
(number)
0
0
3,62569786
17,3993862
132,5636152
30,84034362
6,45315912
Age of onset
(years)
0,5
7,43646492
17,92783469
25,1492645
55,7175274
68,06253485
82,14249112
389
34,13335984
65,88438978
Mortality
(numbers)
0
0
0
3
21
98
134
RR mortality
(number)
0
0
88,5816763
77,06891959
83,16447652
58,66300491
7,64987326
Age of onset
(years)
0
0
17,94526387
33,13030419
54,53143941
68,97269102
83,98037798
256
34,20834225
73,15779269
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Case fatality
(numbers) Duration (years)
0
0
0
0
0
5,3682054
3
4,5958013
21
1,94081114
97
1,54383327
134
1,39169388
255
1,65961492
GRIIA 3
LEUCEMIA
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00014513
0,00013641
0,00007232
0,00003746
0,00007191
0,00014962
0,00024001
Remission
(rates)
0,4
0,4
0,4
0,4
0,4
0,4
0,4
Mortality
(rates)
0,00001594
0,00001327
0,00002291
0,00001812
0,00004007
0,00014508
0,00036776
Incidence
(rates)
0,00014129
0,00012603
0,00007741
0,00003954
0,00006692
0,00014753
0,00025669
Prevalence
(rates)
0,00005632
0,00024196
0,00018237
0,00005885
0,00006792
0,00006681
0,00010655
Remission
(rates)
0,41359247
0,40135698
0,38622748
0,39326398
0,39808705
0,39545799
0,38954805
Case fatality
(rates)
0,05830186
0,05954464
0,11476285
0,31712188
0,5746371
1,7978931
1,95977028
Duration
(years)
2,12505072
2,15463273
1,91087324
1,36192472
0,98415525
0,4431376
0,40699924
Mortality
(rates)
0,00000354
0,00001444
0,00002086
0,00001864
0,00003904
0,0001205
0,0002104
RR mortality
(number)
73,1516365
192,0418182
293,2860922
205,9250021
102,8018279
84,48622272
23,83424245
Age of onset
(years)
0,5
5,37411146
14,41298822
32,26703719
52,50019105
67,35059845
82,46106425
NA
NA
0,0000395
0,00007887
0,00011269
0,39440764
0,2976365
1,42221592
0,0000336
136,3455504
33,3824122
Incidence
(rates)
0,00012657
0,00013022
0,00006624
0,00003832
0,00008493
0,00012324
0,00018571
Remission
(rates)
0,4
0,4
0,4
0,4
0,4
0,4
0,4
Mortality
(rates)
0,00002483
0,00001375
0,00001411
0,00001647
0,00004737
0,00007909
0,00030216
Incidence
(rates)
0,00012695
0,00011347
0,00007216
0,00004024
0,00007099
0,00011763
0,00019989
Prevalence
(rates)
0,00005042
0,0002144
0,00017294
0,0000666
0,00007314
0,00009491
0,00010736
Remission
(rates)
0,41204189
0,40427181
0,38953722
0,38914863
0,3966107
0,39918332
0,3893744
Case fatality
(rates)
0,06741886
0,06559709
0,08440712
0,24778294
0,56400529
0,80570291
1,55949958
Duration
(years)
2,09113224
2,13295137
2,06054893
1,50718779
1,00071129
0,81685123
0,47627436
Mortality
(rates)
0,00000367
0,0000141
0,00001456
0,00001649
0,00004129
0,00007668
0,00016559
RR mortality
(number)
122,4844868
295,990466
396,4919922
447,1517339
192,0770979
74,31777874
24,20049052
Age of onset
(years)
0,5
5,38046878
14,50768507
32,4776206
52,55500568
67,52194697
84,24770492
NA
NA
0,00003689
0,00007533
0,00011134
0,39512515
0,2738074
1,47705635
0,00003044
208,4963719
36,39511882
4,0
3,7
7,9
7,5
3,4
3,0
Masc
Fem
0,6
0,6
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Diferencia en onset
Diferencia entre mortalidad inicial y la estimada
3,0
GRIIA 4
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00014513
0,00013641
0,00007232
0,00003746
0,00007191
0,00014962
0,00024001
Remission
(rates)
0,4
0,4
0,4
0,4
0,4
0,4
0,4
Mortality
(numbers)
2
16
34
56
50
88
69
Incidence
(numbers)
18
152
115
123
84
89
48
Prevalence
(numbers)
7
292
271
183
85
40
20
Remission
(numbers)
3
117
105
72
34
16
8
Case fatality
(numbers)
0
17
31
58
49
72
39
Duration
(years)
2,12505072
2,15463273
1,91087324
1,36192472
0,98415525
0,4431376
0,40699924
Mortality
(numbers)
0
17
31
58
49
73
39
RR mortality
(number)
73,1516365
192,0418182
293,2860922
205,9250021
102,8018279
84,48622272
23,83424245
Age of onset
(years)
0,5
5,37411146
14,41298822
32,26703719
52,50019105
67,35059845
82,46106425
NA
NA
315
628
898
354
267
1,42221592
268
136,3455504
33,3824122
Incidence
(rates)
0,00012657
0,00013022
0,00006624
0,00003832
0,00008493
0,00012324
0,00018571
Remission
(rates)
0,4
0,4
0,4
0,4
0,4
0,4
0,4
Mortality
(numbers)
3
16
20
51
62
57
91
Incidence
(numbers)
15
132
104
124
93
84
60
Prevalence
(numbers)
6
249
248
206
95
68
32
Remission
(numbers)
3
101
97
80
38
27
13
Case fatality
(numbers)
0
16
21
51
54
55
51
Duration
(years)
2,09113224
2,13295137
2,06054893
1,50718779
1,00071129
0,81685123
0,47627436
Mortality
(numbers)
0
16
21
51
54
55
50
RR mortality
(number)
122,4844868
295,990466
396,4919922
447,1517339
192,0770979
74,31777874
24,20049052
Age of onset
(years)
0,5
5,38046878
14,50768507
32,4776206
52,55500568
67,52194697
84,24770492
NA
NA
300
612
905
358
248
1,47705635
247
208,4963719
36,39511882
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 5
CANCER BOCA
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0
0,000007
0,000044
0,00015
0,00016
Remission
(rates)
0,1
0,1
0,1
0,1
0,1
0,1
0,1
Mortality
(rates)
0
0
0
0,00000131
0,00002311
0,00012021
0,00017912
Incidence
(rates)
0
0
0,00000149
0,00000716
0,00003626
0,00013563
0,00016519
Prevalence
(rates)
0
0
0,00000249
0,00004059
0,00009684
0,00018473
0,00019774
Remission
(rates)
0
0
0,09951747
0,10021367
0,10072611
0,10022721
0,099429
Case fatality
(rates)
0
0
0,02246147
0,03156629
0,2072109
0,60888257
0,78069264
Duration
(years)
0
0
7,3766323
6,5195308
2,66680136
1,32677396
0,99163176
Mortality
(rates)
0
0
0,00000006
0,00000128
0,0000201
0,00011263
0,00015385
RR mortality
(number)
0
0
29,86172282
21,45541189
34,16752758
30,37379032
10,04412665
Age of onset
(years)
0,5
5,61430867
17,94367114
32,81609359
53,65382849
66,98641735
82,07868775
NA
NA
0,00001745
0,00002292
0,00005016
0,10029427
0,31503644
2,30989218
0,00001581
26,21597539 61,69731206
Incidence
(rates)
0
0
0
0,0000035
0,000022
0,000075
0,00008
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(rates)
0
0
0
0,000002
0,00000414
0,00002547
0,00011596
Incidence
(rates)
0
0
0,00000083
0,00000386
0,00001862
0,00006796
0,00008399
Prevalence
(rates)
0
0
0,00000119
0,00000943
0,00004248
0,00017243
0,00015517
Remission
(rates)
0
0
0,19509651
0,19687006
0,20278425
0,20155389
0,19516582
Case fatality
(rates)
0
0
0,04397689
0,18937826
0,10289649
0,13986777
0,46769239
Duration
(years)
0
0
3,59794119
2,54720327
3,17014015
2,64551873
1,23549843
Mortality
(rates)
0
0
0,00000005
0,00000179
0,00000439
0,00002415
0,00007197
RR mortality
(number)
0
0
168,2207577
312,5467468
47,43086709
12,40149637
8,05007719
NA
NA
0,00000798
0,0000137
0,00003156
0,20007706
0,19681642
2,43811512
0,00000619
47,60480185 64,42805698
1,7
0,8
2,3
1,4
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
1,6
0,6
Diferencia en onset years
0,2
0,2
Age of onset
(years)
0,5
6,44492975
17,94488045
32,84866389
53,66965635
67,27302846
83,82046709
2,7
GRIIA 6
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0
0,000007
0,000044
0,00015
0,00016
Remission
(rates)
0,1
0,1
0,1
0,1
0,1
0,1
0,1
Mortality
(numbers)
0
0
0
4
29
73
33
Incidence
(numbers)
0
0
2
22
45
82
31
Prevalence
(numbers)
0
0
4
126
121
111
37
Remission
(numbers)
0
0
0
13
12
11
4
Case fatality
(numbers)
0
0
0
4
25
68
29
Duration
(years)
0
0
7,3766323
6,5195308
2,66680136
1,32677396
0,99163176
Mortality
(numbers)
0
0
0
4
25
68
29
NA
NA
139
183
400
40
126
2,30989218
126
Incidence
(rates)
0
0
0
0,0000035
0,000022
0,000075
0,00008
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(numbers)
0
0
0
6
5
18
35
Incidence
(numbers)
0
0
1
12
24
49
25
Prevalence
(numbers)
0
0
2
29
55
123
47
Remission
(numbers)
0
0
0
6
11
25
9
Case fatality
(numbers)
0
0
0
6
6
17
22
Duration
(years)
0
0
3,59794119
2,54720327
3,17014015
2,64551873
1,23549843
Mortality
(numbers)
0
0
0
6
6
17
22
NA
NA
65
111
256
51
50
2,43811512
50
RR mortality
(number)
0
0
29,86172282
21,45541189
34,16752758
30,37379032
10,04412665
Age of onset
(years)
0,5
5,61430867
17,94367114
32,81609359
53,65382849
66,98641735
82,07868775
26,21597539 61,69731206
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
RR mortality
(number)
0
0
168,2207577
312,5467468
47,43086709
12,40149637
8,05007719
Age of onset
(years)
0,5
6,44492975
17,94488045
32,84866389
53,66965635
67,27302846
83,82046709
47,60480185 64,42805698
GRIIA 7
CANCER GASTRICO
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0,00000391
0,00007917
0,00074354
0,00282354
0,00425836
Remission
(rates)
0,14
0,14
0,14
0,14
0,14
0,14
0,14
Mortality
(rates)
0
0
0
0,00002517
0,00030662
0,00158375
0,00400114
Incidence
(rates)
0
0,00000022
0,00000479
0,00006649
0,00058821
0,00240113
0,00425266
Prevalence
(rates)
0
0,0000002
0,00001508
0,00010538
0,00139312
0,00408309
0,00890188
Remission
(rates)
0
0,14
0,13998891
0,14099636
0,14108524
0,14062072
0,13883817
Case fatality
(rates)
0
0
0,00512107
0,23560905
0,19406234
0,36629052
0,35681461
Duration
(years)
0
6,12428912
4,45260912
3,03377052
2,59261941
1,90697682
1,61073391
Mortality
(rates)
0
0
0,00000008
0,00002532
0,00027098
0,00150047
0,00317298
RR mortality
(number)
0
0
32,95530891
458,9749145
31,82587722
20,46111139
4,90979845
Age of onset
(years)
0,5
9,00966525
15,59891627
39,77174459
53,62846416
67,7713918
82,1300768
NA
NA
0,00027174
0,0004009
0,00078095
0,14029268
0,30720756
2,07062851
0,0002405
35,67546422
66,3827822
Incidence
(rates)
0
0
0,00000113
0,00004967
0,00029421
0,00091247
0,00158141
Remission
(rates)
0,19
0,19
0,19
0,19
0,19
0,19
0,19
Mortality
(rates)
0
0
0,0000007
0,00001594
0,000107
0,0004958
0,00184983
Incidence
(rates)
0
0,00003271
0,00002515
0,00004415
0,00024956
0,00083747
0,00158048
Prevalence
(rates)
0
0,0000627
0,00017995
0,00010189
0,00059009
0,00142124
0,00210884
Remission
(rates)
0,19
0,18877461
0,18204143
0,1908707
0,19117862
0,19082881
0,18720199
Case fatality
(rates)
0
0,00172664
0,00427971
0,1401845
0,16425836
0,33577885
0,62485933
Duration
(years)
0
5,0948644
4,74581654
3,07596266
2,52835354
1,81110995
1,05825004
Mortality
(rates)
0
0,00000011
0,00000077
0,00001433
0,00009711
0,00047848
0,00131094
RR mortality
(number)
0
17,88190261
26,9124878
378,9547199
50,63191991
30,46189646
10,12596201
Age of onset
(years)
0,5
7,40125938
12,68795454
38,37648942
53,3547378
67,85522046
84,17106385
NA
NA
0,0001358
0,00019845
0,00037769
0,18937964
0,29694348
1,98284691
0,00011206
41,33359981
65,33969789
27,2
13,6
40,1
19,8
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
24,1
11,2
Diferencia en onset years
3,1
2,4
-1,0
GRIIA 8
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00000594
0,00000264
0,00000391
0,00007917
0,00074354
0,00282354
0,00425836
Remission
(rates)
0,14
0,14
0,14
0,14
0,14
0,14
0,14
Mortality
(numbers)
0
0
0
78
384
955
747
Incidence
(numbers)
1
5
7
207
738
1448
794
Prevalence
(numbers)
0
21
36
330
1747
2463
1661
Remission
(numbers)
0
3
5
47
246
346
231
Case fatality
(numbers)
0
0
0
77
339
902
593
Duration
(years)
6,80124506
6,55794049
4,52281138
3,03607554
2,59260933
1,90697655
1,61073391
Mortality
(numbers)
0
0
0
79
340
905
592
RR mortality
(number)
0
0
30,13501052
451,1774944
31,82605891
20,4611204
4,90979845
Age of onset
(years)
0,5
4,59560012
15,54232816
39,77173231
53,62845668
67,77139263
82,1300768
NA
NA
2165
3199
6258
878
1911
2,07811352
1916
35,40395891
66,28445147
Incidence
(rates)
0
0
0,00000391
0,00007917
0,00074354
0,00282354
0,00425836
Remission
(rates)
0,14
0,14
0,14
0,14
0,14
0,14
0,14
Mortality
(numbers)
0
0
0
78
384
955
747
Incidence
(numbers)
0
0
7
207
738
1448
794
Prevalence
(numbers)
0
0
22
327
1747
2463
1661
Remission
(numbers)
0
0
3
46
246
346
231
Case fatality
(numbers)
0
0
0
77
339
902
593
Duration
(years)
0
6,12428912
4,45260912
3,03377052
2,59261941
1,90697682
1,61073391
Mortality
(numbers)
0
0
0
79
340
905
592
RR mortality
(number)
0
0
32,95530891
458,9749145
31,82587722
20,46111139
4,90979845
Age of onset
(years)
0,5
9,00966525
15,59891627
39,77174459
53,62846416
67,7713918
82,1300768
NA
NA
2165
3194
6221
873
1911
2,07062851
1916
35,67546422
66,3827822
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 9
CANCER COLON
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,000000
0,000000
0,000001
0,000021
0,000119
0,000464
0,000847
Remission
(rates)
0,080000
0,080000
0,080000
0,080000
0,080000
0,080000
0,080000
Mortality (rates)
0,000000
0,000000
0,000000
0,000007
0,000045
0,000311
0,001177
Incidence
(rates)
0,000000
0,000000
0,000002
0,000019
0,000096
0,000395
0,000851
Prevalence
(rates)
0,000000
0,000000
0,000007
0,000065
0,000339
0,000730
0,001389
Remission
(rates)
0,000000
0,080000
0,079577
0,080273
0,080301
0,080048
0,079409
Case fatality
(rates)
0,000000
0,000000
0,016060
0,098695
0,131445
0,403709
0,573197
Duration
(years)
0,000000
8,895584
6,174040
5,464065
3,655954
1,899383
1,252416
Mortality (rates)
0,000000
0,000000
0,000000
0,000006
0,000045
0,000295
0,000794
RR mortality
(number)
0,000000
0,000000
30,074265
94,031398
21,938531
20,429803
7,167738
Age of onset
(years)
0,500000
9,009666
16,174390
37,087821
53,623389
67,784531
82,321088
NA
NA
0,000061
0,000073
0,000168
0,080034
0,300938
2,476176
0,000050
19,399107
65,712413
Incidence
(rates)
0
0
0,00000181
0,00002586
0,00018656
0,00047038
0,00088297
Remission
(rates)
0,12
0,12
0,12
0,12
0,12
0,12
0,12
Mortality (rates)
0
0
0
0,0000107
0,00005253
0,00026801
0,00122255
Incidence
(rates)
0
0,0000001
0,0000028
0,00002452
0,00014946
0,00043106
0,00088457
Prevalence
(rates)
0
0,00000009
0,00000831
0,00006482
0,00047039
0,00106478
0,00146614
Remission
(rates)
0
0,12
0,11998795
0,12071225
0,12121037
0,12011696
0,11857892
Case fatality
(rates)
0
0
0,0024869
0,14017598
0,1041693
0,24277858
0,55157379
Duration
(years)
0
7,07518853
5,28103468
4,09109751
3,84367654
2,46946697
1,24184985
Mortality (rates)
0
0
0,00000002
0,00000911
0,00004908
0,00025883
0,00080454
RR mortality
(number)
0
0
41,36289712
377,1997878
32,17979351
20,93130984
9,01108939
Age of onset
(years)
0,5
9,00973491
16,095819
37,24680569
53,5053961
67,82504109
84,13311287
NA
NA
0,00008156
0,00010465
0,00024986
0,12016959
0,25675841
2,55673267
0,00006405
35,99423371
67,38513167
6,1
8,2
7,3
10,5
5,0
6,4
Masc
Fem
1,1
1,8
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Diferencia en onset y
Diferencia entre mortalidad inicial y la estimada
1,7
GRIIA 10
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0,00000144
0,00002084
0,0001187
0,00046425
0,00084712
Remission
(rates)
0,08
0,08
0,08
0,08
0,08
0,08
0,08
Mortality
(numbers)
0
0
0
23
57
188
220
Incidence
(numbers)
0
0
3
59
121
238
159
Prevalence
(numbers)
0
0
11
201
425
440
259
Remission
(numbers)
0
0
1
16
34
35
21
Case fatality
(numbers)
0
0
0
20
56
178
149
Duration
(years)
0
8,89558431
6,17404018
5,46406488
3,6559539
1,89938262
1,25241603
Mortality
(numbers)
0
0
0
20
56
178
148
RR mortality
(number)
0
0
30,07426517
94,03139849
21,93853097
20,429803
7,16773812
Age of onset
(years)
0,5
9,00966557
16,17438958
37,08782098
53,62338926
67,78453092
82,3210884
NA
NA
487
580
1337
107
402
2,47617589
402
19,39910719
65,71241298
Incidence
(rates)
0
0
0,00000181
0,00002586
0,00018656
0,00047038
0,00088297
Remission
(rates)
0,12
0,12
0,12
0,12
0,12
0,12
0,12
Mortality
(numbers)
0
0
0
33
69
192
370
Incidence
(numbers)
0
0
4
76
195
308
267
Prevalence
(numbers)
0
0
12
200
614
762
443
Remission
(numbers)
0
0
1
24
74
91
53
Case fatality
(numbers)
0
0
0
28
64
185
244
Duration
(years)
0
7,07518853
5,28103468
4,09109751
3,84367654
2,46946697
1,24184985
Mortality
(numbers)
0
0
0
28
64
185
243
RR mortality
(number)
0
0
41,36289712
377,1997878
32,17979351
20,93130984
9,01108939
Age of onset
(years)
0,5
9,00973491
16,095819
37,24680569
53,5053961
67,82504109
84,13311287
NA
NA
663
851
2031
244
521
2,55673267
521
35,99423371
67,38513167
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 11
CANCER RECTO
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0
0,00000753
0,00005271
0,00023383
0,00046491
Remission
(rates)
0,08
0,08
0,08
0,08
0,08
0,08
0,08
Mortality
(rates)
0
0
0,00000067
0,00000228
0,0000204
0,00014535
0,00031064
Incidence
(rates)
0
0
0
0,00000748
0,00004784
0,00021
0,00048161
Prevalence
(rates)
0
0
0
0,00002213
0,0001632
0,00045373
0,00145264
Remission
(rates)
0
0
0
0,08060938
0,08056601
0,08002037
0,07993083
Case fatality
(rates)
0
0
0
0,11136526
0,12411318
0,29193023
0,19244477
Duration
(years)
0
0
0
5,26962015
3,80986051
2,61148381
2,55854925
Mortality
(rates)
0
0
0
0,00000248
0,00002028
0,00013278
0,00027992
RR mortality
(number)
0
0
580,394135
199,9413853
20,11692211
16,13955365
3,20920451
Age of onset
(years)
0
0
0
36,51354474
53,84842455
68,33116701
82,3106355
NA
NA
0,00002251
0,00003763
0,00010271
0,08017667
0,20182251
3,04155904
0,00002077
21,22241852
67,47839723
Incidence
(rates)
0
0
0
0,00000994
0,00005768
0,00017486
0,00021237
Remission
(rates)
0,14
0,14
0,14
0,14
0,14
0,14
0,14
Mortality
(rates)
0
0
0
0,00000273
0,00002256
0,00006705
0,00028298
Incidence
(rates)
0
0
0
0,00000998
0,00005632
0,0001702
0,00022447
Prevalence
(rates)
0
0
0
0,00003122
0,0001798
0,00049354
0,00054817
Remission
(rates)
0
0
0
0,14073737
0,14081632
0,14091397
0,13758026
Case fatality
(rates)
0
0
0
0,0760554
0,1041469
0,13874505
0,34635539
Duration
(years)
0
0
0
4,53743471
3,77535532
3,2015816
1,61164557
Mortality
(rates)
0
0
0
0,00000238
0,00001875
0,00006859
0,00018917
RR mortality
(number)
0
1
0
181,1408508
33,61723602
13,45332206
6,0991483
Age of onset
(years)
0
0
0
36,23959843
52,32514576
67,32971841
84,12432791
NA
NA
0,00002108
0,00003616
0,00010455
0,14021677
0,16257781
3,11790566
0,00001699
22,89795463
64,78775168
2,3
2,1
3,8
3,6
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
2,1
1,7
Diferencia en onset years
0,2
0,4
-2,7
GRIIA 12
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0
0,00000753
0,00005271
0,00023383
0,00046491
Remission
(rates)
0,08
0,08
0,08
0,08
0,08
0,08
0,08
Mortality
(numbers)
0
0
1
7
26
88
58
Incidence
(numbers)
0
0
0
23
60
127
90
Prevalence
(numbers)
0
0
0
69
205
274
271
Remission
(numbers)
0
0
0
6
16
22
22
Case fatality
(numbers)
0
0
0
8
25
80
52
Duration
(years)
0
0
0
5,26962015
3,80986051
2,61148381
2,55854925
Mortality
(numbers)
0
0
0
8
25
80
52
RR mortality
(number)
0
0
580,394135
199,9413853
20,11692211
16,13955365
3,20920451
Age of onset
(years)
0
0
0
36,51354474
53,84842455
68,33116701
82,3106355
NA
NA
179
300
818
66
165
3,04155904
165
21,22241852
67,47839723
Incidence
(rates)
0
0
0
0,00000994
0,00005768
0,00017486
0,00021237
Remission
(rates)
0,14
0,14
0,14
0,14
0,14
0,14
0,14
Mortality
(numbers)
0
0
0
8
29
48
86
Incidence
(numbers)
0
0
0
31
73
122
68
Prevalence
(numbers)
0
0
0
96
235
353
166
Remission
(numbers)
0
0
0
14
33
50
23
Case fatality
(numbers)
0
0
0
7
24
49
57
Duration
(years)
0
0
0
4,53743471
3,77535532
3,2015816
1,61164557
Mortality
(numbers)
0
0
0
7
24
49
57
RR mortality
(number)
0
1
0
181,1408508
33,61723602
13,45332206
6,0991483
Age of onset
(years)
0
0
0
36,23959843
52,32514576
67,32971841
84,12432791
NA
NA
171
294
850
119
138
3,11790566
138
22,89795463
64,78775168
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 13
CANCER HEPATICO
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,000006
0,00000433
0,000002
0,0000064
0,000057
0,00025467
0,000395
Remission
(rates)
0,1
0,1
0,1
0,1
0,1
0,1
0,1
Mortality (rates)
0
0
0
0,00000354
0,00004306
0,00032822
0,00072347
Incidence
(rates)
0,00000467
0,00000376
0,00000251
0,00000452
0,00004458
0,00032147
0,0006085
Prevalence
(rates)
0,00000222
0,00001719
0,00002202
0,00001324
0,00002277
0,000158
0,00033852
Remission
(rates)
0,10000009
0,10000002
0,09959966
0,09916165
0,09952637
0,09965097
0,09945862
Case fatality
Duration (years) Mortality (rates)
(rates)
0
8,68954281
0
0
7,91685239
0
0,03834136
4,78393166
0,00000084
0,26476563
2,51118574
0,0000035
1,67848034
0,53813027
0,00003908
1,80682811
0,52470674
0,00028972
1,71604173
0,51346708
0,00057888
RR mortality
(number)
0
1
115,6275836
167,4685176
261,4589607
91,04812493
19,89700081
Age of onset
(years)
0,5
5,15331606
15,20809595
32,77890857
54,59277763
67,39789271
82,50176214
NA
NA
0,00004996
0,00004849
0,00003538
0,09954388
1,20870947
95,48898364
67,71690494
Incidence
(rates)
0,00000876
0,00000689
0,00000251
0,00001518
0,00006665
0,00021399
0,00031626
Remission
(rates)
0,35
0,35
0,35
0,35
0,35
0,35
0,35
Mortality (rates)
0
0
0
0,00000324
0,00003602
0,00023208
0,0004697
Incidence
(rates)
0,0000076
0,00000584
0,00000286
0,0000106
0,00005397
0,00021648
0,0003242
Prevalence
(rates)
0,0000032
0,00001461
0,00000975
0,00001629
0,00005451
0,00009883
0,00013709
Remission
(rates)
0,34999848
0,34999859
0,34899501
0,35310252
0,34813622
0,34490334
0,34108987
Case fatality
Duration (years) Mortality (rates)
(rates)
0
2,84805008
0
0
2,84718033
0
0,00343251
2,66437264
0,00000003
0,18966032
1,78484631
0,0000031
0,5946443
0,97181974
0,00003257
1,82407076
0,45030727
0,00018083
2
0,41292172
0,00027501
RR mortality
(number)
0
1,00000024
43,98548058
469,8336014
184,9625453
148,1822376
36,74006736
Age of onset
(years)
0,5
5,04097226
14,76624233
37,33156088
53,89371896
67,48536204
83,84157189
NA
NA
0,00004491
0,00004526
0,00003259
0,34728097
0,99549432
130,6989162
65,27399046
5,0
4,5
4,8
4,5
0,73596274
0,00004317
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
0,73386858
0,00003256
4,3
3,3
Diferencia en onset years
0,7
1,2
-2,4
GRIIA 14
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,000006
0,00000433
0,000002
0,0000064
0,000057
0,00025467
0,000395
Remission
(rates)
0,1
0,1
0,1
0,1
0,1
0,1
0,1
Mortality
(numbers)
0
0
0
11
54
198
135
Incidence
(numbers)
1
5
4
14
56
194
114
Prevalence
(numbers)
0
21
33
41
29
95
63
Remission
(numbers)
0
2
3
4
3
9
6
NA
NA
398
386
282
28
Incidence
(rates)
0,00000876
0,00000689
0,00000251
0,00001518
0,00006665
0,00021399
0,00031626
Remission
(rates)
0,35
0,35
0,35
0,35
0,35
0,35
0,35
Mortality
(numbers)
0
0
0
10
47
166
142
Incidence
(numbers)
1
7
4
33
70
155
98
Prevalence
(numbers)
0
17
14
50
71
71
41
Remission
(numbers)
0
6
5
18
25
24
14
NA
NA
365
368
265
92
Case fatality
(numbers) Duration (years)
0
8,68954281
0
7,91685239
1
4,78393166
11
2,51118574
48
0,53813027
172
0,52470674
108
0,51346708
341
0,73596274
Mortality
(numbers)
0
0
1
11
49
175
108
RR mortality
(number)
0
1
115,6275836
167,4685176
261,4589607
91,04812493
19,89700081
Age of onset
(years)
0,5
5,15331606
15,20809595
32,77890857
54,59277763
67,39789271
82,50176214
344
95,48898364
67,71690494
Mortality
(numbers)
0
0
0
10
42
129
83
RR mortality
(number)
0
1,00000024
43,98548058
469,8336014
184,9625453
148,1822376
36,74006736
Age of onset
(years)
0,5
5,04097226
14,76624233
37,33156088
53,89371896
67,48536204
83,84157189
265
130,6989162
65,27399046
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Case fatality
(numbers) Duration (years)
0
2,84805008
0
2,84718033
0
2,66437264
10
1,78484631
42
0,97181974
129
0,45030727
83
0,41292172
264
0,73386858
GRIIA 15
CANCER PANCREAS
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0,00000092
0,00000237
0,000009
0,00009285
0,00023297
0,00038485
Remission
(rates)
0,18
0,18
0,18
0,18
0,18
0,18
0,18
Mortality (rates)
0
0,00000083
0
0,00000515
0,00007177
0,0002901
0,00057341
Incidence
(rates)
0
0,00000095
0,00000232
0,00000888
0,00008711
0,00021158
0,00035738
Prevalence
(rates)
0
0,0000017
0,0000063
0,00001301
0,00011794
0,00010888
0,00019276
Remission
(rates)
0
0,17633419
0,17914994
0,18063749
0,18073356
0,17833011
0,17760278
Case fatality
(rates)
0
0,055391
0,02178339
0,34736617
0,519053
1,71799991
1,83829045
Duration
Mortality (rates)
(years)
0
0
4,32748577
0,00000009
3,22755968
0,00000014
1,96227986
0,00000456
1,31580128
0,00006121
0,51108575
0,00018844
0,47239153
0,00034666
RR mortality
(number)
0
325,3434378
149,9787197
504,503639
87,61030351
77,84768863
23,3537591
Age of onset
(years)
0
7,54366907
17,46727407
38,93956858
53,09457193
68,107439
81,39417047
NA
NA
0,00004883
0,00004215
0,00003783
0,17974408
0,89621813
0,92548189
90,14158407
62,95454007
Incidence
(rates)
0,00000154
0,00000148
0,00000267
0,0000092
0,00007889
0,00018722
0,00036125
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality (rates)
0
0
0
0,00000292
0,00006668
0,00027263
0,00071778
Incidence
(rates)
0,00000154
0,00000147
0,00000265
0,00000923
0,00007135
0,00018061
0,00033932
Prevalence
(rates)
0,0000007
0,00000471
0,00000868
0,00002004
0,00007564
0,00009194
0,00015814
Remission
(rates)
0,2
0,2
0,19634554
0,20061613
0,20040828
0,19739937
0,19620829
Case fatality
(rates)
0
0
0,01916484
0,14388553
0,70076721
1,80096081
2
Duration
Mortality (rates)
(years)
4,92347347
0
4,8156728
0
3,67877814
0,00000017
2,57116093
0,00000289
1,00218279
0,00005322
0,48242375
0,0001654
0,43985663
0,00031432
RR mortality
(number)
0
1
125,4644364
364,1024946
219,493449
147,4415377
37,61976842
Age of onset
(years)
0,5
5,52614326
16,22984657
38,8181
54,31077619
67,56467711
83,19714353
NA
NA
0,00006251
0,00004418
0,00003594
0,19890648
1,00079118
0,82761287
135,4442899
65,99155488
4,9
6,3
4,2
4,4
0,00003384
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
0,00003592
3,4
3,6
Diferencia en onset years
1,5
2,7
3,0
GRIIA 16
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0,00000092
0,00000237
0,000009
0,00009285
0,00023297
0,00038485
Remission
(rates)
0,18
0,18
0,18
0,18
0,18
0,18
0,18
Mortality
(numbers)
0
1
0
16
90
175
107
Incidence
(numbers)
0
1
3
28
109
128
67
Prevalence
(numbers)
0
2
9
40
148
66
36
Remission
(numbers)
0
0
2
7
27
12
6
Case fatality
(numbers)
0
0
0
14
77
113
66
Duration
(years)
0
4,32748577
3,22755968
1,96227986
1,31580128
0,51108575
0,47239153
Mortality
(numbers)
0
0
0
14
77
114
65
RR mortality
(number)
0
325,3434378
149,9787197
504,503639
87,61030351
77,84768863
23,3537591
Age of onset
(years)
0
7,54366907
17,46727407
38,93956858
53,09457193
68,107439
81,39417047
NA
NA
389
336
301
54
270
0,92548189
270
90,14158407
62,95454007
Incidence
(rates)
0,00000154
0,00000148
0,00000267
0,0000092
0,00007889
0,00018722
0,00036125
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(numbers)
0
0
0
9
87
195
217
Incidence
(numbers)
0
2
4
28
93
129
103
Prevalence
(numbers)
0
5
12
62
99
66
48
Remission
(numbers)
0
1
2
12
20
13
9
Case fatality
(numbers)
0
0
0
9
69
118
96
Duration
(years)
4,92347347
4,8156728
3,67877814
2,57116093
1,00218279
0,48242375
0,43985663
Mortality
(numbers)
0
0
0
9
69
118
95
RR mortality
(number)
0
1
125,4644364
364,1024946
219,493449
147,4415377
37,61976842
Age of onset
(years)
0,5
5,52614326
16,22984657
38,8181
54,31077619
67,56467711
83,19714353
NA
NA
508
359
292
58
292
0,82761287
292
135,4442899
65,99155488
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 17
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00000957
0,00000507
0,00000837
0,00001785
0,00024347
0,00091372
0,00104379
Remission
(rates)
0,1
0,1
0,1
0,1
0,1
0,1
0,1
Mortality
(rates)
0
0
0,00000067
0,0000103
0,00021771
0,00118856
0,00234188
Incidence
(rates)
0,00000233
0,00000201
0,00000304
0,00001623
0,00020272
0,000907
0,00120276
Prevalence
(rates)
0,00000111
0,00000867
0,00001391
0,00003313
0,00016666
0,00044373
0,00057311
Remission
(rates)
0,10000107
0,0986511
0,098997
0,09960936
0,10012651
0,09981704
0,09910961
Case fatality
(rates)
0
0,01342467
0,04826732
0,29026013
1,02732162
1,89626897
1,99999999
Duration
(years)
8,22403906
7,27929516
4,99596058
2,27149744
0,82036009
0,49014905
0,45458918
Mortality
(rates)
0
0,00000012
0,00000067
0,00000965
0,00017262
0,00084602
0,00114615
RR mortality
(number)
1,00000001
105,6768262
108,6757467
183,8524061
170,9445764
88,95016337
25,70304662
Age of onset
(years)
0,5
5,31937846
16,3266048
36,66881274
53,96537442
67,2816142
81,99838761
NA
NA
0,00018328
0,00013601
0,0000901
0,09973144
1,34748278
0,6792851
0,00012199
96,24278109
65,64221157
Incidence
(rates)
0,00000243
0,00000108
0,00000105
0,00001333
0,00011215
0,00032633
0,0003689
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(rates)
0
0
0
0,00000778
0,00009274
0,000439
0,00100225
Incidence
(rates)
0,00000243
0,00000186
0,00000116
0,00001221
0,00009454
0,00032658
0,00044024
Prevalence
(rates)
0,0000011
0,0000066
0,00000634
0,00001392
0,00008771
0,00015444
0,00020034
Remission
(rates)
0,2
0,19999999
0,19999258
0,20148126
0,19971122
0,19813731
0,19654006
Case fatality
(rates)
0
0
0,00433988
0,4797437
0,83370769
1,88070716
2
Duration
(years)
4,91597042
4,81042703
3,57059767
1,50634522
0,8918987
0,47212594
0,43928477
Mortality
(rates)
0
0
0,00000003
0,00000676
0,00007343
0,00029179
0,00040075
RR mortality
(number)
0
1,00000003
156,5759749
1729,412888
265,6154602
151,0697709
37,45081058
Age of onset
(years)
0,5
5,03684657
15,20747958
38,03956867
53,57069661
67,61668416
83,69868082
NA
NA
0,00009376
0,00006544
0,00004249
0,19888562
1,28848619
0,66439013
0,00005495
218,5531468
66,36599602
18,3
9,4
13,6
6,5
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
12,2
5,5
Diferencia en onset years
6,1
3,9
0,7
GRIIA 18
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00000957
0,00000507
0,00000837
0,00001785
0,00024347
0,00091372
0,00104379
Remission
(rates)
0,1
0,1
0,1
0,1
0,1
0,1
0,1
Mortality
(numbers)
0
0
1
32
273
717
437
Incidence
(numbers)
0
2
5
50
254
547
224
Prevalence
(numbers)
0
10
21
103
209
268
107
Remission
(numbers)
0
1
2
10
21
27
11
Case fatality
(numbers)
0
0
1
30
215
508
214
Duration
(years)
8,22403906
7,27929516
4,99596058
2,27149744
0,82036009
0,49014905
0,45458918
Mortality
(numbers)
0
0
1
30
216
510
214
RR mortality
(number)
1,00000001
105,6768262
108,6757467
183,8524061
170,9445764
88,95016337
25,70304662
Age of onset
(years)
0,5
5,31937846
16,3266048
36,66881274
53,96537442
67,2816142
81,99838761
NA
NA
1460
1083
718
72
967
0,6792851
972
96,24278109
65,64221157
Incidence
(rates)
0,00000243
0,00000108
0,00000105
0,00001333
0,00011215
0,00032633
0,0003689
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(numbers)
0
0
0
24
121
314
303
Incidence
(numbers)
0
2
2
38
123
234
133
Prevalence
(numbers)
0
8
9
43
114
110
61
Remission
(numbers)
0
2
2
9
23
22
12
Case fatality
(numbers)
0
0
0
21
95
208
121
Duration
(years)
4,91597042
4,81042703
3,57059767
1,50634522
0,8918987
0,47212594
0,43928477
Mortality
(numbers)
0
0
0
21
96
209
121
RR mortality
(number)
0
1,00000003
156,5759749
1729,412888
265,6154602
151,0697709
37,45081058
Age of onset
(years)
0,5
5,03684657
15,20747958
38,03956867
53,57069661
67,61668416
83,69868082
NA
NA
762
532
345
69
445
0,66439013
447
218,5531468
66,36599602
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 19
MELANOMA
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0,00000096
0,00000239
0,00001749
0,00005928
0,00009992
0,00016946
Remission
(rates)
0,12
0,12
0,12
0,12
0,12
0,12
0,12
Mortality (rates)
0
0
0
0,00000428
0,00002205
0,00004598
0,00010792
Incidence
(rates)
0,00000173
0,00000176
0,00000296
0,00001393
0,00004568
0,00009301
0,00015872
Prevalence
(rates)
0,00000082
0,00000684
0,00001519
0,00005657
0,00016221
0,0002986
0,00046912
Remission
(rates)
0,12
0,11513266
0,05594501
0,11790408
0,12017104
0,12034422
0,11947844
Case fatality
(rates)
0
0
0,01976571
0,07392162
0,11125655
0,15044728
0,19548247
NA
NA
0,00001115
0,00002423
0,00008508
0,11734254
0,11845508
Incidence
(rates)
0,00000211
0,00000202
0,00001079
0,00002436
0,00004507
0,00010576
0,00013504
Remission
(rates)
0,19
0,19
0,19
0,19
0,19
0,19
0,19
Mortality (rates)
0
0
0
0,000001
0,00001374
0,00003589
0,0001121
Incidence
(rates)
0,00000208
0,00000142
0,00000471
0,00002061
0,00003943
0,00009743
0,00012632
Prevalence
(rates)
0,00000095
0,00000624
0,00001817
0,00007263
0,00015366
0,00027525
0,00026033
Remission
(rates)
0,19000005
0,10468032
0,15250178
0,19183336
0,18770651
0,19057485
0,18733107
Case fatality
(rates)
0
0
0,00851676
0,0145538
0,06936579
0,125647
0,33899529
NA
NA
0,00000991
0,0000285
0,00009027
0,18762504
0,09378892
1,1
1,0
2,4
2,9
RR mortality
(number)
0
0
43,89714885
46,99764933
20,31880435
8,41755064
3,11942648
Age of onset
(years)
0,5
5,5918047
16,93641903
34,33174072
52,45261929
66,99684727
82,40630486
17,08425494
56,13441352
Duration
Mortality (rates)
(years)
7,07637876
0
8,16178583
0
5,09989312
0,00000015
4,63577991
0,00000106
3,50450825
0,00001066
2,88471597
0,00003462
1,53358135
0,00008808
RR mortality
(number)
0
0
52,85828236
39,97872267
25,03419194
11,46517806
5,87276173
Age of onset
(years)
0,5
4,93928735
15,88972623
36,70398373
52,36399115
66,78167282
84,30101902
3,38726527
13,53184574
56,82351934
Duration
Mortality (rates)
(years)
8,90627566
0
9,49812851
0
6,87401139
0,0000003
4,95967264
0,00000419
3,92682974
0,00001806
3,24061888
0,00004496
2,26481721
0,00009175
3,837527
0,00001009
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
0,00000846
1,0
0,8
Diferencia en onset years
0,1
0,1
0,7
GRIIA 20
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0,00000096
0,00000239
0,00001749
0,00005928
0,00009992
0,00016946
Remission
(rates)
0,12
0,12
0,12
0,12
0,12
0,12
0,12
Mortality
(numbers)
0
0
0
13
28
28
20
Incidence
(numbers)
0
2
4
43
57
56
30
Prevalence
(numbers)
0
8
23
176
203
180
88
Remission
(numbers)
0
1
1
21
24
22
10
Case fatality
(numbers)
0
0
0
13
23
27
17
Duration
(years)
8,90627566
9,49812851
6,87401139
4,95967264
3,92682974
3,24061888
2,26481721
Mortality
(numbers)
0
0
0
13
23
27
17
RR mortality
(number)
0
0
43,89714885
46,99764933
20,31880435
8,41755064
3,11942648
Age of onset
(years)
0,5
5,5918047
16,93641903
34,33174072
52,45261929
66,99684727
82,40630486
NA
NA
89
193
678
80
80
3,837527
80
17,08425494
56,13441352
Incidence
(rates)
0,00000211
0,00000202
0,00001079
0,00002436
0,00004507
0,00010576
0,00013504
Remission
(rates)
0,19
0,19
0,19
0,19
0,19
0,19
0,19
Mortality
(numbers)
0
0
0
3
18
26
34
Incidence
(numbers)
0
2
7
64
51
70
38
Prevalence
(numbers)
0
7
26
224
200
197
79
Remission
(numbers)
0
1
4
43
38
38
15
Case fatality
(numbers)
0
0
0
3
14
25
27
Duration
(years)
7,07637876
8,16178583
5,09989312
4,63577991
3,50450825
2,88471597
1,53358135
Mortality
(numbers)
0
0
0
3
14
25
27
RR mortality
(number)
0
0
52,85828236
39,97872267
25,03419194
11,46517806
5,87276173
Age of onset
(years)
0,5
4,93928735
15,88972623
36,70398373
52,36399115
66,78167282
84,30101902
NA
NA
81
232
734
138
69
3,38726527
69
13,53184574
56,82351934
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 21
Incidence
(rates)
0,00004926
0,00002912
0,00002427
0,0000541
0,0003456
0,00122903
0,00323494
Remission
(rates)
4
4
4
4
4
4
4
Mortality (rates)
0
0
0
0,00000032
0,00000848
0,00002659
0,00024247
Incidence
(rates)
0
0,00000544
0,00000833
0,00004508
0,00030667
0,00110682
0,00276748
Prevalence
(rates)
0
0,00000121
0,00000202
0,00001048
0,00007195
0,00025915
0,00062385
Remission
(rates)
0
4
4
4
4
4
4
NA
NA
0,00000915
0,00021687
0,00005021
Incidence
(rates)
0,00000876
0,00001288
0,00002629
0,0000893
0,00036244
0,00106105
0,00241618
Remission
(rates)
4
4
4
4
4
4
4
Mortality (rates)
0
0
0,0000007
0,00000072
0,00000399
0,00001475
0,00014843
Incidence
(rates)
0,00000917
0,00001293
0,00002191
0,00008372
0,00033299
0,00098572
0,00218705
Prevalence
(rates)
0,00000113
0,0000031
0,00000532
0,00001981
0,00007964
0,0002344
0,00050297
Remission
(rates)
4
4
4
4
4
4
4
NA
NA
0,00000786
0,00025921
0,00006104
0,9
0,8
21,7
25,9
Case fatality
Duration (years) Mortality (rates)
(rates)
0
0
0
0
0,24997713
0
0,01101895
0,24915319
0,00000002
0,03491172
0,24773039
0,00000038
0,08762223
0,24417744
0,00000644
0,09885729
0,2423504
0,00002622
0,26703462
0,22847809
0,00017018
RR mortality
(number)
0
0
29,51765439
24,00504721
15,39303629
6,26346107
3,57644093
Age of onset
(years)
0,5
7,39724185
15,37251501
36,60337257
53,08026302
67,93594975
82,77549126
6,43912152
66,30971992
Case fatality
Duration (years) Mortality (rates)
(rates)
0
0,24995345
0
0,00423466
0,24963961
0,00000001
0,09263848
0,24419799
0,00000049
0,03999158
0,24751031
0,00000081
0,04111695
0,24720556
0,00000333
0,05988249
0,24537319
0,0000143
0,21407339
0,23255632
0,00010949
RR mortality
(number)
0
126,4129167
411,3247751
150,2599528
13,6527453
6,10895794
3,68614986
Age of onset
(years)
0,5
6,19107992
15,03425436
37,21330134
52,88411247
67,92099994
84,36023792
0,10084153
17,93129346
65,74366363
0,1390404
0,23912418
0,00000714
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
0,24200584
0,00000626
0,7
0,6
Diferencia en onset years
0,2
0,2
-0,6
GRIIA 22
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00004926
0,00002912
0,00002427
0,0000541
0,0003456
0,00122903
0,00323494
Remission
(rates)
4
4
4
4
4
4
4
Mortality
(numbers)
0
0
0
0,00000032
0,00000848
0,00002659
0,00024247
Incidence
(numbers)
0
0,00000544
0,00000833
0,00004508
0,00030667
0,00110682
0,00276748
Prevalence
(numbers)
0
0,00000121
0,00000202
0,00001048
0,00007195
0,00025915
0,00062385
Remission
(numbers)
0
4
4
4
4
4
4
NA
NA
0,00000915
0,00021687
0,00005021
Incidence
(rates)
0,00000876
0,00001288
0,00002629
0,0000893
0,00036244
0,00106105
0,00241618
Remission
(rates)
4
4
4
4
4
4
4
Mortality
(numbers)
0
0
1
2
5
11
45
Incidence
(numbers)
1
15
31
258
434
705
661
Prevalence
(numbers)
0
4
8
61
104
168
152
Remission
(numbers)
1
14
31
244
416
671
608
NA
NA
64
2107
496
1985
Case fatality
(numbers) Duration (years)
0
0
0
0,24997713
0,01101895
0,24915319
0,03491172
0,24773039
0,08762223
0,24417744
0,09885729
0,2423504
0,26703462
0,22847809
0,1390404
0,23912418
Mortality
(numbers)
0
0
0,00000002
0,00000038
0,00000644
0,00002622
0,00017018
RR mortality
(number)
0
0
29,51765439
24,00504721
15,39303629
6,26346107
3,57644093
Age of onset
(years)
0,5
7,39724185
15,37251501
36,60337257
53,08026302
67,93594975
82,77549126
0,00000714
6,43912152
66,30971992
Mortality
(numbers)
0
0
1
3
4
10
33
RR mortality
(number)
0
126,4129167
411,3247751
150,2599528
13,6527453
6,10895794
3,68614986
Age of onset
(years)
0,5
6,19107992
15,03425436
37,21330134
52,88411247
67,92099994
84,36023792
51
17,93129346
65,74366363
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Case fatality
(numbers) Duration (years)
0
0,24995345
0
0,24963961
1
0,24419799
2
0,24751031
4
0,24720556
10
0,24537319
33
0,23255632
50
0,24200584
GRIIA 23
CANCER DE MAMA
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0,00000069
0,00000081
0,00000615
0,00001453
0,00001824
Remission
(rates)
0,35
0,35
0,35
0,35
0,35
0,35
0,35
Mortality
(rates)
0
0
0
0
0
0,00000354
0,00001686
Incidence
(rates)
0
0,00000004
0,00000099
0,00000149
0,00000472
0,00001114
0,00001758
Prevalence
(rates)
0
0,00000003
0,00000189
0,00000384
0,00001101
0,00002103
0,00002413
Remission
(rates)
0
0,35
0,35
0,34999991
0,3498213
0,34870916
0,34117443
Case fatality
(rates)
0
0
0
0
0,01235635
0,15561985
0,46751231
Duration
(years)
0
2,85494427
2,85056415
2,83702141
2,56515484
1,81197443
1,04329349
Mortality
(rates)
0
0
0
0
0,00000014
0,00000328
0,0000112
RR mortality
(number)
0
1
1
0
5,52681299
8,20447375
6,07348385
Age of onset
(years)
0,5
9,0096657
15,94198193
35,58496542
53,30393209
67,23212978
82,07390118
NA
NA
0,00000066
0,00000277
0,00000574
0,34871992
0,0928644
2,18645085
0,00000053
7,04540086
55,79327758
Incidence
(rates)
0
0
0,00000446
0,00017189
0,00095796
0,00117989
0,00118895
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(rates)
0
0
0
0,00003747
0,00025801
0,00050318
0,0011783
Incidence
(rates)
0
0,00000025
0,00000713
0,00014943
0,00084484
0,00117861
0,00120896
Prevalence
(rates)
0
0,00000021
0,00001737
0,0002969
0,00246431
0,00345274
0,00267885
Remission
(rates)
0
0,2
0,1999819
0,20228149
0,20134243
0,19914035
0,19576613
Case fatality
(rates)
0
0
0,00488743
0,11739264
0,08340368
0,14281852
0,33892392
Duration
(years)
0
4,70194766
3,62940256
3,34654037
3,32337475
2,66226519
1,54156312
Mortality
(rates)
0
0
0,00000009
0,00003509
0,00020578
0,0004931
0,0009041
RR mortality
(number)
0
0
82,9808208
578,5258404
27,34281166
12,8341906
6,22978773
Age of onset
(years)
0,5
9,00973458
16,15695566
38,95225124
52,57175319
66,85344524
83,5926915
NA
NA
0,00014377
0,00034237
0,00091497
0,20011489
0,13488625
2,89413918
0,00012341
76,0108047
58,96057176
0,1
14,4
0,3
34,2
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
0,1
12,3
Diferencia en onset years
0,0
2,0
3,2
GRIIA 24
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0,00000069
0,00000081
0,00000615
0,00001453
0,00001824
Remission
(rates)
0,35
0,35
0,35
0,35
0,35
0,35
0,35
Mortality
(numbers)
0
0
0
0
0
2
3
Incidence
(numbers)
0
0
1
5
6
7
3
Prevalence
(numbers)
0
0
3
12
14
13
5
Remission
(numbers)
0
0
1
4
5
4
2
Case fatality
(numbers)
0
0
0
0
0
2
2
Duration
(years)
0
2,85494427
2,85056415
2,83702141
2,56515484
1,81197443
1,04329349
Mortality
(numbers)
0
0
0
0
0
2
2
RR mortality
(number)
0
1
1
0
5,52681299
8,20447375
6,07348385
Age of onset
(years)
0,5
9,0096657
15,94198193
35,58496542
53,30393209
67,23212978
82,07390118
NA
NA
22
46
16
2,18645085
7,04540086
55,79327758
Incidence
(rates)
0
0
0,00000446
0,00017189
0,00095796
0,00117989
0,00118895
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(numbers)
0
0
0
116
337
360
356
Incidence
(numbers)
0
0
10
461
1102
843
365
Prevalence
(numbers)
0
0
25
916
3215
2470
810
Remission
(numbers)
0
0
5
185
647
492
159
Case fatality
(numbers)
0
0
0
108
268
353
274
Duration
(years)
0
4,70194766
3,62940256
3,34654037
3,32337475
2,66226519
1,54156312
Mortality
(numbers)
0
0
0
108
268
353
273
RR mortality
(number)
0
0
82,9808208
578,5258404
27,34281166
12,8341906
6,22978773
Age of onset
(years)
0,5
9,00973458
16,15695566
38,95225124
52,57175319
66,85344524
83,5926915
NA
NA
1168
2783
7436
1488
1003
2,89413918
1003
76,0108047
58,96057176
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 25
CANCER CERVICOUTERINO
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
Incidence
(rates)
Remission
(rates)
Mortality (rates)
Incidence
(rates)
Prevalence
(rates)
Remission
(rates)
Case fatality
(rates)
Duration
(years)
Mortality (rates)
RR mortality
(number)
Age of onset
(years)
Incidence
(rates)
0,00000118
0,00000053
0,00000617
0,00024331
0,00049557
0,00056009
0,00044256
Remission
(rates)
0,16
0,16
0,16
0,16
0,16
0,16
0,16
Mortality (rates)
0
0
0
0,00004284
0,00015957
0,00028112
0,000584
Incidence
(rates)
0,00000118
0,00000153
0,00000458
0,0002116
0,00049139
0,00055354
0,00047044
Prevalence
(rates)
0,00000055
0,00000552
0,00001829
0,00059351
0,00210358
0,00194196
0,00111572
Remission
(rates)
0,16
0,07925908
0,12760928
0,16110194
0,15889231
0,15887831
0,15626812
Case fatality
(rates)
0
0
0,0026375
0,0719975
0,06380507
0,14165745
0,38630969
Duration
(years)
8,12811242
8,8104658
4,41297942
4,41917753
4,08508498
2,94200583
1,49958639
Mortality (rates)
0
0
0,00000005
0,00004298
0,00013423
0,00027497
0,00042835
RR mortality
(number)
1
1,00000109
55,70517836
414,6115941
22,02075824
12,74595671
7,16953956
Age of onset
(years)
0,5
6,04735049
16,58304009
37,60387436
51,88636057
66,67465333
83,47387834
NA
NA
0,00008835
0,0002265
0,00077951
0,15917816
0,1000951
3,76401965
0,00007801
98,25163598
52,54786356
0,0
8,8
0,0
22,7
All ages
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
0,0
7,8
Diferencia en onset years
0,0
1,0
52,5
GRIIA 26
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
Incidence
(rates)
Remission
(rates)
Mortality
(numbers)
Incidence
(numbers)
Prevalence
(numbers)
Remission
(numbers)
Case fatality
(numbers)
Duration
(years)
Mortality
(numbers)
RR mortality
(number)
Age of onset
(years)
Incidence
(rates)
0,00000118
0,00000053
0,00000617
0,00024331
0,00049557
0,00056009
0,00044256
Remission
(rates)
0,16
0,16
0,16
0,16
0,16
0,16
0,16
Mortality
(numbers)
0
0
0
132
208
201
177
Incidence
(numbers)
0
2
7
653
641
396
142
Prevalence
(numbers)
0
6
26
1832
2745
1389
337
Remission
(numbers)
0
1
3
295
436
221
53
Case fatality
(numbers)
0
0
0
132
175
197
130
Duration
(years)
8,12811242
8,8104658
4,41297942
4,41917753
4,08508498
2,94200583
1,49958639
Mortality
(numbers)
0
0
0
133
175
197
129
RR mortality
(number)
1
1,00000109
55,70517836
414,6115941
22,02075824
12,74595671
7,16953956
Age of onset
(years)
0,5
6,04735049
16,58304009
37,60387436
51,88636057
66,67465333
83,47387834
NA
NA
718
1841
6335
1008
634
3,76401965
634
98,25163598
52,54786356
All ages
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 27
Incidence
(rates)
Remission
(rates)
Mortality
(rates)
Incidence
(rates)
Prevalence
(rates)
Remission
(rates)
Case fatality
(rates)
Duration
(years)
Mortality
(rates)
RR mortality
(number)
Age of onset
(years)
Incidence
(rates)
0
0
0,00000557
0,0001529
0,00113528
0,00315739
0,00331951
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(rates)
0
0
0
0,0000041
0,00002145
0,00013024
0,00027028
Incidence
(rates)
0
0,00000031
0,0000084
0,00014525
0,00095095
0,00292
0,00308344
Prevalence
(rates)
0
0,00000027
0,00002055
0,00043748
0,00304376
0,01086685
0,01521235
Remission
(rates)
0
0,2
0,19653188
0,20161376
0,20304894
0,20145865
0,19779895
Case fatality
(rates)
0
0
0,0213994
0,01090055
0,00633991
0,0110934
0,01535377
Duration
(years)
0
4,79914642
4,28409477
4,72701052
4,58733103
4,22426918
3,24886986
Mortality
(rates)
0
0
0,00000044
0,00000478
0,00001933
0,00012067
0,00023351
RR mortality
(number)
0
0
109,731891
62,30482467
2,92355899
1,91642761
1,23799483
Age of onset
(years)
0,5
9,00973444
16,04044848
38,0251683
53,62701248
67,28522191
83,39193295
NA
NA
0,00002652
0,00058103
0,00218068
0,20086892
0,01113604
4,17503222
0,0000243
6,66042547
64,33778439
0,0
2,7
0,0
58,1
All ages
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
0,0
2,4
Diferencia en onset years
0,0
0,2
64,3
GRIIA 28
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
Incidence
(rates)
Remission
(rates)
Mortality
(numbers)
Incidence
(numbers)
Prevalence
(numbers)
Remission
(numbers)
Case fatality
(numbers)
Duration
(years)
Mortality
(numbers)
RR mortality
(number)
Age of onset
(years)
Incidence
(rates)
0
0
0,00000557
0,0001529
0,00113528
0,00315739
0,00331951
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(numbers)
0
0
0
13
28
93
82
Incidence
(numbers)
0
0
12
448
1241
2089
932
Prevalence
(numbers)
0
0
29
1350
3971
7773
4599
Remission
(numbers)
0
0
6
272
806
1566
910
Case fatality
(numbers)
0
0
1
15
25
86
71
Duration
(years)
0
4,79914642
4,28409477
4,72701052
4,58733103
4,22426918
3,24886986
Mortality
(numbers)
0
0
1
15
25
86
71
RR mortality
(number)
0
0
109,731891
62,30482467
2,92355899
1,91642761
1,23799483
Age of onset
(years)
0,5
9,00973444
16,04044848
38,0251683
53,62701248
67,28522191
83,39193295
NA
NA
216
4722
17723
3560
197
4,17503222
198
6,66042547
64,33778439
All ages
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 29
CANCER DE OVARIO
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
Incidence
(rates)
Remission
(rates)
Mortality
(rates)
Incidence
(rates)
Prevalence
(rates)
Remission
(rates)
Case fatality
(rates)
Duration
(years)
Mortality
(rates)
RR mortality
(number)
Age of onset
(years)
Incidence
(rates)
0,00000811
0,00000444
0,00000981
0,00006744
0,00027715
0,00035223
0,00025497
Remission
(rates)
0,5
0,5
0,5
0,5
0,5
0,5
0,5
Mortality
(rates)
0
0
0,0000007
0,00001005
0,00007434
0,00016078
0,00028116
Incidence
(rates)
0,00000246
0,00000233
0,00000805
0,00006407
0,00022755
0,00034243
0,00027162
Prevalence
(rates)
0,00000097
0,00000402
0,00001155
0,00009571
0,00030577
0,0003955
0,00017642
Remission
(rates)
0,49999128
0,49999314
0,49719266
0,49790539
0,49822361
0,49562218
0,48661463
Case fatality
(rates)
0
0,0018728
0,04396955
0,09197797
0,19401906
0,39496338
1,23628643
Duration
(years)
1,99445525
1,97043112
1,82083718
1,68528961
1,40234306
1,07615598
0,53771702
Mortality
(rates)
0
0,00000001
0,00000051
0,00000884
0,00005949
0,00015588
0,00021323
RR mortality
(number)
1,00000013
65,8289915
175,1808503
183,4994184
62,48923659
33,55859673
21,40225143
Age of onset
(years)
0,5
5,62139906
16,20103999
36,15258499
52,91946902
66,56696557
83,28141678
NA
NA
0,00004048
0,00010289
0,00012943
0,49683784
0,26901521
1,29662856
0,00003465
53,64647109 55,56708074
0,0
4,0
0,0
10,3
All ages
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
0,0
3,5
Diferencia en onset years
0,0
0,6
55,6
GRIIA 30
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
Incidence
(rates)
Remission
(rates)
Mortality
(numbers)
Incidence
(numbers)
Prevalence
(numbers)
Remission
(numbers)
Case fatality
(numbers)
Duration
(years)
Mortality
(numbers)
RR mortality
(number)
Age of onset
(years)
Incidence
(rates)
0,00000811
0,00000444
0,00000981
0,00006744
0,00027715
0,00035223
0,00025497
Remission
(rates)
0,5
0,5
0,5
0,5
0,5
0,5
0,5
Mortality
(numbers)
0
0
1
31
97
115
85
Incidence
(numbers)
0
3
12
198
297
245
82
Prevalence
(numbers)
0
5
17
295
399
283
53
Remission
(numbers)
0
2
8
147
199
140
26
Case fatality
(numbers)
0
0
1
27
77
112
66
Duration
(years)
1,99445525
1,97043112
1,82083718
1,68528961
1,40234306
1,07615598
0,53771702
Mortality
(numbers)
0
0
1
27
78
111
64
RR mortality
(number)
1,00000013
65,8289915
175,1808503
183,4994184
62,48923659
33,55859673
21,40225143
Age of onset
(years)
0,5
5,62139906
16,20103999
36,15258499
52,91946902
66,56696557
83,28141678
NA
NA
329
836
1052
523
283
1,29662856
282
All ages
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
53,64647109 55,56708074
GRIIA 31
Prostata
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00000235
0,00000104
0
0,00001214
0,00067179
0,00500667
0,00779694
Remission
(rates)
0,1
0,1
0,1
0,1
0,1
0,1
0,1
Mortality
(rates)
0
0
0
0,00000099
0,00004274
0,00075686
0,0056106
Incidence
(rates)
0,00000235
0,00000139
0,00000144
0,00001137
0,00041989
0,00409263
0,00764357
Prevalence
(rates)
0,00000112
0,00000756
0,00000775
0,0000558
0,00104126
0,01535401
0,03818108
Remission
(rates)
0,1
0,1
0,09982238
0,10059224
0,10168722
0,10107372
0,09960078
Case fatality
(rates)
0
0
0,00857456
0,01806471
0,04868602
0,0459374
0,10201893
Duration
(years)
9,52078999
9,34719493
7,96408971
7,38584332
5,88591678
5,02019775
3,0219382
Mortality
(rates)
0
0
0,00000007
0,00000101
0,00005086
0,0007065
0,00389429
RR mortality
(number)
0
0
21,34707093
14,05179811
9,10832458
3,41027622
2,03355861
Age of onset
(years)
0,5
4,31977687
17,83374568
35,74016122
55,95091261
68,02907838
82,1362005
NA
NA
0,00019585
0,00056002
0,00224536
0,10052577
0,06815848
4,50556521
0,00015314
2,91689285
70,94699923
Incidence
(rates)
Remission
(rates)
Mortality
(rates)
Incidence
(rates)
Prevalence
(rates)
Remission
(rates)
Case fatality
(rates)
Duration
(years)
Mortality
(rates)
RR mortality
(number)
Age of onset
(years)
19,6
0,0
56,0
0,0
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masculino (tasa por 100.000)
Femenino (tasa por 100.000)
Diferencia entre mortalidad inicial y la estimada
Masc
Fem
15,3
0,0
Diferencia en onset years
4,3
0,0
-70,9
GRIIA 32
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00000235
0,00000104
0
0,00001214
0,00067179
0,00500667
0,00779694
Remission
(rates)
0,1
0,1
0,1
0,1
0,1
0,1
0,1
Mortality
(numbers)
0
0
0
3
54
457
1047
Incidence
(numbers)
0
2
2
35
527
2469
1426
Prevalence
(numbers)
0
9
12
173
1306
9262
7125
Remission
(numbers)
0
1
1
17
133
936
710
Case fatality
(numbers)
0
0
0
3
64
425
727
Duration
(years)
9,52078999
9,34719493
7,96408971
7,38584332
5,88591678
5,02019775
3,0219382
Mortality
(numbers)
0
0
0
3
64
426
727
RR mortality
(number)
0
0
21,34707093
14,05179811
9,10832458
3,41027622
2,03355861
Age of onset
(years)
0,5
4,31977687
17,83374568
35,74016122
55,95091261
68,02907838
82,1362005
NA
NA
1560
4461
17887
1798
1219
4,50556521
1220
2,91689285
70,94699923
Incidence
(rates)
Remission
(rates)
Mortality
(numbers)
Incidence
(numbers)
Prevalence
(numbers)
Remission
(numbers)
Case fatality
(numbers)
Duration
(years)
Mortality
(numbers)
RR mortality
(number)
Age of onset
(years)
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 33
CANCER DE VEJIGA
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
100000
Incidence
Mortality (rates)
(rates)
0
0,45524026
0
0,3278153
0
0,15332463
0,2647
0,60505063
1,9759
7,17788527
16,454
32,32552652
48,7386
76,95817108
Incidence
(rates)
0,50045432
0,4150428
0,05300337
0,62198934
9,88270011
40,93463807
79,10778215
Remission
(rates)
7000
7000
7000
7000
7000
7000
7000
Prevalence
(rates)
0,21983612
1,75104829
2,19332638
2,41186461
24,94932093
103,1062778
309,1864567
Remission
(rates)
6999,978089
7000,02496
6957,293618
6982,124318
7070,053389
7026,605268
6990,744298
Case fatality
RR mortality
Duration (years) Mortality (rates)
(rates)
(number)
0,00000013
11,67563182
0
0
0,00000032
10,76948418
0
1,00000001
1497,834773
7,27923892
0,03284783
44,95664677
10614,76362
5,96830663
0,2562175
75,77316059
7866,030101
5,23535316
1,96580868
13,11244446
15181,86284
3,92930394
15,67785725
8,7786788
12907,24895
3,09679816
39,93795692
2,38926389
Age of onset
(years)
0,5
4,87278149
15,34851667
36,84578932
54,07655977
68,23714668
82,24294579
NA
NA
2,80195134
5,70184167
20,59556633
7018,526523
12308,90944
9,67668051
67,97058607
Incidence
(rates)
0,00000146
0,0000014
0,00000125
0,00000378
0,00004949
0,00014523
0,00028909
Remission
(rates)
0,12
0,12
0,12
0,12
0,12
0,12
0,12
Mortality (rates)
0
0
0
0
0,00001141
0,00005387
0,00027868
Incidence
(rates)
0,00000144
0,00000138
0,00000129
0,00000354
0,00003882
0,00013076
0,00027921
Prevalence
(rates)
0,00000068
0,00000545
0,00000913
0,00001676
0,00012756
0,00041452
0,0007627
Remission
(rates)
0,11999994
0,11999997
0,11999999
0,11978615
0,12151946
0,1206988
0,11912033
Case fatality
(rates)
0
0
0
0,0035301
0,07328587
0,12642231
0,26609989
RR mortality
Duration (years) Mortality (rates)
(number)
8,27311253
0
0
8,28197194
0
0
8,21943653
0
1
6,71546537
0,00000006
9,03338843
4,50992169
0,00000936
22,20141455
3,52450403
0,00005248
11,77644796
1,98511582
0,00020271
4,67107628
Age of onset
(years)
0,5
5,53795389
14,9668333
37,77734255
53,74084588
67,9947098
84,15633733
NA
NA
0,00001694
0,00002992
0,0000941
0,12032193
0,14543377
280195,1
1,7
570184,2
3,0
4,09535578
2,53824798
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
3,40948389
0,00001368
9,00203045
253824,8
1,4
Diferencia en onset years
26370,3
0,3
69,10080631
1,1
GRIIA 34
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,50045432
0,4150428
0,05300337
0,62198934
9,88270011
40,93463807
79,10778215
Remission
(rates)
7000
7000
7000
7000
7000
7000
7000
Mortality
(numbers)
0
0
0
8
25
99
91
Incidence
(numbers)
1
4
2
19
90
195
144
Prevalence
(numbers)
0
21
33
75
313
622
577
Remission
(numbers)
0
1
2
5
22
44
40
Case fatality
(numbers)
0
0
0
8
25
94
74
Duration (years)
11,67563182
10,76948418
7,27923892
5,96830663
5,23535316
3,92930394
3,09679816
Mortality
(numbers)
0
0
0
8
25
95
75
RR mortality
(number)
0
1,00000001
44,95664677
75,77316059
13,11244446
8,7786788
2,38926389
Age of onset
(years)
0,5
4,87278149
15,34851667
36,84578932
54,07655977
68,23714668
82,24294579
NA
NA
223
454
1641
115
202
4,09535578
202
9,67668051
67,97058607
Incidence
(rates)
0,00000146
0,0000014
0,00000125
0,00000378
0,00004949
0,00014523
0,00028909
Remission
(rates)
0,12
0,12
0,12
0,12
0,12
0,12
0,12
Mortality
(numbers)
0
0
0
0
15
39
84
Incidence
(numbers)
0
2
2
11
51
94
84
Prevalence
(numbers)
0
6
13
52
166
296
231
Remission
(numbers)
0
1
2
6
20
36
27
Case fatality
(numbers)
0
0
0
0
12
37
61
Duration (years)
8,27311253
8,28197194
8,21943653
6,71546537
4,50992169
3,52450403
1,98511582
Mortality
(numbers)
0
0
0
0
12
38
61
RR mortality
(number)
0
0
1
9,03338843
22,20141455
11,77644796
4,67107628
Age of onset
(years)
0,5
5,53795389
14,9668333
37,77734255
53,74084588
67,9947098
84,15633733
NA
NA
138
243
765
92
111
3,40948389
111
9,00203045
69,10080631
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 35
LINFOMA
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00003172
0,00003914
0,00003911
0,00005755
0,00015932
0,00033833
0,00039142
Remission
(rates)
0,35
0,35
0,35
0,35
0,35
0,35
0,35
Mortality (rates)
0,00000797
0,00000083
0,00000472
0,00001683
0,00004689
0,00022137
0,0003875
Incidence
(rates)
0,00003289
0,00003362
0,00003921
0,00005657
0,00014009
0,00032329
0,00036574
Prevalence
(rates)
0,00001374
0,00007306
0,00009503
0,00011404
0,00023267
0,00033534
0,00026665
Remission
(rates)
0,35825143
0,3524898
0,34313574
0,34263052
0,35114266
0,34935766
0,34358251
Case fatality
(rates)
0,01301434
0,01318271
0,04367613
0,13646794
0,20177268
0,60961997
1,15048767
Duration
Mortality (rates)
(years)
2,6953725
0,00000019
2,70557144
0,00000097
2,51665096
0,00000416
2,04108121
0,00001557
1,69951746
0,00004704
0,98931572
0,00020454
0,60906294
0,00030249
RR mortality
(number)
17,10593634
50,49905764
95,03030761
87,70492819
35,09747206
29,92691937
14,29847793
Age of onset
(years)
0,5
5,65232699
15,36788857
33,31154527
52,90242209
66,97962997
81,85754387
NA
NA
0,00004091
0,00009008
0,00014172
0,34693424
0,26141584
1,61526209
38,90033726
48,87775495
Incidence
(rates)
0,00002676
0,00003206
0,00003059
0,00006198
0,00013113
0,00031193
0,00033699
Remission
(rates)
0,4
0,4
0,4
0,4
0,4
0,4
0,4
Mortality (rates)
0
0,00000086
0
0,0000136
0,00003481
0,0001467
0,0003175
Incidence
(rates)
0,00002803
0,00002729
0,00003037
0,0000614
0,00012202
0,00029025
0,00033929
Prevalence
(rates)
0,00001143
0,00005492
0,00006805
0,00011622
0,0001996
0,00035599
0,00029571
Remission
(rates)
0,4055795
0,40157576
0,39094497
0,39297432
0,39965761
0,40106051
0,39103636
Case fatality
(rates)
0,01677295
0,01474373
0,02146286
0,11046823
0,16984707
0,39095606
0,85162863
Duration
Mortality (rates)
(years)
2,37137639
0,00000021
2,41437843
0,00000081
2,35265894
0,00000146
1,96339363
0,00001285
1,67901838
0,00003397
1,21617381
0,00013937
0,73063803
0,00024947
RR mortality
(number)
31,22377986
61,52848423
121,5402945
187,594229
55,74117653
33,23373293
14,20716298
Age of onset
(years)
0,5
5,56082864
15,45484602
33,41193983
52,81139133
67,20372943
83,78876522
NA
NA
0,0000356
0,00009075
0,00013855
0,39652219
0,23320804
1,5645314
55,7248428
52,25271415
4,1
3,6
9,0
9,1
0,00003698
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
0,00003226
3,7
3,2
Diferencia en onset years
0,4
0,3
3,4
GRIIA 36
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00003172
0,00003914
0,00003911
0,00005755
0,00015932
0,00033833
0,00039142
Remission
(rates)
0,35
0,35
0,35
0,35
0,35
0,35
0,35
Mortality
(numbers)
1
1
7
52
59
134
72
Incidence
(numbers)
4
41
58
176
176
195
68
Prevalence
(numbers)
2
88
141
354
292
202
50
Remission
(numbers)
1
31
48
121
102
71
17
Case fatality
(numbers)
0
1
6
48
59
123
57
Duration
(years)
2,6953725
2,70557144
2,51665096
2,04108121
1,69951746
0,98931572
0,60906294
Mortality
(numbers)
0
1
6
48
59
123
56
RR mortality
(number)
17,10593634
50,49905764
95,03030761
87,70492819
35,09747206
29,92691937
14,29847793
Age of onset
(years)
0,5
5,65232699
15,36788857
33,31154527
52,90242209
66,97962997
81,85754387
NA
NA
326
718
1129
392
295
1,61526209
295
38,90033726
48,87775495
Incidence
(rates)
0,00002676
0,00003206
0,00003059
0,00006198
0,00013113
0,00031193
0,00033699
Remission
(rates)
0,4
0,4
0,4
0,4
0,4
0,4
0,4
Mortality
(numbers)
0
1
0
42
45
105
96
Incidence
(numbers)
3
32
44
189
159
208
103
Prevalence
(numbers)
1
64
98
359
260
255
89
Remission
(numbers)
1
26
38
141
104
102
35
Case fatality
(numbers)
0
1
2
40
44
100
76
Duration
(years)
2,37137639
2,41437843
2,35265894
1,96339363
1,67901838
1,21617381
0,73063803
Mortality
(numbers)
0
1
2
40
44
100
75
RR mortality
(number)
31,22377986
61,52848423
121,5402945
187,594229
55,74117653
33,23373293
14,20716298
Age of onset
(years)
0,5
5,56082864
15,45484602
33,41193983
52,81139133
67,20372943
83,78876522
NA
NA
289
738
1126
446
263
1,5645314
262
55,7248428
52,25271415
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 37
MIELOMA
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0
0,00000716
0,00007599
0,000246
0,00031227
Remission
(rates)
0,3
0,3
0,3
0,3
0,3
0,3
0,3
Mortality
(rates)
0
0
0
0,00000263
0,00003603
0,00014822
0,00036305
Incidence
(rates)
0
0
0
0,00000708
0,00006937
0,00023202
0,00028394
Prevalence
(rates)
0
0
0
0,00001044
0,00009722
0,00024612
0,0003053
Remission
(rates)
0
0
0
0,30447007
0,30491011
0,30001961
0,29270391
Case fatality
(rates)
0
0
0
0,22611508
0,31764153
0,57807415
0,82896215
Duration
(years)
0
0
0
1,90532195
1,5119033
1,10182667
0,79853765
Mortality
(rates)
0
0
0
0,0000024
0,00003101
0,00014289
0,00024759
RR mortality
(number)
0
0
0,9530193
390,7705733
50,65159654
30,72231486
10,54563969
Age of onset
(years)
0
0
0
37,94086271
53,73226673
67,45787595
81,20637693
NA
NA
0,00002643
0,0000379
0,00004517
0,30091972
0,49781341
1,22529581
0,00002244
44,85866049
63,9362702
Incidence
(rates)
0
0
0
0,00000773
0,0000791
0,00018572
0,00022997
Remission
(rates)
0,3
0,3
0,3
0,3
0,3
0,3
0,3
Mortality
(rates)
0
0
0
0,00000239
0,00001771
0,00013108
0,00027823
Incidence
(rates)
0
0
0
0,00000778
0,00007203
0,00017193
0,00020834
Prevalence
(rates)
0
0
0
0,0000128
0,0001292
0,00019279
0,00022033
Remission
(rates)
0
0
0
0,29599295
0,30496152
0,2952723
0,29236781
Case fatality
(rates)
0
0
0
0,1649273
0,15331038
0,57440699
0,88181477
Duration
(years)
0
0
0
2,23955904
2,00323598
1,0980177
0,7749438
Mortality
(rates)
0
0
0
0,00000212
0,00001985
0,00011108
0,00018962
RR mortality
(number)
0
0
62,16472742
391,9772584
43,15063365
46,6438573
15,60682098
Age of onset
(years)
0
0
0
36,64597307
54,12402063
68,59729436
82,88585289
NA
NA
0,00002564
0,0000374
0,00005077
0,29883111
0,41278134
1,40111318
0,00002082
48,95306759
64,95307585
2,6
2,6
3,8
3,7
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
2,2
2,1
Diferencia en onset years
0,4
0,5
1,0
GRIIA 38
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0
0,00000716
0,00007599
0,000246
0,00031227
Remission
(rates)
0,3
0,3
0,3
0,3
0,3
0,3
0,3
Mortality
(numbers)
0
0
0
0,00000263
0,00003603
0,00014822
0,00036305
Incidence
(numbers)
0
0
0
0,00000708
0,00006937
0,00023202
0,00028394
Prevalence
(numbers)
0
0
0
0,00001044
0,00009722
0,00024612
0,0003053
Remission
(numbers)
0
0
0
0,30447007
0,30491011
0,30001961
0,29270391
Case fatality
(numbers)
0
0
0
0,22611508
0,31764153
0,57807415
0,82896215
Duration
(years)
0
0
0
1,90532195
1,5119033
1,10182667
0,79853765
Mortality
(numbers)
0
0
0
0,0000024
0,00003101
0,00014289
0,00024759
RR mortality
(number)
0
0
0,9530193
390,7705733
50,65159654
30,72231487
10,54563969
Age of onset
(years)
0
0
0
37,94086271
53,73226673
67,45787595
81,20637693
NA
NA
0,00002643
0,0000379
0,00004517
0,30091972
0,49781341
1,22529581
0,00002244
44,8586605
63,9362702
Incidence
(rates)
0
0
0
0,00000773
0,0000791
0,00018572
0,00022997
Remission
(rates)
0,3
0,3
0,3
0,3
0,3
0,3
0,3
Mortality
(numbers)
0
0
0
7
23
94
84
Incidence
(numbers)
0
0
0
24
94
123
63
Prevalence
(numbers)
0
0
0
40
169
138
67
Remission
(numbers)
0
0
0
12
51
41
19
Case fatality
(numbers)
0
0
0
7
26
79
59
Duration
(years)
0
0
0
2,23955904
2,00323598
1,0980177
0,7749438
Mortality
(numbers)
0
0
0
7
26
79
57
RR mortality
(number)
0
0
62,16472742
391,9772584
43,15063365
46,6438573
15,60682098
Age of onset
(years)
0
0
0
36,64597307
54,12402063
68,59729436
82,88585289
NA
NA
208
304
413
123
170
1,40111318
169
48,95306759
64,95307585
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 39
Incidence
(rates)
0
0
0
0,00002277
0,00019545
0,00065699
0,00130201
Remission
(rates)
0,35
0,35
0,35
0,35
0,35
0,35
0,35
Mortality (rates)
0
0
0
0,00000629
0,00008011
0,00037535
0,00104727
Incidence
(rates)
0
0
0,00000176
0,00001876
0,00015626
0,00060384
0,0011478
Prevalence
(rates)
0
0
0,00000215
0,0000224
0,00019436
0,00059348
0,00097393
Remission
(rates)
0
0
0,34271647
0,34970722
0,3520868
0,35191088
0,34621226
Case fatality
(rates)
0
0
0,02778819
0,29274858
0,36217832
0,59939155
0,85707277
Duration
(years)
0
0
2,3834302
1,59895499
1,31462357
1,02127115
0,74140932
Mortality (rates)
0
0
0,00000006
0,00000664
0,00007076
0,00035745
0,00083239
RR mortality
(number)
0
1
39,17216525
404,0745362
60,82988128
31,79586656
10,15878526
Age of onset
(years)
0,5
5,02297577
17,93807158
38,24314981
53,73637911
67,44705362
82,55423135
NA
NA
0,00006802
0,00010486
0,00010749
0,35053804
0,55950517
1,06281898
0,00006031
46,15319921
66,23347858
Incidence
(rates)
0
0
0,00000184
0,00005891
0,00060875
0,00141626
0,00168933
Remission
(rates)
0,35
0,35
0,35
0,35
0,35
0,35
0,35
Mortality (rates)
0
0
0
0,00001805
0,00022808
0,00074876
0,00157833
Incidence
(rates)
0
0
0,000001
0,00004659
0,00049524
0,00133257
0,00174417
Prevalence
(rates)
0
0
0,00000121
0,0000449
0,00068163
0,00161237
0,00169388
Remission
(rates)
0
0
0,34995836
0,35353315
0,35389143
0,35095088
0,34366023
Case fatality
(rates)
0
0
0,01792208
0,39726459
0,27774132
0,44476279
0,75700166
Duration
(years)
0
0
2,10531561
1,47383148
1,52287007
1,21747499
0,82374732
Mortality (rates)
0
0
0,00000002
0,00001815
0,00019019
0,00071852
0,00127387
RR mortality
(number)
0
1
156,5912887
1598,181148
86,89442485
38,33902385
12,78652535
Age of onset
(years)
0,5
7,26098882
17,98300153
39,46977988
53,53739566
67,32030589
83,79419974
NA
NA
0,00016808
0,00027953
0,0003316
0,35066806
0,44625875
1,22963244
0,00014805
112,7933212
65,94902049
6,8
16,8
10,5
28,0
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
6,0
14,8
Diferencia en onset years
0,8
2,0
-0,3
GRIIA 40
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0
0,00002277
0,00019545
0,00065699
0,00130201
Remission
(rates)
0,35
0,35
0,35
0,35
0,35
0,35
0,35
Mortality
(numbers)
0
0
0
20
100
226
195
Incidence
(numbers)
0
0
3
58
196
364
214
Prevalence
(numbers)
0
0
3
70
244
358
182
Remission
(numbers)
0
0
1
24
86
126
63
Case fatality
(numbers)
0
0
0
20
88
215
156
Duration
(years)
0
0
2,3834302
1,59895499
1,31462357
1,02127115
0,74140932
Mortality
(numbers)
0
0
0
21
89
216
155
RR mortality
(number)
0
1
39,17216525
404,0745362
60,82988128
31,79586656
10,15878526
Age of onset
(years)
0,5
5,02297577
17,93807158
38,24314981
53,73637911
67,44705362
82,55423135
NA
NA
542
835
856
300
479
1,06281898
480
46,15319921
66,23347858
Incidence
(rates)
0
0
0,00000184
0,00005891
0,00060875
0,00141626
0,00168933
Remission
(rates)
0,35
0,35
0,35
0,35
0,35
0,35
0,35
Mortality
(numbers)
0
0
0
56
298
536
477
Incidence
(numbers)
0
0
1
144
646
953
527
Prevalence
(numbers)
0
0
2
139
889
1153
512
Remission
(numbers)
0
0
1
49
315
405
176
Case fatality
(numbers)
0
0
0
55
247
513
388
Duration
(years)
0
0
2,10531561
1,47383148
1,52287007
1,21747499
0,82374732
Mortality
(numbers)
0
0
0
56
248
514
385
RR mortality
(number)
0
1
156,5912887
1598,181148
86,89442485
38,33902385
12,78652535
Age of onset
(years)
0,5
7,26098882
17,98300153
39,46977988
53,53739566
67,32030589
83,79419974
NA
NA
1366
2272
2695
945
1203
1,22963244
1203
112,7933212
65,94902049
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 41
CANCER DE TESTICULO
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00000962
0,00000625
0,00004616
0,00020611
0,00006896
0,00005132
0,0000425
Remission
(rates)
0,35
0,35
0,35
0,35
0,35
0,35
0,35
Mortality
(rates)
0
0
0,00000472
0,00002175
0,00001106
0,0000106
0,00004024
Incidence
(rates)
0,00000601
0,00000546
0,00002972
0,00017753
0,00007052
0,00004531
0,0000445
Prevalence
(rates)
0,00000254
0,00001251
0,00003942
0,00042731
0,0002068
0,00011092
0,00007477
Remission
(rates)
0,34999735
0,35025915
0,34951928
0,35025569
0,34806285
0,34155959
0,33842541
Case fatality
(rates)
0
0,00733186
0,14008986
0,04561652
0,05870661
0,09744702
0,36996323
Duration
(years)
2,81706228
2,62277203
2,15676899
2,5142022
2,40129493
2,07564091
1,16223848
Mortality
(rates)
0
0,00000009
0,00000558
0,00001951
0,00001212
0,0000108
0,00002745
RR mortality
(number)
0
166,2507325
255,7651676
32,42819801
13,00588927
5,80098581
5,13024556
Age of onset
(years)
0,5
5,49897201
17,07494628
32,1999307
51,01810634
66,64564349
81,88180781
NA
NA
0,00001285
0,00009127
0,00021863
0,34947558
0,05498826
2,44815306
0,00001203
45,54580643
35,19570259
Incidence
(rates)
Remission
(rates)
Mortality
(rates)
Incidence
(rates)
Prevalence
(rates)
Remission
(rates)
Case fatality
(rates)
Duration
(years)
Mortality
(rates)
RR mortality
(number)
Age of onset
(years)
1,3
0,0
9,1
0,0
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masculino (tasa por 100.000)
Femenino (tasa por 100.000)
Diferencia entre mortalidad inicial y la estimada
Masc
Fem
1,2
0,0
Diferencia en onset years
0,1
0,0
-35,2
GRIIA 42
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00000962
0,00000625
0,00004616
0,00020611
0,00006896
0,00005132
0,0000425
Remission
(rates)
0,35
0,35
0,35
0,35
0,35
0,35
0,35
Mortality
(numbers)
0
0
7
68
14
6
8
Incidence
(numbers)
1
7
44
552
88
27
8
Prevalence
(numbers)
0
15
58
1328
259
67
14
Remission
(numbers)
0
5
20
465
90
23
5
Case fatality
(numbers)
0
0
8
61
15
7
5
Duration
(years)
2,81706228
2,62277203
2,15676899
2,5142022
2,40129493
2,07564091
1,16223848
Mortality
(numbers)
0
0
8
61
15
7
5
RR mortality
(number)
0
166,2507325
255,7651676
32,42819801
13,00588927
5,80098581
5,13024556
Age of onset
(years)
0,5
5,49897201
17,07494628
32,1999307
51,01810634
66,64564349
81,88180781
NA
NA
102
727
1742
609
96
2,44815306
96
45,54580643
35,19570259
Incidence
(rates)
Remission
(rates)
Mortality
(numbers)
Incidence
(numbers)
Prevalence
(numbers)
Remission
(numbers)
Case fatality
(numbers)
Duration
(years)
Mortality
(numbers)
RR mortality
(number)
Age of onset
(years)
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 43
CANCER DE ENCEFALO
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00006811
0,00006209
0,00002522
0,00001478
0,00004351
0,00008652
0,00012986
Remission
(rates)
0,45
0,45
0,45
0,45
0,45
0,45
0,45
Mortality (rates)
0
0,00000912
0,00001078
0,00000856
0,00004627
0,00009014
0,00014308
Incidence
(rates)
0,00006955
0,00005976
0,00002488
0,00001359
0,00004147
0,00008797
0,00011385
Prevalence
(rates)
0,00002714
0,00010583
0,00005387
0,0000109
0,00002078
0,00003518
0,00004736
Remission
(rates)
0,44141858
0,437535
0,41940605
0,4441445
0,44205012
0,44004478
0,43762245
Case fatality
(rates)
0,07649589
0,08559843
0,19951538
0,78562174
1,53859589
1,99791411
1,9962461
NA
NA
0,00002419
0,00003594
0,00003778
0,43407803
0,5112431
Incidence
(rates)
0,00006426
0,00004686
0,00001293
0,00000964
0,00002808
0,00004032
0,00004909
Remission
(rates)
0,45
0,45
0,45
0,45
0,45
0,45
0,45
Mortality (rates)
0
0,00000688
0,00000714
0,00000955
0,00002345
0,00006399
0,00009713
Incidence
(rates)
0,00005384
0,00004228
0,00001274
0,00000896
0,00002568
0,00004604
0,00005347
Prevalence
(rates)
0,00002102
0,00007726
0,00002861
0,00000509
0,00001248
0,00001916
0,00002126
Remission
(rates)
0,44189466
0,43399404
0,41214732
0,44275257
0,44500174
0,43427998
0,43222446
Case fatality
(rates)
0,07457302
0,08870382
0,24312982
1,24498937
1,58634763
1,9630609
1,99999999
NA
NA
0,00001888
0,00002267
0,00002283
0,43093724
0,55655046
2,4
1,9
3,6
2,3
Duration
Mortality (rates)
(years)
1,92174714
0,00000225
1,882391
0,00000907
1,50832838
0,00001064
0,80611392
0,00000858
0,48510382
0,00003207
0,40592179
0,00007084
0,39471486
0,00009418
RR mortality
(number)
95,6677081
290,1689503
551,6618017
551,7044459
277,1767456
96,99211781
26,04797945
Age of onset
(years)
0,5
5,28402721
13,81773631
34,22940463
52,81853533
67,21157411
81,79370841
1,0386732
274,7483672
36,5233485
Duration
Mortality (rates)
(years)
1,92744998
0,0000017
1,87826413
0,00000686
1,39403683
0,00000685
0,59274349
0,0000064
0,48188399
0,00001988
0,41403807
0,00003763
0,39747488
0,00004298
RR mortality
(number)
135,3758255
475,1948549
1389,913148
2218,424072
538,7451486
175,6645853
35,15602046
Age of onset
(years)
0,5
5,07965371
13,59997795
36,09810168
52,70576385
66,56409776
84,25222097
0,99329975
776,4077776
37,57243004
0,00001935
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
0,00001275
1,9
1,3
Diferencia en onset years
0,5
0,6
1,0
GRIIA 44
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00006811
0,00006209
0,00002522
0,00001478
0,00004351
0,00008652
0,00012986
Remission
(rates)
0,45
0,45
0,45
0,45
0,45
0,45
0,45
Mortality
(numbers)
0
11
16
27
58
54
27
Incidence
(numbers)
9
72
37
42
52
53
21
Prevalence
(numbers)
3
128
80
34
26
21
9
Remission
(numbers)
2
56
34
15
12
9
4
Case fatality
(numbers)
0
11
16
27
40
42
18
Duration
(years)
1,92174714
1,882391
1,50832838
0,80611392
0,48510382
0,40592179
0,39471486
Mortality
(numbers)
0
11
16
27
40
43
18
RR mortality
(number)
95,6677081
290,1689503
551,6618017
551,7044459
277,1767456
96,99211781
26,04797945
Age of onset
(years)
0,5
5,28402721
13,81773631
34,22940463
52,81853533
67,21157411
81,79370841
NA
NA
193
286
301
131
154
1,0386732
154
274,7483672
36,5233485
Incidence
(rates)
0,00006426
0,00004686
0,00001293
0,00000964
0,00002808
0,00004032
0,00004909
Remission
(rates)
0,45
0,45
0,45
0,45
0,45
0,45
0,45
Mortality
(numbers)
0
8
10
29
31
46
29
Incidence
(numbers)
7
49
18
28
34
33
16
Prevalence
(numbers)
3
90
41
16
16
14
6
Remission
(numbers)
1
39
17
7
7
6
3
Case fatality
(numbers)
0
8
10
20
26
27
13
Duration
(years)
1,92744998
1,87826413
1,39403683
0,59274349
0,48188399
0,41403807
0,39747488
Mortality
(numbers)
0
8
10
20
26
27
13
RR mortality
(number)
135,3758255
475,1948549
1389,913148
2218,424072
538,7451486
175,6645853
35,15602046
Age of onset
(years)
0,5
5,07965371
13,59997795
36,09810168
52,70576385
66,56409776
84,25222097
NA
NA
153
184
186
80
103
0,99329975
104
776,4077776
37,57243004
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 45
TUMORES OSEOS
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00000463
0,00000889
0,00002546
0,00000921
0,0000165
0,00002468
0,0000591
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality (rates)
0
0,00000166
0,00000674
0,00000521
0,00001362
0,00003706
0,00011546
Incidence
(rates)
0,00000538
0,00000898
0,00001948
0,00000957
0,00001364
0,00002578
0,00006199
Prevalence
(rates)
0,0000023
0,00001898
0,00005593
0,00003194
0,00001262
0,00001195
0,00002691
Remission
(rates)
0,19564874
0,1982365
0,20224962
0,19663791
0,19806159
0,19710131
0,19681337
Case fatality
(rates)
0,12169413
0,09116221
0,09325128
0,16688339
0,9008488
1,9072619
2
Duration
(years)
3,2420634
3,46614908
3,31503817
2,52590052
0,8511295
0,46457037
0,43406698
Mortality (rates)
0,0000003
0,00000174
0,00000522
0,00000532
0,00001135
0,00002296
0,00005453
RR mortality
(number)
151,6029139
290,6210405
220,9388572
116,9975149
164,4459691
86,66231906
24,04294564
Age of onset
(years)
0,5
6,42571828
15,08821484
30,83668627
52,49878861
67,77120017
82,68152158
NA
NA
0,00001119
0,00001436
0,0000293
0,19890301
0,27615216
2,07616635
0,00000812
124,4201875
38,22729622
Incidence
(rates)
0,00000101
0,00000457
0,00001492
0,00000765
0,00000967
0,00001306
0,00001439
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality (rates)
0
0,00000086
0,00000505
0,00000432
0,00000729
0,00002404
0,00005823
Incidence
(rates)
0,00000132
0,00000425
0,00001168
0,00000797
0,00000867
0,00001267
0,00001532
Prevalence
(rates)
0,00000055
0,00000739
0,00003035
0,00002216
0,00001236
0,00000628
0,00000696
Remission
(rates)
0,18972438
0,19663228
0,20191489
0,19773531
0,19728444
0,19698159
0,19698678
Case fatality
(rates)
0,19207458
0,11833609
0,12571796
0,19748838
0,54648333
1,83999558
1,99999998
Duration
(years)
2,74909222
3,20573736
2,97747656
2,39980597
1,24876233
0,476718
0,43906591
Mortality (rates)
0,00000011
0,00000088
0,00000382
0,00000437
0,00000673
0,00001156
0,00001393
RR mortality
(number)
347,1061481
621,8578359
533,3738155
349,4909331
191,8570323
148,4111936
37,49078698
Age of onset
(years)
0,5
6,98617694
15,13334715
31,60968377
52,09809532
67,6715337
83,74773917
NA
NA
0,00000811
0,0000088
0,00001764
0,19885007
0,28817045
2,03865613
0,00000508
275,0193936
37,54133587
1,1
0,8
1,4
0,9
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Masc
Fem
0,8
0,5
Diferencia en onset years
0,3
0,3
-0,7
GRIIA 46
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00000463
0,00000889
0,00002546
0,00000921
0,0000165
0,00002468
0,0000591
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(numbers)
0
2
10
16
17
22
22
Incidence
(numbers)
1
11
29
30
17
16
12
Prevalence
(numbers)
0
23
83
99
16
7
5
Remission
(numbers)
0
5
17
20
3
1
1
Case fatality
(numbers)
0
2
8
17
14
14
10
Duration
(years)
3,2420634
3,46614908
3,31503817
2,52590052
0,8511295
0,46457037
0,43406698
Mortality
(numbers)
0
2
8
17
14
14
10
RR mortality
(number)
151,6029139
290,6210405
220,9388572
116,9975149
164,4459691
86,66231906
24,04294564
Age of onset
(years)
0,5
6,42571828
15,08821484
30,83668627
52,49878861
67,77120017
82,68152158
NA
NA
89
114
233
46
64
2,07616635
65
124,4201875
38,22729622
Incidence
(rates)
0,00000101
0,00000457
0,00001492
0,00000765
0,00000967
0,00001306
0,00001439
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(numbers)
0
1
7
13
10
17
18
Incidence
(numbers)
0
5
17
25
11
9
5
Prevalence
(numbers)
0
9
44
68
16
4
2
Remission
(numbers)
0
2
9
14
3
1
0
Case fatality
(numbers)
0
1
5
14
9
8
4
Duration
(years)
2,74909222
3,20573736
2,97747656
2,39980597
1,24876233
0,476718
0,43906591
Mortality
(numbers)
0
1
5
13
9
8
4
RR mortality
(number)
347,1061481
621,8578359
533,3738155
349,4909331
191,8570323
148,4111936
37,49078698
Age of onset
(years)
0,5
6,98617694
15,13334715
31,60968377
52,09809532
67,6715337
83,74773917
NA
NA
66
71
143
29
41
2,03865613
41
275,0193936
37,54133587
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIA 47
Incidence
(rates)
0,00002229
0,00001653
0,00001616
0,000015
0,00003031
0,00005772
0,00007233
Remission
(rates)
0,22
0,22
0,22
0,22
0,22
0,22
0,22
Mortality
(rates)
0
0
0,00000067
0,00000358
0,00001114
0,00002312
0,00008137
Incidence
(rates)
0,00001802
0,00001614
0,00001521
0,00001277
0,00002852
0,00005144
0,0000732
Prevalence
(rates)
0,00000809
0,0000502
0,00006419
0,00004895
0,00007163
0,00010698
0,00013596
Remission
(rates)
0,21999946
0,21800909
0,21752185
0,21362318
0,21987198
0,22064688
0,21510979
Case fatality
(rates)
0
0,00485377
0,01095609
0,06526382
0,13860942
0,2117776
0,40861002
Duration
(years)
4,47673291
4,41657576
4,24478302
3,36614029
2,63313191
2,12760952
1,29528613
Mortality
(rates)
0
0,00000024
0,0000007
0,00000319
0,00000994
0,00002269
0,00005524
RR mortality
(number)
0
36,24766885
29,60617857
47,12583058
25,68161208
11,84270865
5,49203825
Age of onset
(years)
0,5
5,4004457
15,06024513
31,686159
52,02210533
67,43391505
81,98359576
NA
NA
0,00000693
0,00002064
0,00006133
0,21709356
0,09771725
3,061136
0,00000599
21,96002085
41,44304503
Incidence
(rates)
0,00000649
0,00000488
0,00000669
0,00000827
0,00001594
0,00002773
0,00002527
Remission
(rates)
0,15
0,15
0,15
0,15
0,15
0,15
0,15
Mortality
(rates)
0
0
0,0000007
0,00000381
0,00000892
0,00002264
0,0000546
Incidence
(rates)
0,00000535
0,00000495
0,00000611
0,00000778
0,00001613
0,0000272
0,0000289
Prevalence
(rates)
0,00000248
0,00001793
0,00002919
0,00002835
0,00004754
0,00004582
0,0000198
Remission
(rates)
0,15000039
0,14777832
0,14863302
0,14737052
0,1491763
0,14934666
0,14763706
Case fatality
(rates)
0
0,01047694
0,02375669
0,11672239
0,1759754
0,46627856
1,48537069
Duration
(years)
6,26320376
5,93397736
5,20463153
3,53300526
2,77666425
1,49311228
0,55026929
Mortality
(rates)
0
0,00000019
0,00000069
0,00000331
0,00000837
0,00002133
0,00002883
RR mortality
(number)
1
117,0307688
106,8041851
214,2536978
59,74103747
39,45502504
25,21540698
Age of onset
(years)
0,5
5,4825664
15,31855223
34,3233578
52,24457074
66,86743232
83,83658638
NA
NA
0,00000702
0,00001088
0,00003092
0,14832766
0,18507766
2,95141504
0,0000057
81,91417289
47,09135621
0,7
0,7
2,1
1,1
0,6
0,6
Masc
Fem
0,1
0,1
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Diferencia en onset
Diferencia entre mortalidad inicial y la estimada
5,6
GRIIA 48
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00002229
0,00001653
0,00001616
0,000015
0,00003031
0,00005772
0,00007233
Remission
(rates)
0,22
0,22
0,22
0,22
0,22
0,22
0,22
Mortality
(numbers)
0
0
1
11
14
14
15
Incidence
(numbers)
2
19
23
40
36
31
14
Prevalence
(numbers)
1
61
95
152
90
65
25
Remission
(numbers)
0
13
21
32
20
14
5
Case fatality
(numbers)
0
0
1
10
12
14
10
Duration
(years)
4,47673291
4,41657576
4,24478302
3,36614029
2,63313191
2,12760952
1,29528613
Mortality
(numbers)
0
0
1
10
12
14
10
RR mortality
(number)
0
36,24766885
29,60617857
47,12583058
25,68161208
11,84270865
5,49203825
Age of onset
(years)
0,5
5,4004457
15,06024513
31,686159
52,02210533
67,43391505
81,98359576
NA
NA
55
164
489
106
48
3,061136
48
21,96002085
41,44304503
Incidence
(rates)
0,00000649
0,00000488
0,00000669
0,00000827
0,00001594
0,00002773
0,00002527
Remission
(rates)
0,15
0,15
0,15
0,15
0,15
0,15
0,15
Mortality
(numbers)
0
0
1
12
12
16
17
Incidence
(numbers)
1
6
9
24
21
19
9
Prevalence
(numbers)
0
21
42
87
62
33
6
Remission
(numbers)
0
3
6
13
9
5
1
Case fatality
(numbers)
0
0
1
10
11
15
9
Duration
(years)
6,26320376
5,93397736
5,20463153
3,53300526
2,77666425
1,49311228
0,55026929
Mortality
(numbers)
0
0
1
10
11
15
9
RR mortality
(number)
1
117,0307688
106,8041851
214,2536978
59,74103747
39,45502504
25,21540698
Age of onset
(years)
0,5
5,4825664
15,31855223
34,3233578
52,24457074
66,86743232
83,83658638
NA
NA
57
88
251
37
47
2,95141504
46
81,91417289
47,09135621
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIB 1
Incidence
(rates)
0,000005
0,00000389
0,000003
0,0000062
0,000013
0,000012
0,00001867
Remission
(rates)
0,6
0,6
0,6
0,6
0,6
0,6
0,6
Mortality
(rates)
0
0
0
0
0
0
0
Incidence
(rates)
0,00000429
0,00000258
0,00000128
0,00000512
0,00001248
0,00001782
0,00001682
Prevalence
(rates)
0,00000169
0,00000536
0,00000231
0,00000903
0,00002361
0,00003401
0,00003629
Remission
(rates)
0,5
0,49998609
0,49963101
0,49999353
0,50000118
0,5
0,5
Case fatality
(rates)
0
0,00000464
0,0001242
0,00003834
0,00000002
0,00000001
0,00000003
Duration
(years)
1,99429686
1,99692131
1,99724382
1,9910399
1,97157228
1,88951274
1,64402304
Mortality
(rates)
0
0
0
0
0
0
0
RR mortality
(number)
1,00000018
1,03272759
1,26458617
1,25361063
1,00001247
1,00000121
1,00000028
Age of onset
(years)
0,5
4,37912992
16,40691721
36,23136068
52,04601244
66,91237901
81,5863915
NA
NA
0,0000064
0,00001193
0,49998422
0,00001612
1,94291745
1,25219612
47,42198002
Incidence
(rates)
0,000005
0,00000278
0,000003
0,0000052
0,000014
0,000018
0,00000683
Remission
(rates)
0,52
0,52
0,52
0,52
0,52
0,52
0,52
Mortality
(rates)
0
0
0
0
0
0
0
Incidence
(rates)
0
0,00000017
0,00000383
0,00000505
0,00001147
0,00001521
0,00000724
Prevalence
(rates)
0
0,00000012
0,00000598
0,00000982
0,00002016
0,0000318
0,0000167
Remission
(rates)
0
0,5
0,5
0,5
0,5
0,5
0,5
Case fatality
(rates)
0
0
0
0
0,00000001
0,00000001
0
Duration
(years)
0
1,99943758
1,99887413
1,99660512
1,98281111
1,94047205
1,70856122
Mortality
(rates)
0
0
0
0
0
0
0
RR mortality
(number)
0
1,00000001
1,00000177
1,00000176
1,00000502
1,00000186
1,00000002
Age of onset
(years)
0,5
9,00973501
15,69089841
33,75782841
53,19966303
65,98926258
83,13355548
NA
NA
0,00000607
0,00001146
0,5
0,00000001
1,96749588
1,00000408
47,03878532
0,0
0,0
0,6
0,6
0,0
0,0
Masc
Fem
0,0
0,0
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Diferencia en onset y
Diferencia entre mortalidad inicial y la estimada
-0,4
GRIIB 2
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,000005
0,00000389
0,000003
0,0000062
0,000013
0,000012
0,00001867
Remission
(rates)
0,6
0,6
0,6
0,6
0,6
0,6
0,6
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
1
3
2
16
16
11
3
Prevalence
(numbers)
0
6
3
28
30
21
7
Remission
(numbers)
0
3
2
14
15
10
3
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
1,99429686
1,99692131
1,99724382
1,9910399
1,97157228
1,88951274
1,64402304
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1,00000018
1,03272759
1,26458617
1,25361063
1,00001247
1,00000121
1,00000028
Age of onset
(years)
0,5
4,37912992
16,40691721
36,23136068
52,04601244
66,91237901
81,5863915
NA
NA
51
95
48
1,94291745
1,25219612
47,42198002
Incidence
(rates)
0,000005
0,00000278
0,000003
0,0000052
0,000014
0,000018
0,00000683
Remission
(rates)
0,52
0,52
0,52
0,52
0,52
0,52
0,52
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
5
16
15
11
2
Prevalence
(numbers)
0
0
9
30
26
23
5
Remission
(numbers)
0
0
4
15
13
11
3
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
1,99943758
1,99887413
1,99660512
1,98281111
1,94047205
1,70856122
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1,00000001
1,00000177
1,00000176
1,00000502
1,00000186
1,00000002
Age of onset
(years)
0,5
9,00973501
15,69089841
33,75782841
53,19966303
65,98926258
83,13355548
NA
NA
49
93
47
1,96749588
1,00000408
47,03878532
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIC 1
DIABETES MELLITUS I
Males, Disease: diabetes 1 a (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
RR Mortality Incidence
Prevalence
Remission
Case fatality Duration
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (years)
0,015
0
1,9
0,015
0,0075
0
0,2179
67,129
0,0239
0
1,9
0,0242
0,1075
0
0,2017
61,794
0,0245
0
1,9
0,0248
0,392
0
0,4002
55,0308
0
0
1,9
0
0,466
0
1,4783
0
0
0
1,9
0
0,4437
0
4,9429
0
0
0
1,9
0
0,3804
0
19,1952
0
0
0
1,9
0
0,2469
0
60,9004
0
NA
NA
NA
0,0085
0,3756
Incidence
Remission
RR Mortality Incidence
(rates * 1000) (rates * 1000) (rates * 1000) (numbers)
0,015
0
1,9
2
0,0239
0
1,9
29
0,0245
0
1,9
37
0
0
1,9
0
0
0
1,9
0
0
0
1,9
0
0
0
1,9
0
Prevalence
(numbers)
1
130
582
1448
556
229
46
4,1311
Mortality
RR mortality
(rates * 1000) (number)
0
1,0235
0
1,9361
0,0002
1,7961
0,0007
1,8838
0,0022
1,8757
0,0073
1,8573
0,015
1,7139
58,2754
0,0016
Duration
(years)
67,129
61,794
55,0308
0
0
0
0
Mortality
(numbers)
0
0
0
2
3
4
3
1,8324
Age of onset
(years)
0,5
6,3466
13,2983
0
0
0
0
9,9528
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
NA
NA
NA
68
2992
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
2
3
4
3
12
58,2754
12
RR mortality
(number)
1,0235
1,9361
1,7961
1,8838
1,8757
1,8573
1,7139
1,8324
Age of onset
(years)
0,5
6,3466
13,2983
0
0
0
0
9,9528
GRIIC 2
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
RR Mortality Incidence
Prevalence
Remission
Case fatality Duration
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (years)
0,014
0
2,6
0,014
0,007
0
0,3339
71,0436
0,0134
0
2,6
0,0134
0,0771
0
0,2726
66,4695
0,029
0
2,6
0,0293
0,3309
0
0,3386
59,0369
0
0
2,6
0
0,4196
0
1,0026
0
0
0
2,6
0
0,403
0
4,6104
0
0
0
2,6
0
0,3445
0
19,8402
0
0
0
2,6
0
0,2215
0
62,669
0
NA
NA
NA
0,0073
0,3321
Incidence
Remission
RR Mortality Incidence
(rates * 1000) (rates * 1000) (rates * 1000) (numbers)
0,014
0
2,6
2
0,0134
0
2,6
16
0,029
0
2,6
42
0
0
2,6
0
0
0
2,6
0
0
0
2,6
0
0
0
2,6
0
Prevalence
(numbers)
1
90
475
1295
526
246
67
4,8132
Mortality
RR mortality
(rates * 1000) (number)
0
1,0462
0
2,7902
0,0001
2,4215
0,0004
2,5496
0,0019
2,5225
0,0068
2,5471
0,0139
2,0463
61,3335
0,0016
Duration
(years)
71,0436
66,4695
59,0369
0
0
0
0
Mortality
(numbers)
0
0
0
1
2
5
4
2,3799
Age of onset
(years)
0,5
5,5331
13,1778
0
0
0
0
10,8059
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
NA
NA
NA
59
2699
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
1
2
5
4
13
61,3335
13
RR mortality
(number)
1,0462
2,7902
2,4215
2,5496
2,5225
2,5471
2,0463
2,3799
Age of onset
(years)
0,5
5,5331
13,1778
0
0
0
0
10,8059
GRIIC 3
DIABETES TIPO II
DisMod II input and output, database OA
Females, Disease: diabetes 2_inciden (Rates * 100), sex: Females
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
RR Mortality Incidence
(rates * 100) (rates * 100) (rates * 100) (rates * 100)
0
0
1
0
0
0
1
0
0
0
1
0,0038
0,02
0
2,6
0,0233
1
0
2,6
0,7067
0,7
0
2,6
0,7464
1
0
2,6
0,9421
NA
NA
NA
0,2237
0
0
0,038
0,233
7,067
7,464
9,421
Prevalence Remission
Case fatality Duration
(rates * 100) (rates * 100) (rates * 100) (years)
0
0
0
0
0
0
0
0
0,0076
0
0,005
55,3015
0,2789
0
0,1214
39,4268
4,5329
0
0,6169
22,7563
15,0872
0
2,1784
13,008
18,2524
0
6,3875
6,4202
2,8417
2,7065
Mortality
RR mortality Age of onset
(rates * 100) (number)
(years)
0
0
0
0
0
0
0
1,2017
17,9474
0,0003
2,5329
34,5903
0,028
2,5556
53,1747
0,3287
2,5496
66,5144
1,1658
2,0096
84,091
18,0911
0,0769
Mortality
(numbers)
0
0
0
10
365
2351
3525
2,2454
60,7893
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
RR Mortality Incidence
(rates * 100) (rates * 100) (rates * 100) (numbers)
0
0
1
0
0
0
1
0
0
0
1
54
0,02
0
2,6
719
1
0
2,6
9220
0,7
0
2,6
5339
1
0
2,6
2848
NA
NA
NA
18180
Prevalence
(numbers)
0
0
109
8606
59143
107914
55181
230953
Remission
(numbers)
0
0
0
0
0
0
0
0
6251
18,0911
6251
60,7893
GRIIC 4
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
Remission
RR Mortality Incidence
(rates * 100) (rates * 100) (rates * 100) (rates * 100)
0
0
1
0
0
0
1
0
0
0
1
0,0071
0,04
0
1,9
0,0451
1,7
0
1,9
1,1729
0,6
0
1,9
0,7328
0,8002
0
1,9
0,7601
All ages
NA
NA
NA
0,2768
0
0
0,071
0,451
11,729
7,328
7,601
Prevalence Remission
Case fatality Duration
(rates * 100) (rates * 100) (rates * 100) (years)
0
0
0
0
0
0
0
0
0,0143
0
0,0158
51,5256
0,5391
0
0,1697
36,6514
7,7439
0
0,6423
20,8276
22,3474
0
2,0472
12,0345
22,7889
0
6,1872
5,7063
3,658
2,0738
Mortality
RR mortality Age of onset
(rates * 100) (number)
(years)
0
0
0
0
0
0
0
1,1856
17,9466
0,0009
1,8799
34,3484
0,0498
1,8762
52,8619
0,4575
1,8574
65,6367
1,4098
1,702
82,3444
19,2452
0,0759
Mortality
(numbers)
0
0
0
28
624
2760
2631
1,7918
55,3948
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
Remission
RR Mortality Incidence
(rates * 100) (rates * 100) (rates * 100) (numbers)
0
0
1
0
0
0
1
0
0
0
1
106
0,04
0
1,9
1401
1,7
0
1,9
14707
0,6
0
1,9
4420
0,8002
0
1,9
1418
All ages
Discapacidad
NA
NA
0,00416667
NA
Prevalence
(numbers)
0
0
212
16749
97106
134810
42525
Remission
(numbers)
0
0
0
0
0
0
0
GRIIC 5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Case fatality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
4500
100
0
0
0
0
0
4500
100
0
0
0
0
0
4500
100
0
0
0
0
0,22
4500
100
0,22
0,0467
4500
100
3,26
4500
100
3,2578
0,678
4500
100
12,26
4500
100
12,2286
2,5633
4500
100
20,24
4500
100
20,1536
4,2669
4500
100
NA
NA
NA
1,9967
Duration
(years)
0
0
0
0,2173
0,2171
0,2163
0,2129
Mortality
RR mortality
(rates * 1000)
(number)
0
0
0
0
0
0
0,0047
65,489
0,0695
21,1089
0,2618
6,1163
0,4333
2,2304
Age of onset
(years)
0
0
0
32,3837
51,6577
66,4407
82,0202
0,419
4500
100
0,2157
0,0428
11,5958
65,1408
Incidence
(numbers)
0
0
0
683
4085
7377
3761
Prevalence
(numbers)
0
0
0
145
850
1546
796
Remission
(numbers)
0
0
0
654
3826
6958
3583
Case fatality
(numbers)
0
0
0
15
85
155
80
Duration
(years)
0
0
0
0,2173
0,2171
0,2163
0,2129
Mortality
(numbers)
0
0
0
15
87
158
81
RR mortality
(number)
0
0
0
65,489
21,1089
6,1163
2,2304
Age of onset
(years)
0
0
0
32,3837
51,6577
66,4407
82,0202
15906
3338
15021
334
0,2157
341
11,5958
65,1408
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000)
0
4500
100
0
4500
100
0
4500
100
0,22
4500
100
3,26
4500
100
12,26
4500
100
20,24
4500
100
NA
NA
NA
GRIIC 6
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Case fatality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
4500
100
0
0
0
0
0
4500
100
0
0
0
0
0
4500
100
0
0
0
0
0,4
4500
100
0,4
0,085
4500
100
5,12
4500
100
5,1145
1,066
4500
100
12,92
4500
100
12,8848
2,7248
4500
100
9,64
4500
100
9,6195
2,1317
4500
100
NA
NA
NA
2,4648
Duration
(years)
0
0
0
0,2174
0,2172
0,2168
0,2139
Mortality
RR mortality
(rates * 1000)
(number)
0
0
0
0
0
0
0,0086
184,719
0,1092
38,6984
0,2769
9,828
0,2109
2,8182
Age of onset
(years)
0
0
0
32,4838
51,7432
66,7132
83,7038
0,5225
4500
100
0,2165
0,053
29,1296
62,4645
Incidence
(numbers)
0
0
0
1234
6673
9216
2908
Prevalence
(numbers)
0
0
0
262
1391
1949
644
Remission
(numbers)
0
0
0
1181
6259
8770
2900
Case fatality
(numbers)
0
0
0
26
139
195
64
Duration
(years)
0
0
0
0,2174
0,2172
0,2168
0,2139
Mortality
(numbers)
0
0
0
27
143
198
64
RR mortality
(number)
0
0
0
184,719
38,6984
9,828
2,8182
Age of onset
(years)
0
0
0
32,4838
51,7432
66,7132
83,7038
20032
4247
19110
425
0,2165
431
29,1296
62,4645
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000)
0
4500
100
0
4500
100
0
4500
100
0,4
4500
100
5,12
4500
100
12,92
4500
100
9,64
4500
100
NA
Discapacidad 0,22
NA
NA
GRIIC 7
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0,02
0,28
1,06
1,75
Remission
(rates * 1000)
0
0
0
0
0
0
0
RR Mortality
(rates * 1000)
3
3
3
3
3
3
3
Incidence
(rates * 1000)
0
0
0
0,02
0,2794
1,0505
1,7275
Prevalence
(rates * 1000)
0
0
0
0,2411
2,2148
8,9344
12,8752
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
3,8889
13,1629
49,5156
137,9478
Duration
(years)
0
0
0
33,0796
17,556
8,4184
3,7939
Mortality (rates
* 1000)
0
0
0
0,0009
0,0292
0,4425
1,7759
RR mortality
(number)
0
10,2733
2,7018
2,9805
2,9459
2,8959
2,5482
Age of onset
(years)
0
0
0
32,3827
51,6533
66,4305
82,0208
NA
NA
NA
0,1718
1,4209
56,3466
10,7607
0,0801
2,7185
65,0516
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0,02
0,28
1,06
1,75
Remission
(rates * 1000)
0
0
0
0
0
0
0
RR Mortality
(rates * 1000)
3
3
3
3
3
3
3
Incidence
(numbers)
0
0
0
62
350
634
322
Prevalence
(numbers)
0
0
0
749
2777
5390
2403
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
3
37
267
331
Duration
(years)
0
0
0
33,0796
17,556
8,4184
3,7939
Mortality
(numbers)
0
0
0
3
37
267
331
RR mortality
(number)
0
10,2733
2,7018
2,9805
2,9459
2,8959
2,5482
Age of onset
(years)
0
0
0
32,3827
51,6533
66,4305
82,0208
NA
NA
NA
1369
11319
638
10,7607
638
2,7185
65,0516
GRIIC 8
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0,03
0,44
1,11
0,83
Remission
(rates * 1000)
0
0
0
0
0
0
0
RR Mortality
(rates * 1000)
3
3
3
3
3
3
3
Incidence
(rates * 1000)
0
0
0
0,03
0,4384
1,096
0,8166
Prevalence
(rates * 1000)
0
0
0
0,3708
3,5908
12,5824
16,0957
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
1,5699
7,0596
28,5355
79,1999
Duration
(years)
0
0
0
39,3276
22,161
11,4382
5,514
Mortality (rates
* 1000)
0
0
0
0,0006
0,0254
0,3591
1,2745
RR mortality
(number)
0
0
2,9779
2,9364
2,932
2,9344
2,2799
Age of onset
(years)
0
0
0
32,4823
51,7358
66,6999
83,7074
NA
NA
NA
0,2086
2,4233
34,3779
15,6749
0,0833
2,5618
62,6389
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0,03
0,44
1,11
0,83
Remission
(rates * 1000)
0
0
0
0
0
0
0
RR Mortality
(rates * 1000)
3
3
3
3
3
3
3
Incidence
(numbers)
0
0
0
93
572
784
247
Prevalence
(numbers)
0
0
0
1144
4685
9000
4866
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
2
33
257
385
Duration
(years)
0
0
0
39,3276
22,161
11,4382
5,514
Mortality
(numbers)
0
0
0
2
33
257
385
RR mortality
(number)
0
0
2,9779
2,9364
2,932
2,9344
2,2799
Age of onset
(years)
0
0
0
32,4823
51,7358
66,6999
83,7074
NA
NA
NA
1695
19695
677
15,6749
677
2,5618
62,6389
Discapacidad 0,19
GRIIC 9
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0,03
0,57
2,71
10,07
Remission
(rates * 1000)
160
160
160
160
160
160
160
RR Mortality
(rates * 1000)
1
1
1
2,2
2,5
2,5
2,5
Incidence
(rates * 1000)
0
0
0,0058
0,0315
0,5013
2,5535
7,9042
Prevalence
(rates * 1000)
0
0
0,0091
0,1482
1,5027
9,3984
20,6818
Remission
(rates * 1000)
0
0
160
159,9996
159,9997
160,0105
160,0137
Case fatality
(rates * 1000)
0
0
0,0075
2,2706
10,6449
37,3972
106,7113
Duration
(years)
0
0
6,1779
5,9973
5,2725
4,0687
2,567
Age of onset
(years)
0,5
7,5655
17,9456
33,389
54,1952
67,1706
83,305
NA
NA
NA
0,4708
1,4922
160,0094
54,2569
3,735
0,0811
2,2216
70,6854
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0,03
0,57
2,71
10,07
Remission
(rates * 1000)
160
160
160
160
160
160
160
RR Mortality
(rates * 1000)
1
1
1
2,2
2,5
2,5
2,5
Incidence
(numbers)
0
0
9
98
629
1540
1475
Prevalence
(numbers)
0
0
14
460
1884
5670
3859
Remission
(numbers)
0
0
2
74
301
907
618
Case fatality
(numbers)
0
0
0
1
20
212
412
Duration
(years)
0
0
6,1779
5,9973
5,2725
4,0687
2,567
Mortality
(numbers)
0
0
0
1
20
212
413
RR mortality
(number)
0
0
1,0185
2,3883
2,4613
2,4217
2,1066
Age of onset
(years)
0,5
7,5655
17,9456
33,389
54,1952
67,1706
83,305
NA
NA
NA
3750
11887
1902
645
3,735
646
2,2216
70,6854
GRIIC 10
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0,02
0,41
1,9
5,76
Remission
(rates * 1000)
160
160
160
160
160
160
160
RR Mortality
(rates * 1000)
1
1
1
2,2
2,5
2,5
2,5
Incidence
(rates * 1000)
0
0
0,0039
0,0211
0,3623
1,8076
4,7879
Prevalence
(rates * 1000)
0
0
0,0061
0,0997
1,1011
7,0501
14,9367
Remission
(rates * 1000)
0
0
160
159,9999
159,9999
160,0107
160,0114
Case fatality
(rates * 1000)
0
0
0,0028
0,9136
5,7253
21,8597
61,3512
Duration
(years)
0
0
6,2232
6,1207
5,6184
4,6368
3,1283
Age of onset
(years)
0,5
8,5694
17,9473
33,5468
54,2659
67,4322
84,8985
NA
NA
NA
0,404
1,3918
160,0093
34,9891
4,1453
0,0488
2,0596
73,1736
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0,02
0,41
1,9
5,76
Remission
(rates * 1000)
160
160
160
160
160
160
160
RR Mortality
(rates * 1000)
1
1
1
2,2
2,5
2,5
2,5
Incidence
(numbers)
0
0
6
65
473
1293
1447
Prevalence
(numbers)
0
0
9
308
1437
5043
4516
Remission
(numbers)
0
0
1
49
230
807
723
Case fatality
(numbers)
0
0
0
0
8
110
277
Duration
(years)
0
0
6,2232
6,1207
5,6184
4,6368
3,1283
Mortality
(numbers)
0
0
0
0
8
110
278
RR mortality
(number)
0
0
1,0236
2,3704
2,4589
2,451
1,8919
Age of onset
(years)
0,5
8,5694
17,9473
33,5468
54,2659
67,4322
84,8985
NA
NA
NA
3284
11312
1810
396
4,1453
396
2,0596
73,1736
GRIIC 11
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0,04
0
2,6
0,04
0,4849
0
3,5571
0,59
0
3
0,5873
4,6158
0
13,1829
3,48
0
3
3,3925
25,1559
0
50,8611
15,8
0
3
14,7356
67,3655
0
141,853
NA
NA
NA
Duration
(years)
0
0
0
33,3129
17,6452
8,5271
3,9221
Mortality
RR mortality
(rates * 1000)
(number)
0
0
0
0
0
0
0,0017
2,899
0,0609
2,9459
1,2797
2,8943
9,5655
2,4927
Age of onset
(years)
0
0
0
32,3817
51,6482
66,4027
81,9626
0,7101
4,3987
75,2462
7,8926
0,3312
2,6241
71,6423
Incidence
(numbers)
0
0
0
124
736
2046
2750
Prevalence
(numbers)
0
0
0
1507
5788
15175
12571
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
5
76
772
1783
Duration
(years)
0
0
0
33,3129
17,6452
8,5271
3,9221
Mortality
(numbers)
0
0
0
5
76
772
1785
RR mortality
(number)
0
0
0
2,899
2,9459
2,8943
2,4927
Age of onset
(years)
0
0
0
32,3817
51,6482
66,4027
81,9626
5657
35041
2637
7,8926
2639
2,6241
71,6423
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission RR Mortality
(rates * 1000) (rates * 1000) (rates * 1000)
0
0
1
0
0
1
0
0
1
0,04
0
2,6
0,59
0
3
3,48
0
3
15,8
0
3
NA
NA
NA
GRIIC 12
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0,04
0
2,6
0,04
0,4952
0
1,4623
0,59
0
3
0,5872
4,8072
0
7,0601
3,48
0
3
3,3811
28,4076
0
30,0053
15,8
0
3
14,4549
85,1338
0
82,1579
NA
NA
NA
0,9447
Duration
(years)
0
0
0
39,5319
22,3156
11,6214
5,7171
Mortality
RR mortality
(rates * 1000)
(number)
0
0
0
0
0
0
0,0007
2,8636
0,0339
2,932
0,8525
2,9345
6,9996
2,1879
Age of onset
(years)
0
0
0
32,4818
51,7332
66,6653
83,6135
6,6268
51,4461
9,5961
0,3411
2,3646
74,8776
Incidence
(numbers)
0
0
0
123
766
2418
4370
Prevalence
(numbers)
0
0
0
1528
6272
20319
25738
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
2
44
610
2115
Duration
(years)
0
0
0
39,5319
22,3156
11,6214
5,7171
Mortality
(numbers)
0
0
0
2
44
610
2116
RR mortality
(number)
0
0
0
2,8636
2,932
2,9345
2,1879
Age of onset
(years)
0
0
0
32,4818
51,7332
66,6653
83,6135
7678
53857
2771
9,5961
2772
2,3646
74,8776
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission RR Mortality
(rates * 1000) (rates * 1000) (rates * 1000)
0
0
1
0
0
1
0
0
1
0,04
0
2,6
0,59
0
3
3,48
0
3
15,8
0
3
NA
Discapacidad: 0,254
NA
NA
GRIID 1
HIPOTIROIDISMO CONGENITO
DisMod II input and output, database OA
Males, Disease: hipotiroidismo (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0,105
0
1
0,105
0,0525
0
0
0
0
1
0
0,105
0
0
0
0
1
0
0,105
0
0
0
0
1
0
0,105
0
0
0
0
1
0
0,105
0
0
0
0
1
0
0,105
0
0
0
0
1
0
0,105
0
0
NA
NA
NA
Duration
(years)
74,2701
0
0
0
0
0
0
Mortality
RR mortality
(rates * 1000)
(number)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0017
0,1042
74,2701
0,5
Incidence
(numbers)
13
0
0
0
0
0
0
Prevalence
(numbers)
7
127
156
326
132
63
20
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
74,2701
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
13
830
74,2701
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission RR Mortality
(rates * 1000) (rates * 1000) (rates * 1000)
0,105
0
1
0
0
1
0
0
1
0
0
1
0
0
1
0
0
1
0
0
1
NA
NA
NA
GRIID 2
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0,105
0
1
0,105
0,0525
0
0
0
0
1
0
0,105
0
0
0
0
1
0
0,105
0
0
0
0
1
0
0,105
0
0
0
0
1
0
0,105
0
0
0
0
1
0
0,105
0
0
0
0
1
0
0,105
0
0
NA
NA
NA
0,0016
Duration
(years)
80,3515
0
0
0
0
0
0
Mortality
RR mortality
(rates * 1000)
(number)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,1042
80,3515
0,5
Incidence
(numbers)
13
0
0
0
0
0
0
Prevalence
(numbers)
6
122
151
324
137
75
32
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
80,3515
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
13
847
80,3515
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission RR Mortality
(rates * 1000) (rates * 1000) (rates * 1000)
0,105
0
1
0
0
1
0
0
1
0
0
1
0
0
1
0
0
1
0
0
1
NA
NA
NA
Discapacidad
Usada en
0,0009
Discapacidad cercana a cero asumiendo que el 100% son tratados
GRIID 3
HIPOTIROIDISMO
DisMod II input and output, database OA
Males, Disease: hipotiroidismo (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0
4,2162
0,0088
0,0088
0,009
Prevalence
(rates *
1000)
0
0
0
45
45
45
45
Remission
(rates *
1000)
0
0
0
0
0
0
0
Mortality
(rates *
1000)
0
0
0
0
0
0,0066
0,0322
Incidence
(rates *
1000)
0
0
0
4,0036
0,0079
0,0079
0,0081
Prevalence
(rates *
1000)
0
0
0
50,4236
100,0808
100,1565
100,1375
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case fatality
(rates *
1000)
0
0
0
0,0061
0,0086
0,0613
0,245
Duration
(years)
0
0
0
44,1962
26,5301
15,0069
8,014
Mortality
(rates *
1000)
0
0
0
0,0003
0,0009
0,0061
0,0245
NA
29,0953
NA
0,0013
1,5634
45,3494
0,0286
44,1665
0,0013
31,9738
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0
4,2162
0,0088
0,0088
0,009
Prevalence
(numbers)
0
0
0
139805
56428
27146
8397
Remission
(rates *
1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
4
6
Incidence
(numbers)
0
0
0
12438
10
5
2
Prevalence
(numbers)
0
0
0
156655
125498
60419
18686
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
1
1
4
5
Duration
(years)
0
0
0
44,1962
26,5301
15,0069
8,014
Mortality
(numbers)
0
0
0
1
1
4
5
NA
231777
NA
10
12454
361258
10
44,1665
10
31,9738
GRIID 4
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0
8,1318
0,6713
0,0081
0,0082
Prevalence
(rates *
1000)
0
0
0
90
90
90
90
Remission
(rates *
1000)
0
0
0
0
0
0
0
Mortality
(rates *
1000)
0
0
0
0,0003
0,0032
0,0099
0,1447
Incidence
(rates *
1000)
0
0
0
7,3597
0,5454
0,0065
0,0066
Prevalence
(rates *
1000)
0
0
0
94,9501
187,626
192,0913
191,8638
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case fatality
(rates *
1000)
0
0
0
0,0035
0,0143
0,0521
0,5619
Duration
(years)
0
0
0
49,6471
30,9644
18,2186
9,8461
Mortality
(rates *
1000)
0
0
0
0,0003
0,0027
0,01
0,1078
NA
59,8918
NA
0,0069
2,883
90,2183
0,0604
49,0701
0,0054
32,1883
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0
8,1318
0,6713
0,0081
0,0082
Prevalence
(numbers)
0
0
0
277746
117427
64374
27209
Remission
(rates *
1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
1
4
7
44
Incidence
(numbers)
0
0
0
22712
712
5
2
Prevalence
(numbers)
0
0
0
293022
244804
137397
58004
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
1
3
7
33
Duration
(years)
0
0
0
49,6471
30,9644
18,2186
9,8461
Mortality
(numbers)
0
0
0
1
3
7
33
NA
486756
NA
56
23431
733228
44
49,0701
44
32,1883
GRIID 5
OBESIDAD
Males, Disease: obesidad_inciden (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
45
33,8889
17,6
6,8
4,5
3,8333
3,5
Remission
(rates * 1000)
600
497,7778
262
20
0
0
0
RR Mortality
(rates * 1000)
1
1
1
2
2
2
2
Incidence
(rates * 1000)
46,9936
34,4695
17,5581
6,799
4,5801
3,9355
3,5337
Prevalence
(rates * 1000)
18,4305
70,7893
78,6664
152,1913
235,5561
265,7288
220,9715
Remission
(rates * 1000)
500
438,0685
186,0275
14,1077
0
0
0
Case fatality
(rates * 1000)
0
0
0,0725
1,6653
5,6769
22,0301
68,1325
Duration
(years)
2,1355
3,6765
19,1103
36,4881
21,8683
11,5698
5,5391
Mortality (rates
* 1000)
0
0
0,0057
0,2535
1,3373
5,8538
15,0506
RR mortality
(number)
1
1
1,1757
1,9591
1,9728
1,9505
1,7848
Age of onset
(years)
0,5
5,0241
14,6331
29,5387
51,488
66,1089
82,1307
NA
NA
NA
12,9832
147,3951
57,0157
7,5062
15,3811
1,1063
1,902
15,7668
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
45
33,8889
17,6
6,8
4,5
3,8333
3,5
Remission
(rates * 1000)
600
497,7778
262
20
0
0
0
RR Mortality
(rates * 1000)
1
1
1
2
2
2
2
Incidence
(numbers)
5896
41576
26054
21123
5743
2374
659
Prevalence
(numbers)
2312
85384
116732
472824
295379
160301
41234
Remission
(numbers)
1156
37404
21715
6670
0
0
0
Case fatality
(numbers)
0
0
8
787
1677
3531
2809
Duration
(years)
2,1355
3,6765
19,1103
36,4881
21,8683
11,5698
5,5391
Mortality
(numbers)
0
0
8
787
1677
3531
2808
RR mortality
(number)
1
1
1,1757
1,9591
1,9728
1,9505
1,7848
Age of onset
(years)
0,5
5,0241
14,6331
29,5387
51,488
66,1089
82,1307
NA
NA
NA
103426
1174165
66946
8814
15,3811
8813
1,902
15,7668
GRIID 6
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
45
35,2222
18,2
17
0,2
0,1
0,05
Remission
(rates * 1000)
600
497,7778
262
20
0
0
0
RR Mortality
(rates * 1000)
1
1
1
2
2
2
2
Incidence
(rates * 1000)
45
34,786
18,3092
16,9508
0,2
0,1114
0,05
Prevalence
(rates * 1000)
17,346
67,3896
77,4938
210,2368
366,6154
345,1078
284,8307
Remission
(rates * 1000)
500
440,3174
186,2496
8,7518
0,0004
0,0004
0,0002
Case fatality
(rates * 1000)
0
0
0,0189
0,7308
2,911
12,8798
40,3146
Duration
(years)
2,1458
3,7136
19,8631
42,4608
26,8219
16,5256
7,6021
Mortality (rates
* 1000)
0
0
0,0015
0,1537
1,0672
4,4448
11,4812
RR mortality
(number)
1
1
1,1448
1,9561
1,9561
1,9811
1,6533
Age of onset
(years)
0,5
4,8839
14,1266
31,8533
51,776
64,4635
83,9123
NA
NA
NA
15,3606
203,2384
37,5065
5,1578
21,8697
1,0482
1,8419
16,0089
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
45
35,2222
18,2
17
0,2
0,1
0,05
Remission
(rates * 1000)
600
497,7778
262
20
0
0
0
RR Mortality
(rates * 1000)
1
1
1
2
2
2
2
Incidence
(numbers)
5344
37742
24292
40746
165
52
11
Prevalence
(numbers)
2096
78393
111184
648805
478340
246845
86110
Remission
(numbers)
1048
34518
20708
5678
0
0
0
Case fatality
(numbers)
0
0
2
474
1392
3179
3472
Duration
(years)
2,1458
3,7136
19,8631
42,4608
26,8219
16,5256
7,6021
Mortality
(numbers)
0
0
2
474
1392
3179
3471
RR mortality
(number)
1
1
1,1448
1,9561
1,9561
1,9811
1,6533
Age of onset
(years)
0,5
4,8839
14,1266
31,8533
51,776
64,4635
83,9123
NA
NA
NA
108350
1651773
61952
8519
21,8697
8519
1,8419
16,0089
GRIID 7
OBESIDAD MORBIDA
DisMod II input and output, database OA
Males, Disease: obesidad morbida incid (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
RR Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,09
0
1,2
0,087
0,1291
0
1,8122
0,0608
0
4
0,0639
2,1357
0
5,0291
0,001
0
4
0,001
1,9704
0
16,1631
0,0003
0
4
0,0004
1,2196
0
58,9054
0
0
4
0
0,2972
0
193,9961
NA
NA
NA
0,0413
Duration
(years)
0
0
41,7763
38,2358
15,4089
8,8198
0
Mortality
(rates * 1000)
0
0
0,0002
0,0107
0,0318
0,0718
0,0575
RR mortality
(number)
0
0
2,8632
3,9528
3,9187
3,8676
3,5209
Age of onset
(years)
0
0
18,486
22,6061
51,6591
62,3956
0
1,2665
12,6623
39,5145
0,016
3,874
21,1307
Incidence
(numbers)
0
0
129
199
1
0
0
Prevalence
(numbers)
0
0
192
6635
2471
736
55
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
33
40
43
11
Duration
(years)
0
0
41,7763
38,2358
15,4089
8,8198
0
Mortality
(numbers)
0
0
0
33
40
43
11
RR mortality
(number)
0
0
2,8632
3,9528
3,9187
3,8676
3,5209
Age of onset
(years)
0
0
18,486
22,6061
51,6591
62,3956
0
329
10089
128
39,5145
128
3,874
21,1307
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
RR Mortality
(rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0,09
0
1,2
0,0608
0
4
0,001
0
4
0,0003
0
4
0
0
4
NA
NA
NA
GRIID 8
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
RR Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,9
0
1,2
0,8684
1,2924
0
0,5264
0,96
0
4
0,9568
25,2558
0
2,0192
0,1
0
4
0,097
30,4817
0
8,6323
0,0333
0
4
0,0398
23,9708
0
36,1011
0
0
4
0
10,7153
0
115,5946
NA
NA
NA
0,5357
Duration
(years)
0
0
49,7527
41,7475
19,9241
12,1983
0
Mortality
(rates * 1000)
0
0
0,0007
0,051
0,2631
0,8652
1,2371
RR mortality
(number)
0
0
2,8894
3,9024
3,8544
3,9018
3,0259
Age of onset
(years)
0
0
18,483
26,9906
51,7496
62,4171
0
17,22
10,6831
43,2111
0,1839
3,6711
25,465
Incidence
(numbers)
0
0
1246
2953
126
28
0
Prevalence
(numbers)
0
0
1854
77941
39771
17146
3239
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
1
157
343
619
374
Duration
(years)
0
0
49,7527
41,7475
19,9241
12,1983
0
Mortality
(numbers)
0
0
1
157
343
619
374
RR mortality
(number)
0
0
2,8894
3,9024
3,8544
3,9018
3,0259
Age of onset
(years)
0
0
18,483
26,9906
51,7496
62,4171
0
4354
139951
1495
43,2111
1495
3,6711
25,465
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
RR Mortality
(rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0,9
0
1,2
0,96
0
4
0,1
0
4
0,0333
0
4
0
0
4
NA
NA
NA
GRIID 9
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0,16
0
0
2,3
0,16
0,08
0
0,3128
0
0
0
2,3
0
0,1597
0
0,296
0
0
0
2,3
0
0,1592
0
0,5893
0
0
0,0003
2,3
0
0,1551
0
1,9431
0
0
0,0016
2,3
0
0,1448
0
7,6225
0
0
0
2,3
0
0,1223
0
13,3537
0
0
0
2,3
0
0,1082
0
1,8953
NA
NA
0,0004
Duration
(years)
67,5263
0
0
0
0
0
0
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
1,0338
0,5
0
2,2205
0
0,0001
2,2629
0
0,0003
2,1939
0
0,0011
2,3755
0
0,0016
1,7304
0
0,0002
1,0793
0
NA
0,0025
0,1502
2,9617
67,5263
0,0004
Mortality
(numbers)
0
0
0
1
2
0
0
RR Mortality
(rates * 1000)
2,3
2,3
2,3
2,3
2,3
2,3
2,3
Incidence
(numbers)
20
0
0
0
0
0
0
Prevalence
(numbers)
10
193
236
482
182
74
20
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
1
1
1
0
Duration
(years)
67,5263
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
1
1
1
0
NA
20
1196
67,5263
2,126
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0,16
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
0,5
GRIID 10
FIBROSIS QUISTICA
DisMod II input and output, database OA
Males, Disease: fibrosis quistica (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Case fatality Mortality
Incidence
Prevalence Remission
Case fatality Duration
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (years)
0,125
0
30
0,0162
0,125
0,0616
0
30
17,3988
0
0
30
0,0008
0
0,1072
0
31,5926
0
0
0
50
0,0003
0
0,0752
0
47,6568
0
0
0
200
0
0
0,0169
0
133,6556
0
0
0
900
0
0
0,0001
0
423,8008
0
0
0
1000
0
0
0
0
957,3621
0
0
0
1000
0
0
0
0
1000
0
NA
NA
NA
0,0004
0,002
Incidence
Remission
Case fatality Mortality
(rates * 1000) (rates * 1000) (rates * 1000) (numbers)
0,125
0
30
2
0
0
30
1
0
0
50
1
0
0
200
0
0
0
900
0
0
0
1000
0
0
0
1000
0
Incidence
(numbers)
16
0
0
0
0
0
0
0,0378
55,5252
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0,0019
4,2421
0,5
0,0034
133,5318
0
0,0036
131,9276
0
0,0023
113,9254
0
0,0001
125,8674
0
0
77,5905
0
0
18,4563
0
17,3988
0,0021
Mortality
(numbers)
0
4
5
7
0
0
0
122,9567
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
NA
NA
NA
16
Prevalence
(numbers)
8
129
112
53
0
0
0
301
Remission
(numbers)
0
0
0
0
0
0
0
0
17
17,3988
17
0,5
GRIID 11
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Case fatality Mortality
Incidence
Prevalence Remission
Case fatality Duration
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (years)
0,125
0
30
0,0162
0,125
0,0616
0
30
17,4505
0
0
30
0,0008
0
0,1072
0
31,5934
0
0
0
50
0,0003
0
0,0752
0
47,6675
0
0
0
200
0
0
0,0167
0
134,0837
0
0
0
900
0
0
0,0001
0
424,2944
0
0
0
1000
0
0
0
0
957,4619
0
0
0
1000
0
0
0
0
1000
0
NA
NA
NA
0,0004
0,0019
0,0359
55,8288
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0,0019
5,1529
0,5
0,0034
187,3527
0
0,0036
219,1222
0
0,0022
337,8574
0
0
238,1933
0
0
128,0684
0
0
29,9841
0
17,4505
0,002
Mortality
(numbers)
0
4
5
7
0
0
0
258,9312
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Case fatality Mortality
(rates * 1000) (rates * 1000) (rates * 1000) (numbers)
0,125
0
30
2
0
0
30
1
0
0
50
0
0
0
200
0
0
0
900
0
0
0
1000
0
0
0
1000
0
NA
NA
NA
Incidence
(numbers)
15
0
0
0
0
0
0
15
Prevalence
(numbers)
7
125
108
52
0
0
0
292
Remission
(numbers)
0
0
0
0
0
0
0
0
16
17,4505
16
0,5
GRIID 12
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,1932
0
0
0
0
0
0
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
0
0
0,1932
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
0,003
Prevalence
(rates * 1000)
0,0966
0,1932
0,1932
0,1932
0,1932
0,1932
0,1932
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
74,2701
0
0
0
0
0
0
Mortality (rates
* 1000)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,1917
74,2701
0,5
Prevalence
(rates * 1000)
0,0966
0,1932
0,1932
0,1932
0,1932
0,1932
0,1932
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
80,3515
0
0
0
0
0
0
Mortality (rates
* 1000)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,1917
80,3515
0,5
16
336
4,761904762
73
73
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates * 1000)
0,1932
0
0
0
0
0
0
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
0
0
0,1932
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
All ages
NA
NA
0,0029
supuestos
Incidencia
Remisin
mortalidad
nota: el 99% de los casos tiene un a evolucin benigna, con igual riesgo de muerte que la poblacin general
se trabaja con el supuesto que todos los casos reciben tratamiento (programa catastrficas FONASA)
peso discapacidad:
0,0009
GRIID 13
Age
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0,1932
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
Mortality
(numbers)
NA
0
0
0
0
0
0
0
Incidence
(numbers)
24
0
0
0
0
0
0
Prevalence
(numbers)
12
233
287
600
242
117
36
24
1527
0
0
0
0
0
0
0
Incidence
(numbers)
23
0
0
0
0
0
0
Prevalence
(numbers)
12
225
277
596
252
138
58
23
1558
Remission
(numbers)
Case fatality
(numbers)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Duration
(years)
74,2701
0
0
0
0
0
0
74,2701
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Duration
(years)
80,3515
0
0
0
0
0
0
80,3515
Mortality
(numbers)
RR mortality
(number)
0
0
0
0
0
0
0
0
1
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,5
0
0
0
0
0
0
0
0
1
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,5
Age
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0,1932
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
Mortality
(numbers)
Remission
(numbers)
Case fatality
(numbers)
Mortality
(numbers)
RR mortality
(number)
GRIID 14
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,0249
0
0
0
0
0
0
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
0
0
0,0249
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
Prevalence
(rates * 1000)
0,0124
0,0249
0,0249
0,0249
0,0249
0,0249
0,0249
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
74,2701
0
0
0
0
0
0
Mortality (rates
* 1000)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0004
0,0247
74,2701
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,0249
0
0
0
0
0
0
Remission
(rates * 1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
3
0
0
0
0
0
0
Prevalence
(numbers)
2
30
37
77
31
15
5
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
74,2701
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
NA
NA
197
74,2701
0,5
GRIID 15
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,0249
0
0
0
0
0
0
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
0
0
0,0249
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
Prevalence
(rates * 1000)
0,0124
0,0249
0,0249
0,0249
0,0249
0,0249
0,0249
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
80,3515
0
0
0
0
0
0
Mortality (rates
* 1000)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0004
0,0247
80,3515
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,0249
0
0
0
0
0
0
Remission
(rates * 1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
3
0
0
0
0
0
0
Prevalence
(numbers)
2
29
36
77
32
18
8
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
80,3515
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
NA
NA
201
80,3515
0,5
GRIID 16
FENILCETONURIA
Males, Disease: fenilcetonuria (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,05
0
0
0
0
0
0
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
RR Mortality
(rates * 1000)
1
1
1
1
1
1
1
NA
Incidence
(rates * 1000)
0,05
0
0
0
0
0
0
0,0008
Prevalence
(rates * 1000)
0,025
0,05
0,05
0,05
0,05
0,05
0,05
0,0496
Remission
(rates * 1000)
0
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
0
Duration
(years)
74,2701
0
0
0
0
0
0
74,2701
Age of onset
(years)
0,5
0
0
0
0
0
0
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,05
0
0
0
0
0
0
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
RR Mortality
(rates * 1000)
1
1
1
1
1
1
1
NA
Incidence
(numbers)
6
0
0
0
0
0
0
6
Prevalence
(numbers)
3
60
74
155
63
30
9
395
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
0
Duration
(years)
74,2701
0
0
0
0
0
0
74,2701
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,5
GRIID 17
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,05
0
0
0
0
0
0
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
RR Mortality
(rates * 1000)
1
1
1
1
1
1
1
Incidence
(rates * 1000)
0,05
0
0
0
0
0
0
NA
0,0007
Prevalence
(rates * 1000)
0,025
0,05
0,05
0,05
0,05
0,05
0,05
0,0496
Remission
(rates * 1000)
0
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
0
Duration
(years)
80,3515
0
0
0
0
0
0
80,3515
Age of onset
(years)
0,5
0
0
0
0
0
0
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,05
0
0
0
0
0
0
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
RR Mortality
(rates * 1000)
1
1
1
1
1
1
1
NA
Incidence
(numbers)
6
0
0
0
0
0
0
6
Prevalence
(numbers)
3
58
72
154
65
36
15
403
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
0
Duration
(years)
80,3515
0
0
0
0
0
0
80,3515
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,5
GRIIE 1
DEPRESION UNIPOLAR
Males, Disease: DEPRE UNI (Rates), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(rates)
0
0
0,02
0,09
0,03
0,015
0,02
0,0452
Remission
(rates)
0
1,5
1,5
1,5
1,5
1,5
1,5
NA
Mortality
(rates)
0
0
0
0
0
0
0
Incidence
(rates)
0
0,0009
0,027
0,1031
0,0461
0,0252
0,0295
Prevalence
(rates)
0
0,0004
0,0159
0,0682
0,0319
0,0172
0,0196
Remission
(rates)
0
1,5
1,5
1,5
1,5
1,5
1,5
0,0552
0,0364
Incidence
(numbers)
0
1079
40000
320357
57812
15178
5511
Prevalence
(numbers)
0
428
23602
211747
40009
10370
3657
Remission
(numbers)
0
641
35403
317620
60013
15556
5486
439938
289813
434720
1,5
Case fatality
(rates)
0
0
0
0
0
0,0001
0,0003
0
Duration
(years)
0
0,6666
0,6663
0,6659
0,6637
0,6578
0,6436
Mortality
(rates)
0
0
0
0
0
0
0
0,6651
RR mortality
(number)
0
1,05
1,0125
1,0034
1,002
1,0052
1,0051
1,0045
Age of onset
(years)
0,5
8,9634
16,2489
32,9123
52,0297
67,2208
93,7914
36,048
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(numbers)
0
0
29678
279610
37619
9049
3732
359687
Remission
(rates)
0
1,5
1,5
1,5
1,5
1,5
1,5
NA
Mortality
(numbers)
0
0
0
0
0
1
1
2
Case fatality
(numbers)
0
0
0
1
0
1
1
4
Duration
(years)
0
0,6666
0,6663
0,6659
0,6637
0,6578
0,6436
0,6651
Mortality
(numbers)
0
0
0
1
0
1
1
4
RR mortality
(number)
0
1,05
1,0125
1,0034
1,002
1,0052
1,0051
1,0045
Age of onset
(years)
0,5
8,9634
16,2489
32,9123
52,0297
67,2208
93,7914
36,048
GRIIE 2
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(rates)
0
0
0,05
0,21
0,08
0,05
0,02
0,1066
Remission
(rates)
0
1,6
1,6
1,6
1,6
1,6
1,6
NA
Mortality
(rates)
0
0
0
0
0
0
0
Incidence
(rates)
0
0,0024
0,0683
0,2151
0,12
0,0755
0,0332
Prevalence
(rates)
0
0,0009
0,0383
0,1332
0,0769
0,0489
0,0211
Remission
(rates)
0
1,6
1,6
1,6
1,6
1,6
1,6
0,1212
0,0749
Incidence
(numbers)
0
2795
98049
663695
156561
53974
10050
Prevalence
(numbers)
0
1051
54989
411202
100284
35003
6374
Remission
(numbers)
0
1681
87982
657923
160454
56005
10199
985124
608902
974244
3,7 hombres
7,5 mujeres
(ao)
Case fatality
(rates)
0
0
0
0
0
0
0,0007
1,6
Duration
(years)
0
0,625
0,6249
0,6247
0,6236
0,6205
0,6133
Mortality
(rates)
0
0
0
0
0
0
0
0,6242
RR mortality
(number)
0
1,0732
1,026
1,0086
1,0025
1,0045
1,0253
1,016
Age of onset
(years)
0,5
8,9932
16,1353
32,9281
52,174
66,7358
96,0389
37,056
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(numbers)
0
0
71737
648074
104380
35763
6046
866001
Remission
(rates)
0
1,6
1,6
1,6
1,6
1,6
1,6
NA
Mortality
(numbers)
0
0
0
0
0
1
5
6
Case fatality
(numbers)
0
0
0
3
1
1
4
Se modela con duracin del tratamiento: 6 meses (0,5) algo mayor a 6 meses (>0,5 y menor que Victoria)
Victoria estima 0,73
La estimacin se bas no en distimia sino en casos depresion,usar peso leve.
Duration
(years)
0
0,625
0,6249
0,6247
0,6236
0,6205
0,6133
0,6242
Mortality
(numbers)
0
0
0
3
1
1
4
9
RR mortality
(number)
0
1,0732
1,026
1,0086
1,0025
1,0045
1,0253
1,016
Age of onset
(years)
0,5
8,9932
16,1353
32,9281
52,174
66,7358
96,0389
37,056
GRIIE 3
DEPRESION BIPOLAR
Males, Disease: Bipolar (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(rates * 100)
0
0
0,3
1,1
0,7
0,4
0,3
0,6324
Remission
(rates * 100)
0
0
1
1
1
1
1
NA
Mortality
(rates * 100)
0
0
0
0
0
0,0002
0
0
Incidence
(rates * 100)
0
0,0061
0,0507
0,0312
0,0006
0,0006
0,0006
Prevalence
(rates * 100)
0
0,0137
0,2523
1,0244
0,9899
0,8588
0,5751
Remission
(rates * 100)
0
0
1
1
1
1
1
0,0227
0,6829
0,997
Incidence
(numbers)
0
74
753
970
8
3
1
Prevalence
(numbers)
0
166
3744
31826
12413
5181
1073
Remission
(numbers)
0
0
37
318
124
52
11
Case fatality
(rates * 100)
0
0,0004
0,0006
0,0006
0,0016
0,0479
1,2956
0,0309
Duration
(years)
0
51,1506
45,8865
40,9675
25,2064
17,5209
11,8866
Mortality
(rates * 100)
0
0
0
0
0
0,0004
0,0075
43,2941
0,0002
Duration
(years)
0
51,1506
45,8865
40,9675
25,2064
17,5209
11,8866
Mortality
(numbers)
0
0
0
0
0
2
14
RR mortality
(number)
0
1,0441
1,0119
1,0034
1,0035
1,1329
1,7591
1,6479
Age of onset
(years)
0,5
7,7601
15,9461
25,5817
52,4869
67,4555
93,7704
21,0908
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(numbers)
0
0
4452
34175
8778
2413
560
50377
Remission
(rates * 100)
0
0
1
1
1
1
1
NA
Mortality
(numbers)
0
0
0
0
0
1
0
1
1809
54401
542
Case fatality
(numbers)
0
0
0
0
0
2
14
17
43,2941
17
RR mortality
(number)
0
1,0441
1,0119
1,0034
1,0035
1,1329
1,7591
1,6479
Age of onset
(years)
0,5
7,7601
15,9461
25,5817
52,4869
67,4555
93,7704
21,0908
GRIIE 4
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(rates * 100)
0
0
1
3,3
2,1
1,2
0,9
1,9058
Remission
(rates * 100)
0
0
1
1
1
1
1
NA
Mortality
(rates * 100)
0
0
0
0
0
0,0002
0
0
Incidence
(rates * 100)
0
0,0084
0,1749
0,0878
0,0006
0,0006
0,0006
Prevalence
(rates * 100)
0
0,0112
0,7721
3,0893
2,9461
2,5426
1,9514
Remission
(rates * 100)
0
0
1
1
1
1
1
0,0656
2,0803
0,9992
Incidence
(numbers)
0
97
2509
2708
8
4
2
Prevalence
(numbers)
0
130
11078
95338
38440
18187
5899
Remission
(numbers)
0
0
111
953
384
182
59
5329
169072
Case fatality
(rates * 100)
0
0,0005
0,0006
0,0006
0,0009
0,0123
0,4627
0,0181
Duration
(years)
0
56,2166
52,193
47,562
32,7682
25,3706
18,4074
Mortality
(rates * 100)
0
0
0
0
0
0,0003
0,009
49,8292
0,0004
Duration
(years)
0
56,2166
52,193
47,562
32,7682
25,3706
18,4074
Mortality
(numbers)
0
0
0
1
0
2
27
RR mortality
(number)
0
1,0698
1,0223
1,0085
1,0029
1,0457
1,2811
1,2548
Age of onset
(years)
0,5
8,6645
15,879
25,5857
52,5006
67,4888
96,6047
20,8148
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(numbers)
0
0
14347
101840
27400
8583
2721
154891
Remission
(rates * 100)
0
0
1
1
1
1
1
NA
Mortality
(numbers)
0
0
0
0
0
1
0
1
1689
Case fatality
(numbers)
0
0
0
1
0
2
27
31
49,8292
31
RR mortality
(number)
0
1,0698
1,0223
1,0085
1,0029
1,0457
1,2811
1,2548
Age of onset
(years)
0,5
8,6645
15,879
25,5857
52,5006
67,4888
96,6047
20,8148
GRIIE 5
ESQUIZOFRENIA
Males, Disease: Esquizofrenia (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0,001
0
0
0
0,001
0,0045
0
0,0028
0,3
0
0
1,2
0,2995
1,5071
0
0,1107
0,5
0
0,001
1,2
0,4954
9,1959
0
0,1139
0,03
0
0,003
1,2
0,0295
15,5664
0
0,163
0,003
0
0,002
1,2
0,003
15,7735
0
0,1408
0
0
0,016
1,2
0
15,6176
0
0,9046
NA
NA
0,0014
Duration
(years)
0
75,4502
66,2481
50,3248
32,6858
23,0937
0
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0
0
1,0684
5,5
0,0002
1,1413
14,9951
0,001
1,0714
32,4481
0,0025
1,0283
52,499
0,0022
1,0076
67,5
0,0141
1,0186
0
NA
0,254
7,8785
0,1698
53,4906
0,0013
Mortality
(numbers)
0
0
0
3
4
1
3
RR Mortality
(rates * 1000)
0
0
1,2
1,2
1,2
1,2
1,2
Incidence
(numbers)
0
1
444
1539
37
2
0
Prevalence
(numbers)
0
5
2236
28570
19520
9515
2914
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
3
3
1
3
Duration
(years)
0
75,4502
66,2481
50,3248
32,6858
23,0937
0
Mortality
(numbers)
0
0
0
3
3
1
3
11
NA
2024
62761
11
53,4906
11
1,0391
28,9693
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0,001
0
0,3
0
0,5
0
0,03
0
0,003
0
0
0
NA
NA
28,9693
GRIIE 6
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,05
0
0
1,2
0,05
0,2499
0
0,0529
0,6
0
0
1,2
0,5952
7,9492
0
0,163
0,07
0
0,001
1,2
0,0689
15,8092
0
0,6763
0,004
0
0,003
1,2
0,0039
16,0127
0
2,1858
0
0
0,001
1,2
0
14,9065
0
5,5466
NA
NA
0,0005
Duration
(years)
0
0
75,5444
58,8331
40,3804
29,9615
0
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0
0
1,07
0
0
1,1584
14,9992
0,0013
1,2008
32,4377
0,0107
1,1887
52,4978
0,035
1,1978
67,5012
0,0827
1,1905
0
NA
0,2463
7,5643
1,1061
58,5625
0,0084
Mortality
(numbers)
0
0
0
0
1
2
0
RR Mortality
(rates * 1000)
0
0
1,2
1,2
1,2
1,2
1,2
Incidence
(numbers)
0
0
72
1837
90
3
0
Prevalence
(numbers)
0
0
359
24532
20627
11453
4507
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
4
14
25
25
Duration
(years)
0
0
75,5444
58,8331
40,3804
29,9615
0
Mortality
(numbers)
0
0
0
4
14
25
25
NA
2001
61477
68
58,5625
68
1,1934
32,7507
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0
0
0,05
0
0,6
0
0,07
0
0,004
0
0
0
NA
NA
1,1934
32,7507
GRIIE 7
TRASTORNOS ANSIOSOS
DisMod II input and output, database Sepsis
Males, Disease: trastornos ansiosos (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0,321
0
300
0
0,3208
0,6971
300
0,0031
8,0582
20
300
0
7,9107
18,3039
300
0,0061
12,0818
55
300
0
11,6355
36,942
300
0,0061
12,7708
65
300
0
12,2551
40,3784
300
0,0061
4,7872
33
300
0
4,6858
21,1827
300
0,0061
6,3728
32
300
0
6,2441
20,189
300
0,0061
NA
38,6558
NA
Duration
(years)
0
3,327
3,3223
3,3099
3,2322
3,1003
2,8002
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0
0
1,0352
5,4987
0,0001
1,0142
14,9646
0,0002
1,0034
32,4658
0,0002
1,0012
52,4958
0,0001
1,0003
67,5485
0,0001
1,0001
93,5842
8,4902
26,3555
300
0,0061
3,277
0,0002
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
387
11739
36149
15368
2827
1165
Prevalence
(numbers)
0
841
27161
114771
50633
12778
3767
Remission
(numbers)
0
252
8148
34431
15190
3834
1130
Case fatality
(numbers)
0
0
0
1
0
0
0
Duration
(years)
0
3,327
3,3223
3,3099
3,2322
3,1003
2,8002
Mortality
(numbers)
0
0
0
1
0
0
0
67634
209951
62985
3,277
1,0041
36,6304
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
(rates * 1000) (numbers) (rates * 1000)
0
0
0
0,321
0
300
8,0582
29678
300
12,0818
170873
300
12,7708
81508
300
4,7872
19907
300
6,3728
5971
300
NA
307937
NA
36,6304
GRIIE 8
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
1,9728
0
300
0
1,9644
4,2709
300
0,0031
48,685
90
300
0
43,713
102,1266
300
0,0061
70,2105
229
300
0
57,3104
183,7353
300
0,0061
75,4743
280
300
0
60,4569
198,9736
300
0,0066
9,2477
100
300
0,0017
8,6308
66,7116
300
0,0225
14,9728
60
300
0
14,2905
45,568
300
0,0115
NA
158,8272
NA
0,0001
Duration
(years)
0
3,3287
3,3289
3,323
3,2753
3,1964
3,0024
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0
0
1,0497
5,4918
0,0006
1,0286
14,7955
0,0011
1,0085
32,3568
0,0013
1,0023
52,4753
0,0015
1,0026
67,8377
0,0005
1,0012
96,4637
40,7567
127,917
300
0,0071
3,3062
0,0009
Mortality
(numbers)
0
0
0
0
0
1
0
Incidence
(numbers)
0
2285
62717
176864
78881
6173
4320
Prevalence
(numbers)
0
4968
146525
567019
259610
47717
13776
Remission
(numbers)
0
1490
43958
170106
77883
14315
4133
Case fatality
(numbers)
0
0
1
3
2
1
0
Duration
(years)
0
3,3287
3,3289
3,323
3,2753
3,1964
3,0024
Mortality
(numbers)
0
0
1
3
2
1
0
331240
1039616
311885
3,3062
1,0086
35,3417
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
(rates * 1000) (numbers) (rates * 1000)
0
0
0
1,9728
0
300
48,685
129127
300
70,2105
706709
300
75,4743
365329
300
9,2477
71527
300
14,9728
18139
300
NA
1290831
NA
35,3417
GRIIE 9
ESTRS POST-TRAUMATICO
DisMod II input and output, database Sepsis
Males, Disease: TSP (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0,0586
1,1756
2,6372
8,9542
3,5822
2,5093
Prevalence
(rates *
1000)
0
0
5
10
40
15
10
Remission
(rates *
1000)
0
0
400
400
400
400
400
Mortality
(rates *
1000)
0
0
0
0
0
0
0
Incidence
(rates *
1000)
0
0,0586
1,1728
2,6209
8,7808
3,5426
2,493
Prevalence
(rates *
1000)
0
0,2636
2,3343
6,1809
19,3642
11,0448
6,4928
Remission
(rates *
1000)
0
0
400
400
400
400
400
Case fatality
(rates *
1000)
0
0,0035
0,0061
0,0061
0,0061
0,0061
0,0061
Duration
(years)
0
6,9804
2,4943
2,4875
2,4472
2,3704
2,1925
Mortality
(rates *
1000)
0
0
0
0
0,0001
0,0001
0
NA
12,498
NA
2,9584
6,9219
397,6935
0,0061
2,4662
45,0999
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0,0586
1,1756
2,6372
8,9542
3,5822
2,5093
Prevalence
(numbers)
0
0
7419
31068
50159
9049
1866
Remission
(rates *
1000)
0
0
400
400
400
400
400
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
71
1740
8142
11011
2137
465
Prevalence
(numbers)
0
318
3464
19203
24282
6663
1212
Remission
(numbers)
0
0
1386
7681
9713
2665
485
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
6,9804
2,4943
2,4875
2,4472
2,3704
2,1925
Mortality
(numbers)
0
0
0
0
0
0
0
NA
99561
NA
23567
55141
21929
2,4662
45,0999
GRIIE 10
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0,2663
8,0505
21,5585
19,8231
6,9877
5,5678
Prevalence
(rates *
1000)
0
0
22
61
56
20
15
Remission
(rates *
1000)
0
0
400
400
400
400
400
Mortality
(rates *
1000)
0
0
0
0
0
0
0
Incidence
(rates *
1000)
0
0,2659
7,9257
20,5218
18,8746
6,833
5,4895
Prevalence
(rates *
1000)
0
1,1972
15,4945
48,0868
47,8478
22,1489
14,0655
Remission
(rates *
1000)
0
0
400
400
400
400
400
Case fatality
(rates *
1000)
0
0,0035
0,0061
0,0061
0,0061
0,0061
0,0061
Duration
(years)
0
6,9863
2,4977
2,4946
2,4699
2,4249
2,3129
Mortality
(rates *
1000)
0
0
0,0001
0,0003
0,0003
0,0001
0,0001
NA
38,3549
NA
13,0654
31,32
397,8115
0,0061
2,4963
0,0002
38,2487
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0,2663
8,0505
21,5585
19,8231
6,9877
5,5678
Prevalence
(numbers)
0
0
31564
188250
73066
14305
4535
Remission
(rates *
1000)
0
0
400
400
400
400
400
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
309
11371
63332
24627
4887
1660
Prevalence
(numbers)
0
1393
22231
148399
62429
15842
4252
Remission
(numbers)
0
0
8892
59360
24972
6337
1701
Case fatality
(numbers)
0
0
0
1
0
0
0
Duration
(years)
0
6,9863
2,4977
2,4946
2,4699
2,4249
2,3129
Mortality
(numbers)
0
0
0
1
0
0
0
NA
311720
NA
106186
254546
101261
2,4963
38,2487
GRIIE 11
DEPENDENCIA A DROGAS
Males, Disease: Dependencia Droga (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,05
0
0,001
0,05
0,245
0
4,1776
0,9
0
0,001
0,8895
11,6353
0
0,101
0,4
0
0,002
0,3898
25,6125
0
0,0674
0
0
0
0
28,5175
0
0,0065
0
0
0
0
28,5172
0
0
NA
NA
0,0009
0,4176
Duration
(years)
0
0
65,0289
50,5728
32,9112
0
0
Mortality
RR mortality
(rates * 1000)
(number)
0
0
0
0
0,001
24,4424
0,0012
1,1324
0,0017
1,013
0,0002
1,0016
0
1
Age of onset
(years)
0
0
14,9992
32,4065
52,4851
0
0
11,4427
0,0817
48,3003
0,0009
5,8513
34,9267
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0
0
0,05
0
0,9
0
0,4
0
0
0
0
0
NA
NA
Mortality
(numbers)
0
0
1
3
3
0
0
Incidence
(numbers)
0
0
74
2764
489
0
0
Prevalence
(numbers)
0
0
363
36148
32117
17203
5321
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
2
4
2
0
0
Duration
(years)
0
0
65,0289
50,5728
32,9112
0
0
Mortality
(numbers)
0
0
2
4
2
0
0
RR mortality
(number)
0
0
24,4424
1,1324
1,013
1,0016
1
Age of onset
(years)
0
0
14,9992
32,4065
52,4851
0
0
3326
91153
48,3003
5,8513
34,9267
GRIIE 12
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,03
0
0
0,03
0,15
0
0
0,72
0
0
0,7133
9,2435
0
0
0,3
0
0
0,2939
20,3395
0
0
0
0
0
0
22,542
0
0
0
0
0
0
22,542
0
0
NA
NA
0,3233
Duration
(years)
0
0
79,572
62,7896
44,1913
0
0
Mortality
RR mortality
(rates * 1000)
(number)
0
0
0
0
0
0
0
0
0
0
0
0
0
1
Age of onset
(years)
0
0
14,9995
32,4251
52,4888
0
0
9,6241
60,3506
35,0358
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0
0
0,03
0
0,72
0
0,3
0
0
0
0
0
NA
NA
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
43
2201
383
0
0
Prevalence
(numbers)
0
0
215
28526
26538
16124
6815
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
79,572
62,7896
44,1913
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
1
Age of onset
(years)
0
0
14,9995
32,4251
52,4888
0
0
2628
78218
60,3506
35,0358
Discapacid
0,11
Vicente datos duros prevalencia ao
GRIIE 13
DEPENDENCIA A ALCOHOL
Males, Disease: Dependencia OH (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates *
1000)
0
0
0,9
6,7
2,9
0,6
0,3
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case
fatality
(rates *
1000)
0
0
20
20
20
20
20
Mortality
(rates *
1000)
0
0
0,001
0,038
0,126
0,177
0,155
All ages
NA
NA
NA
0,0519
RR Mortality Incidence
(rates *
(rates *
1000)
1000)
0
0
0
0
0
0,896
1,2
6,1155
1,2
2,3823
1,2
0,4811
1,2
0,2394
NA
2,969
Prevalence Remission
(rates *
(rates *
1000)
1000)
0
0
0
0
4,4865
0
87,2364
0
178,5202
0
198,0884
0
202,1284
0
82,6945
Case
fatality
(rates *
1000)
0
0
0,003
0,3718
0,6197
0,8637
0,7762
Duration
(years)
0
0
65,7931
50,214
32,5241
23,0622
14,2054
Mortality
(rates *
1000)
0
0
0
0,0324
0,1106
0,1711
0,1569
0,5647
48,4542
0,0467
Case
fatality
(numbers)
0
0
0
101
139
103
29
Duration
(years)
0
0
65,7931
50,214
32,5241
23,0622
14,2054
Mortality
(numbers)
0
0
0
101
139
103
29
372
48,4542
372
RR
mortality
(number)
Age of
onset
(years)
0
0
1,0126
1,219
1,1028
1,044
1,0171
0
0
14,9852
31,8081
52,396
67,4841
93,5713
1,1112
33,6512
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates *
1000)
0
0
0,9
6,7
2,9
0,6
0,3
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case
fatality
(rates *
1000)
0
0
20
20
20
20
20
Mortality
(numbers)
0
0
1
118
158
107
29
All ages
NA
NA
NA
413
RR Mortality
(rates *
Incidence
1000)
(numbers)
0
0
0
0
0
1330
1,2
19000
1,2
2987
1,2
290
1,2
45
NA
23651
Prevalence Remission
(numbers) (numbers)
0
0
0
0
6657
0
271024
0
223858
0
119497
0
37718
0
658754
RR
mortality
(number)
Age of
onset
(years)
0
0
1,0126
1,219
1,1028
1,044
1,0171
0
0
14,9852
31,8081
52,396
67,4841
93,5713
1,1112
33,6512
GRIIE 14
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates *
1000)
0
0
0,09
1
0,6
0,1
0,08
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case
fatality
(rates *
1000)
0
0
20
20
20
20
20
Mortality
(rates *
1000)
0
0
0
0,005
0,011
0,02
0,032
All ages
NA
NA
NA
0,0066
RR Mortality Incidence
(rates *
(rates *
1000)
1000)
0
0
0
0
0
0,09
1,2
0,9868
1,2
0,5821
1,2
0,0965
1,2
0,0771
NA
0,4954
Prevalence Remission
(rates *
(rates *
1000)
1000)
0
0
0
0
0,4499
0
13,2454
0
29,7697
0
34,6321
0
35,8316
0
14,2689
Case
fatality
(rates *
1000)
0
0
0,0027
0,318
0,3513
0,5767
0,8621
Duration
(years)
0
0
78,2471
61,7122
43,4176
32,8861
22,6424
Mortality
(rates *
1000)
0
0,00E+00
0
0,0042
0,0105
0,02
0,0309
0,4335
58,0703
0,0062
Case
fatality
(numbers)
0
0
0
13
14
14
9
Duration
(years)
0
0
78,2471
61,7122
43,4176
32,8861
22,6424
Mortality
(numbers)
0
0,00E+00
0
13
14
14
9
50
58,0703
50
Hombre
5.844.626
8%
1,40%
3790824,4
Hombres
Mujeres
RR
mortality
(number)
Age of
onset
(years)
0
0
1,028
1,47
1,1127
1,0524
1,0321
0
0
14,9985
32,3965
52,478
67,497
96,5027
1,173
36,7043
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates *
1000)
0
0
0,09
1
0,6
0,1
0,08
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case
fatality
(rates *
1000)
0
0
20
20
20
20
20
Mortality
(numbers)
0
0
0
15
14
14
10
All ages
NA
NA
NA
54
RR Mortality
(rates *
Incidence
1000)
(numbers)
0
0
0
0
0
129
1,2
3045
1,2
760
1,2
69
1,2
23
NA
4026
Prevalence Remission
(numbers) (numbers)
0
0
0
0
645
0
40876
0
38842
0
24771
0
10833
0
115967
0,6486
Incidenci DEPENDENCIA
RR
mortality
(number)
Age of
onset
(years)
0
0
1,028
1,47
1,1127
1,0524
1,0321
0
0
14,9985
32,3965
52,478
67,497
96,5027
1,173
36,7043
665668,77
GRIIE 15
EPILEPSIA
DisMod II input and output, database Parlisis cerebral
Males, Disease: Epilepsia (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
Duration
(years)
Age of onset
(years)
0,82
0,6978
0,51
0,284
0,2933
0,5267
1,4
136
136
113
54,8
46
23,3333
12
0,024
0,007
0,003
0,015
0,026
0,035
0,08
0,8197
0,696
0,508
0,2827
0,2919
0,5227
1,3661
0,3826
2,7204
3,9806
4,5444
4,9219
7,3372
24,2241
136
136
112,1973
54,3104
46
20,6986
12
2,9505
2,0593
0,9008
2,9368
4,9483
4,9414
3,1986
8,0387
9,1104
13,2862
18,0311
17,4003
17,6295
12,0497
0,0012
0,0056
0,0036
0,0133
0,0244
0,0363
0,0775
1,3529
9,2034
4,3516
2,6915
1,8786
1,2577
1,0759
0,5
5,1456
14,5579
31,3001
53,2372
68,1833
93,4113
NA
NA
0,0165
0,4407
4,8295
60,0957
3,1335
14,0504
0,0151
2,469
31,9981
Mortality
(numbers)
Incidence
(numbers)
Prevalence
(numbers)
Remission
(numbers)
Case fatality
(numbers)
Duration
(years)
Mortality
(numbers)
RR mortality
(number)
Age of onset
(years)
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0,82
0,6978
0,51
0,284
0,2933
0,5267
1,4
136
136
113
54,8
46
23,3333
12
3
8
4
47
33
21
15
103
839
754
878
366
315
255
48
3281
5907
14118
6172
4426
4520
7
446
663
767
284
92
54
0
7
5
41
31
22
14
8,0387
9,1104
13,2862
18,0311
17,4003
17,6295
12,0497
0
7
5
41
31
22
14
1,3529
9,2034
4,3516
2,6915
1,8786
1,2577
1,0759
0,5
5,1456
14,5579
31,3001
53,2372
68,1833
93,4113
NA
NA
131
3511
38473
2312
121
14,0504
121
2,469
31,9981
GRIIE 16
Age
Incidence
Remission Mortality (rates
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Duration
(years)
Age of onset
(years)
0,82
0,6978
0,51
0,284
0,2933
0,5267
1,4
136
136
113
54,8
46
23,3333
12
0,008
0,002
0,002
0,009
0,008
0,01
0,033
0,8197
0,6959
0,508
0,2827
0,2918
0,5225
1,3648
0,383
2,7326
3,9966
4,5926
5,0772
7,6806
25,1604
136
136
112,2077
54,2539
46
20,6844
12
0,8378
0,7057
0,5481
1,6978
1,6137
1,3642
1,2311
8,2735
9,4274
14,1753
20,5538
22,5121
24,328
18,1345
0,0003
0,0019
0,0022
0,0078
0,0082
0,0105
0,031
1,1253
5,6435
4,1805
3,424
1,6147
1,1262
1,0491
0,5
5,1456
14,5579
31,2997
53,2369
68,1826
96,2961
NA
NA
0,0076
0,4524
5,2732
55,0809
1,3309
16,8239
0,007
2,5206
37,9123
Mortality
(numbers)
Incidence
(numbers)
Prevalence
(numbers)
Remission
(numbers)
Case fatality
(numbers)
Duration
(years)
Mortality
(numbers)
RR mortality
(number)
Age of onset
(years)
Age
Incidence
Remission
(rates * 1000) (rates * 1000)
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Discapacidad
0,82
0,6978
0,51
0,284
0,2933
0,5267
1,4
136
136
113
54,8
46
23,3333
12
1
2
3
28
10
7
10
99
810
729
872
381
374
413
46
3179
5734
14173
6624
5494
7607
6
432
643
769
305
114
91
0
2
3
24
11
7
9
8,2735
9,4274
14,1753
20,5538
22,5121
24,328
18,1345
0
2
3
24
11
7
9
1,1253
5,6435
4,1805
3,424
1,6147
1,1262
1,0491
0,5
5,1456
14,5579
31,2997
53,2369
68,1826
96,2961
NA
NA
62
3677
42857
2361
57
16,8239
57
2,5206
37,9123
0,11
GRIIE 17
DEMENCIA
DisMod II input and output, database Chile fint
Males, Disease: Demencia (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
RR Mortality Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,68
0
0,007
1,6667
0,6766
3,3714
0
2,8832
3,9667
0
0,162
3
3,8203
34,3784
0
8,9593
10,625
0
3,516
4
9,4541
106,3108
0
63,2487
NA
NA
0,0957
Duration
(years)
0
0
0
0
22,8769
14,9163
8,2701
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0
0
0
0
0
0
0
0
0
0
0,0097
1,3705
54,9833
0,308
1,4846
68,0758
6,7253
2,3428
94,6775
NA
0,6173
5,6244
32,4235
13,9053
0,1824
Mortality
(numbers)
0
0
0
0
9
98
656
RR Mortality
(rates * 1000)
0
0
0
0
1,6667
3
4
Incidence
(numbers)
0
0
0
0
848
2305
1764
Prevalence
(numbers)
0
0
0
0
4228
20739
19838
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
12
186
1255
Duration
(years)
0
0
0
0
22,8769
14,9163
8,2701
Mortality
(numbers)
0
0
0
0
12
186
1255
763
NA
4917
44804
1453
13,9053
1453
2,2249
76,9465
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0,68
0
3,9667
0
10,625
0
NA
NA
76,9465
GRIIE 18
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
RR Mortality Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,5067
0
0,007
1,6667
0,5048
2,5109
0
3,291
3,6733
0
0,162
3
3,5546
27,5294
0
10,7957
11,6923
0
3,516
4
10,2001
120,4984
0
50,5639
NA
NA
0,1462
Duration
(years)
0
0
0
0
27,5112
18,6986
12,0767
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0
0
0
0
0
0
0
0
0
0
0,0083
1,691
54,9876
0,2972
1,9899
68,8426
6,0942
2,7384
97,4977
NA
0,7733
7,3083
34,7727
16,373
0,2542
Mortality
(numbers)
0
0
0
0
9
116
1063
RR Mortality
(rates * 1000)
0
0
0
0
1,6667
3
4
Incidence
(numbers)
0
0
0
0
659
2543
3084
Prevalence
(numbers)
0
0
0
0
3276
19691
36429
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
11
213
1842
Duration
(years)
0
0
0
0
27,5112
18,6986
12,0767
Mortality
(numbers)
0
0
0
0
11
213
1842
1188
NA
6285
59396
2065
16,373
2066
2,6559
84,1388
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0,5067
0
3,6733
0
11,6923
0
NA
NA
84,1388
GRIIE 19
PARKINSON
Males, Disease: PARKINSON (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,01
0
0
2
0,01
0,1233
0
1,9488
0,1
0
0,004
2,5
0,0999
0,9506
0
10,8456
1,1
0
0,099
2,5
1,0907
8,4126
0
31,4618
3,8
0
0,836
3
3,6806
31,4316
0
101,8573
NA
NA
0,0277
Duration
(years)
0
0
0
36,9417
20,2641
12,4322
5,9833
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0
0
0
0
0
0
0
0,0002
2,0447
32,499
0,0103
2,4039
52,4966
0,2647
2,5925
67,4688
3,2013
2,9056
93,5734
NA
0,1884
1,571
61,5857
10,6425
0,0968
Mortality
(numbers)
0
0
0
0
5
60
156
RR Mortality
(rates * 1000)
0
0
0
2
2,5
2,5
3
Incidence
(numbers)
0
0
0
31
125
658
687
Prevalence
(numbers)
0
0
0
383
1192
5075
5865
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
1
13
160
597
Duration
(years)
0
0
0
36,9417
20,2641
12,4322
5,9833
Mortality
(numbers)
0
0
0
1
13
160
597
221
NA
1501
12515
771
10,6425
771
2,8315
79,4295
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0
0
0
0
0,01
0
0,1
0
1,1
0
3,8
0
NA
NA
79,4295
GRIIE 20
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
Remission
Mortality
RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,001
0
0
2
0,001
0,0124
0
0,824
0,04
0
0,002
2,3
0,04
0,318
0
5,6411
0,3
0
0,052
2,5
0,2992
2,6021
0
17,6228
1,8
0
0,523
3
1,7677
17,9566
0
61,6413
All ages
NA
NA
0,0244
Duration
(years)
0
0
0
45,2501
27,2296
17,8003
9,5091
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0
0
0
0
0
0
0
0
2,0279
32,4999
0,0018
2,2523
52,4986
0,0459
2,597
67,4905
1,1069
2,9076
96,4131
NA
0,0989
0,9527
47,7587
13,0046
0,0455
Mortality
(numbers)
0
0
0
0
3
37
158
RR Mortality
(rates * 1000)
0
0
0
2
2,3
2,5
3
Incidence
(numbers)
0
0
0
3
52
214
534
Prevalence
(numbers)
0
0
0
38
415
1861
5429
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
2
33
335
Duration
(years)
0
0
0
45,2501
27,2296
17,8003
9,5091
Mortality
(numbers)
0
0
0
0
2
33
335
198
NA
804
7743
370
13,0046
370
2,8759
88,3481
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0
0
0
0
0,001
0
0,04
0
0,3
0
1,8
0
All ages
Discapacidad
NA
NA
0,356
88,3481
GRIIE 21
MIGRAA
Males, Disease: Migraa (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(rates * 1000)
0
0
42,3
115
35
30
30
61,2133
Remission
(rates * 1000)
0
0
0
0
300
300
300
NA
Prevalence
(rates * 1000)
0
0,3005
31,7277
112,7214
52,821
30,5947
29,9993
Remission
(rates * 1000)
0
0,005
0,0061
1,5258
201,0845
300,9144
300,0034
3,8001
61,2511
43,2165
Incidence
(numbers)
0
354
10016
6683
6108
5433
1678
Prevalence
(numbers)
0
362
47080
350200
66236
18456
5598
Remission
(numbers)
0
0
0
534
13319
5554
1679
30272
487933
21087
Case fatality
(rates * 1000)
0
0,005
0,0061
0,1044
0,3344
0,0061
0,0061
0,1212
Duration
(years)
0
40,313
33,6253
24,522
3,0978
3,0959
2,7998
18,4751
1,1713
Age of onset
(years)
0
8,9762
15,6909
25,1268
56,4611
67,4654
93,6101
40,5369
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(numbers)
0
0
62768
357279
43889
18097
5598
487632
Remission
(rates * 1000)
0
0
0
0
300
300
300
NA
Mortality
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
37
22
0
0
59
Duration
(years)
0
40,313
33,6253
24,522
3,0978
3,0959
2,7998
18,4751
Mortality
(numbers)
0
0
0
37
22
0
0
59
RR mortality
(number)
0
1,0506
1,0106
1,1772
1,1646
1,0003
1,0001
1,1713
Age of onset
(years)
0
8,9762
15,6909
25,1268
56,4611
67,4654
93,6101
40,5369
GRIIE 22
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Prevalence
(rates * 1000)
0
0
90
300
206,333
64
64
All ages
170,9412
Remission
(rates * 1000)
0
0
0
0
300
300
300
NA
14,0282
Prevalence
(rates * 1000)
0
0,6445
70,0062
295,6159
227,5424
81,778
64,0145
170,8093
Remission
(rates * 1000)
0
0,005
0,0061
1,3086
213,0018
325,3954
300,085
64,3075
Case fatality
(rates * 1000)
0
0,005
0,0061
0,0061
0,0061
0,0061
0,0061
0,0061
Duration
(years)
0
41,4993
34,6376
24,5069
3,2968
3,0471
3,0012
13,4547
0,001
Duration
(years)
0
41,4993
34,6376
24,5069
3,2968
3,0471
3,0012
Mortality
(numbers)
0
0
1
6
2
0
0
1,0077
Age of onset
(years)
0
8,9932
15,7786
25,9109
54,3574
67,316
96,5676
46,2269
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Prevalence
(numbers)
0
0
129127
925820
269212
45777
19349
All ages
Discapacidad
1389285
Remission
(rates * 1000)
0
0
0
0
300
300
300
NA
0,03
Mortality
(numbers)
0
0
0
0
0
0
0
0
Incidence
(numbers)
0
745
21837
22309
49249
14094
5778
Prevalence
(numbers)
0
750
100441
912291
296885
58493
19353
Remission
(numbers)
0
0
1
1194
63237
19033
5808
114011
1388213
89272
Case fatality
(numbers)
0
0
1
6
2
0
0
9
13,4547
RR mortality
(number)
0
1,0742
1,0221
1,0084
1,0025
1,0006
1,0002
1,0077
Age of onset
(years)
0
8,9932
15,7786
25,9109
54,3574
67,316
96,5676
46,2269
GRIIE 23
PARALISIS CEREBRAL
Males, Disease: Paralisis cerebral (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,214
0,1189
0
0
0
0
0
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
0,0214
Prevalence
(rates * 1000)
0,105
0,6678
0,9774
0,6975
0,5144
0,4647
0,3411
0,681
Remission
(rates * 1000)
0
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
37,7786
29,8086
23,7902
18,0285
9,4778
4,352
27,1373
19,7496
Duration
(years)
36,4562
38,5706
0
0
0
0
0
38,237
65,6031
Age of onset
(years)
0,5
5,4987
0
0
0
0
0
4,7097
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,214
0,1189
0
0
0
0
0
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
Mortality
(numbers)
12
23
39
41
6
1
2
125
Incidence
(numbers)
27
143
0
0
0
0
0
170
Prevalence
(numbers)
13
806
1450
2167
645
280
64
5425
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
24
35
39
6
1
2
107
Duration
(years)
36,4562
38,5706
0
0
0
0
0
38,237
Mortality
(numbers)
1
24
35
39
6
1
2
107
RR mortality
(number)
5,5186
151,3954
84,6887
11,3859
3,0722
1,2497
1,5779
65,6031
Age of onset
(years)
0,5
5,4987
0
0
0
0
0
4,7097
GRIIE 24
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,202
0,1122
0
0
0
0
0
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
0,0191
Prevalence
(rates * 1000)
0,099
0,6264
0,9229
0,7401
0,6288
0,599
0,5984
0,711
Remission
(rates * 1000)
0
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
40,3041
31,1682
21,2858
9,5266
5,9146
0,5432
0
13,5364
Duration
(years)
48,0992
53,0952
0
0
0
0
0
52,3077
120,82
Age of onset
(years)
0,5
5,4988
0
0
0
0
0
4,7105
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,202
0,1122
0
0
0
0
0
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
Mortality
(numbers)
5
22
33
22
5
0
0
Incidence
(numbers)
24
130
0
0
0
0
0
87
Clave incidencia
Peso de discapacidad: 40% sobrevida normal: 0,170
60% deteriorio moderado-severo: 0,430 a 0,760
155
Prevalence
(numbers)
12
729
1324
2284
820
428
181
5779
0,068
0,1935
0,114
0,3755
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
23
28
22
5
0
0
78
Duration
(years)
48,0992
53,0952
0
0
0
0
0
52,3077
Mortality
(numbers)
0
23
28
22
5
0
0
78
RR mortality
(number)
7,0281
211,2527
152,7796
14,9711
3,5254
1,2378
1
120,82
Age of onset
(years)
0,5
5,4988
0
0
0
0
0
4,7105
GRIIE 25
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(rates * 100)
0
8,8889
10
0
0
0
0
Remission
(rates * 100)
0
0
0
0
0
0
0
Mortality
(rates * 100)
0
0
0
0
0
0
0
Incidence
(rates * 100)
0
1,9656
1,3063
0
0
0
0
Prevalence
(rates * 100)
0
5,2785
10,4062
0,0453
0,0116
0,0116
0,0116
Remission
(rates * 100)
0
0,0736
0,5512
0,1472
0
0
0
Case fatality
(rates * 100)
0
0
0
0
0
0
0
Duration
(years)
0
6,4611
2,9051
4,7989
0
0
0
Mortality
(rates * 100)
0
0
0
0
0
0
0
RR mortality
(number)
0
569,3935
992,0987
473,36
0
0
0
Age of onset
(years)
0
7,1494
12,4811
21,2526
52,5
67,5
86,7962
3,2086
NA
0,5409
2,7583
0,4096
4,8616
966,4728
9,4373
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Prevalence
(numbers)
0
107215
148388
0
0
0
0
Remission
(rates * 100)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
23709
19384
0
0
0
0
Prevalence
(numbers)
0
63668
154416
1408
146
70
22
Remission
(numbers)
0
47
851
2
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
6,4611
2,9051
4,7989
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
569,3935
992,0987
473,36
0
0
0
Age of onset
(years)
0
7,1494
12,4811
21,2526
52,5
67,5
86,7962
255603
NA
43092
219730
900
4,8616
966,4728
9,4373
GRIIE 26
0
01-Sep
Oct-19
20-44
45-59
60-74
75+
Prevalence
(rates * 100)
0
4,4444
5
0
0
0
0
Remission
(rates * 100)
0
0
0
0
0
0
0
Mortality
(rates * 100)
0
0
0
0
0
0
0
Incidence
(rates * 100)
0
0,9502
0,6604
0
0
0
0
Prevalence
(rates * 100)
0
2,5036
5,0924
0,0526
0,0235
0,0235
0,0235
Remission
(rates * 100)
0
0,0156
0,1139
0,0217
0
0
0
Case fatality
(rates * 100)
0
0
0
0
0
0
0
Duration
(years)
0
6,4436
3,1023
9,8806
0
0
0
Mortality
(rates * 100)
0
0
0
0
0
0
0
RR mortality
(number)
0
820,8861
1828,8281
907,8027
1
1
1
Age of onset
(years)
0
7,2494
12,4204
21,2522
52,5
67,5
86,7962
All ages
1,5188
NA
0,2526
1,284
0,0844
4,9014
1764,1703
9,5872
Age
0
01-Sep
Oct-19
20-44
45-59
60-74
75+
Prevalence
(numbers)
0
51701
71737
0
0
0
0
Remission
(rates * 100)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
11053
9475
0
0
0
0
Prevalence
(numbers)
0
29124
73063
1623
307
168
71
Remission
(numbers)
0
5
83
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
6,4436
3,1023
9,8806
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
820,8861
1828,8281
907,8027
1
1
1
Age of onset
(years)
0
7,2494
12,4204
21,2522
52,5
67,5
86,7962
All ages
123438
NA
20528
104357
88
4,9014
1764,1703
9,5872
Age
Discapacidad:
0,03
Dato duro prevalencia global por sexo.
Remisin baja dado poco tratamiento
Prevalencia promedio 3-5% en edad escolar. Duplica en hombre
Prevalencia en la poblacion general de 6 a 12 aos es del 4 al 12%
Prevalencia Chile 3-7%
Menores de 15 aos en tratamiento 5% (ENCAVI). 6,1% en hombre y 3% en mujeres
Remisin bajo tratamiento es del 14%.
Se modela solo los nios menores de 15 aos
Duracion estimada 8,6 aos (estudio Australia)
GRIIE 27
ESCLEROSIS MULTIPLE
Males, Disease: Esclerosis multiple (Rates * 100,000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
0,04
0,11
0,35
0,61
0,49
Prevalence
(rates *
100000)
0
0
0,19
1,146
1,53
1,32
0,25
Remission
(rates *
100000)
0
0
0
0
0
0
0
Mortality
(rates *
100000)
0
0
0
0
0,4
0,7
0,5
Incidence
(rates *
100000)
0
0,0166
0,0399
0,1051
0,3269
0,5887
0,4969
Prevalence
(rates *
100000)
0
0,0428
0,3287
1,5438
1,6358
1,1084
0,2666
NA
0,829
NA
0,1277
0,1586
1,0174
13538,3419
Duration
(years)
0
35,9554
29,1926
13,3433
3,3678
1,4877
0,5075
Mortality
(rates *
100000)
0
0
0,0021
0,0465
0,3653
0,6539
0,504
6,9338
0,1374
53,7497
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
0,04
0,11
0,35
0,61
0,49
Prevalence
(numbers)
0
0
3
36
19
8
0
Remission
(rates *
100000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
5
4
1
Incidence
(numbers)
0
0
1
3
4
4
1
Prevalence
(numbers)
0
1
5
48
21
7
0
NA
66
NA
10
13
81
11
Duration
(years)
0
35,9554
29,1926
13,3433
3,3678
1,4877
0,5075
6,9338
36,644
53,7497
GRIIE 28
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
0,06
0,2
0,4
0,61
0,49
Prevalence
(rates *
100000)
0
0
0,39
1,766
2,7767
1,9033
0,2173
Remission
(rates *
100000)
0
0
0
0
0
0
0
Mortality
(rates *
100000)
0
0
0
0
0,6
0,1
0,3
Incidence
(rates *
100000)
0
0,028
0,0671
0,1738
0,3869
0,2301
0,2989
Prevalence
(rates *
100000)
0
0,0722
0,5737
2,5245
2,635
2,8831
0,3271
NA
1,3608
NA
0,1163
0,1753
1,7592
7947,3779
Duration
(years)
0
38,4371
30,6947
13,7658
6,4576
6,8117
0,6636
Mortality
(rates *
100000)
0
0
0
0,0838
0,4421
0,2673
0,359
11,2499
0,1397
48,5705
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
100000)
0
0
0,06
0,2
0,4
0,61
0,49
Prevalence
(numbers)
0
0
6
54
36
14
1
Remission
(rates *
100000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
8
1
1
Incidence
(numbers)
0
0
1
5
5
2
1
Prevalence
(numbers)
0
1
8
78
34
21
1
NA
111
NA
14
143
Dato duro
Prevalencia global. Hay poca informacion
Discapacidad
0,411
No hay como saber distribucin de casos
11
Duration
(years)
0
38,4371
30,6947
13,7658
6,4576
6,8117
0,6636
11,2499
52,9335
48,5705
GRIIF 1
GLAUCOMA
MUJERES GLAUCOMA
INPUT
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
OUTPUT
Incidence
(rates * 100)
0
0
0
0
0,1333
0,8667
1,85
Remission
(rates * 100)
0
0
0
0
0
0
0
RR mortality
(rates * 100)
1
1
1
1
1
1,1
1,1
Incidence
(rates * 100)
0
0
0
0,0002
0,1062
0,7002
1,4656
Prevalence
(rates * 100)
0
0
0
0,0002
0,4292
5,7906
18,27
Remission
(rates * 100)
0
0
0
0
0
0
0
Case fatality
(rates * 100)
0
0
0
0
0,0115
0,1568
0,413
Duration
(years)
0
0
0
37,3749
27,0815
16,7115
9,5415
NA
NA
NA
0,1333
1,2582
0,2872
15,1191
HOMBRES GLAUCOMA
INPUT
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
1,0685
Age of onset
(years)
0,5
9,0097
19,5
44,2437
55,4312
67,9693
83,7471
72,5912
OUTPUT
Incidence
(rates * 100)
0
0
0
0
0,2
1,3
2,25
Remission
(rates * 100)
0
0
0
0
0
0
0
RR mortality
(rates * 100)
1
1
1
1
1,0667
1,1
1,3
Incidence
(rates * 100)
0
0
0
0,0002
0,1429
1,0795
1,9824
Prevalence
(rates * 100)
0
0
0
0,0001
0,5013
8,6439
26,1822
Remission
(rates * 100)
0
0
0
0
0
0
0
Case fatality
(rates * 100)
0
0
0
0,0017
0,0765
0,2817
1,0516
Duration
(years)
0
0
0
32,2497
22,0957
13,6314
7,5187
NA
NA
NA
0,1507
1,3469
0,6203
13,0206
1,1059
Age of onset
(years)
0,5
7,3972
12,3836
44,2434
55,995
67,35
81,9773
69,469
12.009
107.292
10.832
102.258
Case fatality
(rates * 100)
0
0
0
0
5
147
514
665
Case fatality
(rates * 100)
0
0
0
0
1
65
228
294
GRIIF 2
GRIIF 3
CATARATAS FINAL
HOMBRES CATARATAS
INPUT
OUTPUT
Case
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 100) (rates * 100)
0
0
0
0
0
0
0,0224
0
0,42
7,8667
2,1
11,8
3,2
10,1667
NA
Fatality
(rates*100)
0
0
0
0
0
0
0
RR mortality
(rates * 100)
1
1
1
1,016
1,2
1,2
1,2
NA
NA
NA
Preval
ence
Incidence
(rates
(rates * 100) * 100)
0
0
0
0
0
0
0,0122
0,027
0,2938
1,604
1,7149
7,642
3,0664
22,77
0,2527
Remis
sion
(rates
* 100)
0
0
0
1E-04
5,866
11,71
4,98
Case
fatality
(rates
* 100)
0
0
0
0,002
0,002
8E-04
6E-04
Duration
(years)
0
0
0
18,3529
9,6435
6,6806
6,4042
7,3648
Age of
onset
(years)
0,5
7,397
12,38
42,72
53,52
68,35
81,88
1,0021 68,38
MUJERES CATARATAS
INPUT
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
Remission
Incidence
(rates * 100) (rates * 100)
0
0
0
0
0
0
0,0224
0
0,42
6,1733
2,1
9,26
3,2
7,9067
NA
NA
OUTPUT
Case
Fatality
(rates*100)
0
0
0
0
0
0
0
RR mortality
(rates * 100)
1
1
1
1,016
1,2
1,2
1,2
NA
NA
Preval
Incidence
ence
(rates * 100) (rates
0
0
0
0
0
0
0,0125
0,028
0,2964
1,675
1,7695
8,828
3,0612
26,25
0,3219
2,033
Remission
(rates * 100)
0
0
0
0,0001
4,76
9,1764
3,1928
5,6703
9,4234
1,0063
Age of
onset
(years)
0,5
4,534
15,15
42,73
53,6
68,57
83,5
70,62
MUJERES
Incidencia
0
0
0
381
3.684
10.345
5.722
Prevalencia
0
0
0
846
20.115
46.099
42.488
Remisin
0
0
0
0
1.180
5.400
2.116
Incidencia
0
0
0
385
3.867
12.657
9.255
Prevalenci
a
0
0
0
857
21.853
63.144
79.372
Remisin
0
0
0
0
1.040
5.794
2.534
20.131
109.548
8.696
26.163
165.226
9.369
GRIIF 4
GRIIF 5
PRESBICIA TODAS
DisMod II input and output, database andrea
Males, Disease: presbicia severa (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0
0
0,6
1,2
1,4
Remission
(rates *
1000)
0
0
0
0
0
0
0
Mortality
(rates *
1000)
0
0
0
0
0
0
0
RR Mortality
(rates *
1000)
1
1
1
1
1
1
1
Incidence
(rates *
1000)
0
0
0
0
0,5976
1,1801
1,3555
Prevalence
(rates *
1000)
0
0
0
0
3,9835
16,5774
31,7553
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case fatality
(rates *
1000)
0
00-Jan
Jan-00
0
0
0
0
Duration
(years)
0
0
0
0
26,5622
15,0409
8,0324
Mortality
(rates *
1000)
0
0
0
0
0
0
0
NA
NA
NA
0,2152
2,6263
19,0433
62,3389
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0
0
0,5
1
1,2
Remission
(rates *
1000)
0
0
0
0
0
0
0
Mortality
(rates *
1000)
0
0
0
0
0
0
0
RR Mortality
(rates *
1000)
1
1
1
1
1
1
1
Incidence
(rates *
1000)
0
0
0
0
0,4983
0,9859
1,1677
Prevalence
(rates *
1000)
0
0
0
0
3,3637
14,1039
26,8971
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case fatality
(rates *
1000)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
0
31,0183
18,2872
9,9009
Mortality
(rates *
1000)
0
0
0
0
0
0
0
NA
NA
NA
0,2102
2,7818
21,3994
64,8673
GRIIF 6
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality Incidence
Prevalence Remission Case fatality
(rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,8
0
0
1,4312
3,7744
0
0
15
0
0
4,0462
66,829
0
0
7,3333
0
0
0,3388
95,8974
0
0
4
0
0
0,0772
98,0698
0
0
NA
NA
NA
1,2226
Duration
(years)
0
0
0
34,8388
27,6191
16,3912
8,0923
Mortality
RR mortality Age of onset
(rates * 100) (number)
(years)
0
0
0
0
0
0
0
0
0
0
0
42,1159
0
0
48,8613
0
0
63,545
0
0
81,3092
21,551
30,6508
44,4828
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0
20
166,6667
83,3333
50
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case fatality
(rates *
1000)
0
0
0
0
0
0
0
Incidence
(rates *
1000)
0
0
0
15,8271
39,6251
2,6097
0,5875
Prevalence
(rates *
1000)
0
0
0
42,0978
704,247
971,7177
988,2506
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case fatality
(rates *
1000)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
39,8254
32,3701
19,9638
9,9954
Mortality
(rates *
1000)
0
0
0
0
0
0
0
NA
NA
NA
12,6227
251,3254
35,6552
44,1816
GRIIF 7
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0
0
0,6
1,2
1,4
Remission
(rates *
1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR Mortality
(rates *
1000)
1
1
1
1
1
1
1
Incidence
(numbers)
0
0
0
0
749
712
253
Prevalence
(numbers)
0
0
0
0
4995
10000
5926
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
0
26,5622
15,0409
8,0324
Mortality
(numbers)
0
0
0
0
0
0
0
NA
NA
NA
1714
20921
19,0433
62,3389
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0
0
0,5
1
1,2
Remission
(rates *
1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR Mortality
(rates *
1000)
1
1
1
1
1
1
1
Incidence
(numbers)
0
0
0
0
650
705
353
Prevalence
(numbers)
0
0
0
0
4389
10088
8132
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
0
31,0183
18,2872
9,9009
Mortality
(numbers)
0
0
0
0
0
0
0
NA
NA
NA
1708
22608
21,3994
64,8673
GRIIF 8
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality
(rates * 100) (rates * 100) (rates * 100)
0
0
0
0
0
0
0
0
0
1,8
0
0
15
0
0
7,3333
0
0
4
0
0
NA
NA
NA
Incidence
(numbers)
0
0
0
44465
50738
2044
144
Prevalence
(numbers)
0
0
0
117263
838013
578500
183000
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
34,8388
27,6191
16,3912
8,0923
Mortality
(numbers)
0
0
0
0
0
0
0
97391
1716776
30,6508
44,4828
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0
20
166,6667
83,3333
50
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case fatality
(rates *
1000)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
0
48843
51701
1867
178
Prevalence
(numbers)
0
0
0
129917
918864
695040
298769
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
39,8254
32,3701
19,9638
9,9954
Mortality
(numbers)
0
0
0
0
0
0
0
NA
NA
NA
102588
2042589
35,6552
44,1816
GRIIF 9
PRESBIACUSIA
DisMod II input and output, database andrea
Males, Disease: presbiacusia nueva (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,0035
0,0054
0,0027
0
0
2,4
0
0
0,0117
2,0261
20,7543
0,0004
0
3,5
0
0
0,0117
3,3355
72,1071
0,0022
0
9,1667
0
0
0,0117
7,6115
142,8097
0,0004
0
18,3333
0
0
0,0117
17,3835
291,7488
0,0018
0
NA
NA
NA
NA
Duration
(years)
74,2704
69,3867
56,0597
41,7855
26,0793
13,8673
7,9888
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0,5
0
0
5,8989
0
1
19,4997
0
1
34,6801
0
1
52,144
0
1
67,9981
0
1
82,0423
2,2998
37,0938
0,0012
25,2252
Incidence
(numbers)
0
0
8
6295
4183
4592
3244
Prevalence
(numbers)
0
0
4
64479
90420
86150
54441
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
74,2704
69,3867
56,0597
41,7855
26,0793
13,8673
7,9888
Mortality
(numbers)
0
0
0
0
0
0
0
18321
295494
25,2252
53,8141
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality RR Mortality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0,0035
2,4
0
0
0,0117
3,5
0
0
0,0117
9,1667
0
0
0,0117
18,3333
0
0
0,0117
NA
NA
NA
NA
53,8141
GRIIF 10
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,0035
0,133
0,2692
0,0006
0
1,84
0
0
0,0117
1,2267
12,1154
0,0022
0
2,0333
0
0
0,0117
2,0171
45,3222
0,0166
0
8,0667
0
0
0,0117
6,5457
94,2136
0,0036
0
18,3333
0
0
0,0117
17,3023
236,3659
0,0002
0
NA
NA
NA
NA
Duration
(years)
80,3433
75,752
63,4814
45,6752
30,8963
16,3137
9,8349
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0,5
0
0
5,6157
0
1
17,9278
0
1
36,143
0
1
51,8232
0
1
69,1187
0
1
83,8184
2,0328
29,008
0,0056
23,8581
Incidence
(numbers)
0
0
191
3786
2632
4682
5231
Prevalence
(numbers)
0
0
386
37389
59134
67388
71458
Remission
(numbers)
0
0
0
0
1
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
80,3433
75,752
63,4814
45,6752
30,8963
16,3137
9,8349
Mortality
(numbers)
0
0
0
0
0
0
0
16521
235755
23,8581
61,815
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality RR Mortality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0,0035
1,84
0
0
0,0117
2,0333
0
0
0,0117
8,0667
0
0
0,0117
18,3333
0
0
0,0117
NA
NA
NA
NA
61,815
GRIIF 11
ESTRABISMO
DisMod II input and output, database Sepsis
Males, Disease: eSTRABISMO (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
15
10
0
0
0
0
0
NA
Prevalence
(rates * 1000)
7,0158
39,8007
23,2949
1,1564
0,0076
0,0003
0
Remission
(rates * 1000)
120
120
220
220
220
220
220
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
7,0191
6,0079
0
0
0
0
0
Age of onset
(years)
0,5
5,4344
0
0
0
0
0
1,6885
10,9283
163,8446
6,1484
4,7288
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
15
10
0
0
0
0
0
Remission
(rates * 1000)
120
120
220
220
220
220
220
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
1869
11582
0
0
0
0
0
Prevalence
(numbers)
880
48006
34567
3593
10
0
0
Remission
(numbers)
106
5761
7605
790
2
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
7,0191
6,0079
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
0
0
0
0
Age of onset
(years)
0,5
5,4344
0
0
0
0
0
NA
NA
13450
87056
14264
6,1484
4,7288
GRIIF 12
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
15
10
0
0
0
0
0
NA
Prevalence
(rates * 1000)
7,0158
39,8007
23,2949
1,1564
0,0076
0,0003
0
Remission
(rates * 1000)
120
120
220
220
220
220
220
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
7,0404
6,0138
0
0
0
0
0
Age of onset
(years)
0,5
5,4344
0
0
0
0
0
1,5958
10,3538
163,9713
6,1563
4,7296
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
15
10
0
0
0
0
0
Remission
(rates * 1000)
120
120
220
220
220
220
220
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
1800
11170
0
0
0
0
0
Prevalence
(numbers)
848
46299
33422
3569
10
0
0
Remission
(numbers)
102
5556
7353
785
2
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
7,0404
6,0138
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
0
0
0
0
Age of onset
(years)
0,5
5,4344
0
0
0
0
0
NA
NA
12970
84148
13798
6,1563
4,7296
Discapacidad
0,085 con base a pesos Victoria ms pesos alemanes.
Dato duro: Prevalencia
GRIIF 13
DESPRENDIMIENTO DE RETINA
CASOS AGUDOS
90% casos agudos
DisMod II input and output, database mis enfermedades
Females, Disease: Desprendimiento de retina (Rates * ), sex: Females
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality
Mortality
Incidence
Prevalence Remission Case fatality
(rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100)
0
1200
0
0
0
0
0
0
0
1200
0
0
0
0
0
0
0
1200
0
0
0
0
0
0
0,013
1200
0
0
0,013
0,001
1200
0
0,0253
1200
0
0
0,025
0,0021
1200
0
0,038
1200
0
0
0,038
0,0031
1200
0
0,038
1200
0
0
0,038
0,0032
1200
0
NA
NA
NA
Duration
(years)
0
0
0
0,0833
0,0833
0,0832
0,0828
Mortality
RR mortality Age of onset
(rates * 100) (number)
(years)
0
0
0
0
0
0
0
0
0
0
1
31,9689
0
1
52,0946
0
0
66,7137
0
0
84,5105
0,0137
0,0011
1200
0,0832
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
0
401
326
272
115
Prevalence
(numbers)
0
0
0
32
27
22
10
Remission
(numbers)
0
0
0
386
324
268
115
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
0,0833
0,0833
0,0832
0,0828
Mortality
(numbers)
0
0
0
0
0
0
0
1114
91
1093
0,0832
52,09
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality
(rates * 100) (rates * 100) (rates * 100)
0
1200
0
0
1200
0
0
1200
0
0,013
1200
0
0,0253
1200
0
0,038
1200
0
0,038
1200
0
NA
NA
NA
52,09
GRIIF 14
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality
Mortality
Incidence
Prevalence Remission Case fatality
(rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100)
0
1200
0
0
0
0
0
0
0
1200
0
0
0
0
0
0
0
1200
0
0
0
0
0
0
0,0082
1200
0
0
0,0082
0,0006
1200
0
0,0283
1200
0
0
0,0279
0,0023
1200
0
0,038
1200
0
0
0,038
0,0031
1200
0
0,038
1200
0
0
0,038
0,0032
1200
0
NA
NA
NA
Duration
(years)
0
0
0
0,0833
0,0833
0,0832
0,0826
Mortality
RR mortality Age of onset
(rates * 100) (number)
(years)
0
0
0
0
0
0
0
0
0
0
0
38,1468
0
1
51,9717
0
0
66,4413
0
0
83,232
0,0114
0,0009
1200
0,0832
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
0
254
350
229
71
Prevalence
(numbers)
0
0
0
20
29
19
6
Remission
(numbers)
0
0
0
238
348
227
71
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
0,0833
0,0833
0,0832
0,0826
Mortality
(numbers)
0
0
0
0
0
0
0
904
74
884
0,0832
54,3465
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality
(rates * 100) (rates * 100) (rates * 100)
0
1200
0
0
1200
0
0
1200
0
0,0082
1200
0
0,0283
1200
0
0,038
1200
0
0,038
1200
0
NA
Discapacidad
0,43
(prdida severa de la visin)
NA
NA
54,3465
GRIIF 15
CASOS CRONICOS
DisMod II input and output, database mis enfermedades
Males, Disease: Desprendimiento de retina Cr (Rates * 100), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality
Mortality
Incidence
Prevalence Remission Case fatality
(rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,0018
0
0
0
0,0018
0,0248
0
0
0,0028
0
0
0
0,0028
0,0629
0
0
0,0038
0
0
0
0,0038
0,1118
0
0
0,0038
0
0
0
0,0038
0,1717
0
0
NA
NA
NA
Duration
(years)
0
0
0
45,4891
26,3681
15,1287
7,157
Mortality
RR mortality Age of onset
(rates * 100) (number)
(years)
0
0
0
0
0
0
0
0
0
0
1
30,8986
0
1
51,9706
0
1
66,4399
0
1
83,2282
0,0015
0,032
31,9439
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
0
56
35
23
7
Prevalence
(numbers)
0
0
0
769
789
675
320
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
45,4891
26,3681
15,1287
7,157
Mortality
(numbers)
0
0
0
0
0
0
0
121
2553
31,9439
46,9317
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality
(rates * 100) (rates * 100) (rates * 100)
0
0
0
0
0
0
0
0
0
0,0018
0
0
0,0028
0
0
0,0038
0
0
0,0038
0
0
NA
NA
NA
46,9317
GRIIF 16
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality
Mortality
Incidence
Prevalence Remission Case fatality
(rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,0013
0
0
0
0,0013
0,0169
0
0
0,0025
0
0
0
0,0025
0,0488
0
0
0,0038
0
0
0
0,0038
0,0961
0
0
0,0038
0
0
0
0,0038
0,1573
0
0
NA
NA
NA
0,0014
Duration
(years)
0
0
0
50,3258
31,2246
18,8669
9,0774
Mortality
RR mortality Age of onset
(rates * 100) (number)
(years)
0
0
0
0
0
0
0
0
0
0
1
31,9673
0
1
52,0937
0
1
66,7123
0
1
84,5063
0,0286
32,8137
52,0724
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality
(rates * 100) (rates * 100) (rates * 100)
0
0
0
0
0
0
0
0
0
0,0013
0
0
0,0025
0
0
0,0038
0
0
0,0038
0
0
NA
NA
Discapacidad
0,17
(equivalente a prdida moderada de visin)
NA
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
0
40
33
27
11
Prevalence
(numbers)
0
0
0
521
637
687
476
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
50,3258
31,2246
18,8669
9,0774
Mortality
(numbers)
0
0
0
0
0
0
0
111
2320
32,8137
52,0724
GRIIG 1
ENFERMEDAD REUMATICA
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence Remission
(rates)
(rates)
0
0,1
0,00000241
0,1
0,00000407
0,1
0,00001331
0,1
0,00007617
0,1
0,00011821
0,1
0,00014564
0,1
NA
NA
Mortality
(rates)
0
0
0
0,00000443
0,00002188
0,00006608
0,0001458
Incidence
(rates)
0
0,00000249
0,00000404
0,0000132
0,00006936
0,00011598
0,00013926
Prevalence
(rates)
0
0,00000537
0,00002279
0,00004511
0,0002637
0,000529
0,00049643
Remission
(rates)
0
0,1
0,09877217
0,09970269
0,1008871
0,09976801
0,09897777
Case fatality
(rates)
0
0
0,01897171
0,09902806
0,0703145
0,11982214
0,23735687
Duration
(years)
0
8,03807984
5,66627391
5,37487515
5,07062378
3,67989083
2,14406628
Mortality
(rates)
0
0
0,00000043
0,00000448
0,00001857
0,00006338
0,00011759
RR mortality
(number)
1
0
46,7159629
98,5434057
12,6930216
6,68519443
3,62374251
Age of onset
(years)
0
7,54365934
15,8157231
37,8510903
53,7890208
66,7454788
81,6528104
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence Remission
(rates)
(rates)
0
0,15
0,0000025
0,15
0,00000491
0,15
0,00003527
0,15
0,00014259
0,15
0,00021934
0,15
0,00016147
0,15
NA
NA
Mortality
(rates)
0
0
0
0,00000376
0,00002884
0,00009231
0,00023379
Incidence
(rates)
0
0,00000258
0,00000488
0,00003531
0,00013788
0,00021792
0,00012562
Prevalence
(rates)
0
0,00000515
0,00002069
0,00012611
0,00055249
0,00083152
0,00051098
Remission
(rates)
0
0,15
0,1486821
0,15098466
0,15080867
0,14956392
0,14620539
0,150043
Case fatality
(rates)
0
0
0,0164434
0,03025458
0,04455727
0,10840535
0,3096717
Duration
(years)
0
6,24633936
5,33446196
5,42449653
4,59831017
3,36905101
1,77703141
Mortality
(rates)
0
0
0,00000034
0,00000382
0,00002464
0,00009015
0,00015656
RR mortality
(number)
0
0
106,692263
76,1576303
14,7069347
9,86237224
5,97012491
Age of onset
(years)
0
7,54397561
16,0528511
36,796807
52,5588324
66,8398015
81,3918861
2,9
6,1
Masc
Fem
La incidencia en adultos por sobre 45 aos son casos residuales que hoy ya no es enfermedad de notificacin obligatoria
1,2
1,9
Diferencia en onset
0,1
0,4
9,5%
16,0%
-1,4
GRIIG 2
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence Remission
(rates)
(rates)
0
0,1
0,00000241
0,1
0,00000407
0,1
0,00001331
0,1
0,00007617
0,1
0,00011821
0,1
0,00014564
0,1
NA
NA
Mortality
(numbers)
0
0
0
14
27
40
27
Incidence
(numbers)
0
3
6
41
87
70
26
Prevalence
(numbers)
0
6
34
140
331
319
93
108
233
923
Mortality
(numbers)
0
0
0
12
38
66
71
Incidence
(numbers)
0
3
7
109
180
156
38
Prevalence
(numbers)
0
6
30
389
721
595
154
186
493
1895
98
Duration
(years)
0
8,03807984
5,66627391
5,37487515
5,07062378
3,67989083
2,14406628
4,43347891
Mortality RR mortality
(numbers)
(number)
0
1
0
0
1
46,7159629
14
98,5434057
23
12,6930216
38
6,68519443
22
3,62374251
98
Age of onset
(years)
0
7,54365934
15,8157231
37,8510903
53,7890208
66,7454788
81,6528104
20,7210345 56,5859499
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence Remission
(rates)
(rates)
0
0,15
0,0000025
0,15
0,00000491
0,15
0,00003527
0,15
0,00014259
0,15
0,00021934
0,15
0,00016147
0,15
NA
NA
157
Duration
(years)
0
6,24633936
5,33446196
5,42449653
4,59831017
3,36905101
1,77703141
4,19520927
Mortality RR mortality
(numbers)
(number)
0
0
0
0
0
106,692263
12
76,1576303
32
14,7069347
64
9,86237224
47
5,97012491
156
Age of onset
(years)
0
7,54397561
16,0528511
36,796807
52,5588324
66,8398015
81,3918861
14,9863239 55,1691962
GRIIG 3
ENFERMEDAD HIPERTENSIVA
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,000009
0,00000789
0,000023
0,0001048
0,00069067
0,00209033
0,00386083
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality (rates)
0
0
0
0,00000613
0,00007666
0,00059886
0,00508732
Incidence
(rates)
0,00000804
0,00000542
0,00001863
0,00006492
0,00023354
0,00095694
0,00441094
Prevalence
(rates)
0,00000364
0,00002372
0,00009313
0,00022479
0,00061461
0,00113467
0,00430638
Remission
(rates)
0,20000014
0,10275515
0,05436204
0,21463762
0,21340993
0,20529538
0,18192746
Case fatality
(rates)
0
0
0,01125896
0,02839388
0,12293202
0,53045152
0,81674181
Duration
Mortality (rates)
(years)
8,27882195
0
11,22494476
0
6,6267039
0,00000105
3,95303032
0,00000639
2,52443003
0,00007564
1,31339318
0,00060503
0,86742012
0,0035169
RR mortality
(number)
1
0
23,33448193
20,38811481
22,29551838
27,16935018
9,13442556
Age of onset
(years)
0,5
4,88108827
16,14205148
34,94416091
53,04877544
68,19728272
83,12841384
NA
NA
0,00017898
0,00024229
0,00039221
0,19575928
0,36344092
1,69615448
16,2343765
68,3057905
Incidence
(rates)
0,0000078
0,00000636
0,0000325
0,00018408
0,00096287
0,0025506
0,00454848
Remission
(rates)
0,15
0,15
0,15
0,15
0,15
0,15
0,15
Mortality (rates)
0
0
0
0,00000542
0,00004851
0,00046575
0,00538439
Incidence
(rates)
0,00000653
0,00000738
0,00002681
0,00007637
0,00031788
0,00105328
0,00494556
Prevalence
(rates)
0,00000303
0,00002416
0,00009386
0,00029737
0,00122556
0,00235668
0,00722954
Remission
(rates)
0,15000025
0,15000024
0,15087012
0,16209112
0,16193152
0,15806679
0,14008841
Case fatality
(rates)
0
0
0,00809976
0,01885191
0,0424694
0,19948032
0,52822278
Duration
Mortality (rates)
(years)
6,54042007
0
6,41987756
0
5,75676262
0,00000076
5,46106023
0,00000561
4,08143763
0,00005209
2,50972986
0,00047124
1,25350073
0,00381737
RR mortality
(number)
0
1,00000003
47,85603241
38,8334847
14,41995279
17,4030276
7,81751417
Age of onset
(years)
0,5
5,98240349
15,80707865
36,03126841
52,76213014
68,62578875
84,83834771
NA
NA
0,00025113
0,00036258
0,00080607
0,1533928
0,24072973
2,38447838
10,51826355
72,02691355
17,9
25,1
24,2
36,3
14,3
19,4
Masc
Fem
3,6
5,7
0,00014279
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
0,0001941
Diferencia en onset
Diferencia entre mortalidad inicial y la estimada
Peso mx a prevalencia
20,2%
22,7%
3,7
GRIIG 4
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,000009
0,00000789
0,000023
0,0001048
0,00069067
0,00209033
0,00386083
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(numbers)
0
0
0
19
96
361
949
Incidence
(numbers)
1
7
28
202
293
577
823
Prevalence
(numbers)
0
29
138
698
771
684
804
Remission
(numbers)
0
3
8
150
164
141
146
Case fatality
(numbers)
0
0
2
20
95
363
656
Duration
(years)
8,27882195
11,22494476
6,6267039
3,95303032
2,52443003
1,31339318
0,86742012
Mortality
(numbers)
0
0
2
20
95
365
656
RR mortality
(number)
1
0
23,33448193
20,38811481
22,29551838
27,16935018
9,13442556
Age of onset
(years)
0,5
4,88108827
16,14205148
34,94416091
53,04877544
68,19728272
83,12841384
NA
NA
1426
1930
3124
612
1136
1,69615448
1137
16,2343765
68,3057905
Incidence
(rates)
0,0000078
0,00000636
0,0000325
0,00018408
0,00096287
0,0025506
0,00454848
Remission
(rates)
0,15
0,15
0,15
0,15
0,15
0,15
0,15
Mortality
(numbers)
0
0
0
17
63
333
1628
Incidence
(numbers)
1
9
38
236
415
753
1495
Prevalence
(numbers)
0
28
135
918
1599
1686
2186
Remission
(numbers)
0
4
20
149
259
266
306
Case fatality
(numbers)
0
0
1
17
68
336
1155
Duration
(years)
6,54042007
6,41987756
5,75676262
5,46106023
4,08143763
2,50972986
1,25350073
Mortality
(numbers)
0
0
1
17
68
337
1154
RR mortality
(number)
0
1,00000003
47,85603241
38,8334847
14,41995279
17,4030276
7,81751417
Age of onset
(years)
0,5
5,98240349
15,80707865
36,03126841
52,76213014
68,62578875
84,83834771
NA
NA
2041
2947
6551
1005
1577
2,38447838
1578
10,51826355
72,02691355
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIG 5
HIPERTENSION ARTERIAL
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0,00000028
0,00932535
0,06555362
0,11319802
0,12062873
0,10257266
Prevalencia
(rates)
0
0
0,02234622
0,24116696
0,587
0,67699534
0,746
Remission
(rates)
0,1
0,1
0,1
0,1
0,1
0,1
0,1
Mortality
(rates)
0
0
0
0
0
0
0
RR mortality
(number)
0,015
0,015
0,015
0,015
0,015
0,015
0,015
Incidence
(rates)
0
0,00000028
0,00901686
0,04503489
0,05867961
0,05559632
0,04848374
Prevalence
(rates)
0
0,00000097
0,03308062
0,31300679
0,48161982
0,5391121
0,52732296
Remission
(rates)
0
0,10028201
0,10043644
0,10004318
0,10011002
0,09990912
0,09953716
Case fatality
(rates)
0
0
0
0,00000001
0,00000003
0,0000001
0,00000029
Duration
(years)
0
9,89344061
9,83957899
9,57987504
8,66479245
6,85722509
4,51955442
Mortality
RR mortality
Age of onset
(rates)
(number)
(years)
0
0
0
0
1,00000034
5,61430745
0
1,00000464 14,90073421
0
1,0000069 31,55085337
0,00000002
1,00000577 51,36487457
0,00000006
1,00000446 66,38846331
1,00000315 82,09566324
0,00000015
NA
0,25936002
NA
NA
0,03382597
0,25722517
0,10002672
0,00000005
8,64650714
0,00000001
Incidence
(rates)
0
0,00000012
0,00414236
0,03822368
0,10652661
0,13818495
0,10594105
Prevalencia
(rates)
0
0
0,01017676
0,13497295
0,489
0,68332678
0,818
Remission
(rates)
0,08
0,08
0,08
0,08
0,08
0,08
0,08
Mortality
(rates)
0
0
0
0
0
0
0
RR mortality
(number)
0,015
0,015
0,015
0,015
0,015
0,015
0,015
Incidence
(rates)
0
0,00000012
0,00407688
0,02952801
0,05634665
0,05422003
0,0423079
Prevalence
(rates)
0
0,00000045
0,01580525
0,22749421
0,47105562
0,60762713
0,60064674
Remission
(rates)
0
0,080173
0,07991016
0,08032817
0,07966705
0,0797258
0,08022612
Case fatality
(rates)
0
0
0
0,00000001
0,00000002
0,00000007
0,00000022
Duration
(years)
0
12,38189383
12,32907474
11,95630161
10,84926705
8,57795064
5,57715546
Mortality
RR mortality
Age of onset
(rates)
(number)
(years)
0
0
0
0
0
5,61573914
0
1,00000499 14,92845433
0
1,00000783 31,80828727
0,00000001
1,00000629 51,19846751
0,00000004
1,00000497 66,49927172
0,00000013
1,00000324 83,85080506
NA
0,22211879
NA
NA
0,0273235
0,24061625
0,07997219
0,00000004
10,20428338
0,00000001
1,00000466
42,26190359
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Peso mx a prevalencia
1,00000448
47,10650453
GRIIG 6
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0,00000028
0,00932535
0,06555362
0,11319802
0,12062873
0,10257266
Prevalencia
(rates)
0
0
33159
749252
736077
408397
139205
Remission
(rates)
0,1
0,1
0,1
0,1
0,1
0,1
0,1
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0,015
0,015
0,015
0,015
0,015
0,015
0,015
Incidence
(rates)
0
0
13380
139913
73582
33538
9047
Prevalence
(rates)
0
1
49088
972442
603934
325219
98400
Remission
(rates)
0
0
4930
97286
60460
32492
9794
Case fatality
(rates)
0
0
0
0
0
0
0
Duration
(years)
0
9,89344061
9,83957899
9,57987504
8,66479245
6,85722509
4,51955442
Mortality
(rates)
0
0
0
0
0
0
0
NA
2066090
NA
NA
269461
2049084
204963
8,64650714
Incidence
(rates)
0
0,00000012
0,00414236
0,03822368
0,10652661
0,13818495
0,10594105
Prevalencia
(rates)
0
0
14601
416536
638021
488762
247299
Remission
(rates)
0,08
0,08
0,08
0,08
0,08
0,08
0,08
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0,015
0,015
0,015
0,015
0,015
0,015
0,015
Incidence
(rates)
0
0
5849
91125
73518
38782
12791
Prevalence
(rates)
0
1
22676
702062
614608
434617
181588
Remission
(rates)
0
0
1812
56395
48964
34650
14568
Case fatality
(rates)
0
0
0
0
0
0
0
Duration
(years)
0
12,38189383
12,32907474
11,95630161
10,84926705
8,57795064
5,57715546
Mortality
(rates)
0
0
0
0
0
0
0
NA
1805219
NA
NA
222065
1955553
156390
10,20428338
RR mortality
(number)
Age of onset
(years)
0
1,00000034
1,00000464
1,0000069
1,00000577
1,00000446
1,00000315
0
5,61430745
14,90073421
31,55085337
51,36487457
66,38846331
82,09566324
1,00000466
42,26190359
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
RR mortality
(number)
Age of onset
(years)
0
0
1,00000499
1,00000783
1,00000629
1,00000497
1,00000324
0
5,61573914
14,92845433
31,80828727
51,19846751
66,49927172
83,85080506
1,00000448
47,10650453
GRIIG 7
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0,2876
7,6843
12,2757
14,207
NA
Remission
(rates * 1000)
300
300
300
300
300
300
300
NA
2,5097
Prevalence
(rates * 1000)
0
0
0
0,7814
18,1101
37,566
44,6442
7,046
Remission
(rates * 1000)
0
0
0
300
300
300
300
300
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
0
Duration
(years)
0
0
0
3,3085
3,2205
3,0997
2,8002
3,1281
Age of onset
(years)
0
0
0
35,546
53,6039
67,6781
93,5847
63,9837
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0,2876
7,6843
12,2757
14,207
NA
Remission
(rates * 1000)
300
300
300
300
300
300
300
NA
Mortality
(numbers)
0
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
0
893
9441
7126
2533
Prevalence
(numbers)
0
0
0
2428
22709
22662
8331
Remission
(numbers)
0
0
0
728
6813
6798
2499
19992
56129
16839
Case fatality
(numbers)
0
0
0
0
0
0
0
0
Duration
(years)
0
0
0
3,3085
3,2205
3,0997
2,8002
3,1281
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
1
1
0
0
1
Age of onset
(years)
0
0
0
35,546
53,6039
67,6781
93,5847
63,9837
GRIIG 8
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0,2872
1,4437
6,7143
10,795
NA
Remission
(rates * 1000)
175
175
175
175
175
175
175
NA
1,2923
Prevalence
(rates * 1000)
0
0
0
0,9702
4,8196
25,9342
54,6547
5,4576
Remission
(rates * 1000)
0
0
0
175
175
175
175
175
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
0
Duration
(years)
0
0
0
5,6583
5,4565
5,2757
4,7662
5,1905
Age of onset
(years)
0
0
0
38,3207
55,4158
68,7578
96,437
74,9108
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates * 1000)
0
0
0
0,2872
1,4437
6,7143
10,795
Remission
(rates * 1000)
175
175
175
175
175
175
175
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
0
885
1871
4662
3085
Prevalence
(numbers)
0
0
0
2994
6288
18550
16523
Remission
(numbers)
0
0
0
524
1100
3246
2892
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
5,6583
5,4565
5,2757
4,7662
All ages
NA
NA
0
10503
44356
7762
0
5,1905
Supuestos:
Estudio National Heart Foundation Survey 1989 de Australia. Provee prevalencia e incidencia de angina estable.
Se us datos de incidencia de angina estable sin ajustar a los descensos observados en Australia, dada nuestra situacin epidemiolgica.
La duracin estimada por seguimiento es de 3 aos promedio a mujeres y 5 aos promedio a hombres.
Peso de discapacidad con tratamiento es de 0,08 hasta los 44 aos, luego se reduce a 0,078 hasta los 64 aos, luego se reduce 0,075.
Se asume para Chile:
Hombres cidad hasta los 44 de 0,08
Discapacidad entre 44 y 64 aos de 0,078
Discapacidad entre 65 y 74 aos de 0,075
Discapacidad de 75 y ms de 0,071
Mujeres
Similar
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
1
0
1
0
1
Age of onset
(years)
0
0
0
38,3207
55,4158
68,7578
96,437
74,9108
GRIIG 9
ENFERMEDAD ISQUEMICA
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00001564
0,00001498
0,00003062
0,00037688
0,00357625
0,00858746
0,01129916
Remission
(rates)
1
1
1
1
1
1
1
Mortality
(rates)
0
0
0
0,00004602
0,00061421
0,0032673
0,01162308
Incidence
(rates)
0,00001564
0,00001495
0,00003032
0,00037317
0,00331879
0,0081397
0,0112423
Prevalence
(rates)
0,00000494
0,00001444
0,00002274
0,00028528
0,00252783
0,00480233
0,00458462
Remission
(rates)
1
1
1
1
1
1
1
Case fatality
(rates)
0
0
0,25278152
0,16407528
0,22472052
0,65619725
1,61461551
Duration
(years)
0,9985788
0,99899591
0,76816416
0,86331911
0,80107767
0,59107071
0,36115679
Mortality
(rates)
0
0
0,00000575
0,00004749
0,00057104
0,00316531
0,00723414
RR mortality
(number)
0
1
506,5181301
258,8237801
36,04948949
33,04006434
19,06333112
Age of onset
(years)
0,5
5,52599061
16,36622087
38,4526153
53,26125305
67,27334596
82,02631396
NA
NA
0,00063432
0,00155585
0,00098673
0,98673
0,52778255
0,64943793
0,00051864
38,03576992
62,29998184
Incidence
(rates)
0,0000142
0,00000631
0,00001594
0,00011508
0,00129638
0,00417197
0,00678556
Remission
(rates)
1
1
1
1
1
1
1
Mortality
(rates)
0
0
0,0000007
0,00000681
0,00018101
0,00132512
0,00791732
Incidence
(rates)
0,0000142
0,00000605
0,00001568
0,00011542
0,00120482
0,00397549
0,00720026
Prevalence
(rates)
0,00000449
0,00000715
0,00001199
0,00009708
0,00094042
0,00250454
0,00265691
Remission
(rates)
1
1
1
1
1
1
1
Case fatality
(rates)
0
0,00004469
0,02882028
0,06548028
0,18314094
0,52248981
1,7587981
Duration
(years)
0,99891938
0,99889421
0,96743929
0,93783743
0,83066984
0,64553528
0,34190646
Mortality
(rates)
0
0
0,00000035
0,00000642
0,00017317
0,00131709
0,00465851
RR mortality
(number)
0
21,7372555
102,4851382
187,2759491
52,8943652
45,84898822
26,88763323
Age of onset
(years)
0,5
3,01606645
17,46872717
38,35912784
53,55849687
67,79940426
84,17199562
NA
NA
0,0004429
0,00085881
0,0005103
0,62535788
0,6089354
0,0003195
37,26795293
68,59217286
63,4
44,3
155,6
85,9
51,9
32,0
Masc
Fem
11,6
12,3
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Diferencia en onset
Diferencia entre mortalidad inicial y la estimada
18,2%
27,9%
6,3
GRIIG 10
Incidecia estimada por egresos fue incrementada un 25%, por personas que mueren sin atencin.
Dato ms relevante es la mortalidad.
Masculino
Incidence
Remission
Mortality
Incidence
Prevalence
Remission
Age
(rates)
(rates)
(numbers)
(numbers)
(numbers)
(numbers)
0
0,00001564
1
0
2
1
1
1-9
0,00001498
1
0
18
17
17
10-19
0,00003062
1
0
45
34
34
20-44
0,00037688
1
143
1159
886
886
45-59
0,00357625
1
770
4162
3170
3170
60-74
0,00858746
1
1971
4910
2897
2897
75 +
0,01129916
1
2169
2098
855
855
All ages
Case fatality
(numbers)
0
0
9
145
712
1901
1381
Duration
(years)
0,9985788
0,99899591
0,76816416
0,86331911
0,80107767
0,59107071
0,36115679
Mortality
(numbers)
0
0
9
148
716
1909
1350
RR mortality
(number)
0
1
506,5181301
258,8237801
36,04948949
33,04006434
19,06333112
Age of onset
(years)
0,5
5,52599061
16,36622087
38,4526153
53,26125305
67,27334596
82,02631396
NA
NA
5053
12394
7860
7860
4149
0,64943793
4132
38,03576992
62,29998184
Incidence
(rates)
0,0000142
0,00000631
0,00001594
0,00011508
0,00129638
0,00417197
0,00678556
Remission
(rates)
1
1
1
1
1
1
1
Mortality
(numbers)
0
0
1
21
236
948
2394
Incidence
(numbers)
2
7
22
356
1572
2844
2177
Prevalence
(numbers)
1
8
17
300
1227
1791
803
Remission
(numbers)
1
8
17
300
1227
1791
803
Case fatality
(numbers)
0
0
0
20
225
936
1413
Duration
(years)
0,99891938
0,99889421
0,96743929
0,93783743
0,83066984
0,64553528
0,34190646
Mortality
(numbers)
0
0
1
20
226
942
1408
RR mortality
(number)
0
21,7372555
102,4851382
187,2759491
52,8943652
45,84898822
26,88763323
Age of onset
(years)
0,5
3,01606645
17,46872717
38,35912784
53,55849687
67,79940426
84,17199562
NA
NA
3600
6980
4147
4147
2594
0,6089354
2597
37,26795293
68,59217286
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIG 11
HEMORRAGIA INTRAENCEFALICA
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00002252
0,00001579
0,00001213
0,00003419
0,00038469
0,00123599
0,00215293
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality (rates)
0
0
0,00000067
0,00001706
0,00016337
0,00059129
0,00132226
Incidence
(rates)
0,00002252
0,00001556
0,00001213
0,00003418
0,00035429
0,00116422
0,0021503
Prevalence
(rates)
0,00001021
0,00005737
0,00005841
0,00009916
0,00061375
0,00195201
0,00483567
Remission
(rates)
0,2
0,19803834
0,19033551
0,14482666
0,24552559
0,21897475
0,17927256
Case fatality
(rates)
0
0,00511191
0,01207156
0,14444592
0,22847961
0,29757085
0,23671746
Duration
(years)
4,92231583
4,88757405
4,97065174
3,13803856
2,00008147
1,90226674
1,87350125
Mortality (rates)
0
0,00000029
0,00000071
0,00001434
0,00014075
0,00058281
0,0011456
RR mortality
(number)
0
38,34051127
33,19542097
96,66959544
38,49835822
16,74216231
3,66519747
Age of onset
(years)
0,5
4,7521867
14,98997433
35,78216057
53,50290708
67,44800842
82,04884713
NA
NA
0,00010824
0,0002126
0,0004161
0,20624688
0,23704678
2,06895749
0,0000989
22,62084499
64,19478545
Incidence
(rates)
0,00000815
0,00000571
0,00000875
0,00002916
0,00013886
0,00053567
0,00121664
Remission
(rates)
0,1
0,1
0,1
0,1
0,1
0,1
0,1
Mortality (rates)
0
0,00000086
0,0000007
0,00001591
0,000092
0,00033918
0,00130922
Incidence
(rates)
0,00000815
0,00000563
0,00000875
0,00002929
0,0001337
0,00051205
0,00141706
Prevalence
(rates)
0,00000377
0,0000236
0,00004315
0,00010801
0,00033732
0,00082311
0,00220039
Remission
(rates)
0,12007661
0,12143287
0,11271729
0,09657687
0,10248536
0,10650745
0,08989405
Case fatality
(rates)
0,0382063
0,0329346
0,01858413
0,12740926
0,24241455
0,41828592
0,46842742
Duration
(years)
6,49173818
6,68431573
6,70827318
4,13673425
2,58259222
1,89796672
1,48173705
Mortality (rates)
0,00000015
0,00000078
0,0000008
0,00001377
0,00008184
0,00034562
0,00103499
RR mortality
(number)
69,84532174
135,3691186
95,81722865
220,5755572
77,19895726
40,29330638
7,71199288
Age of onset
(years)
0,5
4,7523637
14,99094917
34,84896813
52,67268727
67,77618577
84,79453609
NA
NA
0,00009961
0,00013283
0,00026051
0,09926618
0,33491973
2,11942288
0,00008754
42,48429095
69,18988577
10,8
10,0
21,3
13,3
9,9
8,8
Masc
Fem
0,9
1,2
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Diferencia en onset y
Diferencia entre mortalidad inicial y la estimada
Incidencia global del estudio Piscis, con distribucin de egresos, asume que piscis presenta una incidencia baja por ser de una zon con menor incidencia en el pas.
Se asume que el archivo de egresos subestina en un 146% debido a las personas que no se atineden o no se diagnostican
5,0
GRIIG 12
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00002252
0,00001579
0,00001213
0,00003419
0,00038469
0,00123599
0,00215293
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(numbers)
0
0
1
53
205
357
247
Incidence
(numbers)
3
19
18
106
444
702
401
Prevalence
(numbers)
1
69
87
308
770
1178
902
Remission
(numbers)
0
14
16
45
189
258
162
Case fatality
(numbers)
0
0
1
45
176
350
214
Duration
(years)
4,92231583
4,88757405
4,97065174
3,13803856
2,00008147
1,90226674
1,87350125
Mortality
(numbers)
0
0
1
45
176
352
214
RR mortality
(number)
0
38,34051127
33,19542097
96,66959544
38,49835822
16,74216231
3,66519747
Age of onset
(years)
0,5
4,7521867
14,98997433
35,78216057
53,50290708
67,44800842
82,04884713
NA
NA
862
1694
3315
684
786
2,06895749
788
22,62084499
64,19478545
Incidence
(rates)
0,00000815
0,00000571
0,00000875
0,00002916
0,00013886
0,00053567
0,00121664
Remission
(rates)
0,1
0,1
0,1
0,1
0,1
0,1
0,1
Mortality
(numbers)
0
1
1
49
120
243
396
Incidence
(numbers)
1
7
13
90
174
366
428
Prevalence
(numbers)
0
27
62
333
440
589
665
Remission
(numbers)
0
3
7
32
45
63
60
Case fatality
(numbers)
0
1
1
42
107
246
312
Duration
(years)
6,49173818
6,68431573
6,70827318
4,13673425
2,58259222
1,89796672
1,48173705
Mortality
(numbers)
0
1
1
43
107
247
313
RR mortality
(number)
69,84532174
135,3691186
95,81722865
220,5755572
77,19895726
40,29330638
7,71199288
Age of onset
(years)
0,5
4,7523637
14,99094917
34,84896813
52,67268727
67,77618577
84,79453609
NA
NA
810
1080
2117
210
709
2,11942288
711
42,48429095
69,18988577
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIG 13
RR mortality
(number)
206,359613
141,6360074
34,62742449
16,56692686
3,354237
2,0866388
1,33659257
Age of onset
(years)
0,5
4,7521929
16,64150256
36,38805572
53,74047451
67,84178592
82,7683541
6,5201549
67,66894844
Duration
Mortality (rates)
(years)
4,1765889
0
4,21876914
0,00000041
5,98853657
0,00000073
3,92913084
0,00000376
3,32041202
0,00001826
3,12486297
0,00010256
2,52358904
0,00070843
RR mortality
(number)
0
71,35166817
67,25128157
30,54825024
5,68366073
3,35366726
1,75060462
Age of onset
(years)
0,5
4,20335571
16,84926051
37,16509575
52,86503119
68,10261712
84,69068101
2,99217705
3,74365199
70,28820285
Incidence
(rates)
0,00003487
0,00002445
0,0000114
0,00008232
0,00063122
0,0031884
0,00627597
Remission
(rates)
0,22
0,22
0,22
0,22
0,22
0,22
0,22
Mortality (rates)
0,00000797
0
0
0,00000344
0,00002424
0,0001578
0,00103345
Incidence
(rates)
0,00003487
0,0000241
0,00001127
0,00008162
0,00057467
0,00291784
0,00677558
Prevalence
(rates)
0,00001453
0,00006547
0,00004908
0,00023013
0,00146064
0,00745212
0,02212872
Remission
(rates)
0,21006642
0,2142841
0,2178738
0,25512074
0,27499205
0,25986566
0,20132673
Case fatality
(rates)
0,16594008
0,09548394
0,01324808
0,01564701
0,01473243
0,02066743
0,03395349
Duration
Mortality (rates)
(years)
2,89656473
0,00000256
3,58090973
0,00000627
3,85997181
0,00000065
3,79860955
0,00000361
3,19891253
0,00002157
3,31975759
0,00015445
2,73896583
0,00075239
NA
NA
0,00004144
0,00050826
0,00142164
0,24007229
0,02473233
3,14827366
Incidence
(rates)
0,00003153
0,00001863
0,00001567
0,00008374
0,00042506
0,00169349
0,00408037
Remission
(rates)
0,24
0,24
0,24
0,24
0,24
0,24
0,24
Mortality (rates)
0
0
0,0000007
0,00000408
0,0000198
0,00010318
0,00093664
Incidence
(rates)
0,00003153
0,0000182
0,00001547
0,00008361
0,00040578
0,00159168
0,00463399
Prevalence
(rates)
0,00001401
0,00006666
0,00005082
0,00024238
0,00121223
0,00384324
0,01200448
Remission
(rates)
0,24
0,233325
0,18669719
0,2392728
0,25928272
0,28351994
0,23232093
Case fatality
(rates)
0
0,00618696
0,01425914
0,01547219
0,01504205
0,02661706
0,05887637
NA
NA
0,00004877
0,00041516
0,00109015
0,25324111
0,03653823
4,1
4,9
50,8
41,5
3,5
4,0
Masc
Fem
0,6
0,9
0,00003523
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
0,00003992
Diferencia en onset
Diferencia entre mortalidad inicial y la estimada
Incidencia global del estudio Piscis, con distribucin de egresos, asume que piscis presenta una incidencia baja por ser de una zon con menor incidencia en el pas.
Se asume que el archivo de egresos subestina en un 421% debido a las personas que no se atineden o no se diagnostican
2,6
GRIIG 14
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00003487
0,00002445
0,0000114
0,00008232
0,00063122
0,0031884
0,00627597
Remission
(rates)
0,22
0,22
0,22
0,22
0,22
0,22
0,22
Mortality
(numbers)
1
0
0
11
30
95
193
Incidence
(numbers)
4
29
17
254
721
1760
1264
Prevalence
(numbers)
2
79
73
715
1832
4495
4129
Remission
(numbers)
0
17
16
182
504
1168
831
Case fatality
(numbers)
0
8
1
11
27
93
140
Duration
(years)
2,89656473
3,58090973
3,85997181
3,79860955
3,19891253
3,31975759
2,73896583
Mortality
(numbers)
0
8
1
11
27
93
140
RR mortality
(number)
206,359613
141,6360074
34,62742449
16,56692686
3,354237
2,0866388
1,33659257
Age of onset
(years)
0,5
4,7521929
16,64150256
36,38805572
53,74047451
67,84178592
82,7683541
NA
NA
330
4049
11325
2719
280
3,14827366
281
6,5201549
67,66894844
Incidence
(rates)
0,00003153
0,00001863
0,00001567
0,00008374
0,00042506
0,00169349
0,00408037
Remission
(rates)
0,24
0,24
0,24
0,24
0,24
0,24
0,24
Mortality
(numbers)
0
0
1
13
26
74
283
Incidence
(numbers)
4
21
22
258
529
1138
1401
Prevalence
(numbers)
2
78
73
748
1582
2749
3629
Remission
(numbers)
0
18
14
179
410
779
843
Case fatality
(numbers)
0
0
1
12
24
73
214
Duration
(years)
4,1765889
4,21876914
5,98853657
3,92913084
3,32041202
3,12486297
2,52358904
Mortality
(numbers)
0
0
1
12
24
73
214
RR mortality
(number)
0
71,35166817
67,25128157
30,54825024
5,68366073
3,35366726
1,75060462
Age of onset
(years)
0,5
4,20335571
16,84926051
37,16509575
52,86503119
68,10261712
84,69068101
NA
NA
396
3374
8860
2244
324
2,99217705
324
3,74365199
70,28820285
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIG 15
HEMORRAGIA SUBARACNOIDEA
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00000151
0,00000223
0,00000781
0,00002729
0,00008654
0,00013376
0,00016836
Remission
(rates)
0,45
0,45
0,45
0,45
0,45
0,45
0,45
Mortality (rates)
0
0,00000166
0,00000404
0,00001583
0,0000365
0,00008808
0,00009739
Incidence
(rates)
0,00000151
0,00000225
0,00000783
0,00002712
0,00008341
0,00013645
0,00017645
Prevalence
(rates)
0,00000048
0,00000191
0,00000758
0,00002386
0,00010492
0,00012682
0,00012945
Remission
(rates)
0,11894405
0,28914751
0,3959379
0,38551049
0,41747023
0,43454414
0,48284752
Case fatality
(rates)
0,89230431
0,79023395
0,56327473
0,64008262
0,33272632
0,65649425
0,77282006
Duration
(years)
0,98425572
0,92356851
1,04797489
1,02352878
1,28842762
0,88168853
0,73611195
Mortality (rates)
0,0000005
0,00000152
0,0000043
0,00001537
0,00003499
0,00008309
0,00010101
RR mortality
(number)
1105,273722
2421,221896
1636,839451
507,9878335
62,71444358
33,23359391
10,697738
Age of onset
(years)
0,5
6,24562105
14,57709027
35,18262339
52,45766983
66,09497863
82,3911262
NA
NA
0,00002188
0,00004
0,00004017
0,41734617
0,52607955
1,0441545
0,0000212
259,6123953
52,92798569
Incidence
(rates)
0,00000095
0,00000188
0,00000534
0,00002227
0,00007738
0,00010802
0,00014556
Remission
(rates)
0,05
0,05
0,05
0,05
0,05
0,05
0,05
Mortality (rates)
0
0,00000172
0,00000432
0,00002194
0,00007726
0,00014507
0,00025777
Incidence
(rates)
0,00000095
0,00000191
0,00000529
0,00002233
0,00007608
0,0001045
0,00013135
Prevalence
(rates)
0,00000029
0,00000196
0,00000733
0,00002431
0,00011107
0,00005625
0,00006913
Remission
(rates)
0,04366639
0,04723001
0,04924048
0,05047354
0,04811938
0,04670248
0,04551951
Case fatality
(rates)
1,01238026
0,7347152
0,51937994
0,76746757
0,62047353
1,84313802
2
Duration
(years)
0,95604192
1,36620669
1,75599613
1,3067305
1,40755131
0,51224235
0,47139734
Mortality (rates)
0,00000035
0,00000146
0,00000384
0,0000188
0,00006881
0,00010353
0,00013584
RR mortality
(number)
1825,244699
3887,065884
2246,452836
1712,4244
209,3651185
152,4577823
38,69225622
Age of onset
(years)
0,5
6,58708074
16,3251496
35,62528516
52,15565567
67,49565951
82,84828742
NA
NA
0,0000441
0,000036
0,00003616
0,04837413
0,92077487
1,0365515
0,00003324
555,4687292
55,44235981
2,2
4,4
4,0
3,6
2,1
3,3
Masc
Fem
0,1
1,1
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Diferencia en onset y
Diferencia entre mortalidad inicial y la estimada
Incidencia global del estudio Piscis, con distribucin de egresos, asume que piscis presenta una incidencia baja por ser de una zon con menor incidencia en el pas.
Se asume que el archivo de egresos sobrestima en un 20% debido a las personas que no se atineden o no se diagnostican
2,5
GRIIG 16
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,00000151
0,00000223
0,00000781
0,00002729
0,00008654
0,00013376
0,00016836
Remission
(rates)
0,45
0,45
0,45
0,45
0,45
0,45
0,45
Mortality
(numbers)
0
2
6
49
46
53
18
Incidence
(numbers)
0
3
12
84
105
82
33
Prevalence
(numbers)
0
2
11
74
132
77
24
Remission
(numbers)
0
1
4
29
55
33
12
Case fatality
(numbers)
0
2
6
47
44
50
19
Duration
(years)
0,98425572
0,92356851
1,04797489
1,02352878
1,28842762
0,88168853
0,73611195
Mortality
(numbers)
0
2
6
48
44
50
19
RR mortality
(number)
1105,273722
2421,221896
1636,839451
507,9878335
62,71444358
33,23359391
10,697738
Age of onset
(years)
0,5
6,24562105
14,57709027
35,18262339
52,45766983
66,09497863
82,3911262
NA
NA
174
319
320
134
168
1,0441545
169
259,6123953
52,92798569
Incidence
(rates)
0,00000095
0,00000188
0,00000534
0,00002227
0,00007738
0,00010802
0,00014556
Remission
(rates)
0,05
0,05
0,05
0,05
0,05
0,05
0,05
Mortality
(numbers)
0
2
6
68
101
104
78
Incidence
(numbers)
0
2
8
69
99
75
40
Prevalence
(numbers)
0
2
11
75
145
40
21
Remission
(numbers)
0
0
1
4
7
2
1
Case fatality
(numbers)
0
2
5
58
90
74
42
Duration
(years)
0,95604192
1,36620669
1,75599613
1,3067305
1,40755131
0,51224235
0,47139734
Mortality
(numbers)
0
2
6
58
90
74
41
RR mortality
(number)
1825,244699
3887,065884
2246,452836
1712,4244
209,3651185
152,4577823
38,69225622
Age of onset
(years)
0,5
6,58708074
16,3251496
35,62528516
52,15565567
67,49565951
82,84828742
NA
NA
358
293
294
14
271
1,0365515
270
555,4687292
55,44235981
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIG 17
TRASTORNOS VALVULARES
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,000008
0,00000689
0,000006
0,0000166
0,00012933
0,00037733
0,000355
Remission
(rates)
0,25
0,25
0,25
0,25
0,25
0,25
0,25
Mortality (rates)
0
0
0
0
0
0,00007139
0,00165096
Incidence
(rates)
0,00000748
0,00000495
0,00000162
0,00000621
0,00010192
0,000386
0,00064198
Prevalence
(rates)
0,00000331
0,00001658
0,00000917
0,00001502
0,00026318
0,00117753
0,0014743
Remission
(rates)
0,24999993
0,24999961
0,2499989
0,25000158
0,25000304
0,20080398
0,01924409
Case fatality
(rates)
0
0
0
0
0
0,05207043
0,5527835
Duration
Mortality (rates)
(years)
3,98095854
0
3,98999781
0
3,98653202
0
3,95060582
0
3,83167849
0
3,19976466
0,0000614
1,34590904
0,00080725
RR mortality
(number)
0
1,00000311
1,000003
1,00000004
1
4,68392934
7,35229346
Age of onset
(years)
0,5
4,64532809
15,51036192
37,93476272
53,92759129
67,7181343
81,77456029
NA
NA
0,00004408
0,0000639
0,00017526
0,1795001
0,13541826
2,96502888
6,82567294
65,56912481
Incidence
(rates)
0,000003
0,00000522
0,0000085
0,0000194
0,00009233
0,000248
0,00033633
Remission
(rates)
0,24
0,24
0,24
0,24
0,24
0,24
0,24
Mortality (rates)
0
0
0
0
0
0,00008825
0,00178044
Incidence
(rates)
0,000003
0,0000053
0,00000848
0,00001947
0,00008494
0,00024037
0,00033692
Prevalence
(rates)
0,00000133
0,00001258
0,00002933
0,00006507
0,0002533
0,00079677
0,00034516
Remission
(rates)
0,24
0,24
0,24
0,24
0,24000001
0,21033262
0,119901
Case fatality
(rates)
0
0
0
0
0
0,05556247
1,15363821
RR mortality
Duration
Mortality (rates)
(number)
(years)
4,15134125
0
0
4,16184083
0
0
4,16117625
0
0
4,14430941
0
1
4,03779889
0
1
3,06579995
0,0000442
10,14537145
0,61892181
0,00038565
22,14580681
Age of onset
(years)
0,5
6,45179204
15,38971802
35,45627215
53,85157436
67,44028489
83,72182675
NA
NA
0,000074
0,00005702
0,00015533
0,21668027
0,12043818
2,94441404
61,98216487
4,4
7,4
6,4
5,7
2,4
1,8
Masc
Fem
2,1
5,6
0,00002356
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
0,00001824
19,58570039
Diferencia en onset
Diferencia entre mortalidad inicial y la estimada
-3,6
GRIIG 18
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,000008
0,00000689
0,000006
0,0000166
0,00012933
0,00037733
0,000355
Remission
(rates)
0,25
0,25
0,25
0,25
0,25
0,25
0,25
Mortality
(numbers)
0
0
0
0
0
43
308
Incidence
(numbers)
1
6
2
19
128
233
120
Prevalence
(numbers)
0
20
14
47
330
710
275
Remission
(numbers)
0
5
3
12
83
143
5
Case fatality
(numbers)
0
0
0
0
0
37
152
Duration
(years)
3,98095854
3,98999781
3,98653202
3,95060582
3,83167849
3,19976466
1,34590904
Mortality
(numbers)
0
0
0
0
0
37
151
RR mortality
(number)
0
1,00000311
1,000003
1,00000004
1
4,68392934
7,35229346
Age of onset
(years)
0,5
4,64532809
15,51036192
37,93476272
53,92759129
67,7181343
81,77456029
NA
NA
351
509
1396
251
189
2,96502888
188
6,82567294
65,56912481
Incidence
(rates)
0,000003
0,00000522
0,0000085
0,0000194
0,00009233
0,000248
0,00033633
Remission
(rates)
0,24
0,24
0,24
0,24
0,24
0,24
0,24
Mortality
(numbers)
0
0
0
0
0
63
538
Incidence
(numbers)
0
6
12
60
111
172
102
Prevalence
(numbers)
0
15
42
201
330
570
104
Remission
(numbers)
0
4
10
48
79
120
13
Case fatality
(numbers)
0
0
0
0
0
32
120
Duration
(years)
4,15134125
4,16184083
4,16117625
4,14430941
4,03779889
3,06579995
0,61892181
Mortality
(numbers)
0
0
0
0
0
32
117
RR mortality
(number)
0
0
0
1
1
10,14537145
22,14580681
Age of onset
(years)
0,5
6,45179204
15,38971802
35,45627215
53,85157436
67,44028489
83,72182675
NA
NA
601
463
1262
274
152
2,94441404
148
19,58570039
61,98216487
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIG 19
TRASTORNOS DE LA CONDUCCION
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,000048
0,00003411
0,000059
0,0001136
0,000466
0,00171167
0,00399517
Remission
(rates)
0
0
0
0
0
0
0
Mortality (rates)
0
0
0,00000152
0,00000313
0,00001472
0,00013238
0,00129927
Incidence
(rates)
0,000048
0,00003365
0,00005879
0,00011274
0,00043014
0,00153954
0,00425905
Prevalence
(rates)
0,000024
0,00023194
0,00061033
0,00202214
0,00597536
0,01810697
0,04502927
Remission
(rates)
0
0,00000017
0,00000195
0,00000183
0,0000024
0,00000243
0,00000054
Case fatality
(rates)
0
0,00189025
0,00266456
0,00154571
0,00248923
0,00697969
0,02125427
Duration
RR mortality
Mortality (rates)
(years)
(number)
67,53610317
0
0
63,79457657
0,00000044
13,92976332
55,03190021
0,00000163
8,59697554
38,54531155
0,00000313
2,11528286
22,73490794
0,00001487
1,39597403
12,44555563
0,00012639
1,3382816
6,61182836
0,00095724
1,20667367
Age of onset
(years)
0,5
4,79152605
15,36800413
34,82364996
53,29559998
67,91632363
82,83533782
NA
NA
0,00004428
0,00034483
0,00430439
0,00000182
0,0083447
18,15023485
1,37074109
62,86844205
Incidence
(rates)
0,000041
0,00003656
0,000043
0,0000852
0,00038067
0,001315
0,0029595
Remission
(rates)
0
0
0
0
0
0
0
Mortality (rates)
0
0,00000086
0
0,00000112
0,00001104
0,00011508
0,00140337
Incidence
(rates)
0,000041
0,0000364
0,00004307
0,0000849
0,00035601
0,00121689
0,00341889
Prevalence
(rates)
0,00002045
0,00021516
0,00058723
0,00157349
0,0048336
0,01464255
0,03414843
Remission
(rates)
0,0000027
0,00000188
0,00000042
0,00000177
0,00000242
0,00000236
0,00000046
Case fatality
(rates)
0,0052733
0,0038554
0,00095383
0,00073201
0,00233738
0,00768342
0,03122279
Duration
RR mortality
Mortality (rates)
(years)
(number)
71,55758267
0,00000011
10,50215086
68,6464262
0,00000083
18,35163416
61,1862261
0,00000056
8,75099548
41,57682613
0,00000115
2,5217734
25,43033946
0,0000113
1,68768252
14,0342489
0,00011251
1,63678263
7,19145599
0,00106646
1,39209493
Age of onset
(years)
0,5
5,37222939
14,60614417
35,60796544
53,28037835
68,16473707
84,93582456
NA
NA
0,00006465
0,00033709
0,00406717
0,00000164
0,01279342
17,87653186
67,54450653
4,4
6,5
34,5
33,7
3,6
5,2
Masc
Fem
0,8
1,3
0,00003592
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
0,00005204
1,51140371
Diferencia en onset y
Diferencia entre mortalidad inicial y la estimada
0,188798555
0,195050271
4,7
GRIIG 20
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,000048
0,00003411
0,000059
0,0001136
0,000466
0,00171167
0,00399517
Remission
(rates)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
2
10
18
80
242
Incidence
(numbers)
6
41
87
350
539
929
795
Prevalence
(numbers)
3
280
906
6282
7493
10923
8403
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
1
2
10
19
76
179
Duration
(years)
67,53610317
63,79457657
55,03190021
38,54531155
22,73490794
12,44555563
6,61182836
Mortality
(numbers)
0
1
2
10
19
76
179
RR mortality
(number)
0
13,92976332
8,59697554
2,11528286
1,39597403
1,3382816
1,20667367
Age of onset
(years)
0,5
4,79152605
15,36800413
34,82364996
53,29559998
67,91632363
82,83533782
NA
NA
353
2747
34289
286
18,15023485
286
1,37074109
62,86844205
Incidence
(rates)
0,000041
0,00003656
0,000043
0,0000852
0,00038067
0,001315
0,0029595
Remission
(rates)
0
0
0
0
0
0
0
Mortality
(numbers)
0
1
0
3
14
82
424
Incidence
(numbers)
5
42
62
262
465
870
1034
Prevalence
(numbers)
2
250
843
4856
6307
10473
10324
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
1
1
4
15
80
322
Duration
(years)
71,55758267
68,6464262
61,1862261
41,57682613
25,43033946
14,0342489
7,19145599
Mortality
(numbers)
0
1
1
4
15
80
322
RR mortality
(number)
10,50215086
18,35163416
8,75099548
2,5217734
1,68768252
1,63678263
1,39209493
Age of onset
(years)
0,5
5,37222939
14,60614417
35,60796544
53,28037835
68,16473707
84,93582456
NA
NA
525
2740
33055
423
17,87653186
423
1,51140371
67,54450653
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIG 21
ANEURISMA AORTA
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0,00000205
0,00001032
0,00006839
0,00032591
0,00053699
Remission
(rates)
10
10
10
10
10
10
10
Mortality (rates)
0
0
0,0000001
0,00000052
0,00000311
0,000015
0,00002947
Incidence
(rates)
0
0
0,00000202
0,0000103
0,0000622
0,00030003
0,00058946
Prevalence
(rates)
0
0
0,00000018
0,00000096
0,00000562
0,00002719
0,00005213
Remission
(rates)
0
0
10
10
10
10
10
Case fatality
(rates)
0
0
0,20990208
0,52272778
0,53029086
0,52987104
0,52964377
Duration
(years)
0
0
0,09801121
0,0950159
0,09490181
0,09472522
0,09403841
Mortality (rates)
0
0
0,00000004
0,00000051
0,0000031
0,00001497
0,00002927
RR mortality
(number)
0
1,00068986
296,5784627
298,9770458
88,75513466
25,06963488
7,19177529
Age of onset
(years)
0
0
17,46728529
35,14221656
53,821213
67,85694447
82,73483942
NA
NA
0,00000254
0,00005071
0,00000457
10
0,5269879
0,09461971
0,00000251
54,98515189
66,58717622
Incidence
(rates)
0
0
0,00000142
0,00000322
0,00002017
0,00011893
0,00038639
Remission
(rates)
10
10
10
10
10
10
10
Mortality (rates)
0
0,00000004
0,00000007
0,00000016
0,00000096
0,00000545
0,00001737
Incidence
(rates)
0
0
0,00000139
0,00000324
0,00001916
0,00010905
0,0003473
Prevalence
(rates)
0
0
0,00000012
0,00000031
0,00000174
0,00000986
0,00003456
Remission
(rates)
0
0
10
10
10
10
10
Case fatality
(rates)
0
0
0,00000611
0,48411804
0,52991812
0,5308364
0,52274226
Duration
(years)
0
0
0,09999713
0,09533257
0,094936
0,0948145
0,09437574
Mortality (rates)
0
0
0
0,00000015
0,00000096
0,00000545
0,00001742
RR mortality
(number)
1,0110505
0
1,02190898
629,9207172
180,8607539
39,25444656
11,27139825
Age of onset
(years)
0
0
17,46874636
37,49653777
53,02170862
68,82888445
82,81337732
NA
NA
0,00000136
0,00002707
0,00000257
10
0,52002261
0,09468949
0,00000134
67,10093973
72,3390708
0,3
0,1
5,1
2,7
0,5
0,3
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
0,3
0,1
Diferencia en onset y
Masc
Fem
0,0
0,0
5,8
GRIIG 22
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0
0
0,00000205
0,00001032
0,00006839
0,00032591
0,00053699
Remission
(rates)
10
10
10
10
10
10
10
Mortality
(numbers)
0
0
0
2
4
9
6
Incidence
(numbers)
0
0
3
32
78
181
110
Prevalence
(numbers)
0
0
0
3
7
16
10
Remission
(numbers)
0
0
3
30
70
164
97
Case fatality
(numbers)
0
0
0
2
4
9
5
Duration
(years)
0
0
0,09801121
0,0950159
0,09490181
0,09472522
0,09403841
Mortality
(numbers)
0
0
0
2
4
9
5
RR mortality
(number)
0
1,00068986
296,5784627
298,9770458
88,75513466
25,06963488
7,19177529
Age of onset
(years)
0
0
17,46728529
35,14221656
53,821213
67,85694447
82,73483942
NA
NA
20
404
36
364
19
0,09461971
20
54,98515189
66,58717622
Incidence
(rates)
0
0
0,00000142
0,00000322
0,00002017
0,00011893
0,00038639
Remission
(rates)
10
10
10
10
10
10
10
Mortality
(numbers)
0
0
0
1
1
4
5
Incidence
(numbers)
0
0
2
10
25
78
105
Prevalence
(numbers)
0
0
0
1
2
7
10
Remission
(numbers)
0
0
2
9
23
71
104
Case fatality
(numbers)
0
0
0
0
1
4
5
Duration
(years)
0
0
0,09999713
0,09533257
0,094936
0,0948145
0,09437574
Mortality
(numbers)
0
0
0
0
1
4
5
RR mortality
(number)
1,0110505
0
1,02190898
629,9207172
180,8607539
39,25444656
11,27139825
Age of onset
(years)
0
0
17,46874636
37,49653777
53,02170862
68,82888445
82,81337732
NA
NA
11
220
21
209
11
0,09468949
11
67,10093973
72,3390708
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
GRIIG 23
VENAS VARICOSAS
DisMod II input and output, database Chile fint
Males, Disease: Varices (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
230
0
0
0
0
0
0
0
230
0
0
0
0
0
0,0661
0
230
0
0,0661
0,1745
230
0,0017
15,4379
71,6397
230
0
14,6249
52,6605
230
0,0061
13,4644
120
230
0
12,6929
57,301
230
0,0159
17,8124
120
230
0,0119
16,6096
67,5247
230
0,1703
19,6
120
230
0,0407
18,0846
77,3146
230
0,4795
NA
58,7271
NA
Duration
(years)
0
0
4,3274
4,3047
4,1615
3,9434
3,4642
Mortality
RR mortality
(rates * 1000)
(number)
0
1
0
1
0
1,0026
0,0003
1,0034
0,0009
1,0034
0,0115
1,0088
0,0371
1,0098
0,0019
9,3954
36,5144
230
0,055
4,188
0,002
1,0085
Mortality
(numbers)
0
0
0
0
0
7
8
Incidence
(numbers)
0
0
98
45436
15916
10020
3375
Prevalence
(numbers)
0
0
259
163604
71853
40734
14427
Remission
(numbers)
0
0
60
37629
16526
9369
3318
Case fatality
(numbers)
0
0
0
1
1
7
7
Duration
(years)
0
0
4,3274
4,3047
4,1615
3,9434
3,4642
Mortality
(numbers)
0
0
0
1
1
7
7
RR mortality
(number)
1
1
1,0026
1,0034
1,0034
1,0088
1,0098
15
74845
290878
66902
16
4,188
16
1,0085
Age of onset
(years)
0
0
14,9996
32,3155
52,516
67,4647
93,5734
44,6702
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0,0661
15,4379
13,4644
17,8124
19,6
NA
Prevalence
Remission
(numbers) (rates * 1000)
0
230
0
230
0
230
222569
230
150476
230
72390
230
22392
230
467827
NA
Age of onset
(years)
0
0
14,9996
32,3155
52,516
67,4647
93,5734
44,6702
GRIIG 24
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
230
0
0
0
0
0
0
0
230
0
0
0
0
0
0,1698
0
230
0
0,1697
0,448
230
0,0017
44,9253
180,8699
230
0
38,6536
139,6041
230
0,0071
55,9035
300
230
0,0024
45,3909
188,0492
230
0,0148
62,4771
300
230
0,0103
49,3949
209,3916
230
0,0479
61,4721
300
230
0,0228
48,4905
211,1781
230
0,1009
NA
154,4034
NA
Duration
(years)
0
0
4,3396
4,3282
4,24
4,1091
3,7881
Mortality
RR mortality
(rates * 1000)
(number)
0
1
0
1
0
1,0064
0,001
1,0093
0,0028
1,0048
0,01
1,0044
0,0213
1,0037
0,0021
28,1454
109,5623
230
0,0228
4,2369
0,0025
1,005
Mortality
(numbers)
0
0
0
0
3
7
7
Incidence
(numbers)
0
0
244
119288
59224
35331
14660
Prevalence
(numbers)
0
0
643
430828
245357
149771
63844
Remission
(numbers)
0
0
148
99090
56432
34447
14684
Case fatality
(numbers)
0
0
0
3
4
7
6
Duration
(years)
0
0
4,3396
4,3282
4,24
4,1091
3,7881
Mortality
(numbers)
0
0
0
3
4
7
6
RR mortality
(number)
1
1
1,0064
1,0093
1,0048
1,0044
1,0037
17
228745
890442
204802
20
4,2369
20
1,005
Age of onset
(years)
0
0
14,999
31,9961
52,4226
67,4548
96,5229
47,8293
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0,1698
44,9253
55,9035
62,4771
61,4721
NA
Prevalence
Remission
(numbers) (rates * 1000)
0
230
0
230
0
230
558177
230
391424
230
214581
230
90696
230
1254878
NA
Age of onset
(years)
0
0
14,999
31,9961
52,4226
67,4548
96,5229
47,8293
GRIIG 25
Incidence
(rates)
0,000041
0,00002378
0,0000305
0,0000674
0,00019967
0,000418
0,00056867
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality (rates)
0,00003188
0,00000249
0,00000286
0,0000179
0,00008488
0,0002778
0,00073259
Incidence
(rates)
0,000041
0,00002321
0,00003033
0,0000671
0,0001866
0,00041083
0,00058888
Prevalence
(rates)
0,00001783
0,00008276
0,00010448
0,00027541
0,00051775
0,00070947
0,0006889
Remission
(rates)
0,257551
0,21155773
0,15990746
0,14962751
0,18532543
0,19051667
0,12952754
Case fatality
Duration (years) Mortality (rates)
(rates)
0,02845589
3,88913087
0,00000053
0,02963632
4,46867887
0,00000246
0,0289782
6,26770483
0,00000303
0,05879635
4,31894048
0,0000162
0,14501918
2,57757031
0,00007514
0,37723537
1,64201145
0,00026778
0,76341936
0,95752493
0,00052396
RR mortality
(number)
36,21566865
85,34373769
76,90985668
36,95054127
25,56585604
19,09075967
9,46322965
Age of onset
(years)
0,5
4,13535296
15,72293834
34,90577972
53,15759691
66,74164476
82,30360532
NA
NA
0,00005995
0,00011026
0,00029104
0,16951516
0,17751297
21,58292761
52,78845427
Incidence
(rates)
0,00005
0,00002944
0,000011
0,000028
0,00009
0,000209
0,00025533
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality (rates)
0,00009802
0,0000043
0,00000307
0,0000053
0,00002229
0,00010291
0,00042066
Incidence
(rates)
0,00005
0,00002875
0,00001095
0,00002805
0,00008573
0,00019976
0,00025801
Prevalence
(rates)
0,00002163
0,00009592
0,00005666
0,00009928
0,0002544
0,0004021
0,00053656
Remission
(rates)
0,25578553
0,22539622
0,16791967
0,18866954
0,20408822
0,18909667
0,10220172
Case fatality
Duration (years) Mortality (rates)
(rates)
0,04105
3,5761778
0,00000093
0,04320742
3,9329381
0,00000415
0,05425213
4,50637739
0,00000307
0,05423095
4,11105003
0,00000539
0,08482301
3,04200052
0,0000216
0,25096203
2,15712992
0,00010109
0,48405283
1,38972473
0,00025808
RR mortality
(number)
74,96947909
187,8363227
257,5061382
101,34852
27,08880144
21,8080677
8,37668427
Age of onset
(years)
0,5
4,19128228
15,62991184
34,02113494
52,94759917
67,80214331
83,78864112
NA
NA
0,00003291
0,00005838
0,00015794
0,18384035
0,15955514
32,90673871
54,30439659
6,0
3,3
11,0
5,8
5,2
2,5
Masc
Fem
0,8
0,8
2,78097826
0,00005164
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
2,81690995
0,00002516
Diferencia en onset y
Diferencia entre mortalidad inicial y la estimada
1,5
GRIIG 26
Masculino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Incidence
(rates)
0,000041
0,00002378
0,0000305
0,0000674
0,00019967
0,000418
0,00056867
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(numbers)
4
3
4
56
106
168
137
Incidence
(numbers)
5
28
45
208
234
248
110
Prevalence
(numbers)
2
100
155
856
649
428
129
Remission
(numbers)
1
21
25
128
120
82
17
NA
NA
478
878
2318
393
Incidence
(rates)
0,00005
0,00002944
0,000011
0,000028
0,00009
0,000209
0,00025533
Remission
(rates)
0,2
0,2
0,2
0,2
0,2
0,2
0,2
Mortality
(numbers)
12
5
4
16
29
74
127
Incidence
(numbers)
6
33
16
87
112
143
78
Prevalence
(numbers)
3
112
81
306
332
288
162
Remission
(numbers)
1
25
14
58
68
54
17
NA
NA
267
475
1284
236
Case fatality
(numbers) Duration (years)
0
3,88913087
3
4,46867887
4
6,26770483
50
4,31894048
94
2,57757031
161
1,64201145
98
0,95752493
412
2,78097826
Mortality
(numbers)
0
3
4
50
94
162
98
RR mortality
(number)
36,21566865
85,34373769
76,90985668
36,95054127
25,56585604
19,09075967
9,46322965
Age of onset
(years)
0,5
4,13535296
15,72293834
34,90577972
53,15759691
66,74164476
82,30360532
411
21,58292761
52,78845427
Mortality
(numbers)
0
5
4
17
28
72
78
RR mortality
(number)
74,96947909
187,8363227
257,5061382
101,34852
27,08880144
21,8080677
8,37668427
Age of onset
(years)
0,5
4,19128228
15,62991184
34,02113494
52,94759917
67,80214331
83,78864112
204
32,90673871
54,30439659
Femenino
Age
0
1-9
10-19
20-44
45-59
60-74
75 +
All ages
Case fatality
(numbers) Duration (years)
0
3,5761778
5
3,9329381
4
4,50637739
17
4,11105003
28
3,04200052
72
2,15712992
79
1,38972473
205
2,81690995
GRIIH 1
ASMA
Males, Disease: asma (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
1
0,9111
0,8
0,8
0,056
0,03
0,03
NA
Prevalence
(rates * 1000)
0,4875
4,5228
8,0778
5,801
3,5279
2,068
1,5467
Remission
(rates * 1000)
50
56,2338
80,4603
160
70
0
0
Case fatality
(rates * 1000)
0
0
0,0432
0,2817
2,9183
22,8684
88,4639
Duration
(years)
13,4232
11,7442
8,0359
7,829
13,1793
10,3294
4,4145
Age of onset
(years)
0,5
5,3587
14,9453
32,3951
51,665
66,4419
82,0226
0,0106
0,6223
5,2078
107,6892
1,7492
8,961
0,0091
1,8923
21,9552
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
1
0,9111
0,8
0,8
0,056
0,03
0,03
Remission
(rates * 1000)
50
54,4444
80
160
70
0
0
Mortality
(numbers)
0
0
0
5
14
30
35
Incidence
(numbers)
125
1089
1178
2471
70
18
6
Prevalence
(numbers)
61
5455
11987
18023
4424
1248
289
Remission
(numbers)
3
307
964
2884
310
0
0
Case fatality
(numbers)
0
0
1
5
13
29
26
Duration
(years)
13,4232
11,7442
8,0359
7,829
13,1793
10,3294
4,4145
Mortality
(numbers)
0
0
1
5
13
29
26
RR mortality
(number)
0
0
1,1119
1,1771
1,6379
2,0581
1,9937
Age of onset
(years)
0,5
5,3587
14,9453
32,3951
51,665
66,4419
82,0226
NA
NA
84
4957
41486
4468
73
8,961
73
1,8923
21,9552
GRIIH 2
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
1
0,9111
0,8
0,8
0,056
0,03
0,03
NA
0,0177
Prevalence
(rates * 1000)
0,4875
4,5238
8,0782
5,79
3,5089
2,1003
1,4349
Remission
(rates * 1000)
50
56,2357
80,4833
160
70
0
0
Case fatality
(rates * 1000)
0
0
0,0436
0,2851
3,0758
20,0503
136,2641
Duration
(years)
13,461
11,7713
8,0754
8,0695
14,1913
10,9368
3,7938
Age of onset
(years)
0,5
5,3601
14,9492
32,4951
51,7506
66,7142
83,7065
0,5989
5,0809
106,8214
2,6375
9,0999
0,0134
2,7921
22,2867
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
1
0,9111
0,8
0,8
0,056
0,03
0,03
Remission
(rates * 1000)
50
54,4444
80
160
70
0
0
Mortality
(numbers)
0
0
0
5
16
31
92
Incidence
(numbers)
121
1051
1139
2455
73
21
9
Prevalence
(numbers)
59
5262
11590
17868
4578
1502
434
Remission
(numbers)
3
296
933
2859
320
0
0
Case fatality
(numbers)
0
0
1
5
14
30
59
Duration
(years)
13,461
11,7713
8,0754
8,0695
14,1913
10,9368
3,7938
Mortality
(numbers)
0
0
1
5
14
30
59
RR mortality
(number)
0
0
1,3394
1,4931
2,2071
2,5979
3,1553
Age of onset
(years)
0,5
5,3601
14,9492
32,4951
51,7506
66,7142
83,7065
NA
NA
144
4868
41294
4411
109
9,0999
109
2,7921
22,2867
GRIIH 3
EPOC
Females, Disease: epoc inc (Rates * 1000), sex: Females
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,1331
0
0,008
0,1332
0,3204
0
14,9842
0,6657
0
0,0398
0,6608
7,3548
0
7,4472
1,0775
0
0,3817
1,059
17,2012
0
21,5709
1,2476
0
3,192
1,2216
20,8568
0
106,7355
NA
NA
0,1617
Duration
(years)
0
0
0
28,5857
22,1961
11,55
4,5325
Mortality
RR mortality
(rates * 1000)
(number)
0
0
0
0
0
0
0,0048
13,7111
0,0548
3,8957
0,3711
2,7159
2,2246
2,5812
Age of onset
(years)
0
0
0
42,4672
51,7207
66,688
83,7188
0,2953
3,5921
35,0997
17,2121
0,126
2,8689
60,1396
Mortality
(numbers)
0
0
0
25
52
273
965
Incidence
(numbers)
0
0
0
411
862
757
369
Prevalence
(numbers)
0
0
0
989
9596
12303
6305
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
15
71
265
673
Duration
(years)
0
0
0
28,5857
22,1961
11,55
4,5325
Mortality
(numbers)
0
0
0
15
71
265
673
RR mortality
(number)
0
0
0
13,7111
3,8957
2,7159
2,5812
Age of onset
(years)
0
0
0
42,4672
51,7207
66,688
83,7188
1315
2400
29194
1025
17,2121
1024
2,8689
60,1396
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0
0
0
0
0,1331
0
0,6657
0
1,0775
0
1,2476
0
NA
NA
GRIIH 4
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0,2
0
0,0096
0,1963
0,4725
0
13,8355
1
0
0,049
0,989
11,0232
0
7,0786
1,6
0
0,774
1,5611
24,3144
0
30,0079
3,5
0
5,252
3,3838
33,2041
0
111,4549
NA
NA
0,1931
Duration
(years)
0
0
0
26,0618
19,5706
9,8584
4,0903
Mortality
RR mortality
(rates * 1000)
(number)
0
0
0
0
0
0
0,0065
6,4027
0,078
2,3832
0,7297
2,3767
3,6996
2,1916
Age of onset
(years)
0
0
0
42,4627
51,6238
66,4113
82,0203
0,4297
4,5385
34,5428
15,1997
0,1568
2,3404
59,8012
Mortality
(numbers)
0
0
0
30
61
467
980
Incidence
(numbers)
0
0
0
610
1240
942
631
Prevalence
(numbers)
0
0
0
1468
13823
14668
6196
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
20
98
440
691
Duration
(years)
0
0
0
26,0618
19,5706
9,8584
4,0903
Mortality
(numbers)
0
0
0
20
98
440
690
RR mortality
(number)
0
0
0
6,4027
2,3832
2,3767
2,1916
Age of onset
(years)
0
0
0
42,4627
51,6238
66,4113
82,0203
1538
3423
36154
1249
15,1997
1249
2,3404
59,8012
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0
0
0
0
0,2
0
1
0
1,6
0
3,5
0
NA
NA
GRIIH 5
SILICOSIS (HOMBRES)
DisMod II input and output, database OA
Males, Disease: neumoconiosis (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0
0,0116
0,16
0,194
0,19
NA
Prevalence
(rates *
1000)
0
0
0
2,7034
26,1003
45
45
9,6247
Remission
(rates *
1000)
0
0
0
0
0
0
0
RR Mortality Incidence
(rates *
(rates *
1000)
1000)
0
0
0
0
0
0
1,92
0,0116
2
0,1408
2
0,1951
2
0,1893
NA
NA
0,0459
Prevalence
(rates *
1000)
0
0
0
0,0873
0,9183
3,4476
3,8897
0,5308
Remission
(rates *
1000)
0
0
0
0
0
0
0
0
Case fatality
Duration
(rates *
(years)
1000)
0
0
0
0
0
0
2,1392
32,7724
7,2106
18,4217
23,3952
10,7055
68,5518
5,1262
25,376
Mortality
(rates *
1000)
0
0
0
0,0002
0,0066
0,0807
0,2666
16,055
0,0135
Mortality
(numbers)
0
0
0
1
8
49
50
59,4478
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0
0,0116
0,16
0,194
0,19
NA
Prevalence
(numbers)
0
0
0
8399
32729
27146
8397
76671
Remission
(rates *
1000)
0
0
0
0
0
0
0
NA
RR Mortality
Incidence
(rates *
(numbers)
1000)
0
0
0
0
0
0
1,92
36
2
177
2
118
2
35
NA
365
Prevalence
(numbers)
0
0
0
271
1152
2080
726
4228
Remission
(numbers)
0
0
0
0
0
0
0
0
107
16,055
107
59,4478
GRIIi 1
ULCERA PEPTICA
Males, Disease: ulcera pp (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
1,18
40,4
1700
0
1,1515
24,1694
1700
0,0061
6
40,4
1700
0
5,9768
3,8717
1700
0,0061
248,9
46,88
1700
0
219,1714
119,44
1700
0,0102
222,66
73,84
1700
0,003
196,8033
116,1265
1700
0,0281
52,82
78,1
1700
0,0215
51,0149
34,1744
1700
0,7921
1,12
70,7667
1700
0,0729
1,1177
2,0501
1700
26,1026
1,12
67,1
1700
0,2465
1,1194
0,5286
1700
426,6553
NA
63,5081
NA
Duration
(years)
0,5858
0,5879
0,588
0,5876
0,5855
0,5552
0,4577
Mortality
RR mortality
(rates * 1000)
(number)
0,0001
1,0007
0
1,026
0,0012
1,0198
0,0033
1,0164
0,027
1,1492
0,0522
6,0105
0,2253
9,8052
Age of onset
(years)
0,5
5,5027
14,9164
32,5085
52,556
67,5193
93,5976
0,0159
126,6435
74,0519
1700
0,204
0,5875
0,015
5,4678
28,0941
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
1,18
6
248,9
222,66
52,82
1,12
1,12
Prevalence
(numbers)
5069
48729
69564
229404
97935
42690
12521
Remission
(rates * 1000)
1700
1700
1700
1700
1700
1700
1700
Mortality
(numbers)
0
0
0
9
27
44
46
Incidence
(numbers)
144
7209
325225
611424
63971
674
209
Prevalence
(numbers)
3033
4670
177235
360779
42853
1237
99
Remission
(numbers)
5155
7939
301300
613325
72851
2102
168
Case fatality
(numbers)
0
0
2
10
34
32
42
Duration
(years)
0,5858
0,5879
0,588
0,5876
0,5855
0,5552
0,4577
Mortality
(numbers)
0
0
2
10
34
32
42
RR mortality
(number)
1,0007
1,026
1,0198
1,0164
1,1492
6,0105
9,8052
Age of onset
(years)
0,5
5,5027
14,9164
32,5085
52,556
67,5193
93,5976
NA
505912
NA
126
1008856
589906
1002839
120
0,5875
119
5,4678
28,0941
GRIIi 2
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
1,18
40,4
1700
0
1,1515
24,1694
1700
0,0061
6
40,4
1700
0
5,9768
3,8717
1700
0,0061
248,9
46,88
1700
0
219,1713
119,4402
1700
0,006
222,66
73,84
1700
0,0007
196,803
116,1276
1700
0,0062
52,82
78
1700
0,0046
51,0144
34,1838
1700
0,2246
1,12
70,7333
1700
0,028
1,1177
2,0683
1700
9,9839
1,12
67,1
1700
0,1852
1,1194
0,5639
1700
292,6004
NA
63,9408
NA
Duration
(years)
0,5862
0,5879
0,5881
0,588
0,5868
0,5737
0,4931
Mortality
RR mortality
(rates * 1000)
(number)
0,0001
1,0009
0
1,0358
0,0007
1,0346
0,0007
1,0087
0,0077
1,0876
0,0202
4,5765
0,1649
11,686
Age of onset
(years)
0,5
5,5027
14,9164
32,5085
52,5559
67,5192
96,5133
0,0103
122,6233
71,7854
1700
0,1337
0,5879
0,0095
8,5417
28,318
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
1,18
6
248,9
222,66
52,82
1,12
1,12
Prevalence
(numbers)
4882
46996
67261
227875
101770
50593
20286
Remission
(rates * 1000)
1700
1700
1700
1700
1700
1700
1700
Mortality
(numbers)
0
0
0
2
6
20
56
Incidence
(numbers)
139
6953
314454
607347
66561
799
338
Prevalence
(numbers)
2921
4504
171366
358378
44601
1479
170
Remission
(numbers)
4965
7656
291322
609242
75822
2515
290
Case fatality
(numbers)
0
0
1
2
10
15
50
Duration
(years)
0,5862
0,5879
0,5881
0,588
0,5868
0,5737
0,4931
Mortality
(numbers)
0
0
1
2
10
14
50
RR mortality
(number)
1,0009
1,0358
1,0346
1,0087
1,0876
4,5765
11,686
Age of onset
(years)
0,5
5,5027
14,9164
32,5085
52,5559
67,5192
96,5133
NA
519664
NA
84
996592
583419
991813
78
0,5879
78
8,5417
28,318
GRIIi 3
CIRROSIS
DisMod II input and output, database Parlisis cerebral
Males, Disease: CIRROSISHEPATICA (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0,0003
2,1116
5,1636
5,1888
5,7048
Prevalence
(rates *
1000)
0
0
0,05
26,7834
18,705
18,705
18,705
Remission
(rates *
1000)
0
0
0
0
0
0
0
Mortality
(rates *
1000)
0
0
0
0,0406
0,2695
0,5889
0,4448
RR Mortality
(rates *
1000)
0
5
5
5
10
10
5
Incidence
(rates *
1000)
0
0
0,0003
2,0598
4,8228
4,9444
5,5205
Prevalence
(rates *
1000)
0
0
0,0015
24,5177
65,9927
47,1008
32,3146
NA
15,2538
NA
0,1133
NA
2,0663
24,274
56,4544
Duration
(years)
0
0
38,3485
24,2623
9,522
5,5423
3,8006
Mortality
(rates *
1000)
0
0
0
0,1985
3,6548
7,5269
6,2824
14,1743
1,3699
50,7552
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0
0
0,0003
2,1116
5,1636
5,1888
5,7048
Prevalence
(numbers)
0
0
74
83210
23455
11284
3490
Remission
(rates *
1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
126
338
355
83
NA
121514
NA
902
RR Mortality
Incidence
(rates *
(numbers)
1000)
0
0
5
0
5
0
5
6399
10
6048
10
2983
5
1030
NA
16460
Prevalence
(numbers)
0
0
2
76171
82753
28413
6030
193369
10917
Duration
(years)
0
0
38,3485
24,2623
9,522
5,5423
3,8006
14,1743
8,5505
50,7552
GRIIi 4
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates *
1000)
0
0
0,0003
0,5758
1,3625
1,4136
1,5729
Prevalence
(rates *
1000)
0
0
0,05
7,758
2,37
2,37
2,37
Remission
(rates *
1000)
0
0
0
0
0
0
0
Mortality
(rates *
1000)
0
0
0
0,0055
0,0537
0,0881
0,0034
RR Mortality
(rates *
1000)
0
5
5
5
10
10
5
Incidence
(rates *
1000)
0
0
0,0003
0,5718
1,3342
1,3847
1,5472
Prevalence
(rates *
1000)
0
0
0,0015
6,9997
20,7583
20,4154
16,3198
NA
3,6319
NA
0,0186
NA
0,6108
8,3945
All ages
41,2735
Duration
(years)
0
0
46,0106
30,1816
13,7671
9,2062
6,134
Mortality
(rates *
1000)
0
0
0
0,0243
0,6489
1,8773
1,823
17,9754
0,3464
54,583
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates *
1000)
0
0
0,0003
0,5758
1,3625
1,4136
1,5729
Prevalence
(numbers)
0
0
72
23942
3092
1695
717
Remission
(rates *
1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
17
70
63
1
NA
29517
NA
151
All ages
Datos duros
Discapacidad
RR Mortality
Incidence
(rates *
(numbers)
1000)
0
0
5
0
5
0
5
1765
10
1741
10
990
5
468
NA
4964
Prevalence
(numbers)
0
0
2
21602
27084
14602
4934
68224
2816
Duration
(years)
0
0
46,0106
30,1816
13,7671
9,2062
6,134
17,9754
8,2865
54,583
GRIIi 5
APENDICITIS
Males, Disease: apendicitis (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,3347
3,701
5,3468
2,4479
1,2002
0,8554
0,8253
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
40000
0
0,3347
40000
0,0025
3,7007
40000
0,0007
5,3461
40000
0,001
2,4477
40000
0,0008
1,2002
40000
0,0149
0,8553
40000
0,0482
0,8253
NA
0,0033
Prevalence
(rates * 1000)
0,0042
0,0878
0,1316
0,0626
0,031
0,0213
0,0196
Remission
(rates * 1000)
40000
40000
40000
40000
40000
40000
40000
Case fatality
(rates * 1000)
0,1253
2,7193
5,7576
14,292
60,9642
678,838
2096,659
Duration
(years)
0,025
0,025
0,025
0,025
0,025
0,0246
0,0238
Mortality (rates
* 1000)
0
0,0002
0,0008
0,0009
0,0019
0,0144
0,0411
RR mortality
(number)
2,3546
3288,7409
1822,609
802,1206
1299,2573
3523,225
4126,8787
Age of onset
(years)
0,5
5,5
15
32,5
52,5
67,5
102,8513
2,7891
0,0693
40000
41,6457
0,025
0,0029
3082,6397
24,0428
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,3347
3,701
5,3468
2,4479
1,2002
0,8554
0,8253
Remission
(rates * 1000)
40000
40000
40000
40000
40000
40000
40000
Mortality
(numbers)
0
3
1
3
1
9
9
Incidence
(numbers)
42
4464
7933
7605
1505
516
154
Prevalence
(numbers)
1
106
195
195
39
13
4
Remission
(numbers)
21
4238
7810
7782
1555
514
147
Case fatality
(numbers)
0
0
1
3
2
9
8
Duration
(years)
0,025
0,025
0,025
0,025
0,025
0,0246
0,0238
Mortality
(numbers)
0
0
1
3
2
9
8
RR mortality
(number)
2,3546
3288,7409
1822,609
802,1206
1299,2573
3523,225
4126,8787
Age of onset
(years)
0,5
5,5
15
32,5
52,5
67,5
102,8513
NA
NA
26
22218
552
22066
23
0,025
23
3082,6397
24,0428
GRIIi 6
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates)
0,0002
0,0028
0,0046
0,0021
0,0012
0,0007
0,0005
Remission
(rates)
40
40
40
40
40
40
40
Mortality
(numbers)
0
0
0
3
2
6
3
Incidence
(numbers)
21
3228
6598
6512
1621
518
145
Prevalence
(numbers)
0
76
162
167
41
13
4
Remission
(numbers)
10
3060
6467
6663
1656
525
144
Case fatality
(numbers)
0
0
0
3
3
6
3
Duration
(years)
0,025
0,025
0,025
0,025
0,025
0,0247
0,0245
Mortality
(numbers)
0
0
0
3
3
6
3
RR mortality
(number)
1,2028
8,1035
73,2299
2280,3873
1939,6972
4073,0506
2883,2194
Age of onset
(years)
0,5
5,5
15
32,5
52,5
67,5
102,917
NA
NA
14
18643
463
18525
14
0,025
14
3083,0479
25,5431
Prevalence
(rates * 1000)
0,0022
0,0658
0,1127
0,054
0,0317
0,0183
0,0119
Remission
(rates * 1000)
40000
40000
40000
40000
40000
40000
40000
Case fatality
(rates * 1000)
0,0146
0,0131
0,0541
15,2888
65,0646
444,3746
802,207
Duration
(years)
0,025
0,025
0,025
0,025
0,025
0,0247
0,0245
Mortality (rates
* 1000)
0
0
0
0,0008
0,002
0,008
0,0095
RR mortality
(number)
1,2028
8,1035
73,2299
2280,3873
1939,6972
4073,0506
2883,2194
Age of onset
(years)
0,5
5,5
15
32,5
52,5
67,5
102,917
0,057
40000
30,1402
0,025
0,0017
3083,0479
25,5431
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,1738
2,7749
4,5994
2,1101
1,2424
0,7242
0,4796
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
40000
0
0,1738
40000
0
2,7747
40000
0
4,5989
40000
0,001
2,11
40000
0,0015
1,2423
40000
0,0084
0,7242
40000
0,0099
0,4796
NA
0,0017
2,2938
GRIIi 7
HERNIAS
Males, Disease: Hernias (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
8,3136
1,2933
0,3607
1,0779
2,669
6,2797
7,7326
NA
0,0041
Prevalence
(rates * 1000)
0,4614
0,1623
0,1427
1,6802
4,8322
20,691
42,9497
Remission
(rates * 1000)
9000
11000
2500
600
500
230
150
Case fatality
(rates * 1000)
0
0
0
0,0253
0,196
0,5321
2,7373
Duration
(years)
0,1088
0,094
0,4504
1,6831
2,243
4,341
4,7001
Age of onset
(years)
0,5
5,5004
15
32,4976
52,4948
67,4559
93,4959
1,8707
4,0473
416,806
0,9274
2,4288
0,0038
1,0483
46,7397
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
8,3136
1,2933
0,3607
1,0779
2,669
6,2797
7,7326
Remission
(rates * 1000)
9000
11000
2500
600
500
230
150
Mortality
(numbers)
0
0
0
0
1
7
25
Incidence
(numbers)
1043
1560
535
3343
3331
3710
1381
Prevalence
(numbers)
58
196
212
5220
6059
12482
8015
Remission
(numbers)
521
2153
529
3132
3030
2871
1202
Case fatality
(numbers)
0
0
0
0
1
7
22
Duration
(years)
0,1088
0,094
0,4504
1,6831
2,243
4,341
4,7001
Mortality
(numbers)
0
0
0
0
1
7
22
RR mortality
(number)
0
1
1
1,0488
1,0333
1,0272
1,0555
Age of onset
(years)
0,5
5,5004
15
32,4976
52,4948
67,4559
93,4959
NA
NA
33
14902
32241
13438
30
2,4288
30
1,0483
46,7397
GRIIi 8
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates * 1000)
3,8411
0,856
0,1704
0,2751
0,7158
1,1167
1,3468
All ages
NA
0,0015
Prevalence
(rates * 1000)
0,2133
0,0972
0,0687
0,4315
1,2975
3,8645
7,7265
Remission
(rates * 1000)
9000
11000
2500
600
500
230
150
Case fatality
(rates * 1000)
0
0
0
0
0,0813
1,0546
3,4287
Duration
(years)
0,1088
0,094
0,4505
1,6865
2,2739
4,5685
5,2963
Age of onset
(years)
0,5
5,5002
15
32,4994
52,4986
67,4931
96,4941
0,5765
1,0289
520,6522
1,3229
2,045
0,0014
1,1146
40,6375
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates * 1000)
3,8411
0,856
0,1704
0,2751
0,7158
1,1167
1,3468
Remission
(rates * 1000)
9000
11000
2500
600
500
230
150
Mortality
(numbers)
0
0
0
0
0
3
9
Incidence
(numbers)
464
996
245
848
933
796
404
Prevalence
(numbers)
26
113
99
1332
1693
2764
2336
Remission
(numbers)
232
1244
247
799
846
636
350
Case fatality
(numbers)
0
0
0
0
0
3
8
Duration
(years)
0,1088
0,094
0,4505
1,6865
2,2739
4,5685
5,2963
Mortality
(numbers)
0
0
0
0
0
3
8
RR mortality
(number)
0
0
0
1
1,0486
1,0947
1,123
Age of onset
(years)
0,5
5,5002
15
32,4994
52,4986
67,4931
96,4941
NA
NA
12
4685
8362
4354
11
2,045
11
1,1146
40,6375
All ages
Discapacidad:
Datos duros:
0,05
GRIIi 9
COLELITIASIS
Males, Disease: Colelitiasis (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60,987
6,3
1000
0
57,8451
51,5179
1000
1,0137
132,57
90,128
1000
0,0019
117,3609
114,7251
1000
0,0269
102,214
200,1
1000
0,0032
92,5702
94,3494
1000
0,035
44,25
228,7
60
0,0216
32,8993
256,5121
60
0,0845
39,8
228,7
10
0,1768
17,9335
549,4093
10
0,2857
NA
90,4975
NA
Duration
(years)
0
0
0,9984
0,9981
1,8322
14,8168
13,0801
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0
0
0
0
0,0533
8,1546
14,9499
0,0031
1,0397
32,4386
0,0033
1,0057
52,5231
0,0217
1,0043
66,6493
0,157
1,0059
88,6965
0,007
74,0289
101,4855
694,5345
0,1652
1,696
0,017
Mortality
(numbers)
0
0
0
6
4
13
33
Incidence
(numbers)
0
0
85835
364614
116080
19846
3346
Prevalence
(numbers)
0
0
76447
356425
118311
154741
102521
Remission
(numbers)
0
0
76447
356425
118311
9284
1025
Case fatality
(numbers)
0
0
77
10
4
13
29
Duration
(years)
0
0
0,9984
0,9981
1,8322
14,8168
13,0801
Mortality
(numbers)
0
0
79
10
4
13
29
56
589722
808444
561492
134
1,696
135
5,1863
34,9111
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
(rates * 1000) (numbers) (rates * 1000)
0
0
0
0
0
0
60,987
9348
1000
132,57
280008
1000
102,214
250918
1000
44,25
137963
60
39,8
42676
10
NA
720913
NA
34,9111
GRIIi 10
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
136,61
39,6
1000
0
121,796
108,4403
1000
0,6777
296,96
252,632
500
0,0016
190,2678
359,2815
500
0,0047
228,96
560,6
600
0,0046
163,8459
284,3908
600
0,0165
99,11
640,6
90
0,0266
55,3503
441,5262
90
0,0597
89,15
640,6
20
0,1621
25,4539
714,4818
20
0,2024
All ages
NA
273,1255
NA
Duration
(years)
0
0
1,0965
1,9712
2,7957
14,6606
16,6972
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0
0
0
0
0,0757
14,8531
14,8918
0,0017
1,0064
31,9981
0,0047
1,0048
52,6389
0,0264
1,0054
66,5549
0,1447
1,0073
89,7609
0,0097
125,8711
266,6605
445,4298
0,0827
2,596
0,0225
Mortality
(numbers)
0
0
0
5
6
19
49
Incidence
(numbers)
0
0
184421
610097
223226
40835
7736
Prevalence
(numbers)
0
0
164185
1152442
387140
327509
220661
Remission
(numbers)
0
0
164185
576221
232284
29476
4413
Case fatality
(numbers)
0
0
112
5
6
19
44
Duration
(years)
0
0
1,0964
1,9713
2,7952
14,6529
16,7127
Mortality
(numbers)
0
0
115
5
6
19
44
79
1066316
2251937
1006579
186
2,585
189
9,2467
34,0173
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
Prevalence
Remission
(rates * 1000) (numbers) (rates * 1000)
0
0
0
0
0
0
145,15
56816
1000
315,52
779639
500
243,27
731441
600
105,31
458201
90
94,73
193667
20
All ages
NA
2219764
NA
Datos duros:
Estudios de prevalencia de Miquel y Roa (estructura y tasa global)
Duracin expertos
Discapacidad
0,04
33,884
GRIIi 11
COLECISTITIS
Males, Disease: Colecis aguda (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0,0066
20000
0
0,0066
0,0003
20000
0
0,0249
20000
0
0,0249
0,0012
20000
38,1268
0,3446
20000
0,0032
0,3446
0,0168
20000
172,7936
1,0258
20000
0,0032
1,0258
0,05
20000
73,5279
1,6917
15000
0,0199
1,6915
0,1094
15000
179,9566
2,1178
15000
0,1501
2,1175
0,1319
15000
1012,1752
NA
NA
0,0068
Duration
(years)
0
0,05
0,0499
0,0496
0,0499
0,0658
0,0623
Age of onset
(years)
0
5,5
15
32,5
52,5
67,5
93,5972
0,4792
0,0261
17816,4586
243,1611
0,0553
0,0064
32,7951
56,0195
Mortality
(numbers)
0
0
0
10
4
12
28
Incidence
(numbers)
0
8
37
1071
1286
1020
395
Prevalence
(numbers)
0
0
2
52
63
66
25
Remission
(numbers)
0
8
36
1042
1253
990
369
Case fatality
(numbers)
0
0
0
9
5
12
25
Duration
(years)
0
0,05
0,0499
0,0496
0,0499
0,0658
0,0623
Mortality
(numbers)
0
0
0
9
5
12
25
RR mortality
(number)
0
1
79,1643
100,9659
15,4424
10,4504
21,7579
Age of onset
(years)
0
5,5
15
32,5
52,5
67,5
93,5972
54
3817
208
3697
50
0,0553
51
32,7951
56,0195
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0,0066
20000
0,0249
20000
0,3446
20000
1,0258
20000
1,6917
15000
2,1178
15000
NA
NA
GRIIi 12
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
0
0
0
0
0
0,0129
20000
0
0,0129
0,0006
20000
0
0,1387
20000
0
0,1387
0,0066
20000
3,5957
1,1294
20000
0,001
1,1294
0,0554
20000
17,4121
1,8812
20000
0,0031
1,881
0,0926
20000
34,7799
1,9292
15000
0,0154
1,929
0,1265
15000
119,6616
1,6155
15000
0,0628
1,6154
0,1044
15000
540,0346
NA
NA
0,0046
Duration
(years)
0
0,05
0,05
0,05
0,05
0,0661
0,0642
Age of onset
(years)
0
5,5
15
32,5
52,5
67,5
96,513
0,987
0,0522
18561,625
82,7163
0,0536
0,0043
17,2294
49,5911
Mortality
(numbers)
0
0
0
3
4
11
19
Incidence
(numbers)
0
15
199
3485
2454
1380
488
Prevalence
(numbers)
0
1
9
171
121
90
32
Remission
(numbers)
0
14
190
3421
2418
1357
473
Case fatality
(numbers)
0
0
0
3
4
11
17
Duration
(years)
0
0,05
0,05
0,05
0,05
0,0661
0,0642
Mortality
(numbers)
0
0
0
3
4
11
17
RR mortality
(number)
0
0
18,615
24,8017
11,4059
12,1496
20,5816
Age of onset
(years)
0
5,5
15
32,5
52,5
67,5
96,513
37
8022
424
7873
35
0,0536
35
17,2294
49,5911
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0
0
0,0129
20000
0,1387
20000
1,1294
20000
1,8812
20000
1,9292
15000
1,6155
15000
NA
NA
Datos duros:
Egresos hospitalarios que se consideran incidentes (por ser ag
Duracin por expertos
Peso discapacidad:
0,349
(Victoria)
(e
GRIIK 1
PSORIASIS
DisMod II input and output, database Piel v2
Males, Disease: Psoriasis 1 (Rates * 1000), sex: Males
Age
0
1a9
10 a 19
20-44
45-59
60-74
75+
All ages
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
3,5
0
0
0,0061
3,503
0,0061
0,0061
3,5
0
0
0,1437
3,8482
0,0061
0,0061
10
0
0
0,7867
8,4326
0,0061
0,0061
17,7891
0
0
0,3559
17,2818
0,0061
0,0171
22,6832
0
0,002
0,1381
22,6014
0,0061
0,0828
21,2125
0
0
0,0067
23,2597
0,0062
0,0158
12,8857
0
0
0,0059
23,3307
0,0062
0,0062
14,8644
NA
0,0003
Duration
(years)
74,1991
67,504
60,1337
44,7439
28,8539
15,3819
8,0318
Mortality
(rates * 1000)
0
0
0,0001
0,0003
0,0019
0,0004
0,0001
RR mortality
(number)
1,0007
1,0261
1,0156
1,0153
1,0173
1,0021
1,0001
Age of onset
(years)
0,5
7,7019
15,206
31,5226
48,9353
65,9265
82,0075
0,3296
14,8141
0,0062
0,0307
51,9359
0,0005
1,0158
23,911
Age
0
1a9
10 a 19
20-44
45-59
60-74
75+
Prevalence
(numbers)
439
4222
14839
55267
28444
12796
2404
Remission
(rates * 1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
3
0
0
Incidence
(numbers)
1
173
1167
1106
173
4
1
Prevalence
(numbers)
440
4642
12513
53691
28341
14031
4354
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
1
2
0
0
Duration
(years)
74,1991
67,504
60,1337
44,7439
28,8539
15,3819
8,0318
Mortality
(numbers)
0
0
0
1
2
0
0
RR mortality
(number)
1,0007
1,0261
1,0156
1,0153
1,0173
1,0021
1,0001
Age of onset
(years)
0,5
7,7019
15,206
31,5226
48,9353
65,9265
82,0075
All ages
118411
NA
2625
118011
51,9359
1,0158
23,911
GRIIK 2
Age
0
1a9
10 a 19
20-44
45-59
60-74
75+
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
4
0
0
0,0061
4,003
0,0061
0,0061
4
0
0
0,1612
4,3926
0,0061
0,0061
11
0
0
0,8022
9,2682
0,0061
0,0061
16,6565
0
0
0,207
16,2879
0,0061
0,0061
20,3274
0
0
0,2497
20,45
0,0061
0,0079
18,563
0
0,001
0,0468
22,4781
0,009
0,0419
7,1661
0
0,003
0,0058
22,7169
0,0122
0,1102
All ages
14,0623
NA
0,0002
Duration
(years)
80,2917
73,5399
66,2483
50,8344
32,0358
20,076
9,8816
Mortality
(rates * 1000)
0
0
0,0001
0,0001
0,0002
0,0009
0,0025
RR mortality
(number)
1,0009
1,0371
1,0269
1,011
1,0027
1,0034
1,0017
Age of onset
(years)
0,5
7,6873
15,072
30,8452
50,5663
64,3419
83,7293
0,2878
14,6155
0,0069
0,0174
57,0957
0,0003
1,0052
24,489
Age
0
1a9
10 a 19
20-44
45-59
60-74
75+
Prevalence
(numbers)
483
4653
15782
51403
26522
13278
2166
Remission
(rates * 1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
1
1
Incidence
(numbers)
1
188
1151
639
326
33
2
Prevalence
(numbers)
484
5110
13298
50266
26682
16078
6868
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
1
1
Duration
(years)
80,2917
73,5399
66,2483
50,8344
32,0358
20,076
9,8816
Mortality
(numbers)
0
0
0
0
0
1
1
RR mortality
(number)
1,0009
1,0371
1,0269
1,011
1,0027
1,0034
1,0017
Age of onset
(years)
0,5
7,6873
15,072
30,8452
50,5663
64,3419
83,7293
All ages
114288
NA
2339
118784
57,0957
1,0052
24,489
Discapacidad
0,056
GRIIL 1
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
rate
(*100.000)
0
0
0
6,48
44,27
70,93
101,9
NA
INPUT
rate
Mortality rate
(*100.000)
(*100.000) RR Mortality
1
0
0
1
0
0
1
0
0
2,26
0
0
2,26
0
0,8
2,26
0
0,66
2,26
0
3,75
NA
NA
0,2636
rate
(*100.000)
0
0
0,62
6,27
33,85
67,41
97,19
rate
(%)
0
0
0
0,06
0,35
1,08
2,05
15,27
0,2
rate
(*100.000)
0
0
2,07
22,95
82,31
111,15
110,16
rate
0
0
0
0,2
1,08
2,52
3,71
36,17
0,61
rate
(*100.000)
0
0
0
24,4
96,37
112,9
109,8
NA
rate
Mortality rate
(*100.000)
(*100.000) RR Mortality
1
0
0
1
0
0
1
0
0
2,26
0
0,16
2,26
0
1
2,26
0
7,55
2,26
0
21,5
NA
NA
NA
HOMBRES
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
OUTPUT
y
rate
rate
Duration
(*100.000) (*100.000)
(years)
0
0
0
0
0
0
0
17,46
54,6
0,01
250,63
38,24
0,03
227,93
24,81
0,02
68,21
14,43
0
138,69
7,9
0,02
146,22
21,19
OUTPUT
y
rate
rate
Duration
(*100.000) (*100.000)
(years)
0
0
0
0
0
0
0
7,89
61,33
0,02
58,08
43,38
0,03
93,78
28,94
0,02
293,01
17,45
0
501,14
9,43
0,02
253,23
27,43
Mortality rate
Age of onset
(*100.000) RR mortality
(years)
0
0
0
0
0
7,51
0
1,2
17,95
0,14
2,23
36,57
0,79
1,55
53,09
0,74
1,04
67,11
2,85
1,01
82,24
0,3
1,46
59,37
Mortality rate
Age of onset
(*100.000) RR mortality
(years)
0
0
0
0
0
7,51
0
1,28
17,95
0,12
1,95
36,91
1,02
1,28
52,6
7,38
1,24
66,7
18,61
1,08
83,67
1,55
1,19
56,01
MUJERES
CASOS
Incidence
Prevalence
Remission
Letalidad
0
0
9
194
423
402
178
0
0
18
1.784
4.339
6.532
3.832
0
0
0
0
0
0
0
0
0
0
4
10
4
5
Muertes
0
0
0
4
10
4
5
1.206
16.506
24
24
CASOS
Incidence
Prevalence Remission
Letalidad
Edad
0
0
0
0
<1 ao
0
0
0
0
01-Sep
29
59
0
0
Oct-19
706
6.308
0
4
20-44
1062
14.133
0
13
45-59
775
18.024
0
53
60-74
321
11.229
0
56
75+
All ages
2.893
49.753
126
Muertes
0
0
0
4
13
53
56
126
NA
NA
GRIIL 2
OUTPUT
Incidence
(rates *
100.000)
Case fatality
(rates *
100.000)
0
0
0
0
0
0
0
Prevalence
(rates *
100.000)
Remission
(rates *
100.000)
Case fatality
(rates *
100.000)
Duration
(years)
Mortality
(rates *
100.000)
RR mortality
(number)
Age of onset
(years)
0
0
0
1,6
32,7
331,4
509,4
0
0
0
16,1
193,1
2.380,00
7.844,10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,7995
28,319
17,0575
10,0102
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,0196
54,6885
68,238
82,8749
54
538,4
16,0156
71,8229
NA
HOMBRES
INPUT
Incidence
(rates *
100.000)
Edad
0
Menos 1 ao
0
1-9
0
10-19
7,4
20-44
25
45-59
253,7
60-74
414,8
75+
All ages
NA
Remission
(rates *
100.000)
0
0
0
0
0
0
0
Case fatality
(rates *
100.000)
0
0
0
0
0
0
0
NA
NA
HOMBRES
Incidence
Prevalence
Edad
0
0
Menos 1 ao
0
0
1-9
0
0
10-19
228
1.303
20-44
306
4.270
45-59
1.347
10.408
60-74
636
10.860
75+
All ages
2.517
26.841
CASOS
Remission
0
0
0
0
0
0
0
0
OUTPUT
Incidence
(rates *
100.000)
0
0
0
7,3
24,5
228,2
361,5
32,5
Letalidad
Prevalence
(rates *
100.000)
0
0
0
41,9
340,5
1.725,30
5.820,00
Remission
(rates *
100.000)
0
0
0
0
0
0
0
Case fatality
(rates *
100.000)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
37,6718
26,1839
13,8251
8,1851
Mortality
(rates *
100.000)
0
0
0
0
0
0
0
336,9
15,9241
Muertes
MUJERES
Incidence
Prevalence
Edad
Menos 1 ao
0
0
1-9
0
0
10-19
0
0
20-44
50
497
45-59
425
2.520
60-74
2.302
17.023
75+
1.421
23.714
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0 All ages
4.198
43.754
CASOS
Remission
0
0
0
0
0
0
0
0
RR mortality
(number)
Age of onset
(years)
0
0
0
0
0
0
0
0
0
0
39,2072
52,0823
68,2206
80,7695
66,9799
Letalidad
Muertes
0
0
0
0
0
0
0
0
0
0
0
0
0
0
GRIIL 3
ARTROSIS DE RODILLA
MUJERES %
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 100)
0
0
0
0,03
0,22
0,8
1,08
INPUT
Remission
(rates * 100)
0
0
0
0
0
0
0
Case fatality
(rates * 100)
0
0
0
0
0
0
0
Incidence
(rates * 100)
0
0
0
0,03
0,21
0,77
1,07
Prevalence
(rates * 100)
0
0
0
0,14
1,99
8,4
18,45
Remission
(rates * 100)
0
0
0
0
0
0
0
NA
NA
NA
0,15
1,8
20,19
HOMBRES %
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
HOMBRES
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
OUTPUT
Case fatality
Duration
(rates * 100)
(years)
0
0
0
0
0
0
0
41,46
0
29,81
0
17,63
0
9,91
Incidence
(rates * 100)
0
0
0
0,04
0,21
0,6
0,8
Remission
(rates * 100)
0
0
0
0
0
0
0
Case fatality
(rates * 100)
0
0
0
0
0
0
0
Incidence
(rates * 100)
0
0
0
0,04
0,2
0,57
0,74
Prevalence
(rates * 100)
0
0
0
0,25
2,17
7,17
15,03
Remission
(rates * 100)
0
0
0
0
0
0
0
Case fatality
(rates * 100)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
38,06
25,57
14,44
8,12
NA
NA
NA
0,11
1,34
20,16
0
0
0
1.281
2.393
3.192
1.172
0
0
0
7.845
27.196
43.268
28.054
CASOS
Remission
0
0
0
0
0
0
0
8.038
106.364
Prevalence
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0
0
0
40,56
53,02
67,4
83,52
65,92
OUTPUT
INPUT
Incidence
Mortality
(rates * 100)
0
0
0
0
0
0
0
Letalidad
Muertes
MUJERES
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0 All ages
Mortality
RR mortality
(rates * 100) (number)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
968
2.697
5.025
2.630
0
0
0
42.62
25.997
60.057
55.765
CASOS
Remission
0
0
0
0
0
0
0
11.320
146.080
Incidence
Prevalence
Age of onset
(years)
0
0
0
38,79
52,76
67,22
81,23
60,6
Letalidad
Muertes
0
0
0
0
0
0
0
0
0
0
0
0
0
0
GRIIL 4
LUPUS FINAL
LUPUS MUJERES (tasas por 100.000)
INPUT
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
rates
1,8
1,83
3,05
3,6
3,57
2,73
1,86
NA
NA
OUTPUT
Mortality
Rates
0
0
0,21
1
1,76
2,1
4,3
1,0441
Incidence
RR mortality
rates
6,4
1,8248
6,4
1,9451
6,4
2,9227
5,64
3,6344
2,6
3,5848
1
2,7577
1
1,9567
NA
3,0925
Prevalence
rates
0,9118
10,4649
32,4796
89,7075
149,0559
179,3794
189,3907
88,07
Duration
(years)
70,2673
65,8073
57,0657
42,3806
27,1467
16,692
9,0798
552,364
41,542
Mortality
rates
0,0012
0,0114
0,0494
0,3404
0,9746
1,3459
1,9338
RR mortality
(number)
1,1892
8,2009
7,3832
6,7925
3,1567
1,6178
1,1779
Age of
onset
(years)
0,5
5,758
15,2931
32,5944
51,6557
66,3464
83,4024
0,4865
3,548
34,5375
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
rates
0,25
0,26
0,38
0,51
0,49
0,37
0,26
NA
NA
OUTPUT
Mortality
Rates
0
0,08
0,07
0,13
0,32
0,17
0
0,1391
Incidence
RR mortality
rates
6,4
0,2767
6,4
0,2907
6,4
0,3907
5,64
0,5137
2,6
0,504
1
0,3887
1
0,2764
NA
0,4367
Prevalence
rates
0,1382
1,5767
4,6356
11,8727
19,3006
23,2119
25,0821
11,1182
794,4572
Duration
(years)
60,4138
56,0507
47,586
35,9152
23,2594
14,0653
7,5816
35,9415
Mortality RR mortality
rates
(number)
0,0002
1,1771
0,0024
7,8837
0,0154
7,3087
0,0981
6,0503
0,1789
2,7303
0,1803
1,4098
0,2151
1,1029
0,0883
4,0403
Age of
onset
(years)
0,5
5,7202
15,2468
32,5275
51,5631
66,0901
81,7211
33,1225
GRIIL 5
NMEROS ABSOLUTOS
MUJERES
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidencia Prevalencia
2
1
23
122
42
466
112
2768
47
1945
20
1283
6
573
251
7158
Remisin
Letalidad
Muertes
0
0
0
0
0
0
0
0
0
1
11
13
10
6
0
0
1
11
13
10
6
40
40
HOMBRES
Incidence Remission Case fatality
Edad
rates
rates
rates
Menos 1 ao
0
0
0
1-9
4
19
0
10-19
6
69
0
20-44
16
369
0
45-59
6
242
0
60-74
2
140
0
75+
1
47
0
All ages
El nico cambio realizado fue fijar la remisin para asegurarnos que diese 0, en el modelo anterior daba
una remisin bajsima de 0,0021*100,000 en hombres y de 0,01 en mujeres.
Este cambio altera marginalmente los resultados (da un muerto ms y 14 casos ms prevalentes)
35
886
Mortality
Rates
0
0
0
3
2
1
0
RR mortality
0
0
0
3
2
1
0
GRIIL 6
ESCOLIOSIS FINAL
MUJERES
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
HOMBRES
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
INPUT
Incidence
(rates * 100)
0
OUTPUT
Remission
(rates * 100)
Case fatality
(rates * 100)
Incidence
(rates * 100)
Prevalence
(rates * 100)
Remission
(rates * 100)
Case fatality
(rates * 100)
Duration
(years)
Mortality
RR mortality
(rates * 100) (number)
Age of onset
(years)
0
1
2,7005
0,005
0,005
0,005
0,005
29
29
29
29
29
29
29
NA
NA
0
0
0
0
0
0
0
NA
INPUT
0
0,9779
2,5153
0,0049
0,005
0,005
0,005
0
2,2074
6,8569
1,1963
0,0188
0,02
0,02
0
29
29
29
29
29
29
0
0
0
0
0
0
0
0
3,4461
3,4448
3,4374
3,3948
3,2226
2,6419
0
0
0
0
0
0
0
0
1
0
0
0
0
0
5,5735
14,872
32,699
51,7436
66,7137
83,7035
0,5873
1,9859
29
3,4446
12,7541
OUTPUT
Incidence
(rates * 100)
0
Remission
(rates * 100)
29
Case fatality
(rates * 100)
0
Incidence
(rates * 100)
0
Prevalence
(rates * 100)
0
Remission
(rates * 100)
0
Case fatality
(rates * 100)
0
Duration
(years)
0
Mortality
RR mortality Age of onset
(rates * 100) (number)
(years)
0
0
0
0,4
0,5401
0,001
0,001
0,001
0,005
29
29
29
29
29
29
0
0
0
0
0
0
0,4
0,5401
0,001
0,001
0,001
0,005
0,8932
1,6443
0,264
0,0038
0,00
0,01
29
29
29
29
29
29
0
0
0
0
0
0
3,445
3,4392
3,4236
3,354
3,1006
2,4908
0
0
0
0
0
0
0
0
0
0
0
0
5,5973
14,9396
32,4309
51,6579
66,4413
82,0206
NA
NA
NA
0,1619
0,5456
29
3,4404
11,5702
GRIIL 7
HOMBRES
Edad
MUJERES
Incidence
Prevalence
0
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
CASOS
Remission
0
Letalidad
Muertes
0
Edad
0
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
4782
7883
31
13
6
9
10774
24400
8.201
48
21
22
3124
7076
2378
14
6
6
0
0
0
0
0
0
0
0
0
0
0
0
12.723
43.464
12605
0 All ages
Incidence
Prevalence
0
11376
36088
152
65
36
15
25678
98379
36.918
246
123
52
47.733
161.396
CASOS
Remission
0
Letalidad
Muertes
0
7447
28530
10706
71
36
15
0
0
0
0
0
0
0
0
0
0
0
0
46805
GRIIL 8
OSTEOPOROSIS FINAL
OUTPUT
Prevalence
(rates * 100)
0
0
Remission
(rates * 100)
0
0
Case fatality
(rates * 100)
0
0
Incidence
(rates * 100)
0
0
Prevalence
(rates * 100)
0
0
Remission
(rates * 100)
0
0
Case fatality
(rates * 100)
0
0
Duration
(years)
0
0
Mortality
(rates * 100)
0
0
RR mortality
(number)
0
0
Age of onset
(years)
0,5
5,6157
10-19
20-44
45-59
60-74
75+
0
0
9,4546
35
35
0
0
0
0
0
0
0
0
0
0
0
0
0,4456
2,9642
0,0003
0
0
0,6837
34,8914
47,0869
0
0
0
0
0
0
0
0
0
0
0
0
25,0044
20,3587
9,8987
0
0
0
0
0
0
0
0
0
0
14,9514
32,4838
58,4026
63,6344
83,7034
All ages
5,9001
NA
NA
0,3324
4,9321
21,1498
62,5094
Incidence
0
0
0
0
5813
21.202
1
Prevalence
0
0
0
0
8.921
249.567
142.354
CASOS
Remission
0
0
0
0
0
0
0
Letalidad
0
0
0
0
0
0
0
27.016
400.842
Edad
Menos 1 ao
1-9
MUJERES
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
Muertes
0
0
0
0
0
0
0
0
Se fij la remisin y la letalidad, por lo que el modelo es ms consistente con la historia natural y los cambios son marhinales con respecto a la entrega anterior
GRIIL 9
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
OUTPUT
Incidence
Remission Case fatality
Duration
Incidence
Prevalence
Remission Case fatality
(rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100)
0
80
0
0,8
0
0
0
0
0
80
0
0,8
0
0
0
0
0,0097
80
0
0,8
0,0097
0,0107
78,3285
0
1,653
80
0
0,8
1,6207
1,952
78,3298
0
2,1047
80
0
0,8
2,0509
2,5554
78,3303
0
1,2719
80
0
0,8
1,2501
1,7135
78,3295
0
0,218
80
0
0,8
0,217
0,4713
78,3286
0
NA
NA
NA
NA
1,0645
1,3217
78,3299
Duration
(years)
0
0
1,2763
1,2755
1,2709
1,2521
1,1569
1,2708
Mortality
RR mortality Age of onset
(rates * 100)
(number)
(years)
0
0
0
0
0
0
0
0
14,9512
0
0
32,4575
0
0
51,7366
0
0
66,7265
0
1
83,7272
0
42,3547
HOMBRES
INPUT
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
All ages
OUTPUT
Incidence
Remission Case fatality
Duration
Incidence
Prevalence
Remission Case fatality
(rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100) (rates * 100)
0
80
0
0,8
0
0
0
0
0
80
0
0,8
0
0
0
0
0,01
80
0
0,8
0,01
0,011
78,3286
0
1,8723
80
0
0,8
1,8311
2,2023
78,3302
0
2,3825
80
0
0,8
2,3138
2,8818
78,331
0
1,883
80
0
0,8
1,8374
2,4205
78,3305
0
1,0565
80
0
0,8
1,04
1,4989
78,3292
0
NA
NA
NA
NA
1,2437
1,533
78,3305
Duration
(years)
0
0
1,2757
1,2737
1,2662
1,2351
1,1278
1,2643
Mortality
RR mortality Age of onset
(rates * 100)
(number)
(years)
0
0
0
0
0
0
0
0
14,9474
0
0
32,3536
0
1
51,6501
0
0
66,449
0
0
82,0382
0
42,8013
GRIIL 10
HOMBRES
Edad
Menos 1 ao
1-9
10-19
20-44
45-59
60-74
75+
CASOS
Incidence
0
0
148
56887
29015
11084
1942
Prevalence
0
0
164
68420
36137
14602
2797
Remission
0
0
128
53594
28306
11438
2191
Letalidad
0
0
0
0
0
0
0
All ages
99076
122119
95657
Muertes
0
0
0
0
0
0
0
0
MUJERES
CASOS
Incidence
Edad
0
Menos 1 ao
0
1-9
139
10-19
50017
20-44
26759
45-59
8942
60-74
656
75+
All ages
86.513
Prevalence
0
0
154
60.240
33.342
12.256
1.425
Remission
0
0
120
47186
26117
9600
1116
Letalidad
0
0
0
0
0
0
0
107.416
84139
Se modific la incidencia para reducir los casos en edades tempranas. Tambin se redujo la duracin de la enfermedad, lo que disminuy la duracin-output.
sta igualmente supera la duracin que indican estudios internacionales, sin embargo, estos han sido realizados encontextos de tratamientos
intensivos ya sea conservadores o quirrgicos que son indicados en torno al 10% de los casos prevalentes.
Muertes
0
0
0
0
0
0
0
0
GRIIM 1
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
1,16
150
0,008
1,1594
0,5376
150
2,6171
0
150
0,002
0
0,5845
150
3,6182
0
150
0,002
0
0,1339
150
11,9713
0
150
0
0
0,0128
150
10,1796
0
150
0
0
0,0004
150
0
0
150
0
0
0
150
0
0
150
0
0
0
150
0
NA
NA
0,0008
Duration
(years)
6,3445
0
0
0
0
0
0
Mortality
(rates * 1000)
0,0014
0,0021
0,0016
0,0001
0
0
0
RR mortality
(number)
1,313
22,6779
38,9244
10,8869
0
1
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0183
0,127
150
5,4483
6,3445
0,0007
28,1154
0,5
Mortality
(numbers)
1
2
3
0
0
0
0
Incidence
(numbers)
145
0
0
0
0
0
0
Prevalence
(numbers)
67
705
199
40
1
0
0
Remission
(numbers)
10
106
30
6
0
0
0
Case fatality
(numbers)
0
3
2
0
0
0
0
Duration
(years)
6,3445
0
0
0
0
0
0
Mortality
(numbers)
0
3
2
0
0
0
0
RR mortality
(number)
1,313
22,6779
38,9244
10,8869
0
1
0
Age of onset
(years)
0,5
0
0
0
0
0
0
145
1012
152
6,3445
28,1154
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
1,16
150
0
150
0
150
0
150
0
150
0
150
0
150
NA
NA
GRIIM 2
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
1,16
50
0
1,1593
0,5654
50
0
0
50
0
0
0,5014
50
205,1364
0
50
0,002
0
0,0006
50
1304,1258
0
50
0
0
0
50
70,34
0
50
0
0
0
50
0
0
50
0
0
0
50
0
0
50
0
0
0
50
0
NA
NA
0,0004
Duration
(years)
4,3106
0
0
0
0
0
0
Mortality
(rates * 1000)
0
0,1001
0,0007
0
0
0
0
RR mortality
(number)
0
3415,2118
16771,9684
532,1876
0
0
1
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0172
0,0803
50
185,0563
4,3106
0,0144
3522,7957
0,5
Mortality
(numbers)
0
0
3
0
0
0
0
Incidence
(numbers)
140
0
0
0
0
0
0
Prevalence
(numbers)
68
583
1
0
0
0
0
Remission
(numbers)
3
29
0
0
0
0
0
Case fatality
(numbers)
0
120
1
0
0
0
0
Duration
(years)
4,3106
0
0
0
0
0
0
Mortality
(numbers)
0
116
1
0
0
0
0
RR mortality
(number)
0
3415,2118
16771,9684
532,1876
0
0
1
Age of onset
(years)
0,5
0
0
0
0
0
0
140
652
33
121
4,3106
117
3522,7957
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
1,16
50
0
50
0
50
0
50
0
50
0
50
0
50
NA
NA
Discapacidad
Palatina trata
0,016
En Chile todas se tratan. 89% son palatina o labio-palatina
Peso discapacidadd ajustado
0,016
0,08722
GRIIM 3
SINDROME DE DOWN
DisMod II input and output, database Chile fint
Males, Disease: Down (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
1,92
0
0
0
0
0
0
NA
Prevalence
(rates *
1000)
1,2
1,2
1,2
1,8
1,7
1
0
1,4695
Remission
(rates *
1000)
0
0
0
0
0
0
0
NA
Mortality
(rates *
1000)
0,158
0,002
0,001
0,004
0,001
0,01
0
0,0055
RR Mortality Incidence
(rates *
(rates *
1000)
1000)
10
1,9159
20
0
10
0
15
0
15
0
15
0
15
0
NA
0,0302
Prevalence
(rates *
1000)
2,1478
2,9914
2,8744
2,1522
1,0186
0,1439
0,0013
2,0328
Remission
(rates *
1000)
0
0
0
0
0
0
0
0
Case fatality
Duration
(rates *
(years)
1000)
9,4146
39,6954
6,401
0
5,0009
0
23,5548
0
69,0517
0
210,1323
0
337,2281
0
19,204
39,6954
Mortality
(rates *
1000)
0,0202
0,0191
0,0144
0,0507
0,0703
0,0301
0,0004
0,039
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
1,92
0
0
0
0
0
0
NA
Prevalence
(numbers)
151
1447
1781
5592
2132
603
0
11706
Remission
(rates *
1000)
0
0
0
0
0
0
0
NA
Mortality
(numbers)
20
2
1
12
1
6
0
43
RR Mortality
Incidence
(rates *
(numbers)
1000)
10
240
20
0
10
0
15
0
15
0
15
0
15
0
NA
240
Prevalence
(numbers)
269
3608
4265
6686
1277
87
0
16194
Remission
(numbers)
0
0
0
0
0
0
0
0
39,6954
Mortality
(numbers)
3
23
21
157
88
18
0
311
0,5
GRIIM 4
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
1,92
0
0
0
0
0
0
NA
Prevalence
(rates *
1000)
0,9
0,8
0,4
0,5
0,5
0,5
0
0,5126
Remission
(rates *
1000)
0
0
0
0
0
0
0
NA
Mortality
(rates *
1000)
0,133
0,004
0,001
0,002
0,005
0,001
0
0,0044
RR Mortality Incidence
(rates *
(rates *
1000)
1000)
13
1,9164
20
0
12,5
0
15
0
15
0
15
0
15
0
NA
0,0285
Prevalence
(rates *
1000)
1,8505
2,7171
2,6273
2,1898
1,2738
0,3055
0,0151
1,9437
Remission
(rates *
1000)
0
0
0
0
0
0
0
0
Case fatality
Duration
(rates *
(years)
1000)
8,3711
45,2662
5,6477
0
3,8002
0
14,6647
0
55,9842
0
133,7902
0
211,4186
0
16,2306
Mortality
(rates *
1000)
0,0155
0,0153
0,01
0,0321
0,0713
0,0408
0,0032
45,2662
0,0315
Mortality
(numbers)
2
18
14
99
93
29
1
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
1,92
0
0
0
0
0
0
Prevalence
(numbers)
109
931
574
1543
652
358
0
NA
4166
Remission
(rates *
1000)
0
0
0
0
0
0
0
NA
Mortality
(numbers)
16
5
1
6
7
1
0
36
RR Mortality
Incidence
(rates *
(numbers)
1000)
13
232
20
0
12,5
0
15
0
15
0
15
0
15
0
NA
232
Prevalence
(numbers)
224
3161
3770
6758
1662
218
5
15797
Remission
(numbers)
0
0
0
0
0
0
0
0
256
45,2662
256
0,5
GRIIM 5
TRISOMIA 18
Males, Disease: Trisomia 18 (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0,403
0
0
0
0
0
0
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case fatality
(rates *
1000)
3000
3000
3000
3000
3000
3000
3000
Mortality
(rates *
1000)
0,303
0,08
0,02
0
0
0
0
Incidence
(rates *
1000)
0,403
0
0
0
0
0
0
Prevalence
(rates *
1000)
0,0681
0,0086
0
0
0
0
0
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case fatality
(rates *
1000)
2773,6975
2773,6752
2765,9516
0
0
0
0
Duration
(years)
0,3596
0
0
0
0
0
0
Mortality
(rates *
1000)
0,2668
0,0151
0
0
0
0
0
NA
NA
NA
0,0206
0,0063
0,0024
2773,6853
0,3596
0,0065
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates *
1000)
0,403
0
0
0
0
0
0
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case fatality
(rates *
1000)
3000
3000
3000
3000
3000
3000
3000
Mortality
(numbers)
38
96
30
0
0
0
0
Incidence
(numbers)
51
0
0
0
0
0
0
Prevalence
(numbers)
9
10
0
0
0
0
0
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
24
29
0
0
0
0
0
Duration
(years)
0,3596
0
0
0
0
0
0
Mortality
(numbers)
33
18
0
0
0
0
0
NA
NA
NA
164
51
19
52
0,3596
52
0,5
GRIIM 6
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates *
1000)
0,403
0
0
0
0
0
0
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case fatality
(rates *
1000)
3000
3000
3000
3000
3000
3000
3000
Mortality
(rates *
1000)
0,303
0,08
0,02
0
0
0
0
Incidence
(rates *
1000)
0,403
0
0
0
0
0
0
Prevalence
(rates *
1000)
0,0681
0,0086
0
0
0
0
0
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case fatality
(rates *
1000)
2773,6975
2773,6752
2765,9516
0
0
0
0
Duration
(years)
0,3598
0
0
0
0
0
0
Mortality
(rates *
1000)
0,2668
0,0151
0
0
0
0
0
NA
NA
NA
0,0195
0,006
0,0022
2773,6853
0,3598
0,0061
All ages
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates *
1000)
0,403
0
0
0
0
0
0
Remission
(rates *
1000)
0
0
0
0
0
0
0
Case fatality
(rates *
1000)
3000
3000
3000
3000
3000
3000
3000
Mortality
(numbers)
37
93
29
0
0
0
0
Incidence
(numbers)
49
0
0
0
0
0
0
Prevalence
(numbers)
8
10
0
0
0
0
0
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
23
28
0
0
0
0
0
Duration
(years)
0,3598
0
0
0
0
0
0
Mortality
(numbers)
32
18
0
0
0
0
0
NA
NA
NA
158
49
18
50
0,3598
50
All ages
Discapacidad:
0,85
0,5
GRIIM 7
HERNIA DIAFRAGMATICA
Males, Disease: Hernia diafragma (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0,37
0
605
0,1
0,3699
0,1388
0
605
0
0
605
0
0
0,0523
0
605
0
0
605
0
0
0,0002
0
605
0
0
605
0
0
0
0
605
0
0
605
0
0
0
0
605
0
0
605
0
0
0
0
605
0
0
605
0
0
0
0
605
NA
NA
NA
Duration
(years)
1,639
0
0
0
0
0
0
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0,0924
73,363
0,5
0,0307
507,0432
0
0,0001
4081,0824
0
0
389,5276
0
0
210,6422
0
0
0
0
0
0
0
0,0016
0,0058
0,0101
605
1,639
0,0061
Mortality
(numbers)
13
0
0
0
0
0
0
Incidence
(numbers)
46
0
0
0
0
0
0
Prevalence
(numbers)
17
63
0
0
0
0
0
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
11
38
0
0
0
0
0
Duration
(years)
1,639
0
0
0
0
0
0
Mortality
(numbers)
12
37
0
0
0
0
0
13
46
81
49
1,639
49
417,0546
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000)
0,37
0
605
0
0
605
0
0
605
0
0
605
0
0
605
0
0
605
0
0
605
NA
NA
NA
0,5
GRIIM 8
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
Remission Case fatality
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0,37
0
605
0,083
0,3699
0,1388
0
605
0
0
605
0
0
0,0523
0
605
0
0
605
0
0
0,0002
0
605
0
0
605
0
0
0
0
605
0
0
605
0
0
0
0
605
0
0
605
0
0
0
0
605
0
0
605
0
0
0
0
605
All ages
NA
NA
NA
0,0012
Duration
(years)
1,6418
0
0
0
0
0
0
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0,0924
91,4864
0,5
0,0307
651,9174
0
0,0001
6756,3033
0
0
1018,1969
0
0
401,6973
0
0
0
0
0
0
0
0,0055
0,0096
605
1,6418
0,0058
Mortality
(numbers)
10
0
0
0
0
0
0
Incidence
(numbers)
45
0
0
0
0
0
0
Prevalence
(numbers)
17
61
0
0
0
0
0
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
10
37
0
0
0
0
0
Duration
(years)
1,6418
0
0
0
0
0
0
Mortality
(numbers)
11
36
0
0
0
0
0
10
45
78
47
1,6418
47
541,2318
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000)
0,37
0
605
0
0
605
0
0
605
0
0
605
0
0
605
0
0
605
0
0
605
All ages
Discapacidad
NA
NA
0,85
NA
0,5
GRIIM 9
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,092
0
0
0
0
0
0
NA
Prevalence
(rates * 1000)
0,0296
0,0075
0,0005
0,0005
0,0005
0,0005
0,0005
Remission
(rates * 1000)
960
932,3796
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
1,4228
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0014
0,002
750,702
1,4228
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,092
0
0
0
0
0
0
Remission
(rates * 1000)
960
533,3333
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
12
0
0
0
0
0
0
Prevalence
(numbers)
4
9
1
2
1
0
0
Remission
(numbers)
4
8
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
1,4228
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
NA
NA
12
16
12
1,4228
0,5
GRIIM 10
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates * 1000)
0,828
0
0
0
0
0
0
All ages
NA
Prevalence
(rates * 1000)
0,266
0,0676
0,0044
0,0044
0,0044
0,0044
0,0044
Remission
(rates * 1000)
960
932,3796
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
1,4928
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0123
0,0173
740,2595
1,4928
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
(rates * 1000)
0,828
0
0
0
0
0
0
Remission
(rates * 1000)
960
533,3333
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
100
0
0
0
0
0
0
Prevalence
(numbers)
32
79
6
14
6
3
1
Remission
(numbers)
31
73
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
1,4928
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
NA
NA
100
141
104
1,4928
0,5
All ages
Discapacidad:
0,041
GRIIM 11
PIE BOT
Males, Disease: Pie bot (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
1,066
10
0
1,0654
0,5301
10
0
0
10
0
0
1,0138
10
0
0
10
0
0
0,922
10
0
0
10
0
0
0,7757
10
0
0
10
0
0
0,634
10
0
0
10
0
0
0,5457
10
0
0
10
0
0
0,4454
10
0
NA
NA
Duration
(years)
53,5786
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0168
0,7877
10
53,5786
0,5
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
134
0
0
0
0
0
0
Prevalence
(numbers)
67
1223
1368
2410
795
329
83
Remission
(numbers)
1
12
14
24
8
3
1
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
53,5786
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
1
Age of onset
(years)
0,5
0
0
0
0
0
0
134
6275
63
53,5786
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
1,066
10
0
10
0
10
0
10
0
10
0
10
0
10
NA
NA
GRIIM 12
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
Remission Mortality (rates
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0,534
10
0
0,5339
0,2656
10
0
0
10
0
0
0,508
10
0
0
10
0
0
0,462
10
0
0
10
0
0
0,3887
10
0
0
10
0
0
0,3177
10
0
0
10
0
0
0,2734
10
0
0
10
0
0
0,2232
10
0
All ages
NA
NA
Duration
(years)
58,8089
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0079
0,3892
10
58,8089
0,5
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
65
0
0
0
0
0
0
Prevalence
(numbers)
32
591
663
1199
415
196
67
Remission
(numbers)
0
6
7
12
4
2
1
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
58,8089
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
65
3163
32
58,8089
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
Remission
(rates * 1000) (rates * 1000)
0,534
10
0
10
0
10
0
10
0
10
0
10
0
10
All ages
Discapacidad
NA
NA
0,041
GRIIM 13
HIDROCEFALIA CONGENITA
Males, Disease: Hidrocefalia (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,61
0
0
0
0
0
0
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
200
0,119
0,6098
200
0,006
0
200
0,004
0
200
0,001
0
200
0
0
200
0
0
200
0
0
NA
0,0039
Prevalence
(rates * 1000)
0,2757
0,2492
0,0271
0,0002
0
0
0
Remission
(rates * 1000)
188,864
187,3463
180,3626
180,9596
200,0003
200
200
Case fatality
(rates * 1000)
16,1071
24,2613
101,7464
544,9481
6,2407
0
0
Duration
(years)
4,5207
0
0
0
0
0
0
Mortality (rates
* 1000)
0,0046
0,006
0,0027
0,0001
0
0
0
RR mortality
(number)
2,9265
157,812
379,0303
372,3819
0
1
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0096
0,0472
186,7306
32,4877
4,5207
0,0015
228,8572
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,61
0
0
0
0
0
0
Remission
(rates * 1000)
200
200
200
200
200
200
200
Mortality
(numbers)
15
7
6
3
0
0
0
Incidence
(numbers)
77
0
0
0
0
0
0
Prevalence
(numbers)
35
301
40
0
0
0
0
Remission
(numbers)
7
56
7
0
0
0
0
Case fatality
(numbers)
1
7
4
0
0
0
0
Duration
(years)
4,5207
0
0
0
0
0
0
Mortality
(numbers)
1
7
4
0
0
0
0
RR mortality
(number)
2,9265
157,812
379,0303
372,3819
0
1
0
Age of onset
(years)
0,5
0
0
0
0
0
0
NA
NA
31
77
376
70
12
4,5207
12
228,8572
0,5
GRIIM 14
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,61
0
0
0
0
0
0
NA
Remission
Mortality (rates
Incidence
(rates * 1000)
* 1000)
(rates * 1000)
200
0,075
0,6098
200
0,006
0
200
0,002
0
200
0
0
200
0
0
200
0
0
200
0
0
NA
0,0023
Prevalence
(rates * 1000)
0,2757
0,2475
0,029
0,0014
0
0
0
Remission
(rates * 1000)
189,0694
192,0976
191,1074
198,3972
200
200
200
Case fatality
(rates * 1000)
16,1884
21,9424
48,6569
5,1752
0
0
0
Duration
(years)
4,5897
0
0
0
0
0
0
Mortality (rates
* 1000)
0,0046
0,0054
0,0014
0
0
0
0
RR mortality
(number)
3,4212
157,2928
420,0429
23,0121
0
0
1
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0091
0,0452
191,7862
24,243
4,5897
0,0011
206,796
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,61
0
0
0
0
0
0
Remission
(rates * 1000)
200
200
200
200
200
200
200
Mortality
(numbers)
9
7
3
0
0
0
0
Incidence
(numbers)
74
0
0
0
0
0
0
Prevalence
(numbers)
33
288
42
4
0
0
0
Remission
(numbers)
6
55
8
1
0
0
0
Case fatality
(numbers)
1
6
2
0
0
0
0
Duration
(years)
4,5897
0
0
0
0
0
0
Mortality
(numbers)
1
6
2
0
0
0
0
RR mortality
(number)
3,4212
157,2928
420,0429
23,0121
0
0
1
Age of onset
(years)
0,5
0
0
0
0
0
0
NA
NA
19
74
367
70
4,5897
206,796
0,5
Peso discapacidad
0,323
GRIIM 15
MIELOMENINGOCELE ALTO
Males, Disease: espinabifidaalta (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0,18
0
0,064
0,18
0,0847
0
122,3935
0
0
0,016
0
0,096
0
153,1897
0
0
0,016
0
0,0114
0
314,7549
0
0
0
0
0,0014
0
9,8351
0
0
0
0
0,0014
0
0
0
0
0
0
0,0014
0
0
0
0
0
0
0,0014
0
0
NA
NA
0,0064
Duration
(years)
6,2939
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0028
0,0189
162,0945
6,2939
0,0031
909,5723
0,5
Mortality
(numbers)
8
19
24
0
0
0
0
Incidence
(numbers)
23
0
0
0
0
0
0
Prevalence
(numbers)
11
116
17
4
2
1
0
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
1
18
5
0
0
0
0
Duration
(years)
6,2939
0
0
0
0
0
0
Mortality
(numbers)
1
18
5
0
0
0
0
RR mortality
(number)
15,6393
756,9906
1651,6243
56,8782
0
0
1
Age of onset
(years)
0,5
0
0
0
0
0
0
51
23
151
24
6,2939
24
909,5723
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0,18
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
GRIIM 16
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission Mortality (rates
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000)
* 1000)
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0,18
0
0
0,18
0,09
0
0
0
0
0
0
0,1595
0
47,5996
0
0
0,016
0
0,0512
0
193,7856
0
0
0
0
0,0044
0
84,7529
0
0
0
0
0,0035
0
0
0
0
0
0
0,0035
0
0
0
0
0
0
0,0035
0
0
NA
NA
0,0028
Duration
(years)
12,7317
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0027
0,0359
83,0555
12,7317
0,003
1170,214
0,5
Mortality
(numbers)
0
0
23
0
0
0
0
Incidence
(numbers)
22
0
0
0
0
0
0
Prevalence
(numbers)
11
186
74
14
5
3
1
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
9
14
1
0
0
0
Duration
(years)
12,7317
0
0
0
0
0
0
Mortality
(numbers)
0
9
14
1
0
0
0
RR mortality
(number)
0
998,9617
1342,5646
352,8343
0
0
1
Age of onset
(years)
0,5
0
0
0
0
0
0
23
22
292
24
12,7317
24
1170,214
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0,18
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
Discapacidad: 0,68
Alta letalidad, especialmente hombres
GRIIM 17
MIELOMENINGOCELE BAJO
Males, Disease: espinamielomeningobaja (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0,72
0
0,0016
3
0,7197
0,3598
0
0,5703
0
0
0,0004
3
0
0,7177
0
0,551
0
0
0,0004
3
0
0,714
0
0,558
0
0
0
3
0
0,6901
0
3,0434
0
0
0
3
0
0,6218
0
9,9584
0
0
0
3
0
0,4852
0
21,9891
0
0
0
3
0
0,3438
0
8,9476
NA
NA
0,0002
NA
Duration
(years)
67,0376
0
0
0
0
0
0
Mortality
RR mortality
(rates * 1000)
(number)
0,0002
1,0682
0,0004
3,4212
0,0004
2,729
0,0021
2,8033
0,0062
2,5881
0,0107
2,1217
0,0031
1,5442
0,0113
0,6592
4,2647
67,0376
0,0028
2,5098
Age of onset
(years)
0,5
0
0
0
0
0
0
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0,72
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
Mortality
(numbers)
0
0
1
0
0
0
0
RR Mortality
(rates * 1000)
3
3
3
3
3
3
3
Incidence
(numbers)
90
0
0
0
0
0
0
Prevalence
(numbers)
45
866
1060
2144
780
293
64
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
1
7
8
6
1
Duration
(years)
67,0376
0
0
0
0
0
0
Mortality
(numbers)
0
0
1
7
8
6
1
RR mortality
(number)
1,0682
3,4212
2,729
2,8033
2,5881
2,1217
1,5442
NA
90
5251
22
67,0376
22
2,5098
Age of onset
(years)
0,5
0
0
0
0
0
0
0,5
GRIIM 18
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
RR Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0,72
0
0
4
0,7197
0,3597
0
0,9567
0
0
0
4
0
0,7167
0
0,7611
0
0
0,0004
4
0
0,7126
0
0,5402
0
0
0
4
0
0,6968
0
1,969
0
0
0
4
0
0,6442
0
8,6775
0
0
0
4
0
0,5045
0
23,1581
0
0
0
4
0
0,3066
0
21,1719
NA
NA
0,0001
NA
Duration
(years)
73,4931
0
0
0
0
0
0
Mortality
RR mortality
(rates * 1000)
(number)
0,0003
1,1431
0,0005
4,341
0,0004
4,0546
0,0014
3,7813
0,0056
3,5047
0,0117
3,0873
0,0065
2,1888
0,0107
0,6575
4,3179
73,4931
0,0028
3,3243
Age of onset
(years)
0,5
0
0
0
0
0
0
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0,72
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
Discapacidad: 0,160
Expectativa de vida cercana a la normal
Mortality
(numbers)
0
0
1
0
0
0
0
RR Mortality
(rates * 1000)
4
4
4
4
4
4
4
Incidence
(numbers)
87
0
0
0
0
0
0
Prevalence
(numbers)
43
834
1022
2150
841
361
93
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
1
1
4
7
8
2
Duration
(years)
73,4931
0
0
0
0
0
0
Mortality
(numbers)
0
1
1
4
7
8
2
RR mortality
(number)
1,1431
4,341
4,0546
3,7813
3,5047
3,0873
2,1888
NA
87
5344
23
73,4931
23
3,3243
Age of onset
(years)
0,5
0
0
0
0
0
0
0,5
GRIIM 19
MENIGOCELE
Males, Disease: Espina bifida meningo (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0,0384
1000
0
0,0384
0,0121
1000
0
0
1000
0
0
0,0029
1000
0
0
1000
0
0
0
1000
0
0
1000
0
0
0
1000
0
0
1000
0
0
0
1000
0
0
1000
0
0
0
1000
0
0
1000
0
0
0
1000
0
NA
NA
0,0006
Duration
(years)
0,9937
0
0
0
0
0
0
Mortality
RR mortality
(rates * 1000)
(number)
0
1
0
1
0
0
0
0
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0006
1000
0,9937
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
0,0384
1000
0
1000
0
1000
0
1000
0
1000
0
1000
0
1000
NA
NA
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
5
0
0
0
0
0
0
Prevalence
(numbers)
2
4
0
0
0
0
0
Remission
(numbers)
2
4
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,9937
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1
1
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,9937
0,5
GRIIM 20
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0,0384
1000
0
0,0384
0,0121
1000
0
0
1000
0
0
0,0029
1000
0
0
1000
0
0
0
1000
0
0
1000
0
0
0
1000
0
0
1000
0
0
0
1000
0
0
1000
0
0
0
1000
0
0
1000
0
0
0
1000
0
All ages
NA
NA
0,0006
Duration
(years)
0,995
0
0
0
0
0
0
Mortality
RR mortality
(rates * 1000)
(number)
0
1
0
1
0
0
0
0
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0006
1000
0,995
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
Incidence
Remission
(rates * 1000) (rates * 1000)
0,0384
1000
0
1000
0
1000
0
1000
0
1000
0
1000
0
1000
All ages
Discapacidad:
NA
NA
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
5
0
0
0
0
0
0
Prevalence
(numbers)
1
3
0
0
0
0
0
Remission
(numbers)
1
3
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,995
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1
1
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,995
0,5
0,08
GRIIM 21
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
4,5
0
0,766
4,4899
2,2412
0
3,3812
0
0
0,015
0
4,4129
0
3,6335
0
0
0,03
0
4,2151
0
6,4988
0
0
0,04
0
3,5915
0
10,653
0
0
0,03
0
2,8717
0
11,8635
0
0
0,08
0
2,0671
0
34,8279
0
0
0,05
0
0,8455
0
58,8712
NA
NA
0,0475
0,0707
Duration
(years)
53,6456
0
0
0
0
0
0
Mortality
RR mortality
(rates * 1000)
(number)
0,0076
1,4044
0,016
19,636
0,0274
17,4723
0,0383
6,9858
0,0341
3,1507
0,072
2,7952
0,0498
2,3502
Age of onset
(years)
0,5
0
0
0
0
0
0
3,5177
9,8223
53,6456
0,0346
7,9913
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
4,5
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
Mortality
(numbers)
96
18
45
124
38
48
9
Incidence
(numbers)
563
0
0
0
0
0
0
Prevalence
(numbers)
281
5323
6255
11158
3601
1247
158
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
1
19
41
119
43
43
9
Duration
(years)
53,6456
0
0
0
0
0
0
Mortality
(numbers)
1
19
41
119
43
43
9
RR mortality
(number)
1,4044
19,636
17,4723
6,9858
3,1507
2,7952
2,3502
Age of onset
(years)
0,5
0
0
0
0
0
0
378
563
28022
275
53,6456
275
7,9913
0,5
GRIIM 22
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
4,5
0
0,77
4,4899
2,2404
0
4,0672
0
0
0,018
0
4,3977
0
4,3258
0
0
0,03
0
4,1858
0
6,1018
0
0
0,02
0
3,7986
0
5,1491
0
0
0,01
0
3,4865
0
3,0541
0
0
0,011
0
3,3291
0
3,2407
0
0
0,01
0
3,1175
0
3,2214
NA
NA
0,0299
0,0668
Duration
(years)
64,7503
0
0
0
0
0
0
Mortality
RR mortality
(rates * 1000)
(number)
0,0091
1,6083
0,019
30,8462
0,0255
35,1749
0,0196
8,4539
0,0106
2,2187
0,0108
1,2931
0,01
1,1241
Age of onset
(years)
0,5
0
0
0
0
0
0
3,8128
4,6755
64,7503
0,0178
17,4475
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
4,5
0
0
0
0
0
0
0
0
0
0
0
0
0
NA
NA
discapacidad
0,11
con secuelas, requieren de tto permanente
Mortality
(numbers)
93
21
43
62
13
8
3
Incidence
(numbers)
543
0
0
0
0
0
0
Prevalence
(numbers)
271
5116
6005
11723
4549
2381
942
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
1
22
37
60
14
8
3
Duration
(years)
64,7503
0
0
0
0
0
0
Mortality
(numbers)
1
22
37
60
14
8
3
RR mortality
(number)
1,6083
30,8462
35,1749
8,4539
2,2187
1,2931
1,1241
Age of onset
(years)
0,5
0
0
0
0
0
0
243
543
30987
145
64,7503
145
17,4475
0,5
GRIIM 23
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
4,5
2000
194
4,4956
0,9712
2000
0,0061
0
1000
0
0
0,2335
1000
0,0059
0
1000
0
0
0
1000
0,0003
0
1000
0
0
0
1000
0
0
1000
0
0
0
0
0
0
1000
0
0
0
0
0
0
1000
0
0
0
0
0
NA
NA
3,0556
Duration
(years)
0,712
0
0
0
0
0
0
Mortality
RR mortality
(rates * 1000)
(number)
0
1,0007
0
1,0016
0
1,0035
0
0
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0708
0,0507
1301,9852
0,006
0,712
1,0013
0,5
Mortality
(numbers)
24341
0
0
0
0
0
0
Incidence
(numbers)
564
0
0
0
0
0
0
Prevalence
(numbers)
122
282
0
0
0
0
0
Remission
(numbers)
244
282
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,712
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1,0007
1,0016
1,0035
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
24341
564
404
525
0,712
1,0013
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
4,5
2000
0
1000
0
1000
0
1000
0
1000
0
1000
0
1000
NA
NA
GRIIM 24
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
Mortality
Incidence
Prevalence
Remission
Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
4,5
2000
191,4
4,4956
0,9712
2000
0,0061
0
1000
0
0
0,2335
1000
0,0059
0
1000
0
0
0
1000
0,0003
0
1000
0
0
0
1000
0
0
1000
0
0
0
0
0
0
1000
0
0
0
0
0
0
1000
0
0
0
0
0
NA
NA
2,846
Duration
(years)
0,7128
0
0
0
0
0
0
Mortality
RR mortality
(rates * 1000)
(number)
0
1,0009
0
1,002
0
1,0055
0
0
0
0
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
0,0668
0,0479
1301,7073
0,006
0,7128
1,0016
0,5
Mortality
(numbers)
23130
0
0
0
0
0
0
Incidence
(numbers)
543
0
0
0
0
0
0
Prevalence
(numbers)
117
272
0
0
0
0
0
Remission
(numbers)
235
272
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,7128
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1,0009
1,002
1,0055
0
0
0
0
Age of onset
(years)
0,5
0
0
0
0
0
0
23130
543
389
506
0,7128
1,0016
0,5
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Remission
(rates * 1000) (rates * 1000)
4,5
2000
0
1000
0
1000
0
1000
0
1000
0
1000
0
1000
NA
NA
GRIIM 25
Incidencia global
Operables global
No operables
Operables con secuela
Operables sin secuela
1%
0,90%
0,10%
0,45%
0,45%
0,001
GRIIN 1
CARIES
DisMod II input and output, database Chile fint
Males, Disease: Caries (Rates * ), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,021
328,6396
375,7825
397,6245
392,0898
303,7956
245,4543
NA
Prevalence
(rates * 1000)
0,0021
58,2147
69,4876
73,5906
72,7477
57,7986
46,9975
Remission
(rates * 1000)
5000
5000
5000
5000
5000
5000
5000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
0,1997
0,1999
0,2
0,1999
0,1997
0,1992
0,1979
Age of onset
(years)
0,5
5,4703
14,996
32,498
52,5005
67,5077
93,6042
340,0446
67,3877
5000
0,1998
32,3433
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,021
328,6396
375,7825
397,6245
392,0898
303,7956
245,4543
Remission
(rates * 1000)
5000
5000
5000
5000
5000
5000
5000
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
3
373317
518870
1144422
455899
172672
43650
Prevalence
(numbers)
0
70216
103112
228630
91223
34867
8770
Remission
(numbers)
1
351082
515558
1143148
456116
174335
43849
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,1997
0,1999
0,2
0,1999
0,1997
0,1992
0,1979
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
1
1
0
Age of onset
(years)
0,5
5,4703
14,996
32,498
52,5005
67,5077
93,6042
NA
NA
2708833
536818
2684089
0,1998
32,3433
GRIIN 2
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,021
323,3509
366,3511
378,2349
355,1508
225,013
141,276
NA
Prevalence
(rates * 1000)
0,0021
57,3346
67,8884
70,2854
66,4543
43,8481
27,782
Remission
(rates * 1000)
5000
5000
5000
5000
5000
5000
5000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
0,1997
0,2
0,2
0,2
0,1999
0,1995
0,1988
Age of onset
(years)
0,5
5,4708
14,9963
32,4989
52,502
67,5114
96,5214
314,7103
62,4407
5000
0,1999
32,5738
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,021
323,3509
366,3511
378,2349
355,1508
225,013
141,276
Remission
(rates * 1000)
5000
5000
5000
5000
5000
5000
5000
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
3
354580
489936
1085217
432588
153888
41524
Prevalence
(numbers)
0
66696
97402
216905
86706
31363
8399
Remission
(numbers)
1
333479
487011
1084527
433530
156816
41995
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,1997
0,2
0,2
0,2
0,1999
0,1995
0,1988
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
0
0
0
0
Age of onset
(years)
0,5
5,4708
14,9963
32,4989
52,502
67,5114
96,5214
NA
NA
2557735
507472
2537361
0,1999
32,5738
GRIIN 3
EDENTULISMO
Males, Disease: edentulismo inc (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0
4,5
20,1667
40
NA
Prevalence
(rates * 1000)
0
0
0
0
29,3341
141,6869
404,0278
Remission
(rates * 1000)
0
0
0
0
0
0,0001
0,0003
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
0
26,6232
13,6313
8,0923
Age of onset
(years)
0
0
0
0
51,4939
68,167
81,3092
2,3517
24,8112
0,0001
16,1145
64,8256
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0
4,5
20,1667
40
Remission
(rates * 1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
0
0
5477
8808
4448
Prevalence
(numbers)
0
0
0
0
36784
85472
75392
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
0
26,6232
13,6313
8,0923
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
1
1
Age of onset
(years)
0
0
0
0
51,4939
68,167
81,3092
NA
NA
18734
197649
16,1145
64,8256
GRIIN 4
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0
12
27,3333
55
NA
Prevalence
(rates * 1000)
0
0
0
0
76,4956
271,5087
551,9348
Remission
(rates * 1000)
0
0
0
0
0
0,0003
0,0004
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
0
31,2107
17,3834
10,0054
Age of onset
(years)
0
0
0
0
51,3062
67,3969
82,5947
4,2673
56,7067
0,0003
21,5632
61,32
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0
0
0
0
12
27,3333
55
Remission
(rates * 1000)
0
0
0
0
0
0
0
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
0
0
14459
12772
7450
Prevalence
(numbers)
0
0
0
0
99807
194202
166861
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
0
0
0
31,2107
17,3834
10,0054
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
1
1
1
Age of onset
(years)
0
0
0
0
51,3062
67,3969
82,5947
NA
NA
34682
460871
21,5632
61,32
GRIIN 5
ENFERMEDAD PERIODONTAL
DisMod II input and output, database OA
Males, Disease: periodontal (Rates * 1000), sex: Males
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0,0192
0
500
0
0,0192
0,0076
500
0
0,0192
0
500
0
0,0192
0,0334
500
0,0002
1,1292
4,9142
500
0
1,1071
1,3875
500
0,0059
40,7529
37,6903
500
0
36,6122
63,4362
500
0,0061
56,2368
105,2473
500
0
50,4657
105,2584
500
0,0061
48,5734
136,9803
250
0
42,2118
147,9926
250
0,0061
45,5376
150
250
0
38,5139
154,2389
250
0,0061
NA
46,0686
NA
Duration
(years)
1,9906
1,999
1,9963
1,9912
2,1498
3,5352
2,7573
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0,5
0
1,0034
5,6143
0
1,0082
17,4205
0,0004
1,0032
36,5207
0,0006
1,0013
51,6416
0,0009
1,0003
66,0104
0,0009
1,0001
82,0218
26,5308
56,3927
434,3
0,0061
2,2508
0,0003
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
2
23
1643
113746
63282
25464
7187
Prevalence
(numbers)
1
40
2059
197082
131990
89276
28781
Remission
(numbers)
0
20
1029
98541
65995
22319
7195
Case fatality
(numbers)
0
0
0
1
1
1
0
Duration
(years)
1,9906
1,999
1,9963
1,9912
2,1498
3,5352
2,7573
Mortality
(numbers)
0
0
0
1
1
1
0
211348
449230
195101
2,2508
1,0019
45,7901
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
(rates * 1000) (numbers) (rates * 1000)
0,0192
0
500
0,0192
0
500
1,1292
7292
500
40,7529
117095
500
56,2368
131976
500
48,5734
82633
250
45,5376
27990
250
NA
366987
NA
45,7901
GRIIN 6
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
Mortality
Incidence
Prevalence
Remission Case fatality
(rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000) (rates * 1000)
0
0
500
0
0
0
0
0
0
0
500
0
0
0
0
0
1,1195
4,9201
500
0
1,0986
1,3629
500
0,006
40,753
37,9415
500
0
36,9157
64,0351
500
0,0061
56,235
105,4027
500
0
50,4526
105,1643
500
0,0061
48,5737
137,7198
250
0
41,9924
148,538
250
0,0061
45,538
150
250
0
38,5147
154,2304
250
0,0061
NA
49,8972
NA
Duration
(years)
0
0
1,9987
1,9961
2,1778
3,6916
2,9442
Mortality
RR mortality Age of onset
(rates * 1000) (number)
(years)
0
0
0
0
1,1423
0
0
1,0215
17,4657
0,0004
1,0084
36,5782
0,0006
1,0024
51,7262
0,0009
1,0005
66,2828
0,0009
1,0001
83,7045
27,4395
60,2486
421,9495
0,0061
2,3276
0,0004
Mortality
(numbers)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
1576
113924
65828
30036
11644
Prevalence
(numbers)
0
0
1955
197617
137213
106245
46627
Remission
(numbers)
0
0
978
98808
68606
26561
11657
Case fatality
(numbers)
0
0
0
1
1
1
0
Duration
(years)
0
0
1,9987
1,9961
2,1778
3,6916
2,9442
Mortality
(numbers)
0
0
0
1
1
1
0
223008
489657
206610
2,3276
1,0043
47,2632
Age
0
01-Sep
Oct-19
20-44
45-59
60-74
75+
All ages
Incidence
Prevalence
Remission
(rates * 1000) (numbers) (rates * 1000)
0
0
500
0
0
500
1,1195
7059
500
40,753
117090
500
56,235
137524
500
48,5737
98507
250
45,538
45348
250
NA
405528
NA
47,2632
TABLAS DISMOD
GRUPO III
viii
GRIIIA 1
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
0
0,6513
32,3072
40,2258
33,0866
31,8408
42,1003
All ages
NA
NA
Incidence
(rates *
100000)
0
0,6513
32,3072
40,2258
33,0866
31,8408
42,1003
0
0,006513
0,323072
0,402258
0,330866
0,318408
0,421003
30,4103
Prevalence Remission
(rates *
(rates *
100000)
100000)
0
0
0,0069
9000000
0,3405
9000000
0,442
9000000
0,3681
9000000
0,3512
9000000
0,4559
9000000
0,3321
9000000
Case fatality
(rates *
100000)
0
0
26629,01
61604,53
76923,08
83333,33
87500
Age of onset
(years)
0
5,6143
14,9475
32,3837
51,6579
66,4413
82,0209
59977,8651
0,011
0,2001
323,2474
36,5597
Case fatality
(numbers)
0
0
1
8
4
2
1
Duration
(years)
0
0,0111
0,0111
0,011
0,011
0,011
0,011
Mortality
(numbers)
0
0
1
8
4
2
1
RR mortality
(number)
0
0
787,5522
400,327
157,4086
44,03
11,837
Age of onset
(years)
0
5,6143
14,9475
32,3837
51,6579
66,4413
82,0209
16
0,011
16
323,2474
36,5597
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
0
0,6513
32,3072
40,2258
33,0866
31,8408
42,1003
Remission
(rates *
100000)
9000000
9000000
9000000
9000000
9000000
9000000
9000000
Case fatality
(rates *
100000)
0
0
26629,01
61604,53
76923,08
83333,33
87500
Incidence
(numbers)
0
8
479
1250
415
192
79
All ages
NA
NA
NA
2423
Prevalence Remission
(numbers) (numbers)
0
0
0
7
5
455
14
1236
5
415
2
191
1
77
26
2381
GRIIIA 2
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
0
1,2023
170,1261
103,248
38,8591
11,4274
11,3541
Remission
(rates *
100000)
11000000
11000000
11000000
11000000
11000000
11000000
11000000
Case fatality
(rates *
100000)
0
0
1432,4807
4608,8843
10837,0086
18333,3333
32013,7538
Incidence
(rates *
100000)
0
1,2023
170,1261
103,248
38,8591
11,4274
11,3541
All ages
NA
NA
NA
77,0768
0
0,012023
1,701261
1,03248
0,388591
0,114274
0,113541
Prevalence Remission
(rates *
(rates *
100000)
100000)
0
0
0,0104
11000000
1,4702
11000000
0,9513
11000000
0,3786
11000000
0,1147
11000000
0,103
11000000
0,697
11000000
Case fatality
(rates *
100000)
0
0
1432,4807
4608,8843
10837,0086
18333,3333
32013,7538
Age of onset
(years)
0
5,6157
14,9514
32,4838
51,7435
66,7137
83,7035
4308,814
0,0091
0,0294
67,3536
27,9162
Case fatality
(numbers)
0
0
0
1
1
0
0
Duration
(years)
0
0,0091
0,0091
0,0091
0,0091
0,0091
0,0091
Mortality
(numbers)
0
0
0
1
0
0
0
RR mortality
(number)
0
0
67,6087
86,2651
42,3957
17,3027
6,7852
Age of onset
(years)
0
5,6157
14,9514
32,4838
51,7435
66,7137
83,7035
0,0091
67,3536
27,9162
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
0
1,2023
170,1261
103,248
38,8591
11,4274
11,3541
Remission
(rates *
100000)
11000000
11000000
11000000
11000000
11000000
11000000
11000000
Case fatality
(rates *
100000)
0
0
1432,4807
4608,8843
10837,0086
18333,3333
32013,7538
Incidence
(numbers)
0
14
2441
3186
507
82
34
All ages
NA
NA
NA
6264
Prevalence Remission
(numbers) (numbers)
0
0
0
13
21
2320
29
3230
5
543
1
90
0
34
57
6231
GRIIIA 3
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
0
0,0113
0,5593
0,6964
0,5728
0,5512
0,7288
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(rates *
100000)
0
0,0113
0,5593
0,6964
0,5728
0,5512
0,7288
All ages
NA
NA
NA
0,5265
0
0,000113
0,005593
0,006964
0,005728
0,005512
0,007288
Prevalence Remission
(rates *
(rates *
100000)
100000)
0
0
0,0521
0
2,8688
0
14,3176
0
26,9147
0
35,2409
0
42,7012
0
14,0318
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Age of onset
(years)
0
5,6143
14,9474
32,3834
51,6578
66,4412
82,0208
40,8954
36,5573
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
69,6225
60,454
44,0149
26,5527
15,0263
8,0303
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0
5,6143
14,9474
32,3834
51,6578
66,4412
82,0208
40,8954
36,5573
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
0
0,0113
0,5593
0,6964
0,5728
0,5512
0,7288
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
8
22
7
3
1
All ages
NA
NA
NA
42
Prevalence Remission
(numbers) (numbers)
0
0
1
0
43
0
445
0
338
0
213
0
80
0
1118
GRIIIA 4
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
0
0,0012
0,1703
0,1034
0,0389
0,0114
0,0114
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(rates *
100000)
0
0,0012
0,1703
0,1034
0,0389
0,0114
0,0114
All ages
NA
NA
NA
0,0772
0
0,000012
0,001703
0,001034
0,000389
0,000114
0,000114
Prevalence Remission
(rates *
(rates *
100000)
100000)
0
0
0,0055
0
0,854
0
3,0046
0
4,561
0
4,9587
0
5,0985
0
2,6507
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Age of onset
(years)
0
5,6157
14,9513
32,4838
51,7435
66,7137
83,7035
53,9236
27,9165
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0
75,636
66,4208
49,2904
31,0099
18,2728
9,8987
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0
5,6157
14,9513
32,4838
51,7435
66,7137
83,7035
53,9236
27,9165
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
0
0,0012
0,1703
0,1034
0,0389
0,0114
0,0114
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(numbers)
0
0
2
3
1
0
0
All ages
NA
NA
NA
Prevalence Remission
(numbers) (numbers)
0
0
0
0
12
0
93
0
60
0
35
0
15
0
215
GRIIIA 5
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
21,065
42,7293
123,2546
136,6541
95,9713
61,4839
53,8226
Remission
(rates *
100000)
1700000
1700000
1700000
1700000
1700000
1700000
1700000
Case fatality
(rates *
100000)
0
170,9
0
0
73,2
474,9
876,8
Incidence
(rates *
100000)
21,0649
42,7283
123,246
136,6431
95,9658
61,4816
53,8209
Prevalence
(rates *
100000)
0,6196
02-Jan
Jan-00
8,0204
5,7522
3,7125
3,1937
Remission
(rates *
100000)
1700000
1700000
1700000
1700000
1700000
1700000
1700000
Case fatality
(rates *
100000)
0
170,9
0
0
73,2
474,9
876,8
Duration
(years)
0,0588
0,0588
0,0588
0,0588
0,0588
0,0587
0,0585
Mortality
(rates *
100000)
0
0,0043
0
0
0,0041
0,0172
0,0278
RR mortality
(number)
0
8,1745
0
1
1,149
1,2457
1,1087
Age of onset
(years)
0,5
5,6143
14,9475
32,3837
51,6579
66,4413
82,0209
All ages
NA
NA
NA
104,0724
6,0761
1700000
54,0956
0,0588
0,0033
2,5789
31,7365
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
21,065
42,7293
123,2546
136,6541
95,9713
61,4839
53,8226
Remission
(rates *
100000)
1700000
1700000
1700000
1700000
1700000
1700000
1700000
Case fatality
(rates *
100000)
0
170,9
0
0
73,2
474,9
876,8
Incidence
(numbers)
26
515
1829
4245
1203
371
100
Prevalence
(numbers)
1
30
104
249
72
22
6
Remission
(numbers)
13
502
1769
4236
1226
381
101
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0588
0,0588
0,0588
0,0588
0,0588
0,0587
0,0585
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
8,1745
0
1
1,149
1,2457
1,1087
Age of onset
(years)
0,5
5,6143
14,9475
32,3837
51,6579
66,4413
82,0209
All ages
NA
NA
NA
8291
484
8229
0,0588
2,5789
31,7365
GRIIIA 6
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
13,8041
29,5114
197,7232
604,5152
241,8501
84,6982
53,1468
Remission
(rates *
100000)
1800000
1800000
1800000
1800000
1800000
1800000
1800000
Case fatality
(rates *
100000)
5262,3
255,7
30,9
32,9
83,5
144,9
1092,7
Incidence
(rates *
100000)
13,804
29,5109
197,7024
604,3152
241,8155
84,6939
53,1452
Prevalence
(rates *
100000)
0,3823
01-Jan
Jan-00
33,0845
14,3167
5,091
3,0485
Remission
(rates *
100000)
1800000
1800000
1800000
1800000
1800000
1800000
1800000
Case fatality
(rates *
100000)
5262,3
255,7
30,9
32,9
83,5
144,9
1092,7
Duration
(years)
0,0554
0,0555
0,0556
0,0556
0,0555
0,0555
0,0553
Mortality
(rates *
100000)
0,038
0,0042
0,0034
0,011
0,0113
0,0069
0,0324
RR mortality
(number)
8,2845
16,0553
2,4353
1,6078
1,3203
1,1293
1,198
Age of onset
(years)
0,5
5,6157
14,9513
32,4837
51,7436
66,7138
83,7035
All ages
NA
NA
NA
317,0512
17,5134
1800000
53,6551
0,0555
0,0096
2,8203
33,6961
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
13,8041
29,5114
197,7232
604,5152
241,8501
84,6982
53,1468
Remission
(rates *
100000)
1800000
1800000
1800000
1800000
1800000
1800000
1800000
Case fatality
(rates *
100000)
5262,3
255,7
30,9
32,9
83,5
144,9
1092,7
Incidence
(numbers)
17
343
2837
18650
3155
606
161
Prevalence
(numbers)
0
19
151
1021
187
36
9
Remission
(numbers)
8
334
2717
18378
3362
655
166
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0554
0,0555
0,0556
0,0556
0,0555
0,0555
0,0553
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
8,2845
16,0553
2,4353
1,6078
1,3203
1,1293
1,198
Age of onset
(years)
0,5
5,6157
14,9513
32,4837
51,7436
66,7138
83,7035
All ages
NA
NA
NA
25768
1423
25621
0,0555
2,8203
33,6961
GRIIIA 7
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
2,8453
5,7716
16,6485
18,4584
12,9632
8,3049
7,27
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(rates *
100000)
2,8453
5,7699
16,6257
18,3756
12,8639
8,2279
7,1956
Prevalence
(rates *
100000)
1,4226
29,4718
137,0521
448,7582
766,077
926,3523
1023,865
Remission
(rates *
100000)
Jan-00
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Duration
(years)
74,2701
69,6229
60,4553
44,024
26,5548
15,0273
8,0304
Mortality
(rates *
100000)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
0
0
1
1
Age of onset
(years)
0,5
5,6135
14,9448
32,3643
51,6532
66,4383
82,0196
All ages
NA
NA
NA
13,9984
419,7529
45,1025
31,6465
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
2,8453
5,7716
16,6485
18,4584
12,9632
8,3049
7,27
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(numbers)
4
70
247
571
161
50
13
Prevalence
(numbers)
2
355
2034
13942
9606
5588
1911
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
74,2701
69,6229
60,4553
44,024
26,5548
15,0273
8,0304
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
0
0
1
1
Age of onset
(years)
0,5
5,6135
14,9448
32,3643
51,6532
66,4383
82,0196
All ages
NA
NA
NA
1115
33438
45,1025
31,6465
GRIIIA 8
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
1,9181
4,1007
27,4741
83,9987
33,6056
11,769
7,3849
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(rates *
100000)
1,9181
4,0998
27,4261
82,8638
32,73
11,4216
7,1578
Prevalence
(rates *
100000)
0,959
20,843
174,6739
1351,1153
2605,5006
2952,1633
3075,2163
Remission
(rates *
100000)
00-Jan
Jan-00
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Duration
(years)
80,3515
75,6363
66,423
49,3334
31,0155
18,2745
9,8988
Mortality
(rates *
100000)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
1
0
Age of onset
(years)
0,5
5,6152
14,9469
32,3955
51,7311
66,7094
83,7021
All ages
NA
NA
NA
43,4477
1339,37
48,4378
33,4765
Age
0
1 a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
1,9181
4,1007
27,4741
83,9987
33,6056
11,769
7,3849
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(numbers)
2
48
393
2557
427
82
22
Prevalence
(numbers)
1
242
2506
41696
33995
21116
9297
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
80,3515
75,6363
66,423
49,3334
31,0155
18,2745
9,8988
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
1
0
Age of onset
(years)
0,5
5,6152
14,9469
32,3955
51,7311
66,7094
83,7021
All ages
NA
NA
NA
3531
108854
48,4378
33,4765
GRIIIA 9
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,743
2,004
13,299
23,543
11,71
6,803
4,716
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Incidence
(rates * 1000)
0,743
2,004
13,298
23,538
11,709
6,803
4,716
Prevalence
(rates * 1000)
0,003
0,016
0,106
0,194
0,102
0,059
0,04
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
0,008
0,008
0,008
0,008
0,008
0,008
0,008
Mortality (rates
* 1000)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,614
14,947
32,384
51,658
66,441
82,021
NA
NA
NA
14,441
0,119
120000
0,008
32,885
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,743
2,004
13,299
23,543
11,71
6,803
4,716
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Incidence
(numbers)
93
2417
19732
73129
14682
4104
880
Prevalence
(numbers)
0
19
157
604
128
35
8
Remission
(numbers)
47
2338
18899
72425
15348
4245
905
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,008
0,008
0,008
0,008
0,008
0,008
0,008
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,614
14,947
32,384
51,658
66,441
82,021
NA
NA
NA
115037
952
114207
0,008
32,885
GRIIIA 10
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,474
1,359
10,828
24,522
11,636
4,954
2,751
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Incidence
(rates * 1000)
0,474
1,359
10,827
24,517
11,635
4,954
2,751
Prevalence
(rates * 1000)
0,002
0,011
0,086
0,202
0,102
0,044
0,024
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
0,008
0,008
0,008
0,008
0,008
0,008
0,008
Mortality (rates
* 1000)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
0
1
1
0
Age of onset
(years)
0,5
5,616
14,951
32,484
51,744
66,714
83,704
NA
NA
NA
13,829
0,115
120000
0,008
33,772
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,474
1,359
10,828
24,522
11,636
4,954
2,751
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Incidence
(numbers)
57
1581
15534
75661
15180
3543
832
Prevalence
(numbers)
0
13
124
623
133
31
7
Remission
(numbers)
29
1527
14860
74749
15918
3755
869
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,008
0,008
0,008
0,008
0,008
0,008
0,008
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
0
1
1
0
Age of onset
(years)
0,5
5,616
14,951
32,484
51,744
66,714
83,704
NA
NA
NA
112389
931
111705
0,008
33,772
GRIIIA 11
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
DE CORTA DURACIN
Incidence
(rates * 1000)
0,321
0,83
5,959
10,221
5,955
3,876
3,34
Remission
(rates * 1000)
16000
16000
16000
16000
16000
16000
16000
Case fatality
(rates * 1000)
41,7
5,2
6,6
9,8
10,5
12,8
21,2
Incidence
(rates * 1000)
0,321
0,83
5,957
10,215
5,953
3,875
3,339
Prevalence
(rates * 1000)
0,01
0,05
0,356
0,632
0,384
0,248
0,211
Remission
(rates * 1000)
16000
16000
16000
16000
16000
16000
16000
Case fatality
(rates * 1000)
41,7
5,2
6,6
9,8
10,5
12,8
21,2
Duration
(years)
0,062
0,062
0,062
0,062
0,062
0,062
0,062
Mortality (rates
* 1000)
0,001
0
0,002
0,006
0,004
0,003
0,004
RR mortality
(number)
5,507
22,844
20,439
7,349
3,14
1,662
1,263
Age of onset
(years)
0,5
5,614
14,947
32,384
51,658
66,441
82,021
NA
NA
NA
6,533
0,405
16000
9,584
0,062
0,004
7,861
33,811
Remission
(numbers)
20
969
8457
31423
7699
2396
629
Case fatality
(numbers)
0
0
3
19
5
2
1
Duration
(years)
0,062
0,062
0,062
0,062
0,062
0,062
0,062
Mortality
(numbers)
0
0
4
19
5
2
1
RR mortality
(number)
5,507
22,844
20,439
7,349
3,14
1,662
1,263
Age of onset
(years)
0,5
5,614
14,947
32,384
51,658
66,441
82,021
31
7,861
33,811
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,321
0,83
5,959
10,221
5,955
3,876
3,34
Remission
(rates * 1000)
16000
16000
16000
16000
16000
16000
16000
Case fatality
(rates * 1000)
41,7
5,2
6,6
9,8
10,5
12,8
21,2
Incidence
(numbers)
40
1001
8839
31734
7464
2338
623
Prevalence
(numbers)
1
61
529
1964
481
150
39
NA
NA
NA
52040
3225
51592
31
0,062
No consistente con muertes reales
GRIIIA 12
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,232
0,549
4,357
8,678
4,649
2,334
1,64
Remission
(rates * 1000)
15500
15500
15500
15500
15500
15500
15500
Case fatality
(rates * 1000)
23,6
6,6
10,5
16,1
17,1
17,5
24,4
Incidence
(rates * 1000)
0,232
0,549
4,356
8,673
4,648
2,334
1,64
Prevalence
(rates * 1000)
0,007
0,034
0,269
0,553
0,311
0,157
0,108
Remission
(rates * 1000)
15500
15500
15500
15500
15500
15500
15500
Case fatality
(rates * 1000)
23,6
6,6
10,5
16,1
17,1
17,5
24,4
Duration
(years)
0,064
0,064
0,064
0,064
0,064
0,064
0,064
Mortality (rates
* 1000)
0
0
0,003
0,009
0,005
0,003
0,003
RR mortality
(number)
4,267
39,883
49,76
30,75
7,548
2,559
1,442
Age of onset
(years)
0,5
5,616
14,951
32,484
51,744
66,714
83,704
NA
NA
NA
5,157
0,33
15500
15,468
0,064
0,005
27,131
34,267
Duration
(years)
0,064
0,064
0,064
0,064
0,064
0,064
0,064
Mortality
(numbers)
0
0
4
28
7
2
1
RR mortality
(number)
4,267
39,883
49,76
30,75
7,548
2,559
1,442
Age of onset
(years)
0,5
5,616
14,951
32,484
51,744
66,714
83,704
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,232
0,549
4,357
8,678
4,649
2,334
1,64
Remission
(rates * 1000)
15500
15500
15500
15500
15500
15500
15500
Case fatality
(rates * 1000)
23,6
6,6
10,5
16,1
17,1
17,5
24,4
Incidence
(numbers)
28
639
6249
26766
6064
1669
496
Prevalence
(numbers)
1
40
385
1707
406
112
33
Remission
(numbers)
14
619
5974
26451
6287
1740
507
Case fatality
(numbers)
0
0
4
27
7
2
1
NA
NA
NA
41911
2683
41593
42
0,064
42
27,131
No consistente con muertes reales
34,267
GRIIIA 13
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
DE LARGA DURACIN
Incidence
(rates * 1000)
0,016
0,041
0,295
0,506
0,295
0,192
0,165
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Incidence
(rates * 1000)
0,016
0,041
0,294
0,501
0,29
0,188
0,161
Prevalence
(rates * 1000)
0,008
0,205
1,842
9,549
17,788
21,414
23,628
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
74,27
69,623
60,456
44,04
26,557
15,029
8,031
Mortality (rates
* 1000)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,614
14,943
32,33
51,647
66,434
82,018
NA
NA
NA
0,32
9,073
43,168
33,623
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,016
0,041
0,295
0,506
0,295
0,192
0,165
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Incidence
(numbers)
2
49
437
1557
363
113
30
Prevalence
(numbers)
1
247
2734
29665
22306
12918
4409
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
74,27
69,623
60,456
44,04
26,557
15,029
8,031
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,614
14,943
32,33
51,647
66,434
82,018
NA
NA
NA
2552
72280
43,168
33,623
GRIIIA 14
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,012
0,028
0,222
0,442
0,237
0,119
0,083
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Incidence
(rates * 1000)
0,012
0,028
0,222
0,438
0,233
0,117
0,081
Prevalence
(rates * 1000)
0,006
0,141
1,362
7,965
15,018
17,729
19,021
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Duration
(years)
80,351
75,636
66,423
49,313
31,014
18,275
9,899
Mortality (rates
* 1000)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
1
1
1
Age of onset
(years)
0,5
5,615
14,948
32,437
51,735
66,709
83,702
NA
NA
NA
0,261
7,964
47,994
34,111
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,012
0,028
0,222
0,442
0,237
0,119
0,083
Remission
(rates * 1000)
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
Incidence
(numbers)
1
33
318
1353
305
84
25
Prevalence
(numbers)
1
164
1954
24580
19594
12681
5750
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
80,351
75,636
66,423
49,313
31,014
18,275
9,899
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
1
1
1
Age of onset
(years)
0,5
5,615
14,948
32,437
51,735
66,709
83,702
NA
NA
NA
2118
64725
47,994
34,111
GRIIIA 15
SUPUESTOS
INCIDENCIA
DURACIN
PESOS DE DISCAPACIDAD
LETALIDAD
0,008
0,008
Juicio de experto equipo
0,05
0,05
Juicio de experto equipo
0,0096
0,061
0,064
Duracin promedio,
Fuente duraciones por NL y
DISMOD
DISMOD
Lesiones que causan
0,147
0,138
0,289
0,299
Peso de discapacidad promedio, ponderado por distribucin de
Fuente de PD por NL: BOD study, Victoria, Australia. 1999. En
0,0153
Se asume que:
1. Todas las muertes ocurren en el grupo de lesiones graves y de mediana gravedad de corta duracin
2. Las lesiones leves no tienen riesgo de morir, por tanto el denominador de la letalidad corresponde slo a lesiones graves y de mediana gravedad
Fuente
Base de datos de defunciones 2005
Las incidencias revisadas no han cambiado respecto a las estimaciones anteriores, por tanto no es necesario recalcular AVISA
Y06-Y07, CIE-10
GRIIIA 16
GRIII B 1
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
6,8
159,9
238,8
597,9
444,6
342,8
252,8
Remission
(rates *
100000)
1600000
1600000
1600000
1600000
1600000
1600000
1600000
Case fatality
(rates *
100000)
22000
2000
2000
4000
7000
12000
21000
Incidence
(rates *
100000)
6,8
159,8848
238,765
597,6802
444,4751
342,7261
252,7596
All ages
NA
NA
NA
403,7265
Age
0
0,068
1,598848
2,38765
5,976802
4,444751
3,427261
2,527596
Prevalence
(rates *
100000)
0,2096
9,4799
14,6593
36,7676
28,0897
21,5667
15,9616
Remission
(rates *
100000)
1600000
1600000
1600000
1600000
1600000
1600000
1600000
Case fatality
(rates *
100000)
22000
2000
2000
4000
7000
12000
21000
Duration
(years)
0,0617
0,0624
0,0624
0,0623
0,0622
0,0619
0,0613
Mortality
(rates *
100000)
0,0865
0,1984
0,2975
1,488
1,9399
2,5559
3,2841
RR mortality
(number)
24,7753
85,1515
60,0366
26,9068
15,2476
7,2027
3,606
Age of onset
(years)
0,5
5,6143
14,9475
32,3836
51,658
66,4413
82,0209
24,9374
1600000
4979,0096
0,0623
1,243
22,4141
35,1542
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
6,8
159,9
238,8
597,9
444,6
342,8
252,8
Remission
(rates *
100000)
1600000
1600000
1600000
1600000
1600000
1600000
1600000
Case fatality
(rates *
100000)
22000
2000
2000
4000
7000
12000
21000
Incidence
(numbers)
9
1928
3543
18569
5574
2067
472
Prevalence
(numbers)
0
114
218
1142
352
130
30
Remission
(numbers)
4
1829
3480
18277
5636
2082
477
Case fatality
(numbers)
0
2
4
46
25
16
6
Duration
(years)
0,0617
0,0624
0,0624
0,0623
0,0622
0,0619
0,0613
Mortality
(numbers)
0
2
4
46
24
15
6
RR mortality
(number)
24,7753
85,1515
60,0366
26,9068
15,2476
7,2027
3,606
Age of onset
(years)
0,5
5,6143
14,9475
32,3836
51,658
66,4413
82,0209
All ages
NA
NA
NA
32161
1987
31785
99
0,0623
99
22,4141
35,1542
Age
0
GRIII B 2
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
4,9
129,5
196,4
296,5
243,6
192,1
140,6
Remission
(rates *
100000)
1650000
1650000
1650000
1650000
1650000
1650000
1650000
Case fatality
(rates *
100000)
33000
2000
2000
1000
2000
5000
9000
Incidence
(rates *
100000)
4,9
129,4904
196,377
296,4472
243,5637
192,0774
140,5878
All ages
NA
NA
NA
227,0763
Age
0
0,049
1,294904
1,96377
2,964472
2,435637
1,920774
1,405878
Prevalence
(rates *
100000)
0,1456
7,4438
11,6862
17,8245
14,8844
11,7447
8,6488
Remission
(rates *
100000)
1650000
1650000
1650000
1650000
1650000
1650000
1650000
Case fatality
(rates *
100000)
33000
2000
2000
1000
2000
5000
9000
Duration
(years)
0,0595
0,0605
0,0605
0,0606
0,0605
0,0604
0,06
Mortality
(rates *
100000)
0,0904
0,1558
0,2373
0,1794
0,2952
0,5811
0,7646
RR mortality
(number)
46,6814
119,0211
93,968
19,4851
8,6388
5,445
2,6294
Age of onset
(years)
0,5
5,6157
14,9513
32,4838
51,7435
66,7137
83,7035
13,6438
1650000
1901,1836
0,0605
0,2606
33,5454
34,7871
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
4,9
129,5
196,4
296,5
243,6
192,1
140,6
Remission
(rates *
100000)
1650000
1650000
1650000
1650000
1650000
1650000
1650000
Case fatality
(rates *
100000)
33000
2000
2000
1000
2000
5000
9000
Incidence
(numbers)
6
1506
2818
9149
3178
1374
425
Prevalence
(numbers)
0
87
168
550
194
84
26
Remission
(numbers)
3
1429
2767
9076
3204
1386
431
Case fatality
(numbers)
0
2
3
6
4
4
2
Duration
(years)
0,0595
0,0605
0,0605
0,0606
0,0605
0,0604
0,06
Mortality
(numbers)
0
2
3
6
4
4
2
RR mortality
(number)
46,6814
119,0211
93,968
19,4851
8,6388
5,445
2,6294
Age of onset
(years)
0,5
5,6157
14,9513
32,4838
51,7435
66,7137
83,7035
All ages
NA
NA
NA
18455
1109
18296
21
0,0605
21
33,5454
34,7871
Age
0
GRIII B 3
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Duration
(years)
74,2701
69,6244
60,4574
44,0673
26,5652
15,0337
8,031
Mortality
(rates *
100000)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
1
0
1
1
1
Age of onset
(years)
0,5
5,6105
14,9405
32,2713
51,6288
66,4192
82,013
70,5456
1975,137
42,1662
34,6711
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
1,21
28,58
42,67
106,86
79,45
61,27
45,17
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(rates *
100000)
1,21
28,542
42,4701
104,7383
76,4225
58,3152
42,694
All ages
NA
NA
NA
Age
0
0,0121
0,28542
0,424701
1,047383
0,764225
0,583152
0,42694
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
1,21
28,58
42,67
106,86
79,45
61,27
45,17
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(numbers)
2
344
630
3254
958
352
80
Prevalence
(numbers)
1
1604
6950
61684
47783
29092
10229
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
74,2701
69,6244
60,4574
44,0673
26,5652
15,0337
8,031
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
1
1
0
1
1
1
Age of onset
(years)
0,5
5,6105
14,9405
32,2713
51,6288
66,4192
82,013
All ages
NA
NA
NA
5620
157342
42,1662
34,6711
Age
0
GRIII B 4
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
0,91
24,04
36,48
55,05
45,24
35,67
26,11
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(rates *
100000)
0,91
24,0131
36,3352
54,3561
44,2276
34,6586
25,2686
All ages
NA
NA
NA
41,5954
Age
0
0,0091
0,240131
0,363352
0,543561
0,442276
0,346586
0,252686
Prevalence
(rates *
100000)
0,455
111,7898
397,0497
1260,4925
2237,7852
2835,3076
3222,6336
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Duration
(years)
80,3515
75,6376
66,4237
49,3186
31,0175
18,2779
9,8992
Mortality
(rates *
100000)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
1
1
0
0
Age of onset
(years)
0,5
5,6125
14,9454
32,4259
51,7268
66,7005
83,6985
1293,3923
47,8502
34,4623
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
0,91
24,04
36,48
55,05
45,24
35,67
26,11
Remission
(rates *
100000)
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
Incidence
(numbers)
1
279
521
1677
577
248
76
Prevalence
(numbers)
1
1300
5697
38900
29197
20280
9743
Remission
(numbers)
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
80,3515
75,6376
66,4237
49,3186
31,0175
18,2779
9,8992
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
1
1
0
0
Age of onset
(years)
0,5
5,6125
14,9454
32,4259
51,7268
66,7005
83,6985
All ages
NA
NA
NA
3381
105117
47,8502
34,4623
Age
0
GRIII B 5
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
76,5129
148,736
89,3601
89,6106
61,4052
52,0515
72,8824
Remission
(rates *
100000)
12000000
12000000
12000000
12000000
12000000
12000000
12000000
Case fatality
(rates *
100000)
561,4
175,4
308,1
475
507,8
514,1
1250,2
Incidence
(rates *
100000)
76,5127
148,7342
89,3594
89,6099
61,4049
52,0512
72,882
All ages
NA
NA
NA
90,6332
Age
0
0,765127
1,487342
0,893594
0,896099
0,614049
0,520512
0,72882
Prevalence
(rates *
100000)
0,3188
01-Jan
Jan-00
0,7467
0,5222
0,4375
0,596
Remission
(rates *
100000)
12000000
12000000
12000000
12000000
12000000
12000000
12000000
Case fatality
(rates *
100000)
561,4
175,4
308,1
475
507,8
514,1
1250,2
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,7517
12000000
390,5747
0,0083
0,003
4,7612
26,6501
Age of onset
(years)
0,5
5,6143
14,9475
32,3837
51,6579
66,4413
82,0209
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
76,5129
148,736
89,3601
89,6106
61,4052
52,0515
72,8824
Remission
(rates *
100000)
12000000
12000000
12000000
12000000
12000000
12000000
12000000
Case fatality
(rates *
100000)
561,4
175,4
308,1
475
507,8
514,1
1250,2
Incidence
(numbers)
96
1794
1326
2784
770
314
136
Prevalence
(numbers)
0
15
11
23
7
3
1
Remission
(numbers)
48
1748
1370
2784
786
317
133
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
1,6067
8,3491
10,1103
4,0792
2,0326
1,2655
1,1548
Age of onset
(years)
0,5
5,6143
14,9475
32,3837
51,6579
66,4413
82,0209
All ages
NA
NA
NA
7220
60
7186
0,0083
4,7612
26,6501
Age
0
GRIII B 6
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
102,6082
133,2446
324,7971
183,405
112,8188
59,8376
80,7089
Remission
(rates *
100000)
12000000
12000000
12000000
12000000
12000000
12000000
12000000
Case fatality
(rates *
100000)
1843
67,1
23,4
51,5
54,7
131,6
551
Incidence
(rates *
100000)
102,6078
133,2432
324,7885
183,4021
112,8177
59,8373
80,7084
All ages
NA
NA
NA
173,9546
Age
0
1,026078
1,332432
3,247885
1,834021
1,128177
0,598373
0,807084
Prevalence
(rates *
100000)
0,4275
01-Jan
Jan-00
1,5538
0,9659
0,5182
0,6628
Remission
(rates *
100000)
12000000
12000000
12000000
12000000
12000000
12000000
12000000
Case fatality
(rates *
100000)
1843
67,1
23,4
51,5
54,7
131,6
551
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
1,4425
12000000
63,4711
0,0083
0,001
2,4177
27,5241
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7435
66,7137
83,7035
1a9
10 a 19
20-44
45-59
60-74
75+
Incidence
(rates *
100000)
102,6082
133,2446
324,7971
183,405
112,8188
59,8376
80,7089
Remission
(rates *
100000)
12000000
12000000
12000000
12000000
12000000
12000000
12000000
Case fatality
(rates *
100000)
1843
67,1
23,4
51,5
54,7
131,6
551
Incidence
(numbers)
124
1550
4660
5660
1472
428
244
Prevalence
(numbers)
1
13
38
48
13
4
2
Remission
(numbers)
62
1531
4523
5754
1512
445
240
Case fatality
(numbers)
0
0
0
0
0
0
0
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
3,5512
4,9423
2,0882
1,9528
1,2088
1,1169
1,0996
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7435
66,7137
83,7035
All ages
NA
NA
NA
14138
117
14068
0,0083
2,4177
27,5241
Age
0
CAIDAS
GRIII B 7
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
8,93
36,82
33,93
21,24
22,17
26,02
44,45
NA
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
NA
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
NA
Incidence
(rates * 1000)
8,9297
36,8092
33,9204
21,2362
22,1659
26,0144
44,434
26,8146
Prevalence
(rates * 1000)
0,0372
0,2946
0,2839
0,1793
0,1844
0,2153
0,3603
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
0,2218
120000
Prevalence
(numbers)
5
355
421
557
231
130
67
Remission
(numbers)
560
42638
50547
66847
27743
15582
8068
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
0
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
Age of onset
(years)
0,5
5,6142
14,9475
32,3838
51,6579
66,4412
82,0207
29,6222
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
8,93
36,82
33,93
21,24
22,17
26,02
44,45
NA
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
NA
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
NA
Incidence
(numbers)
1120
44398
50334
65976
27795
15693
8291
213608
1767
211985
Case fatality
(numbers)
0
0
0
0
0
0
0
0
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
1
1
1
1
1
0
0
1
Age of onset
(years)
0,5
5,6142
14,9475
32,3838
51,6579
66,4412
82,0207
29,6222
GRIII B 8
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
6,09
19,16
8,9
6,54
16,46
37,78
94,79
NA
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
NA
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
NA
Incidence
(rates * 1000)
6,0898
19,1571
8,8993
6,5396
16,4578
37,7684
94,7177
16,3762
Prevalence
(rates * 1000)
0,0254
0,1539
0,0784
0,0549
0,1335
0,3069
0,7628
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
0,1339
120000
Prevalence
(numbers)
3
179
112
169
174
220
231
Remission
(numbers)
368
21490
13499
20339
20906
26340
27675
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
0
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7434
66,7136
83,7031
48,1396
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
6,09
19,16
8,9
6,54
16,46
37,78
94,79
NA
Remission
(rates * 1000)
120000
120000
120000
120000
120000
120000
120000
NA
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
NA
Incidence
(numbers)
736
22285
12768
20182
21473
27015
28635
133094
1088
130616
Case fatality
(numbers)
0
0
0
0
0
0
0
0
Duration
(years)
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
0,0083
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7434
66,7136
83,7031
48,1396
CAIDAS
GRIII B 9
DE CORTA DURACIN
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
4,689
12,136
12,602
15,508
13,906
14,302
18,835
NA
Remission
(rates * 1000)
15000
15000
15000
15000
15000
15000
15000
NA
Case fatality
(rates * 1000)
0
0,3
0,4
1,8
4,7
11,7
33
NA
Incidence
(rates * 1000)
4,688
12,127
12,591
15,492
13,893
14,288
18,812
14,007
Prevalence
(rates * 1000)
0,156
0,782
0,838
1,028
0,931
0,951
1,232
0,925
Remission
(rates * 1000)
15000
15000
15000
15000
15000
15000
15000
15000
Case fatality
(rates * 1000)
0
0,3
0,4
1,8
4,7
11,7
33
3,569
Duration
(years)
0,067
0,067
0,067
0,067
0,067
0,067
0,066
0,067
0,003
Duration
(years)
0,067
0,067
0,067
0,067
0,067
0,067
0,066
Mortality
(numbers)
0
0
0
6
5
7
8
1,761
Age of onset
(years)
0,5
5,614
14,947
32,384
51,658
66,441
82,021
33,094
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
4,689
12,136
12,602
15,508
13,906
14,302
18,835
NA
Remission
(rates * 1000)
15000
15000
15000
15000
15000
15000
15000
NA
Case fatality
(rates * 1000)
0
0,3
0,4
1,8
4,7
11,7
33
NA
Incidence
(numbers)
588
14627
18684
48130
17421
8619
3510
111581
Prevalence
(numbers)
20
944
1243
3195
1167
573
230
7372
Remission
(numbers)
294
14156
18649
47925
17506
8602
3448
Case fatality
(numbers)
0
0
0
6
5
7
8
110581
26
0,067
No consistente con muertes reales
26
RR mortality
(number)
0
2,26
2,182
2,166
1,956
1,604
1,408
1,761
Age of onset
(years)
0,5
5,614
14,947
32,384
51,658
66,441
82,021
33,094
GRIII B 10
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
3,57
6,954
4,684
4,705
9,631
18,082
38,832
NA
Remission
(rates * 1000)
13500
13500
13500
13500
13500
13500
13500
NA
Case fatality
(rates * 1000)
0
0
0
0,4
1,1
2
21,5
NA
Incidence
(rates * 1000)
3,5695
6,9505
4,6823
4,7034
9,6243
18,0583
38,7241
8,2353
Prevalence
(rates * 1000)
0,1322
0,5018
0,3552
0,3484
0,6969
1,3098
2,7786
Remission
(rates * 1000)
13500
13500
13500
13500
13500
13500
13500
0,5993
13500
Case fatality
(rates * 1000)
0
0
0
0,4
1,1
2
21,5
4,3866
Duration
(years)
0,074
0,0741
0,0741
0,0741
0,0741
0,074
0,0735
0,074
1,3773
Age of onset
(years)
0,5
5,6156
14,9514
32,4838
51,7433
66,7134
83,7023
47,2174
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
3,57
6,954
4,684
4,705
9,631
18,082
38,832
NA
Remission
(rates * 1000)
13500
13500
13500
13500
13500
13500
13500
NA
Case fatality
(rates * 1000)
0
0
0
0,4
1,1
2
21,5
NA
Incidence
(numbers)
431
8085
6718
14515
12557
12917
11707
66930
Prevalence
(numbers)
16
584
510
1075
909
937
840
4870
Remission
(numbers)
216
7880
6880
14513
12275
12647
11340
Case fatality
(numbers)
0
0
0
0
1
2
18
Duration
(years)
0,074
0,0741
0,0741
0,0741
0,0741
0,074
0,0735
65750
21
0,074
No consistente con muertes reales
Mortality
(numbers)
0
0
0
0
1
2
19
22
RR mortality
(number)
0
1
1
1,7399
1,4188
1,1774
1,3872
1,3773
Age of onset
(years)
0,5
5,6156
14,9514
32,4838
51,7433
66,7134
83,7023
47,2174
CAIDAS
GRIII B 11
DE LARGA DURACIN
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,156
0,404
0,42
0,516
0,463
0,476
0,627
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
NA
Incidence
(rates * 1000)
0,156
0,4032
0,4175
0,5086
0,452
0,4615
0,604
0,4599
Prevalence
(rates * 1000)
0,078
2,0176
5,852
14,2721
23,6876
30,4284
36,6499
13,8544
Remission
(rates * 1000)
0
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
0
Duration
(years)
74,2701
69,6252
60,4573
44,0402
26,56
15,0321
8,0312
44,3575
Age of onset
(years)
0,5
5,6089
14,9407
32,3294
51,641
66,4241
82,01
32,7043
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,156
0,404
0,42
0,516
0,463
0,476
0,627
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
NA
Incidence
(numbers)
20
486
620
1580
567
278
113
Prevalence
(numbers)
10
2434
8684
44340
29703
18356
6839
3664
110366
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
0
Duration
(years)
74,2701
69,6252
60,4573
44,0402
26,56
15,0321
8,0312
44,3575
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,6089
14,9407
32,3294
51,641
66,4241
82,01
32,7043
GRIII B 12
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,205
0,399
0,269
0,27
0,553
1,038
2,228
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
NA
Incidence
(rates * 1000)
0,205
0,3982
0,2676
0,2674
0,5437
1,0088
2,128
0,464
Prevalence
(rates * 1000)
0,1025
2,044
5,1145
9,8063
16,8192
28,0877
44,9052
Remission
(rates * 1000)
0
0
0
0
0
0
0
11,7631
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
0
Duration
(years)
80,3515
75,6387
66,4229
49,3042
31,0192
18,2877
9,9029
38,3902
Age of onset
(years)
0,5
5,6104
14,947
32,4554
51,7231
66,6754
83,6611
46,4624
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,205
0,399
0,269
0,27
0,553
1,038
2,228
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
NA
Incidence
(numbers)
25
463
384
825
709
722
643
Prevalence
(numbers)
12
2378
7338
30263
21945
20090
13576
3771
95602
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
0
Duration
(years)
80,3515
75,6387
66,4229
49,3042
31,0192
18,2877
9,9029
38,3902
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
1
0
0
0
Age of onset
(years)
0,5
5,6104
14,947
32,4554
51,7231
66,6754
83,6611
46,4624
GRIII B 13
SUPUESTOS
INCIDENCIA
DURACIN
PESOS DE
DISCAPACIDAD
LETALIDAD
M
0,47
0,20
0,40
0,27
0,27
0,55
1,04
2,23
0,008
0,008
Juicio de experto equipo
0,0681
0,0746
Duracin promedio, ponderada
Fuente duraciones por NL y
0,05
0,05
Juicio de experto equipo
0,124
0,139
0,299
0,286
Peso de discapacidad promedio, ponderado por distribucin de
Fuente de PD por NL: BOD study, Victoria, Australia. 1999. En e
0,0035
0,0044
DISMOD
DISMOD
Lesiones que causan
Se asume que:
1. Todas las muertes ocurren en el grupo de lesiones graves y de mediana gravedad de corta duracin
2. Las lesiones leves no tienen riesgo de morir, por tanto el denominador de la letalidad corresponde slo a lesiones graves y de mediana gravedad
Fuente
Base de datos de defunciones 2005
Base de datos de muertes por accidentes del trabajo 2004
GRIII B 14
NA
Remission
(rates *
100000)
4500000
4500000
4500000
4500000
4500000
4500000
4500000
NA
Case fatality
(rates *
100000)
25319
25319
14104
42846
60720
37917
35000
NA
Incidence
(rates *
100000)
4,4496
10,8772
28,9422
12,4774
9,4953
27,7637
31,4143
0,044496
0,108772
0,289422
0,124774
0,094953
0,277637
0,314143
16,3074
Prevalence
(rates *
100000)
0,0492
0,2329
0,6212
0,2828
0,2112
0,5925
0,6874
Remission
(rates *
100000)
4500000
4500000
4500000
4500000
4500000
4500000
4500000
Case fatality
(rates *
100000)
25319
25319
14104
42846
60720
37917
35000
Duration
(years)
0,0221
0,0221
0,0222
0,022
0,0219
0,022
0,022
0,3563
4500000
32429,142
0,0221
0,1155
281,4012
Case fatality
(numbers)
0
1
1
4
2
1
0
Duration
(years)
0,0221
0,0221
0,0222
0,022
0,0219
0,022
0,022
Mortality
(numbers)
0
1
1
4
2
1
0
RR mortality
(number)
28,3622
1062,5604
417,5131
278,9389
124,4927
20,5622
5,3348
Age of onset
(years)
0,5
5,6143
14,9475
32,3837
51,6579
66,4413
82,0209
32,3317
NA
Remission
(rates *
100000)
4500000
4500000
4500000
4500000
4500000
4500000
4500000
NA
Case fatality
(rates *
100000)
25319
25319
14104
42846
60720
37917
35000
NA
Incidence
(numbers)
6
131
429
388
119
167
59
1299
Prevalence
(numbers)
0
3
9
9
3
4
1
28
Remission
(numbers)
3
126
415
395
119
161
58
1277
0,0221
281,4012
Age of onset
(years)
0,5
5,6143
14,9475
32,3837
51,6579
66,4413
82,0209
32,3317
GRIII B 15
NA
Remission
(rates *
100000)
4800000
4800000
4800000
4800000
4800000
4800000
4800000
NA
Case fatality
(rates *
100000)
35000
18846
3125
13090
35000
39565
35000
NA
Incidence
(rates *
100000)
2,3572
6,3668
11,1184
4,1956
2,8382
2,4661
2,8267
0,023572
0,063668
0,111184
0,041956
0,028382
0,024661
0,028267
5,2801
Prevalence
(rates *
100000)
0,0244
0,1278
0,2265
0,0903
0,0599
0,0513
0,058
Remission
(rates *
100000)
4800000
4800000
4800000
4800000
4800000
4800000
4800000
0,1092
4800000
Case fatality
(rates *
100000)
35000
18846
3125
13090
35000
39565
35000
13935,6664
Duration
(years)
0,0207
0,0208
0,0208
0,0208
0,0207
0,0207
0,0207
0,0208
0,0153
374,6516
Duration
(years)
0,0207
0,0208
0,0208
0,0208
0,0207
0,0207
0,0207
Mortality
(numbers)
0
0
0
0
0
0
0
RR mortality
(number)
49,4499
1109,207
146,3092
243,3801
134,6545
36,1518
7,3234
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7435
66,7137
83,7035
25,3495
NA
Remission
(rates *
100000)
4800000
4800000
4800000
4800000
4800000
4800000
4800000
NA
Case fatality
(rates *
100000)
35000
18846
3125
13090
35000
39565
35000
NA
Incidence
(numbers)
3
74
160
129
37
18
9
429
Prevalence
(numbers)
0
1
3
3
1
0
0
9
Remission
(numbers)
1
71
156
134
38
18
8
426
Case fatality
(numbers)
0
0
0
0
0
0
0
1
0,0208
374,6516
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7435
66,7137
83,7035
25,3495
GRIII B 16
NA
Remission
(rates *
100000)
0
0
0
0
0
0
0
NA
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
NA
Incidence
(rates *
100000)
0,1047
0,2561
0,6813
0,2937
0,2235
0,6534
0,7393
0,001047
0,002561
0,006813
0,002937
0,002235
0,006534
0,007393
0,3838
Prevalence
(rates *
100000)
0,0523
1,2864
5,7801
12,8589
18,0515
24,1247
32,5022
11,717
Remission
(rates *
100000)
0
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
0
Duration
(years)
74,2701
69,6226
60,454
44,0151
26,5528
15,0263
8,0303
45,2061
Age of onset
(years)
0,5
5,6143
14,9474
32,3834
51,6578
66,441
82,0207
32,3276
NA
Remission
(rates *
100000)
0
0
0
0
0
0
0
NA
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
NA
Incidence
(numbers)
0
3
10
9
3
4
1
31
Prevalence
(numbers)
0
16
86
399
226
146
61
933
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
0
Duration
(years)
74,2701
69,6226
60,454
44,0151
26,5528
15,0263
8,0303
45,2061
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
0
0
0
0
0
0
0
0
Age of onset
(years)
0,5
5,6143
14,9474
32,3834
51,6578
66,441
82,0207
32,3276
GRIII B 17
NA
Remission
(rates *
100000)
0
0
0
0
0
0
0
NA
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
NA
Incidence
(rates *
100000)
0,0071
0,0192
0,0335
0,0126
0,0085
0,0074
0,0085
0,000071
0,000192
0,000335
0,000126
0,000085
0,000074
0,000085
0,0159
Prevalence
(rates *
100000)
0,0035
0,0957
0,3458
0,6722
0,8872
1,0071
1,1022
0,6021
Remission
(rates *
100000)
0
0
0
0
0
0
0
0
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
0
Duration
(years)
80,3515
75,636
66,4208
49,2904
31,0099
18,2728
9,8987
56,8066
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7435
66,7137
83,7035
25,3161
NA
Remission
(rates *
100000)
0
0
0
0
0
0
0
NA
Case fatality
(rates *
100000)
0
0
0
0
0
0
0
NA
Incidence
(numbers)
0
0
0
0
0
0
0
1
Prevalence
(numbers)
0
1
5
21
12
7
3
49
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
0
Duration
(years)
80,3515
75,636
66,4208
49,2904
31,0099
18,2728
9,8987
56,8066
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
0
1
1
0
1
1
1
1
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7435
66,7137
83,7035
25,3161
GRIII B 18
POR FUEGO
Lesiones debidas a exposicin a fuego, humo y llamas y a objetos calientes
DE CORTA DURACIN
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
1,271
1,445
0,328
0,46
0,416
0,498
1,517
NA
Remission
(rates * 1000)
11900
11900
11900
11900
11900
11900
11900
NA
Case fatality
(rates * 1000)
4
5,8
10,4
23,9
46,1
105,2
87,2
NA
Incidence
(rates * 1000)
1,2709
1,4448
0,328
0,46
0,416
0,498
1,5168
0,618
Prevalence
(rates * 1000)
0,0534
0,1206
0,0322
0,0383
0,035
0,0412
0,121
0,0515
Remission
(rates * 1000)
11900
11900
11900
11900
11900
11900
11900
11900
Case fatality
(rates * 1000)
4
5,8
10,4
23,9
46,1
105,2
87,2
26,364
Duration
(years)
0,0839
0,084
0,084
0,0839
0,0837
0,0831
0,0828
0,0838
11,4737
Age of onset
(years)
0,5
5,6143
14,9475
32,3837
51,6579
66,4413
82,0208
27,3437
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
1,271
1,445
0,328
0,46
0,416
0,498
1,517
NA
Remission
(rates * 1000)
11900
11900
11900
11900
11900
11900
11900
NA
Case fatality
(rates * 1000)
4
5,8
10,4
23,9
46,1
105,2
87,2
NA
Incidence
(numbers)
159
1743
487
1429
522
300
283
4923
Prevalence
(numbers)
7
145
48
119
44
25
23
410
Remission
(numbers)
80
1731
569
1417
522
295
269
4883
Case fatality
(numbers)
0
1
0
3
2
3
2
11
Duration
(years)
0,0839
0,084
0,084
0,0839
0,0837
0,0831
0,0828
0,0838
Mortality
(numbers)
0
1
0
3
2
3
2
11
RR mortality
(number)
1,4323
25,3125
32,3056
16,4842
10,3769
6,4279
2,0754
11,4737
Age of onset
(years)
0,5
5,6143
14,9475
32,3837
51,6579
66,4413
82,0208
27,3437
GRIII B 19
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,552
0,599
0,083
0,067
0,097
0,115
0,341
NA
Remission
(rates * 1000)
11200
11200
11200
11200
11200
11200
11200
NA
Case fatality
(rates * 1000)
11,6
3
6,5
15,1
34,8
62,7
72,8
NA
Incidence
(rates * 1000)
0,552
0,599
0,083
0,067
0,097
0,115
0,341
0,1724
Prevalence
(rates * 1000)
0,0246
0,0532
0,0097
0,006
0,0085
0,0101
0,0291
0,0153
Remission
(rates * 1000)
11200
11200
11200
11200
11200
11200
11200
Case fatality
(rates * 1000)
11,6
3
6,5
15,1
34,8
62,7
72,8
Duration
(years)
0,0891
0,0893
0,0892
0,0892
0,089
0,0887
0,0881
11200
16,6492
0,0891
Remission
(numbers)
33
694
156
208
124
81
99
Case fatality
(numbers)
0
0
0
0
0
0
1
Duration
(years)
0,0891
0,0893
0,0892
0,0892
0,089
0,0887
0,0881
11,4271
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7435
66,7137
83,7035
24,1692
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,552
0,599
0,083
0,067
0,097
0,115
0,341
NA
Remission
(rates * 1000)
11200
11200
11200
11200
11200
11200
11200
NA
Case fatality
(rates * 1000)
11,6
3
6,5
15,1
34,8
62,7
72,8
NA
Incidence
(numbers)
67
697
119
207
127
82
103
1401
Prevalence
(numbers)
3
62
14
19
11
7
9
125
1395
0,0891
Mortality
(numbers)
0
0
0
0
0
0
1
2
RR mortality
(number)
2,6058
18,6327
31,6676
28,9486
14,2592
6,5662
2,309
11,4271
Age of onset
(years)
0,5
5,6157
14,9514
32,4838
51,7435
66,7137
83,7035
24,1692
GRIII B 20
DE LARGA DURACIN
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,467
0,531
0,121
0,169
0,153
0,183
0,557
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
NA
Incidence
(rates * 1000)
0,467
0,529
0,12
0,168
0,151
0,18
0,547
0,226
Prevalence
(rates * 1000)
0,233
2,912
5,828
8,512
11,631
14,055
17,661
8,159
Remission
(rates * 1000)
0
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
0
Duration
(years)
74,27
69,626
60,455
44,023
26,555
15,028
8,031
50,096
Age of onset
(years)
0,5
5,607
14,946
32,366
51,652
66,435
82,011
27,116
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,467
0,531
0,121
0,169
0,153
0,183
0,557
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
NA
Incidence
(numbers)
59
639
179
521
190
109
102
Prevalence
(numbers)
29
3512
8647
26444
14585
8479
3296
1797
64992
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
0
Duration
(years)
74,27
69,626
60,455
44,023
26,555
15,028
8,031
50,096
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
0
1
0
0
0
0
0
1
Age of onset
(years)
0,5
5,607
14,946
32,366
51,652
66,435
82,011
27,116
GRIII B 21
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,409
0,444
0,062
0,049
0,072
0,085
0,253
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
NA
Incidence
(rates * 1000)
0,409
0,443
0,062
0,049
0,072
0,084
0,251
0,127
Prevalence
(rates * 1000)
0,204
2,455
4,701
5,621
6,713
7,869
9,564
5,445
Remission
(rates * 1000)
0
0
0
0
0
0
0
0
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
0
Duration
(years)
80,352
75,639
66,421
49,293
31,011
18,274
9,899
59,036
Age of onset
(years)
0,5
5,61
14,95
32,479
51,741
66,711
83,699
24,016
Age
0
1-9
10-19
20-44
45-59
60-74
75+
All ages
Incidence
(rates * 1000)
0,409
0,444
0,062
0,049
0,072
0,085
0,253
NA
Remission
(rates * 1000)
0
0
0
0
0
0
0
NA
Case fatality
(rates * 1000)
0
0
0
0
0
0
0
NA
Incidence
(numbers)
49
515
89
150
93
60
76
Prevalence
(numbers)
25
2855
6745
17346
8759
5629
2891
1033
44250
Remission
(numbers)
0
0
0
0
0
0
0
0
Case fatality
(numbers)
0
0
0
0
0
0
0
0
Duration
(years)
80,352
75,639
66,421
49,293
31,011
18,274
9,899
59,036
Mortality
(numbers)
0
0
0
0
0
0
0
0
RR mortality
(number)
0
0
1
1
0
1
0
1
Age of onset
(years)
0,5
5,61
14,95
32,479
51,741
66,711
83,699
24,016
GRIII B 22
SUPUESTOS
INCIDENCIA
DURACIN
0,084
0,089
DISMOD
DISMOD
Duracin promedio, ponderada
Lesiones que causan
Fuente duraciones por NL y proporcin de casos de larga
PESOS DE DISCAPACIDAD
LETALIDAD
0,0265
0,183
0,169
0,028
0,068
Peso de discapacidad promedio, ponderado por distribucin de
Fuente de PD por NL: BOD study, Victoria, Australia. 1999. En
0,0170
Se asume que:
1. Todas las muertes ocurren en el grupo de lesiones de corta duracin
Fuente
defunciones 2005, DEIS, MINSA